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Abstract 
The principles of Evidence-Based Medicine (EBM) have been well documented in the 
medical literature, with many examples of the successful application of these principles to 
the clinical environment. Despite this widespread acceptance of these principles 
throughout the medical profession, there has been resistance to adopt such an approach in 
the veterinary profession. To date, there are. few examples in the literature of the 
application of the principles of evidence-based medicine to either clinical or scientific 
research. The aim of this study was to design a series of investigations of equine diseases, 
and implement them at three private equine hospitals. A variety of study designs were 
used, providing different classes of evidence when using the classification system proposed 
by Yusuf et al. (1998). The main focus of this investigation was to ascertain whether it 
was possible to apply the ethos of EBM to the veterinary profession, and provide good 
quality research and evidence form private practice. 
It was found that 85.6% of horses (95% c.l. 81.3 to 89.3) treated for septic arthritis were 
successfully discharged from the hospital, with 65% of these horses (95% C.l. 57.9 to 
71.6) able to return to their previous level of athletic function. When considering those 
horses treated for septic digital tenosynovitis, 87.8% survived to be discharged from the 
hospital. However, the prognosis for future soundness was poorer than that achieved 
following resolution of septic arthritis, with only 50% of horses treated for septic digital 
tenosynovitis able to return to their previous level of athletic function. Racing 
Thoroughbreds, both neonates and mature horses, were identified as an important subset of 
the population. It was found that the occurrence of septic arthritis in neonatal 
Thoroughbreds significantly reduced the likelihood of those foals going on to make at least 
one start on a racecourse, with those foals being 3.5 times less likely to start on a 
racecourse when compared to their siblings. In contrast, when considering mature 
Thoroughbred racehorses it was found that the occurrence of septic arthritis did not affect 
the likelihood that they would make at least one start on a racecourse when compared to 
their siblings, or be able to achieve an Official Rating awarded by the British Horseracing 
Board's handicappers equal to, or higher than, either the highest rating achieved prior to 
the onset of sepsis in cases in which horses had raced previously, or equal to the highest 
rating achieved by their siblings. 
In a controlled, randomised trial it was found that 31.6% (95% c.l. 17.5 to 48.7) of horses 
wearing a belly band following an exploratory laparotomy developed incisional 
complications, compared with 76.6% (95% c.I. 62.0 to 87.7) of horses where no belly 
band was used. If a belly band was used following an exploratory laparotomy, the risk of 
developing post-operative incisional complications was reduced by 45% compared to those 
cases where no belly band was used. 
Following a clinical audit of elective surgical procedures at three private equine hospitals, 
there was found to be a higher rate of post-operative complications, when compared to 
results reported in both the medical and small animal veterinary literature. 
It was concluded that it was possible to apply the ethos of EBM to the veterinary 
profession, and provide good quality research and evidence from research performed in 
private practice. However, in order to be able to achieve sufficient case numbers to 
provide answers that are directly relevant to practice-based clinical situations, multi-centre 
studies are likely to be the best way forward. 
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Chapter 1 
Introduction and review of the literature 
1.1. Introduction 
In one year alone approximately 1081 scientific papers are published in the mainstream 
veterinary literature, investigating new treatments, diseases and diagnostic tests, with 317 
of these aimed specifically at the equine practitioner. This wealth of new information is 
not simply adding to and complementing existing knowledge, but also replacing 
knowledge that is out-of-date or obsolete (Cockroft and Holmes, 2003). As these 
information resources continue to grow, it becomes increasingly more time consuming for 
a busy practitioner to read and assimilate all these data (EBM Working Group, 1992; 
Sackett ef at. 1996; Cockroft and Holmes, 2003). However, if a practitioner is to keep up-
to-date with all the important progress in a field experiencing expansion in the techniques 
and technologies available, the ability to assimilate overwhelming volumes of information 
becomes vital (EBM Working Group, 1992; Sackett et at. 1996; Cockroft and Holmes, 
2003). It is the veterinarian, as the reader of these studies, who must decide whether they 
offer any information that is either new or clinically relevant (Muir, 2003). However, to do 
this he or she must be able to understand the principles behind the study design and data 
analyses, in order to evaluate accurately the relevance of the information (Muir, 2003). 
In order for a veterinarian to be able to provide his or her clients with the most efficacious 
diagnostic or treatment options available, he or she must be able to update their knowledge 
on a regular basis (Malynicz, 1998; Cockroft and Holmes, 2003). Evidence-based 
medicine (EBM) offers an efficient way of pursuing knowledge, as it focuses on 
identification of evidence that directly addresses problems encountered in patients 
(Malynicz, 1998; Cockroft and Holmes, 2003; Marr, 2003). However, many vets rely on 
textbooks or the traditional forms of Continuing Professional Development (CPD), such as 
meetings or conferences, to provide access to clinical knowledge (Cockroft and Holmes, 
2003; Marr, 2003). At CPD meetings, veterinarians are frequently subjected to personal 
opinion and conjecture and, whilst this may convey some important information, it is not 
necessarily the best, or the most up to date (Holmes and Cockroft, 2004). 
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The ethos of evidence-base medicine (EBM) necessitates the use of current best evidence 
in making decisions about the care of individual patients (Sackett et at. 1996; Shaw, 2001). 
With the advent of information technology bringing huge resources of this evidence into 
both the home and the workplace (EBM Working Group, 1992; Cockroft and Holmes, 
2003; Marr, 2003; Holmes and Cockroft, 2004), the opportunity to practice EBM has 
increased. A further motivation may be that this increase in access to information 
resources is not limited to the clinician, but has extended to the client as well (Cockroft and 
Holmes, 2003; Marr, 2003; Holmes and Cockroft, 2004). As a result, clients may be very 
well informed and prepared to challenge clinicians on their choice of patient management 
options. 
Practitioners should use both their own individual clinical expertise and the best available 
external evidence, for neither by itself is sufficient to ensure the highest quality of patient 
care (Sackett et at. 1996). Without clinical expertise a clinician does not have sufficient 
background knowledge to assess the evidence, for even the best external evidence may be 
inapplicable to, or inappropriate for, an individual patient (EBM Working Group, 1992; 
Sackett et at. 1996), and only clinical experience can allow this judgement to be made. 
Without current best evidence, practice will rapidly become out-of-date, to the detriment of 
the patients (Sackett ef at. 1996). 
Much has been made in the veterinary literature of the lack of scientific evidence in target 
species for the use of alternative medicine (Fogle, 1998; Anderson, 2000a,b; Kruesi, 2000; 
Ramey and Rollin, 2001; Shaw, 2001), yet veterinarians are often guilty of utilising 
conventional therapies themselves that have no substantiating scientific evidence (Ross ef 
at. 2001). The onus is increasingly on the veterinary profession to prove its right to 
exclusivity in the diagnosis and treatment of animals (Ramey and Rollin, 2001; Holmes 
and Cockroft, 2004), and the application of scientific evidence - evidence based veterinary 
medicine (EBVM) - in diagnosis and treatment is seen as the best way to proceed (Ramey 
and Rollin, 2001), to enable practitioners to continue to provide the best care for both the 
animals and their owners. In order for EBVM to develop further, a large body of high 
quality, patient-centred research is required (Keene, 2000; Holmes and Cockroft, 2004; 
Viner, 2005), and therefore a collaboration is necessary between first-opinion practitioners 
and academics, to allow sufficient case numbers to be generated and to allow answers to 
the most relevant questions to emerge (Marr, 2003; Mair and Cohen, 2003; Browning, 
2004; Holmes and Cockroft, 2004; Viner, 2005). 
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1.2. Development of Evidence-Based Medicine 
1.2.1. Historical background 
Although it may be assumed by the general populace as a whole that all medical treatments 
are founded on good scientific evidence, and all actions performed by a doctor are the best 
available for the patient, this is not always the case. Dubinsky and Ferguson (1990) said 
that only between 10 and 20% of all treatments carried out by physicians were actually 
based on scientific evidence, thereby inferring that 80-90% of treatments were based on 
clinical experience, opinion of colleagues, and conjecture. 
In 1992, a team at McMasters University in Ontario first proposed the idea of evidence 
based medicine (EBM Working Group, Guyatt et at. 1992). What was proposed was not 
supposed to be an entirely new concept to the medical profession, merely an amalgamation 
of a number of ideas (best research evidence, clinical expeliise, patient values) in a logical 
order that would lead to the best outcome for the patient. 
Evidence based medicine (EBM) was first formulated as a new approach to the practice of 
medicine, in recognition of some growing problems within the medical profession that 
needed to be addressed (Sackett et at. 2000): 
• The daily need for valid information about diagnosis, prognosis, therapy and 
prevention 
• The inadequacy of traditional sources for this information because they are either: 
out-of-date (textbooks), frequently inaccurate (expert opinion), ineffective 
(traditional forms of continuing professional education) or too overwhelming in 
volume (along with being wildly variable in validity) for practical clinical use 
Gournals). 
• The growing disparity between diagnostic skills and clinical judgement, which 
increase with experience, and up-to-date knowledge and clinical performance, 
which decline with experience. 
• Under current arrangements in most clinical practices, the inability to afford more 
than a few seconds per patient for finding and assimilating this evidence, or to set 
aside more than half an hour per week for general study and reading. 
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Although these problems were researched exclusively based on the medical profession, 
they can equally be applied to the modern, busy general veterinary practitioner, for whom 
the pressure to see a large number of clients in a short space of time also exists. However, 
EBM as a separate entity in the veterinary profession - evidence based veterinary medicine 
(EBVM) - has been much slower to develop (Malynicz, 1998; Fogle, 1998; Roper, 1998; 
Roper, 2001; Cockroft and Holmes, 2003), and is only now being recognised as a valuable 
tool to be utilised in the class room as well as the consulting room (AVTRW, 2003). 
1.2.2. Principles of evidence-based medicine 
1.2.2.1. Defining evidence-based medicine 
The definition of evidence-based medicine is popularly accepted as: the conscientious, 
judicious and explicit use of current best evidence in making decisions about the care of 
individual patients (Sackett et at. 1996), with the practice of evidence-based medicine 
meaning integrating individual clinical expertise with the best available external clinical 
evidence from systematic research (Sackett et at. 1996; Sackett et at. 2000; Marr, 2003; 
Muir, 2003). Individual clinical expertise is the proficiency and judgement acquired 
through clinical experience and practice (Sackett et at. 1996), whilst the best available 
external clinical evidence is clinically relevant research, but especially patient-centred 
clinical research (Sackett et at. 1996). External clinical evidence might invalidate 
previously accepted diagnostic tests or treatments and replace them with new ones (Sackett 
et at. 1996; Cockroft and Holmes, 2003). However, it might also serve to support the 
continued use of these diagnostic tests or therapies. 
The increasing difficulties faced by busy clinicians in keeping abreast of the latest 
advances repOlied in primary journals are obvious from a comparison of the time required 
for reading these articles with the time available (Sackett et at. 1996; Browning, 2004; 
Holmes and Cockroft, 2004). It was reported that to stay abreast of recent developments a 
practitioner would have to read 17 articles per day, every day of the year (Davidoff et at. 
1995), whereas practitioners only found one hour per week to assimilate all this 
information (Sackett et at. 1996). A mainstay of EBM is the encouragement of the 
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practitioner to target his/her reading time to address issues raised by specific patient 
problems (Sackett et ai. 1996; Cockroft and Holmes, 2003). The benefits are two-fold: 
1. Benefiting an individual patient, 
2. Simultaneously increasing the clinician's knowledge base and keeping it 
appropriate to the patients' needs (Cockroft and Holmes, 2003). 
The practice of EBM incorporates five steps (Sackett, et ai. 2000): 
• Converting the need for information into an answerable question 
• Tracking down the best evidence with which to answer that question 
• Critically appraising the evidence for validity, applicability and impact 
• Integrating the clinical appraisal with clinical expertise and with a patient's unique 
biology, values and circumstances 
• Evaluating both efficacy and efficiency in applying the above steps and looking for 
ways to improve them for the future 
1.2.2.2. Asking an answerable question 
Obviously, to be able to apply EBM to a clinical problem there is a need to be able to 
execute the first step - formulating an answerable question to a particular clinical situation 
(Sackett, et ai. 2000; Marl', 2003; Cockroft and Holmes, 2004). There are two types of 
question commonly proposed in the quest for knowledge - those referring to background 
knowledge and those to foreground knowledge (Sackett et ai. 2000; Marr, 2003). 
Background knowledge is the type of information an undergraduate student would 
commonly be seeking to attain (Cockroft and Holmes, 2003; Marl', 2003). Background 
knowledge refers to the fundamental principles behind all aspects of clinical science which 
are essential to the understanding of disease processes and management (Marr, 2003). 
Accumulation of background knowledge continues throughout a career (Marr, 2003). 
Background questions are formed of two components: a question root with a verb, and 
some aspect of the disorder itself (Sackett et al. 2000). 
An answerable question is constructed to fill in the gaps in foreground knowledge, i.e. 
evidence that relates to a specific question, for which the driving force for acquisition is the 
patient and their problem (EBM Working Group, 1992; Sackett et ai. 2000; Marr, 2003; 
Cockroft and Holmes, 2004). This foreground knowledge is most likely to come from 
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appraisal of recent, primary literature (Cockroft and Holmes, 2003). A question relating to 
this foreground knowledge can be subdivided into four steps that, if each are fulfilled, will 
result in an answerable question with which to continue (Sackett et al. 2000; Badenoch and 
Heneghan, 2002; Marr, 2003): 
• Patient or problem 
• Intervention 
• Comparison intervention (where appropriate) 
• Outcome 
The breadth of the search will depend upon the specificity of the question: a more general 
question will require a broader search, whereas a very specific question, ideally targeted at 
an individual patient or clinical group of interest, will result in a much narrower search 
(Badenoch and Heneghan, 2002). 
1.2.2.3. Tracking down the best evidence 
There are different ways in which clinicians can search for the best available evidence 
(EBM Working Group, 1992; Oxman et al. 1993; Sackett et al. 2000). Looking in a 
textbook is an option followed by many practitioners, coupled with following up 
references cited by the author; however, a textbook is only as up to date as its most recent 
reference, therefore, by definition, it is already partially out of date by the time it is printed 
(Oxman et al. 1993; Sackett et al. 2000; Cockroft and Holmes, 2003). However, the 
information contained in these textbooks will only have been superceded if further research 
into that field has taken place, refuting the findings of the prior research. Asking a 
colleague or consultant is also a highly efficient way of discovering new information, 
although such individuals are also only as up-to-date as the latest clinical research that they 
have read or been involved with, and there is a reliance on them to have assessed the 
evidence accurately and drawn appropriate conclusions (Oxman et al. 1993). It must also 
be borne in mind that some of this information will be subjective and therefore, care must 
be taken to discern valid information from personal opinion (Cockroft and Holmes, 2003). 
Finally, there is searching through bibliographic databases (Oxman et al. 1993; Rosenberg 
and Donald, 1995; Badenoch and Heneghan, 2002; Cockroft and Holmes, 2003). 
However, although bibliographic databases are thought to provide the most up-to-date 
evidence, they will only find those manuscripts that have been published in scientific 
Chapter 1 24 
journals. In these journals there is a reliance on the peer-review system to ensure that 
those manuscripts that are published report high quality evidence and utilise appropriate 
statistical analyses. 
When the concept of EBM was first introduced, easy access to relevant information was 
limited. Database systems were poorly designed and searches were time consuming 
(Rafuse, 1994; Davidoff et al. 1995). Physicians, when faced with the time pressures of 
practice, faced difficulty in finding current clinical information and were more likely to be 
influenced by drug companies than by medical literature (Rafuse, 1994). However, as 
integrated computer networks grew, access to central databanks and current best evidence 
increased (Rafuse, 1994; Davidoff, 1995; Rosenberg and Donald, 1995; Sackett et al. 
2001; Badenoch and Heneghan, 2002) including access to bibliographic databases, 
secondary journals and critically appraised topics (CATs). However, increased access to 
information did not provide physicians with the necessary tools to evaluate critically the 
rapidly growing body of electronic evidence (Kerridge et al. 1998). 
1.2.2.4. Interpreting the available evidence 
Having developed an appropriate question and performed the relevant literature searches, 
the EBM practitioner must then be able to assess the available evidence, to appreciate both 
any advantages offered, as well as limitations, by the study designs adopted (EBM 
Working Group, 1992; Oxman et al. 1993; Rosenberg & Donald, 1995; Kerridge et al. 
1998; Mail', 2001; Muir, 2003). To interpret the results accurately the clinician must 
consider three questions (Oxman et al. 1993): 
• Are the results of the study valid? 
• What are the results? 
• Will the results help in caring for patients? 
It is necessary to decide whether the evidence is valid, and, if so, whether it is of clinical 
importance (Rosenberg and Donald, 1995; Muir, 2003). Claims of significant therapeutic 
or clinical findings must be backed up by appropriate statistical analyses; a feature often 
lacking in both the veterinary and medical literature (Lund et aI, 1998; Greene et aI, 2000; 
Christley & Reid, 2003; Muir, 2003), for a clinician to be able to assess whether the results 
can be applied to a particular clinical situation. 
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Unfortunately there are no easy 'yes/no' answers to these questions, because much of the 
evidence is considered to be suggestive as opposed to definitive (Oxman et al. 1993; 
Taylor, 1995). 'Grey zones' appear where evidence relating to different clinical options is 
either incomplete or contradictory, and the clinician must be able to understand the 
limitations imposed by different classes of evidence (EBM Working Group, 1992; 
Rosenberg and Donald, 1995; Kerridge et al. 1998; Yusuf, 1998; Mair, 2001; Sackett et al. 
2001; Muir, 2003) and in doing so, recognise the level of certainty behind any decisions 
made (Taylor, 1995; CCDR, 1995) 
In order to assist in this interpretation of evidence, a classification system of research 
studies was proposed, adapted from one originally generated by Sackett, reflecting the 
probability that the conclusions and recommendations of the study would be reliable 
(Yusuf et al. 1998): 
• Class A: the most reliable form of evidence is obtained from the results of 
systematic reviews (e.g. meta-analyses) of multiple, randomised, blinded, placebo-
controlled trials designed to address the clinical questions of interest. Individual, 
blinded, placebo-controlled, randomised clinical trials also provide Class A 
evidence, although this evidence is not as strong as that obtained from systematic 
reVIews. 
• Class B: non-randomised clinical trials using historical controls, providing 
significantly less reliable evidence. 
• Class C: evidence obtained from uncontrolled case series, which can be difficult to 
assess 
• Class D: evidence obtained from expert opinion and/or extrapolated evidence from 
basic research. 
Although randomised trials have been cited as the 'gold standard' of evidence (Sackett et 
al. 1996; Keene, 2000; Mair, 2001; Cockroft and Holmes, 2003; Marr, 2003), they are not 
the most appropriate form of evidence to be used in every case. Whilst it is indisputable 
that randomised trials offer the best evidence when considering therapy (Sackett et al. 
1996; Marr, 2003), where non-experimental approaches frequently give a false positive 
result, they are not always appropriate when considering either diagnostic tests or 
prognosis (Sackett et al. 1996; Marr, 2003). 
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Systematic reviews are an overview of several randomised trials for the same treatment in 
the same condition (EBM Working Group, 1992; Sackett et al. 2000). They will be able to 
provide more evidence than the results of a single study alone, as long as they are able to 
fulfil basic criteria: they must use (and specify) specific methods to search systematically 
and appraise critically the literature on a specific topic. If statistical analysis is then 
performed to combine the results of the individual studies, this review becomes a sub-set 
referred to as a meta-analysis (EBM Working Group, 1992; Sackett et al. 2000). It must 
also be specified whether the review utilises randomised, or non-randomised, clinical trials. 
If randomised clinical trials are reviewed, the systematic review will be able to reduce both 
bias and random error, resulting in the highest class of best available evidence (Sackett et 
al. 2000; Mair, 2001). In contrast, if non-randomised trials are reviewed, the problems of 
both bias and random error in individual trials can be compounded, resulting in a much 
poorer quality of evidence (Sackett et al. 2000). 
A disproportionately large percentage of evidence derived from clinical trials utilising 
historical controls (Class B) has found in favour of the experimental therapy (Sacks et al. 
1982; Schulz et al. 1995; Kunz and Oxman, 1998), with 84% of trials using historical 
controls finding the therapy in question effective, compared to only 11 % of the randomised 
controlled trials, evaluating the same therapy, yielding a positive result (Sacks et al. 1982). 
It has been suggested that in general positive results from a trial utilising historical controls 
should be interpreted as a therapy worthy of further evaluation using a randomised, 
controlled trial (Keene, 2000). Where a negative result is reported by a study utilising 
historical controls, this is more likely to be a true finding (Keene, 2000). 
In one study, it was found that clinical trials that lacked adequately concealed random 
allocation produced estimates of effect on average 40% larger than clinical trials with 
adequately concealed random allocation (Schulz et al. 1995). Authors of reviews 
comparing randomised and non-randomised trials (Sacks et al. 1982; Schulz et al. 1995; 
Kunz and Oxman, 1998) have hypothesised that this disparity in results may be due to a 
bias arising from the allocation of those patients with a poorer prognosis to the control 
group - a theory substantiated by the findings of one review (Kunz and Oxman, 1998). 
Similarly, evidence derived from multiple, uncontrolled case series (Class C) yielding a 
positive result can be disproved when the therapy is subjected to a randomised, controlled 
trial (Spilker, 1996), with the best known example being the administration of 
diethylstilboestrol to women in the 1940s and 1950s (Spilker, 1996; Keene, 2000). 
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1.2.2.5. Significance or equivalence? 
With an increasing use of statistical methods to investigate whether a specific factor alters 
an outcome, it is common for researchers to report the results in terms of statistical 
significance. However, the use of the word 'significance' implies little more than 
statistical significance, and has no reflection on whether the finding is of clinical 
significance (Muir, 2003). To compound further the problem faced by the readership, a 
lack of statistical significance is often interpreted by authors as equivalence (Christley and 
Reid, 2003; Muir, 2003). However, if appropriate statistical testing is not performed to 
confirm this equivalence, this claim is erroneous (Christley and Reid, 2003; Muir, 2003) as 
all that has been proved is an absence of evidence of difference (Christley and Reid, 2003). 
1.2.2.6. Sample size and power 
Along with the use of appropriate statistical methods in the analysis of data, two important 
considerations in any study are the sample size and power, which provide an estimate of 
the relevance of the study (Muir, 2003; Holmes and Cockroft, 2004). Optimising sample 
size is the only way to provide a reliable statistical answer to the objective being 
investigated (Mann et at. 1991; Haimez 2002; Muir, 2003). If the sample size is smaller 
than the optimal number, the results are unlikely to be of either statistical or clinical 
significance (Muir, 2003; Holmes and Cockroft, 2004). It could also be considered 
wasteful of resources to have conducted a study whose results have little meaning. If the 
sample size is larger than is necessary, this too is wasteful of resources, and is potentially 
putting larger numbers of subjects in harm's way unnecessarily (Muir, 2003). The optimal 
sample size should be calculated at the outset of a study, either by using data available in 
the existing literature, or by conducting pilot experiments to provide the necessary 
information (Muir, 2003). 
The power of a study is the probability of rejecting the null hypothesis when it is false 
(Curtis, et at. 1990; Holmes and Cockroft, 2004). Studies that have low power have a poor 
chance of detecting a difference when it exists (Muir, 2003; Holmes and Cockroft, 2004), 
therefore a study should be designed so that it has a high power (>0.8), particularly if it 
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relates to life-threatening decisions. The power is affected by the sample size, with power 
increasing as sample size increases, therefore power and sample size should be calculated 
together at the outset of the study (Muir, 2003). 
1.2.2.7. Integration of evidence-based medicine in client care 
Having searched the available literature and found the most relevant evidence to answer 
the question posed, it is necessary to integrate this critical appraisal with clinical expertise, 
in order to apply the results to clinical practice (Sackett, et al. 2000; Katz, 2001; Holmes 
and Cockroft, 2004). A form of such integration is decision analysis, where all the 
evidence available is applied, step-by-step, to the individual patient. At each step the 
evidence is weighed for applicability to the current situation, before a decision is made 
whether or not to act on the evidence (Cockroft and Holmes, 2003). In this way it is 
possible not only to apply evidence to a clinical situation, but to involve the patient in 
every step of the decision process, thereby making it a decision of informed consent 
(Cockroft and Holmes, 2003). 
1.2.2.8. Evaluation 
The fifth and final step when taking an evidence-based approach to medicine is self-
evaluation (Sackett, et aI, 2000). It is necessary to evaluate not only the ability to 
formulate and ask an appropriate question, but also the ability to interpret evidence 
correctly and then apply this new-found knowledge to a particular set of circumstances 
(Sackett et al. 2000). When evaluating the ability to ask a question, it is necessary to 
investigate both the questions formed, and the efficiency and effectiveness of the methods 
used in searching for, and finding, answers. 
Even if evaluation confirms that the most appropriate questions are being asked, with 
answers being found efficiently, to have completed the process of EBM it is necessary to 
then take this information and integrate it with clinical expertise, thereby applying this 
information in a clinical setting. 
Taking self-evaluation one step further is the performance of a clinical audit on EBM 
performances (Sackett et al. 2000). Audits such as these are important, as they not only 
give clinicians an accurate idea of how they are performing, but can also provide strategies 
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that can have a positive effect on clinical performance, for example individual feedback 
(Sackett et ai. 2000). 
1.2.2.9. The application of evidence-based medicine 
Although EBM has been increasingly thought of as simply a comparison of treatment 
options (CCDR, 1995; Maynard, 1997; Ramey and Rollin, 2001), this is a narrow 
viewpoint. When used at its most basic level, EBM can be applied to a much broader 
range of clinical questions: clinical findings, aetiology, differential diagnosis, prognosis, 
therapy, prevention, and cost-effectiveness (Rosenberg and Donald, 1995; Badenoch and 
Heneghan, 2002). Of course, covering such a broad range of subjects, all of which are 
utilised on a daily basis in medicine, raises some difficulties in the application of EBM. 
For example, some of these concepts may be considered difficult to quantify, e.g. quality 
of life or pain (Kerridge et ai. 1998), but this is a necessary step if statistical analysis is to 
be performed, and it should be possible in a properly designed and executed experiment 
(Maxwell, 1984; Stewart and Ware, 1992). 
1.2.3. Limitations of evidence-based medicine 
1.2.3.1. Using evidence-based medicine 
Although appearing to be both a logical and beneficial way to approach patient care, EBM 
must be recognised to have its limitations (Rosenberg and Donald, 1995). Its basic concept 
relies on clinicians having easy, rapid access to the most up to date information (Rafuse, 
1994; Rosenberg and Donald, 1995); without the best evidence being available they will 
not be able to make informed decisions. Coupled with this is the requirement for the 
clinician to interpret that evidence critically, deciding which evidence is relevant and 
which spurious (EBM Working Group, 1992; Oxman, 1993; Rafuse, 1994; Davidoff, 
1995; Rosenberg and Donald, 1995; Kerridge et ai. 1998). 
Even with ready access to clinical research data, physicians have been resistant to the 
notion of EBM, which is considered by many to be a major paradigm shift in clinical 
practice. Concerns have been expressed that EBM would devalue clinical judgement, 
experience and the 'art of medicine' (EBM Working Group, 1992; Rafuse, 1994; 
Grahame-Smith, 1995; Rosenberg and Donald, 1995; Kerridge et ai. 1998). When EBM 
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was first proposed this was a common misconception, as the proponents of EBM did not 
seek to replace current clinical practice but to augment it (EBM Working Group, 1992; 
Oxman, 1993; Rafuse, 1994; CCDR, 1995; Sackett, et at. 1996; Marr, 2003): it was still 
for the clinician to determine the severity of the patient's condition and then apply the 
evidence to the situation (EBM Working Group, 1992; Rafuse, 1994; Sackett et at. 1996). 
Undergraduate students were enthusiastic about the format ofEBM-teaching, as were their 
teachers, and when these students graduated and carried their EBM ethos forward into 
practice this would in itself contribute to its success (Rafuse, 1994; Sackett et at. 1996). 
1.2.3.2. The evidence base of cost-effectiveness 
Doubts that had been raised over the validity of applying EBM in the workplace (Rafuse, 
1994; Sackett et at. 1996; Kerridge et at. 1998) were refuted in a study by Paes et at. 
(1994), where it was established that a substantial cost saving was realised after the 
implementation of the principles of EBM. However, this in turn helped substantiate 
concerns that EBM would become the arena of policymakers and purchasers in an effort to 
curb spending (Rafuse, 1994; Grahame-Smith, 1995; Kerridge et at. 1998), even though 
this was a direct contradiction of the view held by many that EBM may raise the cost of 
health care. An increase in expenditure was predicted through the application of the most 
efficacious interventions to maximise the quality and quantity of life for individual patients 
(Sackett et at. 1996). As EBM developed, and indeed was focused on by governments and 
policy makers (CCDR, 1995; Maynard, 1997; Kerridge et at. 1998), this reckless attitude 
to an increase in spending for the benefit of the few rather than the many was challenged. 
In a publicly financed health care system such as the one that exists in the United 
Kingdom, social issues should be weighted as heavily as medical issues, leading to an 
'evidence base of cost -effectiveness ' (maximum gains in terms of population health from a 
finite budget) on which to base decisions (Maynard, 1997; Kerridge et at. 1998). 
In proposing his defence of EBM Sackett (1996) unwittingly raised two controversial 
points: 
1. even with the best evidence available, patient choice should still allow the patient 
the ultimate, although well informed, decision; 
2. a limitation in the application of EBM. How can something be measured that 
appears to be un-quantifiable e.g. quality of life? In order to collect accurate data 
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to which statistical analysis can be applied, it is important to be able to measure a 
definable quantity. 
1.2.4. Evidence based medicine - a new paradigm or a just new catchphrase? 
Seizing on the concept that only 10-20% of clinical decisions were evidence-based 
(Dubinsky and Ferguson, 1990), Ellis (1995) designed and conducted a study in a 
university-affiliated district hospital investigating each clinical decision relating to 
diagnosis and treatment that was made in a one month period, and categorising this 
decision into one of three possibilities: 
1. intervention with evidence from RCTs 
2. intervention with convincing non-experimental evidence 
3. intervention without substantial evidence 
At the end of the study period the treatment decisions that had been made were reviewed, 
and it was found that 82% of clinical decisions made were considered to be evidence-based 
(category 1 and 2), with 53% of decisions substantiated by the results of randomised 
controlled clinical trials (category 1). The results of this study illustrated that the practice 
of EBM was not a new paradigm, as had been suggested (Rosenberg and Donald, 1995; 
Kerridge, et ai. 1998), but was a way of supporting and substantiating many of the clinical 
decisions that were made. 
Doubts over the validity of applying EBM in the workplace (Rafuse, 1994; Sackett et ai. 
1996) were also refuted (Paes et ai. 1994; Ellis et ai. 1995; Sackett et ai. 1996) when the 
application of EBM to both hospital protocol and continuing medical education rounds was 
found to result in a significant reduction (from 50.5% to 6.9%) in the use of a specific, 
unnecessary, procedure in an intensive care nursery (Paes et ai. 1994), without incurring 
patient morbidity. This decrease in the number of superficial cultures performed also 
realised a substantial cost saving. 
The developments that allowed the concept of EBM to proceed into successful practical 
application were (Sackett et ai. 2000): 
• The development of strategies for efficiently tracking down and appraising the 
evidence 
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• The creation of systematic reviews and concise summaries on the effects of health 
care 
• The creation of evidence-based journals of secondary publication 
• The creation of information systems 
• The identification and application of effective strategies for lifelong learning and 
for improving clinical performance. 
1.2.5. Application of the principles of evidence-based medicine in veterinary 
research 
UnfOliunately, the narrow view of EBM was propagated in the veterinary profession, 
where some of the first calls for the increasing use of scientific evidence and statistical 
analysis were related to the increased use of alternative, or complementary, therapies in 
veterinary medicine (Fogle, 1998; Anderson, 2000a,b; Kruesi, 2000; Ramey & Rollin, 
2001; Shaw, 2001). Evidence-based medicine was seen as a valuable tool to discredit the 
use of alternative therapies, as few studies containing scientific evidence and statistical 
analysis had been published (Anderson, 2000; Ramey and Rollin, 2001). However, the 
dissenting voices had failed to turn their attention to the remainder of the veterinary 
literature, where a similar argument could be made (Fogle, 1998; Ross et ai. 2001). 
A review of the literature in small animal medicine revealed that, in a 5 year period, 23 
randomised controlled trials (class A evidence) were published (Lund et al. 1998). 
However, of these 23 papers, all were judged to have incomplete reporting in key areas, 
including group allocation, blinding, sample size and power and statistical reporting (Lund 
et ai. 1998). Although the absence of reporting in key areas may merely have been a flaw 
in the written article, it casts doubt on the overall quality of the trials performed as it is 
incumbent on the authors of such studies to show readers this essential information to 
allow for the correct interpretation of the data (Lund et at. 1998). No such review has 
occurred in the equine medical literature, although it is unlikely to fare any better. 
It is in the classification of evidence that the veterinary profession faces its biggest 
limitation in the utilisation of EBM. The most widely available form of evidence in 
veterinary medicine is Class D evidence, which is considered to be the least reliable 
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(Keene, 2000; Mair, 2001). Although this evidence is often of importance and correct, it 
should ideally be backed up by controlled clinical trials (Mair, 2001). 
Whilst blinded, placebo-controlled, randomised clinical trials are widely accepted to 
provide the best available evidence (Keene, 2000), these trials are expensive to run, being 
demanding in terms of manpower and case requirements (Keene, 2000; Mair, 2001; Shaw, 
2001). They are a rare occurrence in veterinary science as the veterinary pharmaceutical 
market comprises only a tiny fraction of the pharmaceutical industry as a whole and, in 
circumstances in which an industry is driven by profit margins, it will be unlikely to 
undertake such extensive research that is totally out of proportion to its potential returns 
(Keene, 2000; Mair, 2001). As a direct consequence systematic reviews are a rarity in the 
veterinary literature due to the paucity of randomised, controlled trials that have been 
performed on any single topic (Keene, 2000). However, in recent years some examples of 
systematic reviews have begun to emerge in the small animal veterinary literature (Olivry 
ef at. 2003; Aragon and Budsburg, 2005). 
In veterinary medicine (Keene, 2000), especially in equine medicine (Mail', 2001; Marr, 
2003), randomised trials are few and far between, therefore the next class of best external 
evidence must be found (Sackett et at. 1996). To this end, a much greater importance is 
placed on the evidence that is actually available, i.e. class B (historical controls) and C 
(uncontrolled case series) evidence. These trials are cheaper to run and require lower case 
numbers (Keene, 2000). However, even if a study design is utilised that provides a lower 
class of evidence, the statistical methods used to analyse and interpret the data should be 
appropriate. One study investigating the use of statistical testing procedures in the 
veterinary literature reported that statistical analysis was not performed in 51 % of articles 
published in one year (Hammer and Buffington, 1994), and an additional 26% of articles 
either supplied insufficient information to evaluate the statistical methods or had used 
inappropriate statistical methods (Hammer and Buffington, 1994). A more recent review 
concluded that 67% of the studies reviewed claiming clinical or therapeutic equivalency 
were based on a failure to detect significant differences (Christley and Reid, 2003). 
However, no further statistical investigation was conducted in these studies to support this 
conclusion of equivalency, which could lead to erroneous conclusions being drawn in 
relation to the question being researched (Christley and Reid, 2003). 
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It may be that all of these developments are yet to be realised in the veterinary field, but 
with advancements in information technology (Marl', 2003; Holmes and Cockroft, 2004), 
and increasing availability of access to information (Cockroft and Holmes, 2003; Marr, 
2003), the concepts of EBM should now be able to be applied equally well in the 
veterinary consulting room as in the human. 
In order for the practice ofEBVM to progress further, a large body of high quality, patient-
centred research, made available to veterinarians willing and able to access and critically 
appraise the quality and applicability of clinical trials, is required (Keene, 2000). A move 
towards this is beginning to occur, with increasing publication of patient-centred clinical 
research relating to small animal medicine. In the remainder of veterinary medicine, 
including equine medicine, such studies are unusual (Mair, 2001), although the Equine 
Veterinary Journal launched a Clinical Evidence Category in November 2003 to promote 
the principles of EBM in clinical research, with the intention that articles published in this 
category should help clinicians make specific and day-to-day decisions (Marr and Newton, 
2006). In conjunction with this new section, the Clinical Evidence Notebook was launched 
in May 2005, to address issues relating to the collection, analysis and interpretation of data 
of clinical relevance (Marr and Rossdale, 2005). In a discipline that covers multiple 
species, the importance of data relating to that particular species, in contrast to data 
extrapolated from experimental studies using other species, cannot be underestimated. 
To date in the equine veterinary literature there has been relatively few examples of 
evidence-based clinical research. Many of those that have been published have been in the 
clinical evidence category of the Equine Veterinary Journal (Edwards et al. 2003; Barakzai 
et al. 2004; Johnston et al. 2004; Smith et al. 2004; Proudman et al. 2005a,b; Smith et al. 
2005; Valverde et al. 2005). Some studies containing good quality evidence are starting to 
emerge from research institutes and, although many of these studies (Spike-Pierce and 
Bramlage, 2003; Kane et al. 2003; Barakzai, et aI, 2004; Smith et al. 2004,2005) would be 
classified as providing class B evidence according to Yusuf et al (1998), this still 
represents an improvement not only in the quality of evidence provided, but also in the 
awareness for the need for such evidence. Recent studies have even included examples of 
studies (Denoix et al. 2003; Edwards et al. 2003; Johnston et aI, 2004; Valverde et al. 
2005) providing evidence that would be classified as class A according to Yusuf et al 
(1998), although not all have incorporated blinding in the study design (Valverde et al. 
2005). 
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For further progress to be made it is necessary for veterinarians in first-opinion practice to 
work together with those in academia, in order to provide not only the case numbers 
required for such studies, but also to allow the most relevant questions to emerge (Marr, 
2003; Mair & Cohen, 2003). 
1.3. Epidemiology and Study Design 
1.3.1. Epidemiology 
Epidemiology is concerned primarily with the prevention and control of a disease within a 
population. An epidemiologist aims to identify specific events that could occur, and then 
evaluate their association with specific outcomes of interest, including health, welfare and, 
for veterinary epidemiologists, productivity. 
1.3.2. What to study 
In order to develop a research protocol, it is important to first think of the question to be 
addressed by the study, and then perform a literature search to establish if that question 
already has a definitive answer readily available. If such an answer is not apparent, then 
the original question, and the answer that might be expected, represent the hypothesis on 
which a study can then be based. 
The capacity for evidence to support advances in veterinary medicine depends not just on 
the existence of such evidence, but also on its quality. Different methods of study design 
each carry with them their own intrinsic strengths and weaknesses, with implications for 
the quality of evidence produced and the appropriateness of the future application of this 
evidence. The design of the study therefore has a substantial impact on the quality of the 
evidence produced, including interpretability, reliability and applicability of the reported 
findings. 
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1.3.3. Classification of study design 
There are two different classifications incorporating all study designs - those that are 
experimental and those that are investigational or observational in their data collection. In 
investigational studies, the investigators study the subjects 'as they find them': subjects are 
observed and relevant measurements are recorded, with no attempt made at intervention of 
any kind (Petrie and Watson, 1999; Noordhuizen et al. 2001). This type of study is 
susceptible to confounding. In an experimental study the investigator determines the 
method of selection of the animals studies, and the interventions they receive (Cockroft 
and Holmes, 2003; Dohoo et al. 2003). 
1.3.4. Types of Investigational Study 
There are 4 types of investigational study: longitudinal, cross-sectional, case-control and 
cohort studies. 
1.3.4.1. Cross-sectional studies 
A cross-sectional study measures the prevalence of health outcomes or determinants of 
health in a population at a specific point in time, or over a short time period (Petrie and 
Watson, 1999; Dohoo et al. 2003). It is a study design that can be used to explore 
aetiology (Katz, 2001). However, cross-sectional studies are able to provide only limited 
information, as they do not take into account the temporal relationship between the risk 
factors and the disease state (Petrie and Watson, 1999; Katz, 2001; Cockroft and Homes, 
2003; Dohoo et al. 2003). They are most useful when the aims of the study are of a 
descriptive nature (Petrie and Watson, 1999; Katz, 2001). However, if cross-sectional 
studies are repeated at intervals they can be used to recognise trends in disease prevalence 
in a population over a period of time. Bias can arise due to selection of subjects into or out 
of the study population (Dohoo et al. 2003). It can also be difficult to differentiate 
between what is cause and what is effect when interpreting the data. 
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1.3.4.2. Longitudinal studies 
A longitudinal study, which can be either prospective or retrospective in design, 
investigates changes over time (Petrie and Watson, 1999; Katz, 2001). There are two types 
of longitudinal study, defined primarily by the way the changes over time are investigated. 
When a longitudinal study is designed prospectively a cohort design can be used (Petrie 
and Watson, 1999) to compare those individuals that have been exposed to the factor of 
interest with those individuals that have not been exposed. With a retrospective study a 
case-control study design can be utilised (Petrie and Watson, 1999). 
1.3.4.2.1. Cohort studies 
At the outset of a cohort study the investigator must begin with a group of individuals 
apparently free from the disease of interest (Dohoo et al. 2003). This group of individuals 
is then subdivided into groups (cohorts) of animals, which must be defined according to 
the level of exposure of the animals in each group to the factor of interest (Petrie and 
Watson, 1999; Katz, 2001). These groups are then followed forward in time, to investigate 
which animals will go on to develop the disease under investigation, and compare the 
incidence of the disease between cohorts (Petrie and Watson, 1999; Katz, 200 1; Cockroft 
and Holmes, 2003; Dohoo et al. 2003). 
From the data collected incidence rates can be compared, and attributable and relative risk 
can be calculated (Petrie and Watson, 1999). The attributable risk (AR) is the proportion 
of the total risk of developing the outcome of interest that can be attributed to the factor of 
interest (Petrie and Watson, 1999), whilst the relative risk (RR) is the ratio of the risk of 
disease in the exposed group to the risk of disease in the unexposed group (Petrie and 
Watson, 1999). The RR provides a measure of the strength of association between the 
outcome of interest and exposure to the factor of interest (Petrie and Watson, 1999). 
A difficulty arising if there is low disease incidence is that large and lengthy studies may 
be required to accrue sufficient case numbers in order to give adequate statistical power 
(Noordhuizen et al. 2001; Cockroft and Holmes, 2003). To counteract this problem, it is 
possible to carry out the study retrospectively, as long as the outcome of interest can be 
accurately measured in a retrospective manner, for example mortality rates, with a cohort 
of individuals identified based upon their attributes in the past (Katz, 2001). The disease 
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experience of the cohort is then followed, until some point in the more recent past or up to 
the present time. 
1.3.4.2.2. Case-control studies 
Case-control studies can frequently avoid the complications associated with prospective 
longitudinal studies where lengthy time periods may be required to accrue sufficient case 
numbers. Cases are identified and past exposures to suspected aetiological factors 
investigated, with results compared to suitable controls (Petrie and Watson, 1999; Cockroft 
and Holmes, 2003; Dohoo et al. 2003). In order for the findings of a clinical follow up 
study to be applicable to cases elsewhere (in this instance this would be other practice 
populations), it is necessary to precisely define how cases were selected for inclusion in the 
study (Dohoo et al. 2003). If characteristics of the subject are documented (age, sex, 
duration of clinical signs etc) it will also be possible to investigate the influence any of 
these variables may have on the outcome. 
This study design allows for the estimation of odds ratios where differences exist between 
groups in terms of exposure to a risk factor, but not attributable risk (Petrie and Watson, 
1999; Noordhuizen, et al. 2001). The odds ratio (OR) is the ratio of two odds. In this case 
it is the odds of exposure in the diseased group divided by the odds of exposure in the 
control group, thereby providing an estimate of the relative risk (Petrie and Watson, 1999). 
The odds ratio is a reasonable estimation of the relative risk, provided the incidence of the 
disease is low and the cases and controls represent a truly random sample of the population 
(Petrie and Watson, 1999). 
Matching of cases to controls does not completely eliminate confounding (Katz, 2001) - to 
do this statistical adjustment would be required. Matching of cases to controls entails 
making the distribution of certain factors the same in the groups being compared, whereas 
confounding is where the effects of two or more factors of interest are inter-related and it is 
impossible to separate them into their individual effects. A suitable case definition must 
exist in order to identify cases eligible for inclusion in the study and, where possible, 
incident rather than prevalent cases should be used (Dohoo et al. 2003). Incidence relates 
to the number of new cases of a disease within a specific population in a defined time 
period, whereas prevalence relates to the number of cases of disease existing at a specific 
point in time (Dohoo ef al. 2003). Prevalent cases are not considered suitable for inclusion 
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in a case-control study as there is often uncertainty as to when the disease actually began 
(Dohoo ef al. 2003), and it is often difficult to separate factors that relate to the individual 
developing the disease initially from those factors that relate to the individual having the 
disease at a specific point in time (Dohoo ef al. 2003). 
In the selection of controls, their exposure to risk factors and confounders should be 
representative of that in the population considered to be 'at risk' of becoming cases (Katz, 
2001; Dohoo et al. 2003). If there is low disease incidence, statistical confidence can be 
increased by increasing the number of controls for each case. However, there is a 'law of 
diminishing returns' in that it is usually not worth going beyond four or five controls per 
case, as the benefit of increasing the number of controls per case is frequently small, and 
must be balanced against the inherent difficulties of analysing large quantities of data, and 
the possibility of erroneously influencing the apparent significance of factors on the 
outcome of interest. 
1.3.5. Experimental Studies 
In experimental studies a form of intervention occurs as part of the study (Petrie and 
Watson, 1999; Dohoo ef al. 2003). The effect this intervention exerts on the response of 
interest is then observed. There are 2 main forms of experimental study design: 
randomised controlled trials and cross-over studies. Randomisation is an essential element 
of both forms of experimental trials. To this end experimental studies are less susceptible 
to confounding, but ethical constraints are imposed on clinical research (Petrie and 
Watson, 1999), and experimental studies have a limited use in the investigation of 
aetiology. Their main use is in the evaluation of clinical interventions with randomised 
controlled trials. 
1.3.5.1. Randomised Controlled Trials 
Randomised controlled trials (RCTs) are commonly cited as the 'gold standard' of 
evidence (Katz, 2001; Dohoo ef al. 2003). Although they may be the most appropriate 
form of evidence when considering therapy, they are not always an appropriate study 
design when considering either diagnostic tests or prognosis. The combination of size 
(RCTs generally require very large samples), length (many require years to complete) and 
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rigorous controls leads to enormous expense when designing and running RCTs (Katz, 
2001). 
An impOliant consideration in any study is the sample size, in order to answer the 
frequently asked question of: 'how large a sample do I need to conduct a particular 
experiment?' (Noordhuizen et ai. 2001; Muir, 2003). The sample size must be large 
enough to have a good chance of detecting any clinically relevant differences between 
groups (Noordhuizen et ai. 2001; Dohoo et ai. 2003; Muir, 2003; Holmes and Cockroft, 
2004), without being so large as to be wasteful of individuals and resources (Petrie and 
Watson, 1999; Dohoo et ai. 2003; Muir, 2003). If the sample size is inadequate, it may 
lead to clinically impOliant differences being overlooked, and parameter estimates lacking 
precision (Petrie and Watson, 1999). A power calculation must be performed at the outset 
of the study, to determine the minimum numbers of individuals required in each group at a 
prescribed power (Dohoo et ai. 2003). The power of a study relates to the chance of 
detecting a statistically significant true treatment difference of a pre-determined magnitude 
(Muir, 2003; Holmes and Cockroft, 2004). A pilot study is often conducted at the outset, 
in order to calculate the minimum number of individuals required in each group to permit 
the detection of real treatment effects in the full-scale trial (Petrie and Watson, 1999; Muir, 
2003). 
Although economics are likely to be the main reason for the paucity of RCTs in the 
veterinary literature, ethical considerations are also a limitation to the use of RCTs (Petrie 
and Watson, 1999; Katz, 2001). The welfare of the individuals participating in an RCT 
must lie with the investigators conducting the trial, and many important questions must be 
addressed before the trial can commence (Petrie and Watson, 1999; Dohoo et al. 2003). 
The ethics of withholding treatment from a group of diseased individuals to provide a 
negative control group for comparison to a novel treatment protocol are debatable (Petrie 
and Watson, 1999; Katz, 2001; Noordhuizen et al. 2001). If the disease is either 
debilitating or life-threatening it may be more appropriate to compare the novel treatment 
to the accepted current gold-standard treatment, if such a treatment exists (Petrie and 
Watson, 1999; Katz, 2001; Noordhuizen et ai. 2001). If a standard treatment does not exist 
then the investigators must ensure the risk to participating individuals is minimal (Petrie 
and Watson, 1999). When conducting RCTs using animals as the subjects, all 
interventions must be approved and licensed by the Home Office, adding to the expense of 
conducting such a trial (Petrie and Watson, 1999). 
Chapter 1 41 
At the outset of the study, the criteria for entry into the study group must be specified 
(Noordhuizen et al. 2001; Dohoo et al. 2003), and the subjects studied must be 
representative of the target population in which it is hoped to apply the results 
(Noordhuizen et al. 2001; Dohoo et al. 2003). Subjects are then randomly assigned to one 
of the different treatments being compared (Petrie and Watson, 1999; Noordhuizen et al. 
2001; Dohoo et al. 2003), for example by the use of a table of random numbers, or a 
computer programme capable of generating sets of random numbers. Blinding, the 
withholding of the knowledge of the specific treatment administered from either the 
investigator and/or the individual, may be appropriate if other aspects of patient care will 
influence outcome (Petrie and Watson, 1999; Noordhuizen et al. 2001; Dohoo et al. 2003). 
Any criteria for withdrawing a patient from the prescribed treatment should be specified in 
advance (Petrie and Watson, 1999), although even after the treatment has been withdrawn 
follow up to the end point of the study should still continue. During the course of the study 
it is important to assess not just efficacy of treatment being investigated, but also any 
perceived side effects (Petrie and Watson, 1999). 
1.3.5.2. Cross-over Studies 
A cross-over study design is useful if the outcome is measured by the reporting of 
subjective symptoms, but it is only suitable in situations in which the effects of the 
treatment under investigation are short lived. Subjects receive each treatment sequentially, 
with an intervening 'wash out' period to eliminate any carryover effects (Petrie and 
Watson, 1999; Noordhuizen et al. 2001). It is important to establish the minimum duration 
of wash out period necessary between treatments to eliminate any carryover effect (Petrie 
and Watson, 1999). The order in which the treatments being compared are given is 
randomised, with the patients acting as their own controls (Petrie and Watson, 1999; 
Noordhuizen et al. 2001; Dohoo et al. 2003). 
The aim is to compare the responses to treatment within, rather than between, the animals, 
thereby increasing the precision of the estimate of the difference between treatments 
(Petrie and Watson, 1999; Katz, 2001; Noordhuizen et al. 2001; Dohoo et al. 2003). 
However, this study design does not entirely eliminate individual variation (Petrie and 
Watson, 1999), as a period effect may exist (the treatments are given sequentially, not in 
parallel). Cross-over studies are considered to be ideal for comparing palliative treatments, 
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for example in chronic disease (Petrie and Watson, 1999; Noordhuizen et al. 2001). 
However, they are not suitable for comparing treatments that are considered to 'cure' the 
patient, as the disease must return in order to investigate the comparative treatment (Petrie 
and Watson, 1999; Noordhuizen et al. 2001). 
1.4. Clinical Audit 
1.4.1. What is clinical audit? 
Although clinical audit may appear to be a relatively new concept, in particular in the 
veterinary profession, it is, in fact, a concept that has been recognised for many years 
(Rayment, 2002), although under a variety of different names, including quality assurance 
and clinical governance (Rayment, 2002). Clinical audit has been defined by the 
Department of Health as: 
The systematic and critical analysis of the quality of clinical care, including the 
procedures for diagnosis, treatment and care, the associated use of resources and 
the resulting outcome and quality of life for the patient. 
Florence Nightingale was the first person actively to document the process of clinical audit 
in order to implement and maintain best practice, at which time she stated that: "for us 
who nurse, our nursing is a thing which unless we are making progress every year, every 
month, every week, take my word for it we are going back." 
It is this understanding that audit requires a team approach that has carried over with the 
implementation of audit in other professions, resulting in a more widely accepted 
definition of: "multi-disciplinary professional, patient focused audit, leading to cost-
effective, high quality care delivery in clinical teams" (Batstone and Edwards, 1994), 
where the emphasis has been placed on a group working together to achieve optimal results 
(Rayment, 2002). 
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1.4.2. Why perform clinical audit? 
The driving force behind the implementation of clinical audit has been aimed at the 
benefits to be offered to the patient, in terms of improved standards of patient care and a 
more effective service offered, both in terms of diagnosis, treatment and care (Mosedale, 
1998; Rayment, 2002). Clinical audit not only allows a systematic approach to the 
investigation of specific topics (Mosedale, 1998), it also allows for the implementation of 
any necessary changes and an opportunity to evaluate the results of these changes 
(Mosedale, 1998; Rayment, 2002; Viner, 2005). 
Clinical audit has been forced to the fore front in the veterinary profession, following the 
decision by the Royal College of Veterinary Surgeons (RCVS) to implement compulsory 
clinical audit for all practices that hold Tier 2 or 3 hospital status (RCVS 2005). The 
RCVS Practice Standards Scheme was established in January 2005, in order to "establish a 
quality assurance framework to promote and maintain the highest standards of veterinary 
care" (RCVS 2005). Three tiers were established to encompass all levels of veterinary 
practice: 
1. Tier 1 - minimum requirement core standards relevant to all veterinary practices 
2. Tier 2 - general standards 
3. Tier 3 - veterinary hospital standards 
The three tiers are cumulative, and represent the additional standards it is necessary for a 
practice to achieve in order to receive accreditation at the different levels (RCVS 2005). 
For those practices that are accredited as either Tier 2 or 3 practices, the requirements for 
clinical governance include: "a system for monitoring and discussing the clinical outcome 
of common procedures", whereas those achieving Tier 3 status are required to have: 
"regular morbidity and mortality meetings ...... and demonstrate changes in procedure as 
resultant action", along with evidence of "an audit of standard hospital procedures" (RCVS 
2005). 
With the threat of mandatory audit forced upon them if they do not carry out their own 
internal auditing, practices are having to confront not only what auditing entails, but also 
how to implement clinical audit and the interpretation of the results. A major hurdle to the 
implementation of effective clinical audit is the time commitment required by those 
involved, and it can be hard in a busy practice to justify this extra expenditure in terms of 
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time and effort (Mosedale, 1998; Viner, 2005). It has been pointed out that "we should not 
accept uncritically what is urged upon us" (Ford and Walsh, 1994) - a mainstay of 
evidence-based medicine, where all ideas should be critically appraised for their relevance 
and applicability before being embraced. Similarly, in the application of clinical audit, a 
wise practitioner may consider whether practices that have implemented clinical audit have 
been seen to develop, with clear evidence of improvements in patient care, before 
committing both themselves and their practice resources. 
1.4.3. Clinical audit or clinical research? 
Confusion has arisen in the past between the practice of clinical audit and clinical research. 
The fundamental principles associated with the practice of clinical audit state that audit 
must (Department of Health): 
• Be professionally led 
• Be seen as an educational process 
• Form part of routine clinical practice 
• Be based on the setting of standards 
• Generate results that can be used to improve outcome of quality of care 
• Involve management in both the process and outcome of audit 
• Be confidential at the individual patient/clinician level 
• Be informed by the views of patients/clients 
In contrast, it has been categorically stated that clinical audit is not (Clinical Resource and 
Audit Group): 
• A system of ensuring that staff training are making satisfactory progress 
• Performance appraisal of posts in organisational terms 
• A disciplinary mechanism 
• Research, which is concerned with establishing new knowledge 
• Needs assessment 
Clinical audit is viewed as the regular systematic review of the treatments and services 
health care professionals already provide - a means of monitoring the current system and 
looking for ways to improve (Mosedale, 1998; Rayment, 2002; Viner, 2005). In contrast 
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clinical research is aimed at the generation and development of new data and new ideas 
that in turn may lead to an improvement in treatments and services offered. 
Clinical audit and evidence-based medicine, whilst being separate entities, cannot be 
considered to be mutually exclusive. When applied effectively, both approaches work 
synergistically, with involvement in clinical audit facilitating the review and appraisal of 
the latest available evidence. Clinical audit itself also provides valuable evidence both on 
the effectiveness of diagnostic techniques and treatment regimens, and also on the 
standards of care provided. 
1.4.4. The practice of clinical audit 
The four main stages of clinical audit form a continuous cycle (Mosedale, 1998; Rayment, 
2002), made up of the following (Morrell et at. 1999): 
1. defining best practice 
2. implementing best practice 
3. monitoring & comparing against best practice 
4. taking action to improve 
However, having completed the cycle once the process is not at that point complete, as you 
must then consider whether it is possible to raise the standard to move further towards best 
clinical practice. 
1.4.5. Defining best practice 
1.4.5.1. Identifying an area for clinical audit 
One of the most critical areas for the implementation of clinical audit is the selection of a 
suitable area for investigation. The area identified must address important aspects of 
practice or concerns about quality of patient care (Mosedale, 1998; Rayment, 2002; Viner, 
2005), in order to justify the commitment of practice resources. Once a suitable area for 
investigation has been selected, it is important to step back and take stock before initiating 
clinical audit. This will allow your current practice to be described in such a way to 
illustrate the existing problems and highlight possible areas for improvement. 
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1.4.5.2. Appraising the available evidence 
The available evidence must then be critically appraised (Rayment, 2002; Viner, 2005), to 
make sure that it is of sufficient quality and current enough to be valid and reliable as a 
basis for practice. The more research that exists on a specific topic, the more informed a 
decision you will be able to make about effective practice (Rayment, 2002). However in 
order to utilise this wealth of information time and effort must be invested in order to 
locate and appraise the information appropriately. 
1.4.5.3. Setting a standard 
The next step in the process of audit involves setting a standard. This standard must set out 
what you recognise to be best practice, and give some indication of how that standard is to 
be achieved (Rayment, 2002; Viner, 2005). Standards are compiled from both objectives 
and criteria, with the criteria providing the more detailed information on how the objective 
is to be achieved (Viner, 2005). When faced with a long list of criteria it is important to 
refine this to the pertinent few, and this can be done by applying a simple mnemonic 
(DREAM) to each criterion to justify its inclusion (Morrell et al. 1999): 
• Distinct - does it identify something new? 
• Relevant - is it crucial to the achievement of the objective? 
• Evidence-based - is the source of information clear? 
• Achievable - is it realistic within current resources? 
• Measurable - finally, and most importantly, can the criterion be measured? 
1.4.6. Implementing best practice 
1.4.6.1. Preparing to monitor 
Having identified the area for audit and set a standard, you must now consider how best to 
measure the effect of the process (Rayment, 2002; Viner, 2005). A validated measurement 
tool may already be available, in the form of clinical guidelines, to form the basis of the 
criteria for audit, and if this is not the case the values of a particular measure should be 
compared to a number of key criteria before it is adopted (Morrell et al. 1999): 
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• Reliability and validity 
• Responsiveness (sensitivity) to change 
• Clinical utility 
• Feasibility of data collection 
1.4.6.2. Validity and Reliability 
Validity and reliability are particularly important in the design of measurement tools 
(Petrie and Watson, 1999), as every audit criterion is measuring a particular variable, and it 
is vital to know how well the measurement tool is performing, i.e. how reliable is it, and 
how valid? Reliability refers to the ability for a test to be repeated over and over again, 
and achieving the same results each time, i.e. the repeatability of the test (Petrie and 
Watson, 1999). Validity describes the degree to which the criteria are actually measuring 
what they are supposed to be (Petrie and Watson, 1999). Without confidence in the level 
of reliability and validity of a particular measurement tool, you cannot have confidence in 
your data and any final conclusions drawn from it (Petrie and Watson, 1999). 
1.4.6.3. Collection of baseline data 
By performing a test run with the measurement tools of choice, prior to the main data 
collection phase, any limitations or problems can be highlighted and rectified, before they 
impact on the entire study (Rayment, 2002). Further refinement of the criteria is possible 
at this time, with collection of baseline data prior to the implementation of audit and the 
subsequent changes in the practice that will occur (Rayment, 2002). Collection of baseline 
data will provide a starting point against which any future progress can be measured, and if 
appropriate quantified. 
1.4.7. Monitoring and comparing against best practice 
1.4.7.1. Sources of data 
Many sources of data exist that can be utilised in the institution of clinical audit (Rayment, 
2002; Viner, 2005). These include questionnaires, interviews and direct observation, at 
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which time data are collected specifically for the purpose of clinical audit (Rayment, 2002; 
Viner, 2005). However, it must not be forgotten that a wealth of information already exists 
in data sources that are collected routinely. The most obvious of these pre-existing data 
sources would be patient records, although general practice information systems also 
contain a wealth of data. These data are often readily accessible, providing a saving both 
in terms of time and effort if the information they contain can be utilised. 
1.4.7.2. Defining the sample 
A sample population must be drawn that is considered to be representative of the target 
population (Mosedale, 1998), in order to allow extrapolation of results gained from the 
smaller sample to the larger population as a whole. The validity of an audit project will 
hinge on how the sample is selected, and whether this information can then be used to 
draw accurate, unbiased estimates of the characteristics of the larger population. 
1.4.7.3. Comparison and analysis 
Once clinical audit has been performed, the data must be collated, described and analysed 
appropriately in preparation for feedback (Viner, 2005), in the form of an audit summary. 
An audit aims at identifying patterns or deficiencies, not showing statistical significance in 
its findings (Mosedale, 1998; Rayment, 2002). The summary should be perceived as being 
constructive, highlighting both the high and low areas of achievement (Rayment, 2002; 
Viner, 2005). 
1.4.8. Planning for Improvement 
1.4.8.1. Feedback and Evaluation 
The results are then disseminated to the relevant groups in order for results to be 
interpreted and an action plan for future development to be devised and eventually 
implemented in a systematic fashion (Rayment, 2002; Viner, 2005). Evaluation of the 
results is also important to ensure that all objectives of the audit were met, and if not, why 
not (Rayment, 2002; Viner, 2005). 
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1.4.8.2. Re-audit and Evaluation 
A time-scale for the implementation of any changes must also be considered at this time, in 
order to set a realistic date for re-audit (Mosedale, 1998; Rayment, 2002). Comparison of 
the original and more recent sets of audit results then allow for evaluation and 
quantification of any improvements that have occurred (Mosedale, 1998; Rayment, 2002; 
Viner, 2005). 
On completion of re-audit, the entire clinical audit cycle has undergone one revolution 
(Viner, 2005). At this point it can be decided whether there is further gain to be achieved 
by repeating the process immediately in order to further raise specific standards, or if the 
standards achieved now reflect best practice, in which case a timetable for regular re-audit 
in order to maintain these standards should be formulated. 
1.5. Equine veterinary medicine and surgery 
1.5.1. History 
Although the practice of medical treatment of horses for a multitude of ailments had been 
around for centuries, the first printed texts on 'horse medicine' were published in the late 
fifteenth century (Hall, 1999). Farriers were responsible for much for the veterinary care 
provided, using secret remedies whose component parts were learnt during apprenticeships 
(Hall, 1999). However, it was the founding of the London Veterinary College in 1791, 
followed by the advent of the war with the French in 1793 that prompted the reorganisation 
and improvement in veterinary training with a scientific base, in order to provide care to 
the army's mounts and pack animals (Hall, 1999). Further conflicts around the world, and 
heavy losses of troop animals sustained by the British army continued the furtherment of 
the veterinary profession well into the early twentieth century, before horses were 
gradually phased out and replaced by mechanisation by the mid-twentieth century (Reilly, 
1999). From this point a shift in emphasis was seen, from servant to one of the best kept 
domestic species of the modern day. 
Even in the early twentieth century the practice of veterinary medicine was more of an art 
than a science, with the application of astringents, blisters and purgatives for a variety of 
ailments (Rossdale, 1999). It was not until the middle of the century with the advent of 
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such developments as antibiotics that the application of science became more 
commonplace, prior to the rapid acceleration in progress seen over the last few decades 
(Rossdale, 1999). 
1.5.2. Modern practice 
1.5.2.1. Organisation 
With rapid developments in diagnostic imaging, surgery and therapeutics, along with the 
increasing capability of clinicians to apply these techniques, the inevitable path of 
specialisation of clinicians had begun to occur (Rossdale, 1999; Gripper, 2005). This has 
lead to the formation of group practices, in particular in areas of high density of the horse 
population, with the facilities and reputation to rival veterinary schools (Rossdale, 1999; 
Gripper, 2005). 
With the rapid advances that have occurred in technology, and the increasing availability 
of these advanced technologies such as magnetic resonance imaging (MRI), nuclear 
scintigraphy and specialist surgical procedures, available to the veterinary profession, there 
is the inevitable cost that must be faced (Rossdale, 1999). Unlike in the medical 
profession, there is no version of the National Health Service to provide free veterinary 
care to domestic species (Gripper, 2005). Many horse owners are both willing and able to 
support the application of modern technologies by paying an appropriate fee, and this in 
turn will support the continued development of specialist practices (Rossdale, 1999), 
although some owners still hold the outdated view that the veterinary profession is an 
expensive commodity, rather than a highly skilled service industry (Gripper, 2005). For 
those owners that do not have the finances to cover oftentimes expensive medical 
interventions, they are faced with an unenviable decision. 
F or those owners who do not have the financial wherewithal to pay for advanced 
veterinary treatments out of their own pockets, insurance is a viable alternative (Buckton, 
2003). However, despite the prospect of large veterinary bills for the treatment of any 
injury or disease, insurance for veterinary fees is still viewed by many as a luxury instead 
of a necessity (Keel, 2003). Different levels of horse insurance exist, ranging from all risks 
mortality (loss of the horse), through cover for veterinary fees, to loss of use where the 
horse is deemed incapable of performing the job for which it was insured. At one time 
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insurance for veterinary fees was viewed by many as a license to spend money (Buckton, 
2003; Ordidge, 2003). However, increased regulation in the industry, brought about 
through increased competition amongst insurers, increased expectations by owners, 
spiralling costs of specialist veterinary treatment coupled with an increase in surgical 
interventions and the increased recognition of fraudulent claims by both owners and 
veterinarians, has led to the requirement for justification for expenditure on procedures, 
often before they are performed (Buckton, 2003). If this trend of increasing costs for 
veterinary treatment is to continue, it has been suggested that either owners will face large 
rises in premiums to the point that it is no longer economic to insure a horse, or veterinary 
fee cover may be withdrawn from the market altogether (Buckton, 2003). 
With the increasing computerisation of practice records (Cockroft and Holmes, 2004), 
instead of the more traditional card filing systems there is now the ability to use practice 
data to provide practice specific information (Cockroft and Holmes, 2004). If the records 
are coded in a methodical and consistent manner, it is possible to use them to identify 
information such as the incidence of disease, post-operative complications and survival 
rates (Cockroft and Holmes, 2004). These detailed computerised records are also a vital 
tool in the implementation of clinical audit (Cockroft and Holmes, 2004). 
1.5.2.2. The need for EBVM and clinical audit 
In a time of increasing awareness of litigation, and tightening of European legislation 
(Rossdale, 1999), there is now an expectation for the veterinary profession to be able to 
defend many of its actions (Holmes and Cockroft, 2004). Clients will frequently no longer 
accept a veterinary surgeon's opinion at face value, but will wish to be involved in all 
aspects of the clinical decision making. With increasing access to electronic information 
sources clients are becoming well informed (Holmes and Cockroft, 2004) not only in 
alternative therapies, but also to the risks associated with those already widely accepted 
and employed. An owner, when faced with important decisions, will all too often ask a 
question that is rooted firmly in the principles of EBVM, beginning: 'what is the likelihood 
that .... 7' and they will expect the veterinary surgeon to be able to provide them with a well 
informed answer. With the recent loss of the exclusive right to dispense medicines to 
animals under their care (Gripper, 2005), and the increasing emergence of 
paraprofessionals, it must be accepted that the actions of the veterinary profession will 
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continue to come under increasing scrutiny, as people question the monopoly that they 
hold. 
There are now a wide variety of easily accessible electronic information resources (Holmes 
and Cockroft, 2004) to allow a practitioner to apply the principles of EBVM to their work. 
It is becoming increasingly important that veterinary surgeons are able to account for any 
clinical decisions that they might make, especially in the event of an unfavourable outcome 
(Holmes and Cockroft, 2004). Similarly, access to these information resources will allow 
owners to make informed decisions in the care of their animal, along with avoiding 
unrealistic expectations of outcome (Holmes and Cockroft, 2004). 
With the introduction of the Practice Standards Scheme in 2005, the Royal College of 
Veterinary Surgeons (RCVS) acknowledged that clients wished a means by which they 
could ensure that the services offered by a practice were safe and effective, conforming to 
a minimum standard of care (RCVS, 2005). In order for the profession as a whole to be 
able to demonstrate, not only to clients but also to peers, that the expertise offered is 
reliable and can be held to account, clinical audit and the adoption of the principles of 
EBVM are a necessary step (Cockroft and Holmes, 2003). 
In addition, with the introduction of the new Financial Services Authority (FSA) 
regulations, if a veterinary practice wished to play any part in giving advice or 
recommending a product to a client investigating the purchase of insurance cover, the 
practice must now be either directly authorised by the FSA, or an appointed representative 
of a firm that is (Keel, 2005). This involves not only specialist training, but also the 
performance ofregular audits (Keel, 2005). 
1.5.2.3. Limitations to the adoption of EBVM and clinical audit 
Although both EBVM and clinical audit will playa vital role in the development of the 
veterinary profession in the future, they must be recognised to have their limitations. The 
process of performing an audit requires the mastering of new skills in investigation and 
appraisal, and once these skills have been acquired the actual auditing process is time-
consuming. In a private veterinary practice, diversion of a clinician's time and energy 
from seeing cases to performing an audit is also costly (Viner, 2005). It is liable to be the 
actual expense, in terms of time and energy, of implementing an audit that will limit its use 
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in the veterinary practice. An additional complication in the inception of clinical audit is 
that in order to perform a true clinical audit, there must be pre-existing data with which to 
perform a comparison (Viner, 2005). If this data does not exist, a clinical audit cannot be 
performed until the benchmark data has been produced. 
The practice of EBVM is also viewed to be time-consuming, by the time a question is 
formulated, the literature searched and appraised, and this knowledge then integrated into 
clinical work (Viner, 2005). Not only will an already busy clinician have to contend with 
the time-pressure of applying EBVM, they are also faced with the minefield of poor 
evidence that currently exists in the veterinary literature (Viner, 2005). It has been argued 
that it is inappropriate to practice EBVM at the current time, due to the insufficient depth 
and breadth in the veterinary scientific literature (Cockroft and Holmes, 2003). However, 
a lack of evidence is not a defence for not searching for the best available evidence 
(Cockroft and Holmes, 2003). An understanding of statistical techniques is also vital to 
interpret the appropriateness of their use in clinical studies, and the prospect of learning 
these techniques can be daunting. 
The practice of EBVM is likely to be slow in its inception, in order to allow for time for 
the education of practitioners in matters such as statistical analysis, and the publication of 
studies that contain research of a higher quality of evidence than that which is currently 
available (Cockroft and Homes, 2003; Viner, 2005). As in the medical profession, it is 
liable to be new graduates and their teachers that embrace the principles of EBVM with 
enthusiasm (Rafuse, 1994; Sackett et al. 1996), whilst the established practitioners will no 
doubt greet it with something more akin to scepticism. The education of practitioners is 
being assisted by the formation of programmes designed to educate practitioners in 
methods of clinical research and data analysis, for example the clinical research outreach 
programme run by the Cambridge Infectious Disease Consortium, through the University 
of Cambridge (Viner, 2005). The purpose of this programme is to provide short residential 
courses with a well organised ongoing support structure, to enable practitioners to perform 
clinical research projects and then get the results published (Viner, 2005). By encouraging 
practitioners to answer questions through practice-based clinical research, it is hoped to 
promote not only the ethos of EBVM, but also the analytical skills necessary for both 
clinical research and clinical audit. For those wishing to advance their skills in clinical 
research still further, there is a Masters programme run by the Society of Practising 
Veterinary Surgeons (SPVS) to encourage work-based research (Viner, 2005), and the 
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RCVS is currently reviewing a proposal for a Certificate in Advanced Veterinary Practice, 
which would involve the study of research methodologies and the carrying out of work-
based research (Viner, 2005). 
1.6. Aims of this study 
1.6.1. Study Design 
The purpose of this study was to design a series of investigations of equine diseases, and 
implement them at three private equine hospitals in southern England. The diseases 
investigated were all different forms of sepsis associated with either elective or emergency 
surgical procedures, ranging from sepsis as a result of surgical intervention to sepsis 
requiring surgical intervention. A variety of study designs were used, each providing a 
different class of evidence when using the classification system generated by Yusuf et al 
1998. The principles of EBM were followed, in an attempt to provide the evidence 
required to answer specific questions that could be posed by a veterinary practitioner, and 
to highlight both the strengths and short-comings of different types of study design, along 
with the quality of evidence different study designs could provide. 
Four studies involving the retrospective analysis of case records were conducted, to 
investigate the short and long term prognosis for foals and mature horses treated for either 
septic arthritis or septic digital tenosyinovitis. Two of these studies, investigating the short 
and long term prognosis in Thoroughbred foals and mature horses treated for septic 
arthritis, were case-control studies, utilising siblings as the comparison population (Chapter 
5). The remaining two retrospective studies were case series (Chapters 3 and 4). The final 
two studies conducted were prospective. One was a clinical audit of post-operative 
complications following elective surgery (Chapter 7), with the final study being a 
randomised, controlled clinical trial investigating whether the use of belly bands following 
exploratory laparotomy reduced the prevalence of incisional complications (Chapter 6). 
Due to the diverse nature of the specific conditions investigated, each separate study has a 
review of the literature relevant to that study at the beginning of the appropriate chapter. 
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1.6.2. Providing answers relevant to practice 
The main focus of this investigation was to ascertain whether it was possible to apply the 
ethos of EBM to the veterinary profession, and provide good quality research and evidence 
from private practice. 
A frequent comment when discussing the quality and relevance of publications in the 
equine veterinary literature is that, although studies are well designed and often provide 
significant findings, these findings are of little relevance to the general practitioner, or may 
be worded in such a way that the relevance of results can be difficult to interpret. It was 
thought that in order to provide answers relevant to the general practitioner, the original 
question should stem from a practice population. 
In order to further this aim, studies were carried out on conditions encountered commonly 
in equine practice, where a large amount of information has already been published in the 
literature, frequently of a conflicting nature, and also of a poor quality of evidence as 
defined by Yusuf et al (1998). By addressing these issues, it was intended that data 
generated in these studies would then have a direct relevance to the general practitioner. 
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Chapter 2 
General Materials and Methods 
2.1. Introduction 
The purpose of the study was to conduct a series of investigations into common equine 
problems, applying the principles of evidence-based medicine. Areas for investigation 
were identified by questioning equine clinicians on conditions that were commonly 
encountered in equine practice requiring surgical intervention, where existing evidence 
was considered to be either conflicting or poor. Searches were then performed for each 
condition of interest, in order to identify any studies already existing in the literature, and 
these studies were then classified on the 'class' of evidence that they provided in EBM 
terms, according to the classification system proposed by Yusuf et al. (1998). 
At the outset of the study there were few examples of the application of the principles of 
EBM to clinical research in the equine veterinary literature (Denoix et al. 2003; Edwards et 
al. 2003; Kane et al. 2003; Spike-Pierce and Bramlage, 2003), although during the study 
period more papers were published (Barakzai et al. 2004; Johnston et al. 2004; Smith et al. 
2004; Proudman et al. 2005a,b; Smith et al. 2005; Valverde et al. 2005). One intention of 
the study was to investigate whether it was plausible to conduct practice-based clinical 
research using the principles of EBM. 
2.2. General Study Design 
2.2.1. Recruitment of Veterinary Practices 
Three private equine clinics in the South of England were approached to participate in 
either some, or all, of the clinical research studies. These three practices were selected due 
to pre-existing close links with the primary surgeons, their known willingness to 
participate in clinical research studies, and their interest in, and support for, EBM. It was 
decided not to include veterinary schools in the studies, as the participation of veterinary 
students in the evaluation and care of the cases in addition to that of trained veterinary 
nurses and veterinary surgeons could lead to over-interpretation of specific outcomes, and 
the introduction of bias into the studies. The practice populations treated by the three 
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private practices, along with the standard treatment regimens employed in these practices, 
were also felt to be more comparable with one another than with those of a veterinary 
school. Furthermore, since the intention of the overall study was to provide evidence for 
use by all practitioners, it was considered important to avoid the inevitably biased 
population of animals that are typically referred to veterinary school clinics. In all studies, 
necessary sample size was a critical design consideration, hence the need to have horses 
from up to three clinics available. 
At the outset of the study formal presentations were made to the veterinary surgeons at 
each of the three participating clinics, in order to explain the reasons for the general study 
and the aims of the individual studies being conducted, along with the data collection 
requirements. At this point, surgeons were invited to provide feedback including: areas 
they would like to see investigated fmiher that were within the scope of any of the studies, 
and where they perceived problems could arise, either in case management or data 
collection. Where possible, the results of this feedback were then incorporated into the 
study design. 
2.3.1.1. Participating Veterinary Clinics 
2.3.1.1.1. Rossdales Equine Hospital 
Rossdale and Pminers was first founded in 1959 as an ambulatory practice based in 
Newmarket, and in 1991 the practice was expanded to two sites. Since that time, the 
practice has continued to expand to the current total of 25 veterinary surgeons, and it is 
thought to be the largest private equine practice in the United Kingdom. The ambulatory 
pmi of the practice, Beaufort Cottage Stables, is still based at the original site off 
Newmarket High Street, performing first opinion work for a variety of Thoroughbred 
studs, racehorse trainers and private stables. The Rossdales Diagnostic Centre and 
Rossdales Equine Hospital are both based on the Exning Estate, in Exning, The hospital 
was opened in 1998, in order to 'provide a state of the art surgical facility to deal with the 
ever-increasing surgical caseload, both from the local practice and referred by veterinary 
surgeons'. It is accredited as a Tier 3 hospital under the RCVS Practice Standards Scheme, 
with a surgical caseload evenly divided between orthopaedic and soft tissue cases, 
although a large propOliion of the caseload is from the Thoroughbred breeding and racing 
industry. 
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2.3.1.1.2. Bell Equine Veterinary Clinic 
Bell Equine Veterinary Clinic was established in central Kent as a small, specialist equine 
clinic in 1991. Since that time, it has continued to expand, moving into purpose built 
premises and now employing 14 veterinary surgeons. Although there are two parts to the 
practice (the first opinion practice and the hospital practice, for both surgical and referral 
cases), both sides of the practice are fully integrated with each other, with the main 
clientele of the practice being pleasure horses. The practice is accredited as a Tier 3 
hospital under the RCVS Practice Standards Scheme, and is committed not only to 
providing a high level of veterinary care, but also to clinical research and development, and 
the further education of both clients and veterinary surgeons. 
2.3.1.1.3. Bushy Equine Veterinary Clinic 
Bushy Equine Veterinary Clinic is part of the Vale Veterinary Group, and is based in 
Gloucestershire. It offers first opinion care for horses and ponies within Gloucestershire 
and Somerset, as well as receiving referrals from the South West of England and Wales. 
Although seven vets work at Bushy Equine Veterinary Clinic and it offers full 
hospitalisation and surgical facilities, it is not accredited under the RCVS Practice 
Standards Scheme. However, the Vale Veterinary Group has both Tier 2 general small 
animal practices and a Tier 3 small animal hospital accredited under the scheme. 
2.3.2. Study design principles 
A retrospective study design was chosen for four of the studies, in order to provide 
sufficient case numbers to achieve sufficient statistical power for clinically meaningful 
outcomes, without the necessity for a lengthy study period. The conditions investigated 
were not suitably common that an adequate number of cases would be generated in the 
available time period if a prospective study design was used. The data that were required 
for statistical analyses were all routinely recorded in the hospital records for each horse, 
and although it was accepted that some data may have been missing from some of the 
records, it was anticipated that sufficient data should be present to allow for meaningful 
statistical analyses to be performed. 
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A prospective study design was chosen for the remaining two studies in order to answer 
specific clinical questions that could not be answered by using pre-existing records. The 
prospective design allowed one study to be both controlled and randomised, providing a 
high quality of evidence in EBM terms, whereas if historical controls had been utilised 
through access to case records the resultant conclusions would have constituted a poorer 
quality of evidence. As the two conditions investigated using a prospective study design 
were encountered on a regular basis in the participating practices, it was possible to 
achieve a sufficiently large sample size to achieve sufficient statistical power for a 
clinically meaningful outcome, without having to implement a prohibitively lengthy study 
period. 
2.3.3. Record Keeping 
2.3.3.1. Methods of record keeping within the practices 
The records at Rossdales Equine Hospital and Bushy Equine Veterinary Clinic are all 
paper records, with all daily occurrences noted in the horse's records and then the record is 
filed when the horse is discharged from the hospital. All hospital records are then archived 
by year, in alphabetical order by horse name. 
At Rossdales Equine Hospital, if a horse already had a record existing from a previous 
visit, all new records were archived with the original record under the year of the first visit. 
For horses with multiple visits, especially for the treatment of different conditions, this 
rendered it impossible to search easily for case records when the name of the horse and the 
year of treatment were known. It was also necessary to know whether the horse had ever 
been treated previously, including whether this had occurred under either a different horse 
or owner name. It was possible to perform a computerised search for a condition, but only 
if the horse had been referred to the hospital from outside the main practice, as referral 
letters written after discharge were archived on a computer system under both name and 
condition treated. It was still necessary to then search for the case records in the paper 
archive for all relevant day-to-day case information. 
At Bell Equine Veterinary Clinic, both a paper record and a computer record existed for 
every horse treated. The computer system used for recording clinical and billing details is 
4D, from QVetIT, Quaesitor Solutions Limited, and a brief summary of clinical progress is 
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entered on a daily basis in each record, along with any relevant billing information so that 
a running total of the bill to date is kept. The paper records are filled out in detail on a 
daily basis, and then at the time of discharge the paper records are scanned into another 
computerised database (E-file) prior to archiving. Both these computerised databases 
allow for searching by horse or owner name, date of treatment or category of condition 
treated. 
2.3.3.2. Design of data recording forms 
The forms used for recording the relevant data in each of the studies were designed to be as 
simple as possible (Appendices 1,3, 7 and 10). The design of the forms was important, as 
staff at all the participating practices had stressed that forms requiring long written answers 
would take too much time to complete, leading to poor compliance. The name and 
signalment for each horse were written in a series of blank spaces next to appropriate sub-
headings. Where appropriate, there were a number of choices in answer to a simple 
question, with a tick-box beside each choice. It was only possible to select one answer in 
response to each question. 
2.3.3.3. Data collection 
A small group of people was identified at each practice to be responsible for all the 
identification of cases for inclusion in the prospective studies, and the daily data collection 
for these studies. Study-specific inclusion criteria were listed at the outset of each study, 
and a written and laminated copy of these criteria supplied to each of the participating 
practices for easy reference. The people responsible for data collection were the nurses at 
Rossdales Equine Hospital, and the hospital interns at Bell Equine Veterinary Clinic and 
Bushy Equine Veterinary Clinic. The surgeons participating in the study filled out a 
surgeon's report form for each case, but did not participate in any of the post-operative 
data collection to eliminate any bias that this might introduce. The completed data 
collection forms were then collected by the author on a regular basis, for collation and 
analysis. 
In the retrospective studies, all cases eligible for inclusion in studies were identified by 
analysis of medical records. This case identification and the subsequent data retrieval from 
the medical records was performed solely by the author. The follow-up information was 
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then collected using telephone questionnaires administered to each horse's caretaker, 
performed solely by the author in all retrospective studies. 
2.4. Hardware and Software 
A Hi-Grade Notino 4400 laptop computer was purchased at the outset of the study, in July 
2003, for collation and analysis of all data. Microsoft Office Professional 2000 
incorporating Microsoft Excel, Microsoft Word and Microsoft PowerPoint, was installed 
on the computer, along with Minitab 13.31 for performing all statistical analysis, 
WINPEPI 4.0 for combined regression analysis and Win Episcope 2.0 for performing 
power studies. 
All raw data were entered into study-specific spreadsheets in Microsoft Excel. Data were 
then transferred to worksheets in study-specific projects in Minitab 13.31, where data 
could be manipulated or coded into a form suitable for statistical analysis. Reports, and 
where appropriate graphs, could then be generated in Minitab 13.31 at the conclusion of all 
necessary statistical analyses. 
2.5. Literature Search 
A detailed search of the existing literature was performed for each of the conditions of 
interest at the outset of the study. Each search was conducted using the bibliographic 
databases available through the University of Glasgow Library website, accessed via 
OVID Online. Through this site, it is possible to access multiple electronic bibliographic 
databases, and perform the same search in each database. All searches were initially 
performed in MEDLINE, the electronic library of the United Stated National Library for 
Medicine, via OVID Online, before repeating the searches in CAB Abstracts, providing 
access to agriculture-based scientific literature abstracts, also accessed via OVID Online. 
Both MEDLINE and CAB Abstracts allow for search topics to be combined or refined to 
keywords, specific journals, authors or years using their advanced search settings, and they 
also recognise the need to search using both the American and British spelling of key 
words. All relevant references identified in this manner were then investigated, and all 
references cited by each paper were also accessed. 
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2.6. Statistical Methods Applied 
At the outset of each study, the project team met and carefully considered the clinical 
problem in question and agreed on the aims and objectives for each study. Central to this 
was the definition of biologically meaningful effects which were used to inform sample 
size calculations. A power calculation was performed at the outset of each study, to 
determine the minimum sample size necessary to detect the existence of a statistically 
significant difference for a clinically meaningful outcome. The number of horses required 
(n) for each study, using a significance level of 5%, and study power of 80%, was 
calculated using the statistical freeware software Win Episcope 2.0, which used the 
standard formulae as appropriate for each study (Snedecor and Cochran, 1980): 
n = [(Za + Zb)/(Po - P I)]2 * (PIQI + PoQo) 
where Za is the value of Student's t distribution at the specified confidence level, 
calculated to be 1.96, and Zb is the value of Student's t distribution at the specified power, 
calculated to be -0.842, with Po being the proportion of horses that successfully attain their 
expected level of athletic performance following treatment, Qo being (I-Po), PI is the 
proportion of horses in the control population that attain their expected level of athletic 
performance, and QI is (I-PI). Each power calculation was parameterised with data 
derived from existing literature, where available. 
Data were initially tabulated, summarised and subjected to exploratory data analysis with 
tests for normality and descriptive analyses, using either the chi-squared test for discreet 
data, or a Student's t-test for continuous data, as appropriate using the statistical software 
package Minitab 13.31. Following the initial analysis, categorical variables with more 
than two levels were coded as indicator variables using Minitab 13.31, prior to univariable 
and multivariable logistic regression analyses. For the majority of studies, a dichotomous 
outcome variable, i.e. survival or not; recovery or not; dictated that logistic regression 
analysis would be the most appropriate statistical modelling approach. Univariable 
analysis was used to screen all variables, and from this, all variables with a p-value :s 0.20 
were included in a backward elimination process to fit a multivariable model. The 
inclusion criterion for backward elimination was set at p:S 0.05. The goodness-of-fit of the 
models was assessed using Minitab 13 .31, by the Hosmer-Lemeshow goodness-of-fit test, 
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to test the null hypothesis that the model was considered to be a good fit, with the null 
hypothesis rejected at a p-value:s 0.05. 
Once the main effects model had been fitted, two-way interaction between variables was 
assessed using Minitab 13.31. Variable selection was determined by biological 
plausibility. Assessment between models was obtained using a likelihood ratio test (LRT) 
with significance set at p :s 0.05. 
Additional statistical analyses, specific to each study, were also performed, and are 
described in detail in the relevant chapters. 
On completion of data analyses, findings were considered and discussed. In particular, 
their relevance in EBVM terms was considered with particular attention to the quality of 
evidence provided and their value to the veterinary practitioners. 
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Chapter 3 
What is the likelihood that a horse treated for septic digital tenosynovitis will return 
to its previous level of athletic function? 
3.1. Introduction 
Synovial sepsis in adult horses is a serious clinical problem (Bertone et al. 1987a; 
Schneider et al. 1992a; Booth et al. 2001) that usually affects a single synovial structure 
(Cook & Bertone, 1998). The potential exists to cause permanent fibrosis, damage to 
tendons, adhesion formation and unsoundness when infection is not rapidly eliminated 
from the synovial space (Schneider et al. 1992a; Tremaine, 2000). Rupture of the tendons 
within the sheath, secondary to ongoing sepsis, has also been reported (Honnas et al. 1991; 
McIlwraith 2002; Kidd et al. 2004), presumably due to enzymatic degradation of the 
tendon fibres by bacteria and inflammatory cells present within the sheath. The digital 
flexor tendon sheath is the most commonly affected synovial sheath (Jackman et al. 1989; 
Honnas et al. 1991), although sepsis has also been repOlied frequently in the tarsal, carpal 
and extensor tendon sheaths (Nixon, 1990; Platt and Wright, 1997; Santschi et al. 1997; 
Cauvin et al. 1999). 
3.2. The occurrence of septic digital tenosynovitis 
3.2.1. Routes of infection 
Septic tenosynovitis is caused by the inoculation of a synovial sheath with bacteria, with 
viable organisms overwhelming natural host defences and becoming established. There 
are three recognised routes by which bacteria may become established within a synovial 
cavity (McIlwraith, 1983). 
1. Sepsis can follow a traumatic insult to the tissues overlying the synovial structure 
(Rose & Love, 1979; Madison et al. 1991, Schneider et al. 1992a; Tremaine, 2000) 
2. It may be of iatrogenic origin, for example following an intra-synovial injection or 
surgery (Van Pelt, 1971; McIlwraith, 1983; Mmiens et al. 1986; Schneider et al. 
1992a; Tremaine, 2000) 
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3. More rarely in adults, it can be the result of haematogenous spread from an 
infectious focus elsewhere in the body (Martens et al. 1986; Schneider et al. 
1992a). In the vast majority of reported cases (Schneider et al. 1992a; Chan et al. 
2000; Summerhays, 2000; Frees et aZ. 2002) the route of infection has been 
identified as traumatic in origin. Occasionally, the inciting cause of sepsis is not 
identified. 
3.2.2. Clinical signs associated with sepsis 
Acute severe lameness, synovial effusion, heat and pain on palpation of the joint, localised 
swelling, pyrexia, cellulitis and distal limb oedema are the most commonly reported 
clinical findings (Van Pelt, 1971; Rose & Love, 1979; McIlwraith, 1983; Bertone et al. 
1987a; Honnas et aZ. 1991; Schneider et al. 1992a; Cook & Bertone, 1998; Tremaine, 
2000; Chan et al. 2000), although synovial effusion and lameness may not be as marked if 
the synovial structure is open and draining (McIlwraith, 1983; Honnas et aZ. 1991). 
3.2.3. Involvement of other structures 
When synovial sepsis is a sequel to a traumatic laceration of the digital flexor tendon 
sheath it is also possible for the horse to sustain either a laceration to, or complete 
transection of, the superficial and/or deep digital flexor tendons (Fraser and Bladon, 2004). 
Even if the synovial sepsis is successfully resolved, these concurrent injuries will have 
serious implications on the likelihood of that horse becoming sound. 
Rupture of either the superficial or deep digital flexor tendons has been reported in cases of 
untreated or ongoing sepsis (Honnas et a1.1991; Kidd et aZ 2004) of the digital flexor 
tendon sheath, presumably due to the ongoing degradation of the tendon fibres by 
lysosomal enzymes 
3.2.4. Principles of treatment 
The basic principles for successful resolution of synovial sepsis are treatment with broad-
spectrum systemic antimicrobials and lavage of the septic structure, although the most 
efficacious form of lavage remains a contentious issue. Although many additional 
treatment strategies have been proposed, including open drainage (Schneider et aI, 1992b; 
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Chan and Mumoe, 1997), intra-thecal antimicrobials (Schneider ef al. 1992a,b), regional 
limb perfusion with antimicrobials (Whitehair ef al. 1992) and transection of the proximal 
palmar/plantar annular ligament (Honnas et al 1991; Phillips, 1997), these can only be 
described as being complementary to the basic principles of systemic antimicrobials and 
lavage. 
3.2.5. Treatment Failure 
The main causes of treatment failure are the inability to eliminate the causative agent 
(Bertone et al. 1987a; Schneider ef al. 1992a; Meijer et al. 2000) and to disrupt effectively 
the vicious cycle of fibrosis and subsequent adhesion formation through accumulation of 
inflammatory products (Orsini, 1984; Stover, 1990; Bertone, 1999; McIlwraith 2002). If 
digital tendon sheath sepsis has not been resolved after a single lavage, and there is no 
obvious reason for ongoing sepsis, it must be considered that a focus of infection remains 
within the sheath which will result in re-seeding of bacteria after surgical lavage. Cases 
have been reported in which a small foreign body has been present within the sheath, 
acting as a focus of infection (Magee, et ai, 1997); similarly, if necrosis of tendon fibres 
has occurred (Booth et at, 2000), or osteomyelitis of a sesamoid bone (Chan and Mumoe, 
1997), as a consequence of the initial injury, these foci of infection will continuously 
reseed the tendon sheath until the underlying cause of infection is addressed and resolved. 
Even if there is no focus of infection identified, bacteria can sequester in the synovial 
membrane, leading to re-infection of the sheath after surgical lavage if all bacteria and 
inflammatory cells are not effectively removed. 
3.2.6. Outcome and prognosis 
There are few published studies investigating the long term outcome following septic 
tenosynovitis, specifically septic digital tenosynovitis. Previous studies have frequently 
reported only short term follow up, with the end point commonly being discharge form the 
hospital. Only three studies (Honnas ef at. 1991; Chan et at. 2000; Frees et al. 2002) have 
followed the outcome of horses after they have been discharged from the hospital 
following treatment for septic digital tenosynovitis, and all have included relatively small 
numbers of cases (25, 12 and 20 horses respectively). Between 80% (20/25; Honnas et al. 
1991) and 100% (14114; Schneider et al. 1992) of mature horses treated for septic digital 
tenosynovitis were successfully discharged from the hospital, while the long term studies 
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found that between 50% of horses (I0/20; Frees et al. 2002) and 91% (11112; Chan ef al. 
2000) were able to return to their original level of athletic function, with no adverse affects 
related to the occurrence of septic digital tenosynovitis. Many of the recommended 
treatments for the management of septic digital tenosynovitis are extrapolated from data 
generated from controlled trials investigating the success of treatments for septic arthritis. 
Whilst it is widely accepted that systemic antimicrobial therapy and synovial drainage are 
necessary for the successful resolution of septic digital tenosynovitis, other factors that 
may influence either the short or long term prognosis prior to the commencement of 
treatment have not been examined. Potential factors that could influence the prognosis 
include the age of the horse at the time of admission to the hospital for treatment, whether 
a forelimb or hindlimb is affected, the exact location on the limb of the inciting cause of 
synovial sepsis and the duration of sepsis prior to referral for treatment. 
For the purpose of this study, it was hypothesised that the occurrence of septic digital 
tenosynovitis would significantly reduce the likelihood of a horse returning to its previous 
level of athletic function when compared to a horse treated for septic arthritis in the same 
practice population. 
3.3. Materials and Methods 
3.3.1. Power calculation 
The number of horses required (n) for this study, using a significance level of 5%, and 
study power of 80%, was calculated using the standard formula (Snedecor and Cochran, 
1980): 
n = [(Za + Zb)/(Po - PI)]2 * (PIQI + PoQo) 
where Za is the value of Student's t distribution at the specified confidence level and Zb is 
the value of Student's t distribution at the specified power, with Po being the proportion of 
horses that successfully return to their previous level of athletic performance following 
treatment for septic arthritis, Qo being (I-Po), PI is the proportion of horses that return to 
their previous level of exercise following treatment for septic digital tenosynovitis, and QI 
is (I-PI)' With Po estimated to be 50%, based on data gathered from the same practice 
population, over the same time period, as part of a separate study (see chapter 4) and PI 
Chapter 3 68 
estimated to be 71 %, based on previously published data (Chan et al. 2000; Frees et al. 
2002), the required number of horses for the study was, therefore, 83. 
3.3.2. Data retrieval 
3.3.2.1. Study group 
The admission records for Bell Equine Veterinary Clinic between January 1994 and 
December 2003 were reviewed to identify horses that had been admitted with suspected 
digital sheath pathology, and medical histories were then retrieved. In cases in which 
septic digital tenosynovitis was suspected on the basis of clinical signs, diagnosis was 
confirmed on the result of synoviocentesis of the digital sheath, where an increased 
nucleated cell count (upper end of normal reference limit for laboratory: 3 x 109 cells/I) in 
conjunction with an increased total protein concentration (upper end of normal reference 
limit: 1Sg/l) and the presence of a neutrophilia (>90%) with degenerative 
polymorphonuclear cells on cytological analysis were considered to be diagnostic. 
Information retrieved from the medical records included age, sex, breed, evidence of any 
other pathology outside the digital sheath, the suspected route of infection, anatomical 
location of any wound that may have contributed to the development of synovial sepsis, 
time from onset of clinical signs to presentation at the clinic for treatment, the white cell 
count of the synovial fluid at the time of admission to the hospital, results of bacterial 
culture of the synovial fluid, details of antimicrobial therapy and lavage procedures 
performed and whether the horse was discharged from the hospital following treatment. 
3.3.2.2. Control Group 
Over an identical study period, the same baseline data were collected for horses admitted 
to the clinic for evaluation of suspected septic arthritis. The diagnosis of septic arthritis 
was made based on similar criteria to those used in the diagnosis of septic digital 
tenosynovitis (4.4.1.). The basic information derived from the results of the analysis of 
these data were used to inform the power calculation performed at the outset of the current 
study (3.3.1.). 
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3.3.3. Outcome Measures 
Outcomes that were statistically evaluated included discharge from the hospital and 
whether the horse eventually returned to its previous level, or a higher level, of 
performance. Outcome was determined by evaluation of medical records to determine 
whether the horses were successfully discharged from the hospital. Long term follow up 
was then obtained by means of a questionnaire administered to owners by telephone 
(Appendix 1). The purpose of the questionnaire was to establish the level of athletic 
performance the horse had achieved prior to the occurrence of septic digital tenosynovitis 
and whether, in the owner's opinion, the horse had been able to return to this level of 
performance after discharge from the hospital. If the owner did not consider the horse to 
have successfully returned to its previous level of performance it was established whether 
this was directly attributable to the occurrence of septic digital tenosynovitis, or whether 
there were other factors that had contributed to the eventual outcome. 
3.3.4. Data Analysis 
Variables that were statistically evaluated included age, sex, whether a forelimb or 
hindlimb was affected, location on the limb of any penetrating wound, inciting cause of 
sepsis and duration of onset of sepsis until commencement of treatment. Categorical 
variables with more than two levels were coded as indicator variables. 
Binary logistic regression was used to analyse these data as both outcomes of interest were 
dichotomous. Two binary logistic regression models were constructed using these data. 
Analyses were implemented with the statistical software MINIT AB (version 13 .31). 
Univariable logistic regression was used to screen all variables, and from this all variables 
with a p-value :'S 0.20 were included in a backward elimination process to fit a 
multivariable model. The inclusion criterion for backward elimination was set at p :'S 0.05. 
The goodness-of-fit of the model was evaluated using the Hosmer-Lemeshow goodness-of-
fit test, to test the null hypothesis that the model was a good fit, with the null hypothesis 
accepted at a p-value :'S 0.05. 
Once the main effects model had been fitted, two-way interaction between variables was 
assessed. Variable selection was determined by biological plausibility. Assessment 
Chapter 3 70 
between models was obtained using a likelihood ratio test (LRT) with significance set at p 
:s 0.05. 
Comparison of outcomes for those horses treated for septic arthritis and those treated for 
septic digital tenosynovitis were made using univariate analysis of odds ratios and 95% 
confidence intervals, along with a X2 test. Differences were considered significant at p :s 
0.05. 
3.4. Results 
3.4.1. Descriptive Statistics 
3.4.1.1. Study group 
Ninety horses met the criteria for inclusion in the study, thereby satisfying the power study 
performed at the outset. Forty-three horses were male and forty-seven were female. The 
age at the time of admission was recorded in 85 cases, with the age ranging from 1 month 
old to 30 years old, and the median age was 9 years old (inter-quartile range 5 - 14 years 
old) at the time of admission. Fifteen of the 90 horses (17%) had no breed recorded on 
their admission papers. Of the remaining 75 horses, the breed distribution included 23 
Thoroughbreds (31 %), 19 part-bred Thoroughbreds (25%), 11 Warmbloods (15%), and the 
remaining 22 horses (29%) were a variety of native pony breeds, or of mixed breeding, 
which was considered to be representative of the population of horses treated at the 
hospital during the study period. The athletic use at the time of admission was recorded in 
76 cases (84.4%), with 90.8% of these (69/76) being general purpose riding horses at the 
time of admission. 
All horses had sepsis in a single digital synovial sheath, with no other digital sheath 
affected. However, seven horses also had sepsis present in at least one other synovial 
structure (one in a tibio-tarsal joint, four in a metacarpo/metatarsophalangeal joint, one in 
the tarsal sheath and one with sepsis of the distal inter-phalangeal joint and navicular 
bursa). The cause of sepsis was recorded in all cases (Table 1). No horse developed sepsis 
subsequent to haematogenous spread, and no foals with septic digital tenosynovitis 
secondary to septicaemia were recorded in the 10 year study period. 
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Among the 90 horses, 38 forelimbs were affected and 52 hindlimbs. The site of the injury 
was recorded in all cases (Table 2). One horse developing sepsis as the result of regional 
anaesthesia had a low four-point nerve block performed on a front limb, and thus the site 
of inoculation was at the level of the fetlock joint; one horse developed sepsis in a 
hindlimb following surgical exploration of the digital sheath at the level of the pastern. 
The presence of a wound at the level of the pastern causing synovial sepsis was found to be 
statistically significantly over-represented (p=0.008, 95% CI 0.54 to 0.74), whilst numbers 
in the other two categories (wound at the level of the fetlock and solar penetration) were 
low. 
Table 1: Cause of sepsis of the digital flexor tendon sheath in 90 horses 
Cause of sepsis 
Trauma 
Subsequent to diagnostic 
regional anaesthesia 
Subsequent to surgical 
exploration of sheath 
Number 
88 
% 
97.8 
1.1 
1.1 
Table 2: Site of injury in 90 horses with sepsis of the digital flexor tendon sheath 
Forelimb Hindlimb 
Site of Injury Number 0/0 Number % 
Overall 38 42.2 52 57.8 
Solar Penetration 1 1.1 1 1.1 
Palmar/Plantar pastern 25 27.8 33 36.7 
Palmar/Plantar fetlock 12 13.3 18 20.0 
The time between onset of clinical signs and presentation at the hospital for treatment was 
recorded in 87 cases. Of these, 57.5% of horses (50/87; 95% C.l. 0.464 to 0.680; p=0.198) 
were admitted to the clinic for investigation of suspected septic digital tenosynovitis within 
24 hours of the original inciting incident occurring (in the maj ority of cases the time period 
was, in fact, less than 12 hours after the incident). A further 33.3% (29/87; 95% C.l. 0.236 
to 0.443; p=0.002) were admitted to the clinic between 1 and 7 days of the original wound 
occurring, and 9.2% (8/87; 95% c.l. 0.041 to 0.173; p < 0.001) after more than 7 days. 
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The range for time of wound to admission at the clinic for treatment ranged from less than 
1 hour to 6 weeks. The number of horses that presented for treatment more than 7 days 
after the onset of sepsis was very low compared to those in the other two categories 
(within 24 hours and between 1 and 7 days). 
3.4.1.2. Control group 
One hundred and thirty-six horses met the criteria for inclusion in the study, thereby 
satisfying the power study performed at the outset. Seventy-six horses were male and sixty 
were female. The age at the time of admission was recorded in 134 cases, with the age 
ranging from 6 months old to 30 years old, and the median age was 8 years old (inter-
quartile range 5 13 years old) at the time of admission. Twelve of the 136 horses (8.9%) 
had no breed recorded on their admission papers. Of the remaining 124 horses, the breed 
distribution included 28 Thoroughbreds (22.6%), 31 part-bred Thoroughbreds (25%), 16 
Warmbloods (12.9%), and the remaining 49 horses (39.5%) were a variety of native pony 
breeds, or of mixed breeding, which was considered to be representative of the population 
of horses treated at the hospital during the study period. The athletic use at the time of 
admission was recorded in all cases, with 92.6% of these (1261136) being general purpose 
riding horses at the time of admission. 
All horses had sepsis in at least one joint, with three horses (2.2%) also having sepsis 
present in one other synovial structure (all three horses had sepsis of the distal inter-
phalangeal joint with concomitant sepsis of the navicular bursa). The cause of sepsis was 
recorded in all cases, with the most common cause being sepsis subsequent to external 
trauma (1301136; 95.6%). No horse developed sepsis subsequent to haematogenous spread 
in the 10 year study period. 
The time between onset of clinical signs and presentation at the hospital for treatment was 
recorded in 135 cases. Of these, 59.3% of horses (80/135; 95% c.I. 50.5to 69.6; p=0.038) 
were admitted to the clinic for investigation of suspected septic arthritis within 24 hours of 
the original inciting incident occurring (in the majority of cases the time period was in fact 
less than 12 hours after the incident). A further 25.2% (341135; 95% c.I. 11.7to 25.3; p < 
0.001) were admitted to the clinic between 1 and 7 days of the original wound occurring, 
and 15.5% (21/135; 95% c.I. 9.9 to 22.8; p < 0.001) after more than 7 days. The range for 
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time of wound to admission at the clinic for treatment ranged from less than 1 hour to 60 
days. 
3.4.2. Treatment Options 
Although all horses were treated with systemic broad spectrum antimicrobials and digital 
sheath lavage, there was no standardised treatment protocol. The initial digital sheath 
lavage was performed under general anaesthesia. Affected sheaths were usually lavaged 
on alternate days until a clinical improvement was seen, with lavage being performed 
between one and five times in total (median = 1 lavage). Of the 85 horses that recovered 
successfully from general anaesthesia, 62.4% (53/85) had only one lavage, along with a 
course of parenteral antimicrobials, with no other treatment necessary to eliminate the 
infection from the sheath. Other procedures included transection of the palmar/plantar 
annular ligament of the metacarpo/metatarso-phalangeal joint (10 horses), tenoscopy (14 
horses), or standing lavage of the sheath after insel1ion of a fenestrated drainage tube 
during lavage under general anaesthesia (8 horses). Eight horses received a combination of 
treatments. Standard practice was to review the antimicrobial regimen if antimicrobial 
sensitivity indicated that the organisms cultured were resistant to the initial antimicrobial 
choice, or if there was a failure to respond to treatment. Horses were discharged from the 
hospital when the clinical signs of infection had resolved, although all cases were still 
receiving antimicrobials at the time of discharge. Digital sheath sepsis was deemed to 
have resolved if two synovial fluid samples obtained forty-eight hours apart, with the first 
sample obtained a minimum of forty-eight hours post-operatively, showed no further 
evidence of ongoing sepsis. 
3.4.3. Factors affecting survival 
Of the ninety horses admitted to the hospital for evaluation and treatment of septic digital 
tenosynovitis, 79 horses (87.8%) were successfully discharged from the hospital. Of the 
eleven horses euthanased, only six were euthanased due to a failure of the septic digital 
tenosynovitis to respond to treatment (Table 3). 
Univariable logistic regression analysis showed that none of the variables evaluated were 
associated with an increased risk of a horse failing to survive to be discharged from the 
hospital following treatment for septic digital tenosynovitis (Appendix 2.1). 
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Table 3: Short term follow up of 90 horses treated for septic digital tenosynovitis 
Discharged from hospital 79/90 87.8% 
Euthanased 11190 12.2% 
Euthanased prior to treatment 2111 For financial reasons 
Due to concurrent injuries 
Euthanased under GA 3/11 Due to concurrent injuries 
Due to anaesthetic complications 2 
Euthanased due to failure to 6/11 
respond to treatment 
A multivariable logistic regression model was constructed using backward elimination, 
with all variables with p :::; 0.20 at the univariable level included in the analysis. The 
inclusion criterion for backward elimination was set at p :::; 0.05. None of the variables 
evaluated were associated with an increased risk of a horse failing to survive to be 
discharged from the hospital following treatment for septic digital tenosynovitis. 
3.4.4. Long-term follow-up 
Long term follow up was available for 91.1 % of cases (72/79) (Table 4). Of these seventy-
two horses, thirty-nine (54.2%) returned to their intended use as performance horses, 
although a further six horses (8.3%) were sound and would have been capable of returning 
to their intended use; however, they were retired to pasture with no attempt at a return to 
exercise as an elective decision of their owners. Six horses (8.3%) were euthanased after 
discharge from the hospital due to complications associated with the occurrence of septic 
digital tenosyovitis. 
Of the seven horses that had another septic synovial structure in addition to septic digital 
tenosynovitis, five horses were successfully discharged (Table 5), with 57.1 % (4/7) being 
able to return to their previous level of athletic function. 
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Univariable logistic regression analysis showed that the only variable that was associated 
with an increased risk of a horse being unable to return to its previous level of athletic 
function was the length of time between the onset of sepsis and treatment (Appendix 2.2). 
Table 4: Long term follow up available in 72/79 cases (91.1 %) discharged following treatment for 
septic digital tenosynovitis 
Number 0/0 95% CI 
Returned to intended use 39 54.2 42.6 to 65.7 
Returned to lower level of exercise 3 4.2 0.0 to 8.9 
Retired to pasture with no 6 8.3 1.8 to 14.8 
attempt to return to exercise as 
elective decision by owner 
Chronically lame 18 25 15.0 to 35.0 
14/18 Directly attributable to 
sepsis within digital sheath 
4118 Due to concurrent injuries 
Euthanased due to complications 6 8.3 1.8 to 14.8 
associated with occurrence of 
septic tenosynovitis 
Table 5: 7/90 horses had sepsis of another synovial structure in addition to septic digital tenosynovitis 
Number % 95% CI 
Discharged from hospital 5 71.4 
Euthanased prior to discharge 2 28.6 0.0 to 62.1 
1 Under GA due to conCUITent 
injuries 
Due to failure to respond to 
treatment 
Long term follow up 
Retired to pasture with no attempt to 1 14.3 0.0 to 40.2 
return to exercise as elective decision by 
owner 
Returned to intended use 4 57.1 20.4 to 93.8 
A multivariable logistic regression model was constructed using backward elimination, 
with all variables with p :s 0.20 at the univariable level included in the analysis. The 
inclusion criterion for backward elimination was set at p :s 0.05. The only variable found 
to be associated with an increased risk of a horse being unable to return to its previous 
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level of athletic function was the length of time between the onset of sepsis and treatment 
(Table 6). 
Table 6: Multivariable logistic regression analysis of factors affecting likelihood of a horse returning 
to its' previous level of athletic function following treatment for septic digital tenosynovitis 
Coefficient S.E. OR 95% C.I. p 
Constant 0.47 0.29 0.099 
Time between onset of sepsis and treatment, with <24hrs as referent value 
1-7 ds -2.08 0.83 0.13 0.02 - 0.63 0.012 
3.4.5. Comparison of outcomes for septic arthritis and septic digital tenosynovitis 
Comparison of survival rates for those horses treated for septic mthritis and those horses 
treated for septic digital tenosynovitis showed that there was no statistically significant 
difference in the outcome for either of the two groups. However, when comparing the 
likelihood of a horse being able to return to its previous level of athletic function it was 
found that those horses treated for septic digital tenosynovitis were significantly less likely 
to achieve this level of athletic activity compared to those horses treated for septic arthritis 
(O.R.: 2.67; 95% C.l. 1.26 - 5.67; p=0.005). 
3.5. Discussion of results 
3.5.1. Class of evidence 
Previous studies reported in the literature, investigating septic digital tenosynovitis, only 
included data from low numbers of cases (Honnas et al. 1991; Schneider et a/1992a; Chan 
et al. 2000; Frees et al. 2002), and have frequently focused on the efficacy of a specific 
treatment regimen (Chan et al. 2000; Frees et al. 2002). When considered in the context of 
evidence-based medicine, these studies have only provided class C evidence when using 
the classification system proposed by Yusuf et al. (1998). Whilst these studies contain a 
wealth of useful information, some of their conclusions must be viewed with caution due 
to inadequacies of the study design. By designing a study utilising a comparison 
population, it was hoped that the current study would provide findings in a higher class of 
evidence (class B) than those previously reported. 
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3.5.2. Comparison of survival rates 
The purpose of this study was not to investigate the influence of a specific treatment 
regime on either the short or long term outcome for each case, but to ascertain whether the 
exact location of the inciting cause of sepsis, or the duration from onset of clinical signs to 
presentation at the hospital for treatment influenced either the short or long term outcome 
for the horse. One previous study reported that 100% of cases treated for septic digital 
tenosynovitis survived to be discharged from the hospital (Schneider et ai. 1992a). Whilst 
the current study did not find such a high survival rate (87.8%; 95% CI 81.1 to 94.6), it is 
comparable to the survival rates of between 75% and 91 % reported in other studies 
(Honnas et ai. 1991; Chan et ai. 2000; Frees et ai. 2002). 
3.5.3. Factors affecting short and long term prognosis 
The numbers of male and female horses were evenly represented in the study population, 
as were the numbers of forelimbs and hindlimbs affected. Gender, the age of the horse at 
presentation and the limb affected were not found to have a significant influence on either 
the short or long term prognosis. A majority of the cases treated in the study period (64%) 
had sustained an injury at the level of the pastern, which had resulted in the development 
of septic digital tenosynovitis. Similarly, when investigating the duration from the onset of 
clinical signs to presentation at the hospital for treatment, the majority of cases (50.6%) 
were presented within 24 hours of onset of clinical signs. It may be expected that a longer 
duration from onset of clinical signs to initiation of treatment would reduce the likelihood 
of that horse either surviving to be discharged from the hospital or returning to its original 
level of athletic function, as prolonged exposure of the synovial structures to both bacteria 
and proteolytic enzymes will increase fibrin production and the likelihood of adhesion 
formation. Previous studies have not found a delay in treatment to influence significantly 
the eventual outcome for horses treated for septic digital tenosynovitis (Honnas et al. 1991; 
Chan et al. 2000), although they have suggested that prompt institution of aggressive 
treatment may improve the proportion of horses with a more favourable outcome. Our 
study agreed with those previously reported, finding that the time between onset of clinical 
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signs and the initiation of treatment did not affect the short term prognosis. However, our 
study found that a delay of between 1 and 7 days between the onset of sepsis and treatment 
would reduce the likelihood of a horse being able to return to its previous level of athletic 
function by almost eight times, when compared to a horse treated within 24 hours. 
Although a delay of greater than 7 days between the onset of sepsis and treatment was not 
found to influence the likelihood that a horse would return to its previous level of athletic 
function, the number of horses in this category was very low. 
3.5.4. Study design and power 
Although the current study failed to associate many of the variables investigated with the 
outcome, this does not necessarily mean that these variables do not influence either of the 
outcomes investigated. Despite the careful study design, and the power study performed at 
the outset, there may be a lack of power for some of the variables, in order to be able to 
show a statistically significant difference. For example, when investigating how the limb 
affected (forelimb or hindlimb) affects the long term prognosis, no significant association 
was found. However, at a significance level of 5%, this calculation only has a study power 
of 44%, therefore the power, and also the sample size, are inadequate to be able to detect a 
statistically significant difference. 
3.5.5. Quantification of outcome 
As the majority of the horses included in the study were used primarily for general riding 
purposes at the time of admission to the hospital, it is impossible to quantify their return to 
athletic activity in terms of either competitive winnings or number of events entered. 
Follow up information was therefore obtained by telephone questionnaire to the owners, as 
a successful outcome following treatment was viewed as whether the horse was able to 
fulfil the owner's long-term athletic expectations. 
3.5.6. Study limitations 
Despite the large number of horses in the study, the retrospective study design, coupled 
with the fact that many horses received more than one antimicrobial and lavage technique, 
limits any conclusions that could be drawn regarding the relative efficacy of specific 
treatment modalities. However, the aim of the study was not to compare the relative 
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success associated with one specific treatment, but to investigate the long-term prognosis 
of horses that had survived until discharge from the hospital, and to establish whether the 
occurrence of septic digital tenosynovitis would affect the likelihood of them returning to 
their previous level of athletic function. Studies adopting a prospective, controlled design 
are required in order to be able to draw any conclusions on the efficacy of specific 
treatment regimens. 
In addition, the use of a telephone questionnaire to investigate the long term outcome for 
horses treated for digital sheath sepsis introduces bias. Inevitably, decay of memory will 
occur over time, and the ability for accurate recall of details must be questioned, in 
particular in those cases identified early in the study period, where owners were asked to 
recall events that had occurred upto ten years earlier. In addition, the ability for the owner 
to recall events accurately may not only be tempered by time, but also by the success of the 
outcome. Where a horse went on to return to its' previous level of athletic function, 
owners are less likely to recall negative events that may have occurred during recovery. 
3.5.7. Comparison between septic arthritis and septic digital tenosynovitis 
A comparison of results was made between the current study and a separate study 
conducted at the same practice investigating the long-term prognosis for horses treated for 
septic arthritis (Chapter 4). This comparison showed that whilst there was no difference in 
survival rates between those horses treated for septic arthritis and those treated for septic 
digital tenosynovitis, those horses treated for septic digital tenosynovitis were significantly 
less likely to return to their previous level of athletic function than those treated for septic 
arthritis. Although the findings on survival rates are comparable to a previous study 
(Schneider et al. 1992a), no study has compared the long-term prognosis for these two 
conditions. The difference in long-term prognosis may suggest that it is inappropriate to 
extrapolate data from the management of septic arthritis and apply it to septic digital 
tenosynovitis (Schneider et al. 1992a). Future research should recognise septic digital 
tenosynovitis as a separate condition, as neonatal septic arthritis has been, with research 
targeted accordingly. 
3.5.7. Classification within the literature pool 
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This study has provided results from a higher class of evidence than that previously 
repOlied (Honnas, et al. 1991; Schneider, et aI, 1992a; Chan et al. 2000; Frees ef al. 2002), 
by providing class B evidence, using the classification system proposed by Yusuf, ef al 
(1998). This research is from a practice population primarily consisting of general purpose 
riding horses and not high level competition horses, therefore the results are applicable to 
many different practice populations, where the majority of horses seen are not high level 
competition animals. The current study contradicts a previous study (Schneider et al. 
1992a) by finding that there is a significant difference between the outcome for horses 
treated for septic arthritis and septic digital tenosynovitis, therefore data from one 
condition should not be extrapolated to the other. This study also gives general 
practitioners information on the likely short and long-term prognosis for a horse treated for 
septic digital tenosynovitis. 
3.5.8. Conclusions 
The prognosis for survival following early identification and treatment of septic digital 
tenosynovitis in this particular population of horses is fair. If the infection is successfully 
eliminated from the synovial space, then over 50% of those horses that were discharged 
returned to their previous level, or a higher level, of exercise. However, horses where a 
delay of greater than seven days occurred between the onset of sepsis and the initiation of 
treatment, had a significantly poorer prognosis for returning to their previous level of 
athletic function compared to those horses where treatment was initiated earlier. 
Therefore, horses that require treatment for septic digital tenosynovitis can be given a fair 
prognosis for return to full athletic function. However, the prognosis for return to future 
soundness is not as good as that for horses treated for septic arthritis. 
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Chapter 4 
What is the likelihood that a mature horse treated for septic arthritis will be able to 
return to its' previous level of athletic performance? 
4.1. Introduction 
Septic arthritis in adult horses is a serious clinical problem (Bertone et at. 1987a,b; Tulamo 
et at. 1989a; Schneider et al. 1992b; Cook & Bertone, 1998; Booth et at. 2001), with the 
first case series of monarticular septic arthritis in adult horses described in the veterinary 
literature by Van Pelt in 1971. The potential exists to cause permanent degenerative joint 
disease (Bertone et al. 1987b), irreversible cartilage damage, fibrosis and unsoundness 
when infection is not rapidly eliminated from the synovial space (Tulamo et at. 1989a; 
Schneider et al. 1992a,b; Tremaine, 2000). Historically, joint sepsis was most readily 
recognised as a sequel to septicaemia in foals (Rooney, 1962; Van Pelt & Riley 1969; 
Coffman, 1970) and was thought to be only an infrequent problem in older horses (Van 
Pelt, 1971) although it is now recognised as a more common occurrence (Morris et al. 
1980; Madison et al. 1991; Schneider ef al. 1992a). Initially the prognosis for horses 
treated for septic arthritis had been described as guarded to poor (Martens & Auer, 1980; 
McIlwraith, 1983; Bowman et al. 1991; Brusie et al. 1992; Lapointe et al. 1992). 
However, as more has become known about both the aetiology of the disease and the most 
efficacious treatment regimens the literature has carried reports of a more favourable 
prognosis (Schneider et at. 1992a; Bertone, 1999; Meijer et at. 2000). The main causes of 
treatment failure are the inability to eliminate the causative agent (Bertone et al. 1987a; 
Schneider et at. 1992a,b; Meijer et at. 2000) and to disrupt effectively the vicious cycle of 
articular cmiilage destruction through inflammatory products (Orsini, 1984; Stover, 1990; 
Bertone, 1999). 
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4.2. The occurrence of septic arthritis 
4.2.1. Aetiology and clinical signs of septic arthritis 
Septic arthritis is caused by the inoculation of a synovial cavity with bacteria, with viable 
organisms readily becoming established. Normally, synovium is capable of eliminating a 
certain number of bacteria (Gustafson, McIlwraith & Jones, 1989a; Hardy, Bertone & 
Malemud, 1998; Tremaine, 2000), although these natural defences can be overcome if the 
bacterial load is overwhelming, the organism is highly pathogenic, and therefore able to 
adhere to the synovium and either bypass or compromise the natural defence mechanisms, 
or the synovium is compromised (Cook & Bertone, 1998; Tremaine, 2000). In adult 
horses septic arthritis commonly affects only a single joint (Cook & Bertone, 1998). There 
are three recognised routes by which bacteria may become established within a synovial 
cavity (McIlwraith, 1983): 
1. Sepsis can be seen following a traumatic insult to the tissues overlying the joint, be 
it an apparently innocuous puncture wound or a larger laceration (Rose & Love, 
1979; Madison et at. 1991, Schneider et at. 1992a; Tremaine, 2000); 
2. following surgery involving a joint or joint injection, therefore of iatrogenic origin 
(Van Pelt, 1971; Leitch, 1979; Koch, 1979; McIlwraith, 1983; Martens et at. 1986; 
Schneider et al. 1992a; Tremaine, 2000); 
3. more rarely in adults, it can be the result of haematogenous spread from an 
infectious focus elsewhere in the body (Martens et at. 1986; Schneider et at. 
1992a). 
Occasionally, the inciting cause of sepsis is never recognised. Acute severe lameness, 
synovial effusion, heat and pain on palpation of the joint, periarticular swelling, pyrexia, 
cellulitis and distal limb oedema are the most commonly reported clinical findings (Van 
Pelt, 1971; Rose & Love, 1979; McIlwraith, 1983; Bertone et at. 1987a.b; Gibson et at. 
1989; Tulamo et at. 1989; Bowman et at. 1991; Peremans et at. 1991; Honnas et at. 
1992a,b; Schneider et at. 1992a; Cook & Bertone, 1998; Bertone, 1999; Meijer et at. 2000; 
Tremaine, 2000), although synovial effusion and lameness may not be as marked if the 
joint is open and draining (McIlwraith, 1983; Gibson et at. 1989; Honnas et at. 1992a). 
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4.2.2. Causative organisms of septic arthritis 
4.2.2.1. Response of a synovial structure to bacteria 
The response of a synovial structure to invasion by bacteria has been the subject of a large 
body of experimental research, and the sequence of events is well documented. Once 
bacteria have entered the joint, they localise in the synovial membrane and provoke a 
profound inflammatory reaction, with exudation of proteins and polymorphonUclear cells 
into the synovial cavity (Leitch, 1979; Bertone et al. 1987a; Cook & Bertone, 1998; 
Tremaine, 2000). Release of cellular enzymes, plasmin and prostaglandins leads to 
depletion of proteoglycans from the cartilage matrix within a matter of days (Leitch, 1979; 
McIlwraith, 1983; Bertone et al. 1987a; Peremans et al. 1991; Cook & Bertone, 1998; 
Tremaine, 2000), alteration in cartilage pliability, and subsequent collagen breakdown 
from increased vulnerability to mechanical forces (McIlwraith, 1983; Bertone et al. 1987a; 
Peremans et at. 1991; Tremaine, 2000). The nutritional capacity of the synovial fluid is 
diminished due to the inflammatory changes occurring, and interference with the synovial 
fluid-cartilage interface occurs due to exudates, pannus or granulation tissue, resulting in 
further articular cartilage destruction (Leitch, 1979; Martens & Auer, 1980; McIlwraith, 
1983; Peremans et al. 1991; Tremaine, 2000). These changes within the synovial cavity 
are reflected in the gross appearance of synovial fluid. Following the onset of sepsis 
synovial fluid typically becomes grossly turbid, watery and discoloured (Van Pelt, 1971; 
Rose & Love, 1979; Gibson et al. 1989; Tulamo et al. 1989; Peremans et al. 1991; 
Lapointe et at. 1992; Bertone, 1999; Tremaine, 2000). Laboratory analysis yields an 
increased total protein concentration, increasing with time from onset of sepsis, due to 
synovial inflammation resulting in an increase in synovial permeability (Van Pelt, 1971; 
Gibson et at. 1989; Tulamo et al. 1989; Peremans et at. 1991; Schneider et at. 1992a; 
Belione, 1999; Tremaine, 2000). A significant increase in the total white blood cell count 
within the synovial fluid, increasing with time from onset of sepsis, is also seen, with a 
profound neutrophilia consistent with the onset of clinical signs (Van Pelt, 1971; Rose & 
Love, 1979; Gibson et at. 1989; Tulamo et al. 1989; Peremans et al. 1991; Lapointe et al. 
1992; Schneider et al. 1992a; Bertone, 1999; Tremaine, 2000). Degeneration of the 
neutrophils is an infrequent finding (Van Pelt, 1971; Koch, 1979; Tulamo et al. 1989; 
Bertone, 1999). Synovial fluid pH, normally close in value to blood pH (Tulamo et al. 
1989) will rapidly become acidic following the onset of joint sepsis (Tulamo et al. 1989; 
Peremans et at. 1991). 
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4.2.2.2. Culture and identification of causative organisms 
It has been widely reported in the literature that bacterial culture from cases of suspected 
septic arthritis is umewarding (Van Pelt & Riley, 1969; Van Pelt, 1971; Koch, 1979; 
McIlwraith, 1983; Madison et al. 1991; Peremans et al. 1991), particularly in adult horses 
(Schneider et al. 1992a). Historically, culture was attempted on samples of synovial fluid, 
but a number of factors exist that may have prevented a positive culture. Synovial fluid is 
itself bactericidal in action, prior administration of antimicrobials will impede bacterial 
growth in culture (Koch, 1979; Martens et al. 1980; McIlwraith, 1983), and most 
importantly, when considering the action of bacteria within a joint, the site of 
multiplication is within the synovium rather than the synovial fluid (Martens & Auer, 
1980). However, although it would appear logical that synovial membrane biopsy and 
culture would give an increased bacterial isolation rate (McIlwraith, 1983; Martens et al. 
1986; Madison et al. 1991), this has frequently proved not to be the case. Studies in which 
culture of synovial membrane has been performed found either an identical isolation rate 
for synovial fluid and membrane (Bertone et al. 1987a), or a significantly lower isolation 
rate from synovial membrane compared to the results of isolation of organisms from 
synovial fluid (Madison et al. 1991; Ross et al. 1991). None of the studies investigated 
why culturing organisms from the synovial membrane was less successful than expected. 
One study (Bertone et al. 1987a) suggested that this may have been due to the emichment 
broth used as a transport medium for synovial fluid, inhibiting the antimicrobial activity of 
the systemic antimicrobials used, and also the complement and lysozyme activity, thereby 
achieving a higher isolation rate of organisms. Alternatively, the site from which the 
biopsy was taken may be the cause of the poor culture results. Biopsy samples may 
contain only some of the joint capsule (Madison et al. 1991), or the sample may not have 
been taken at a site where bacteria are sequestered and multiplying. 
When bacteria have been successfully cultured from joints in which sepsis is suspected, a 
mixed growth of bacteria is typically found in joints in which sepsis is due to a traumatic 
incident (Gibson et al. 1989; Madison et al. 1991; Schneider et al. 1992a). However, in 
joints where sepsis has occurred following joint injection or surgery, Staphylococcus 
aureus is the most common bacterial isolate (Koch, 1979; McIlwraith, 1983; Schneider et 
al. 1992a). Studies using an experimental model of septic arthritis have commonly used 
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Staphylococcus aureus as their bacterium of choice to induce sepsis (Bertone et al. 
1987a,b; Tulamo, Bramlage & Gabel, 1989a; Gustafson et al. 1989a,b), despite the fact 
that this may restrict the wider application of their results to the general population. Joints 
act in a very individual way when responding to inoculation of bacteria, with factors such 
as type, number and virulence of the organism (McIlwraith, 1983; Cook & Bertone, 1998), 
as well as the local and general resistance of the host playing important roles (Leitch, 1979; 
McIlwraith, 1983; Gustafson et al. 1989a; Schneider et al. 1992a). The exact anatomical 
joint infected also has an effect on the likely outcome (Peremans et al. 1991; Honnas et al. 
1992a,b; Schneider et al. 1992a). Where surgical access to a joint is poor (Honnas et al. 
1992a,b; Booth et al. 2001), or the anatomical structure of a joint is complex (Peremans et 
al. 1991), it may prohibit thorough lavage and removal of all bacteria and inflammatory 
products. To this end, it is important to study naturally occurring joint sepsis, as well as 
experimentally induced sepsis, in a large population of horses in order to evaluate 
treatment (McIlwraith, 1983; Schneider et al. 1992a). 
The effect of different 'doses' of bacteria has been reported in only one study, in which 
small numbers of joints were inoculated (Gustafson et al. 1989a). Results showed that, at a 
specified dose of bacterial inoculum (between 102 and 7 x 102), only four out of five horses 
developed septic arthritis, supporting the theory of the individuality of the response by a 
joint to infection. Similarly, at a lower dose of bacterial inoculum «102 organisms), all 
joints showed clinical signs consistent with joint sepsis (heat in joint, joint effusion, 
oedema and lameness), although these signs had resolved without therapy within forty-
eight hours. It has also been documented that traumatic septic arthritis is typically due to a 
mixed growth of bacteria, although Enterobacteriaceae are the most common isolate 
within this group (Schneider et al. 1992a) when culture of an organism is possible. It is 
unknown whether equine joints inoculated with these bacteria respond differently to both 
sepsis and the different treatment modalities suggested, when compared to those joints 
with a pure growth of Staphylococcus aureus, as has been found in human septic arthritis 
(Lapointe et al. 1992). It is known that the quantity of bacteria inoculated into joints, 
along with the virulence of the organism, can have a profound effect on the response of the 
joint to sepsis (Leitch, 1979; McIlwraith, 1983; Cook & Bertone, 1998), as it has been 
shown that the reaction of synovial tissue in an infected joint appears to be proportional to 
the extent to which the causative organism can multiply (Ropes & Bauer, 1953). 
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4.2.3. Treatment options for septic arthritis 
Successful resolution of septic arthritis involves treatment with broad-spectrum 
antimicrobials and joint drainage (Ross et al. 1991; Moore et al. 1992; Meijer et al. 2000), 
although controversy exists over the most efficacious form of drainage. There are many 
proposed treatment regimens for the successful resolution of septic arthritis, including: 
synovial fluid aspiration (Van Pelt & Riley, 1969), through-and-through lavage (Koch, 
1979; Leitch, 1979; Morris, 1980; McIlwraith, 1983; Martens et al. 1986; Bertone et al. 
1987a,b; Peremans et al. 1991; Schneider et al. 1992a,b), systemic antimicrobials (Van 
Pelt, 1969; Koch, 1979; Leitch, 1979; Morris, 1980; Martens et al. 1986; Bertone et al. 
1987a,b; Peremans et al. 1991; Honnas et al. 1992a,b; Schneider et al. 1992a,b), intra-
articular antimicrobials, including continuous drug delivery systems (Stover & Pool, 1985; 
Lloyd et al. 1990; Honnas et al. 1992a,b; Schneider et al. 1992a,b; Holcombe et al. 1997; 
Cook et al. 1999; Lescun et al. 2000; Adams & Lescun, 2000; Summerhays, 2000; Booth 
et al. 2001), arthroscopy (Koch, 1979; Morris, 1980; Ross et al. 1991; Honnas et al. 
1992a,b; Schneider et al. 1992a,b), arthrotomy (Leitch, 1979; Morris, 1980; Martens et al. 
1986; Bertone et al. 1992; Honnas et al. 1992a,b; Schneider et al. 1992a,b), synovectomy 
(Leitch, 1979; Martens et al. 1986; Bertone et al. 1992), intra-articular drains (Leitch, 
1979; Martens et al. 1986; Ross et al. 1991), regional perfusion with antimicrobials 
(Whitehair et al. 1992; McClure et al. 1993; Murphey et ai. 1999; Butt et al. 2001; 
Scheuch et al. 2001), and non-steroidal anti-inflammatory drugs (Koch, 1979; Leitch, 
1979; Morris, 1980; McIlwraith, 1983; Martens et al. 1986; Bertone et al. 1987a,b; Honnas 
et ai, 1992a; Schneider et al. 1992a,b; Meijer et al. 2000). 
4.2.3.1. Medical Therapy 
4.2.3.1.1. Historical treatment options 
The first suggestions for treatment of septic arthritis in adult horses were based on sound 
scientific principles. Lameness is initially caused due to massive joint distension, therefore 
aspiration of the synovial fluid would not only relieve the local pressure build up within 
the joint, but also reduce the bacterial load within that joint (Van Pelt & Riley, 1969; Van 
Pelt, 1971). Culture of the aspirated fluid was attempted, although no bacteria were 
isolated (Van Pelt, 1971). Injection of an antimicrobial directly into the affected joint was 
performed after aspiration of the synovial fluid, with a broad-spectrum antimicrobial 
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advocated (Van Pelt, 1971). In some cases, this antimicrobial was in combination with a 
steroid, and in some cases this therapy was combined with systemic administration of 
antimicrobials (Van Pelt & Riley, 1969; Van Pelt, 1971). The majority of horses in these 
studies were reported to have a satisfactory outcome following treatment. 
4.2.3.1.2. Systemic antimicrobials 
Administration of broad-spectrum, systemic antimicrobials is recognised as an important 
treatment for septic arthritis (Leitch, 1979; Bertone et al. 1987a; Gibson et at. 1989; 
Peremans et at. 1991; Ross et at. 1991; Honnas et at. 1992a; Moore et at. 1992; Schneider 
et at. 1992a; Bertone, 1999; Tremaine, 2000). Treatment should ideally be started once an 
initial synovial fluid sample has been obtained, because even if the antimicrobial is 
ineffective against the bacterium within the joint, it may still interfere with successful 
culture of that organism (Peremans et at. 1991). However, antimicrobial therapy should 
be initiated immediately after synovial fluid aspiration, without waiting for culture results 
(McIlwraith, 1983; Gibson et at. 1989; Peremans et at. 1991; Meijer et at. 2000; Tremaine, 
2000). 
Antimicrobials have been shown to relieve systemic signs associated with joint sepsis, 
such as pain and pyrexia, (Bertone et at. 1987a; Bertone, 1999; Tremaine, 2000) and will 
diffuse into the synovial space (Bertone et at. 1992; Cook et al. 1999; Errecalde et al. 
2001), although their trough concentrations may be below the minimum inhibitory 
concentration (MIC) for most isolates (Bertone et al. 1992; Cook et at. 1999), especially in 
the face of ongoing sepsis lowering the pH. The intravenous route of administration is 
recommended at the onset of treatment (Bertone, 1999) in order to achieve therapeutic 
blood and tissue concentrations rapidly, with penicillin in combination with an 
aminoglycoside (Ross et at. 1991; Moore et at. 1992; Schneider et at. 1992a), or a third-
generation cephalosporin (Schneider et al. 1992a), being the most common antimicrobials 
used (Bertone, 1999). 
Early experimental work investigated the efficacy of trimethoprim-sulphadiazine 
combinations in the treatment of Staphylococcus aureus induced septic arthritis (Bertone et 
al. 1987a; Bertone et at. 1988). These studies found that, at the manufacturers 
recommended oral daily dose rate, concentrations of trimethoprim or sulphadiazine were 
not effectively maintained above the MIC for S. aureus in the infected synovial fluid, nor 
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in the serum in the case of trimethoprim. However, doubling the recommended daily dose 
rate was effective in maintaining serum and synovial concentrations in excess of the MIC 
for the infective organism, resulting in a significant decrease in the isolation rate of S. 
aureus by the termination of the study (Bertone et al. 1987a; Bertone et al. 1988). 
Although administration of systemic antimicrobials with no lavage of the joint (Bertone et 
al. 1987a) was found to be effective in reducing the bacterial load within the joint in an 
experimental study, further studies looking at naturally occurring sepsis found conflicting 
evidence (Gibson et al. 1989), with an unfavourable outcome resulting when 
antimicrobials alone were used to treat septic arthritis. An oral trimethoprimlsulfa 
combination was used as the treatment of choice in the treatment of both iatrogenic and 
traumatic septic arthritis (Meijer et al. 2000), in combination with through-and-through 
joint lavage, with 81 % of cases resulting in the resolution of sepsis. Antimicrobials were 
only changed if indicated by bacterial culture and sensitivity, although in the majority of 
cases the infective organism isolated was found to be sensitive to the trimethoprim/sulfa 
combination. Although use of a trimethoprim/sulfa combination as a first choice 
antimicrobial in the treatment of septic arthritis has proved successful (Meijer et al. 2000), 
its narrow spectrum of action against many common pathogenic organisms may limit its 
use in the face of mixed bacterial infections (Moore et al. 1992). 
A study investigating the antimicrobial susceptibility of bacterial isolates from 233 horses 
with musculoskeletal infections (Moore et al. 1992) found that Enterobacteriaceae were 
the most common isolate (28.8%), with only 38.5% of these isolates being sensitive to 
trimethoprim/sulfa, and coagulase-positive staphylococci only comprised 11.8% of 
isolates. Amikacin proved to be the most efficacious antimicrobial, providing broad-
spectrum coverage, especially when in combination with a penicillin, although the cost of 
amikacin precludes its use as the routine drug of choice. This study (Moore et al. 1992) 
advocated the use of broad-spectrum antimicrobials in the management of Olihopaedic 
infections pending culture results, citing a penicillinlaminoglycoside combination as being 
both an effective, and affordable choice, switching only to an oral antimicrobial such as 
trimethoprim/sulfa if indicated by culture and sensitivity. Other studies (Schneider et al. 
1992a), whilst starting with broad-spectrum intravenous antimicrobials (normally a 
penicillinlaminoglycoside combination) have switched to oral trimethoprimlsulfa 
combinations following culture and sensitivity results. All recent studies advocate the use 
of systemic antimicrobials in the treatment of septic arthritis (McIlwraith, 1983; Gibson et 
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ai. 1991; Peremans et ai. 1991; Honnas et ai. 1992a; Schneider et ai. 1992a; Meijer et ai. 
2000), with the initial selection of drug based on the source of infection and the suspected 
organism (Moore et ai. 1992), until culture and sensitivity results dictate otherwise. 
4.2.3.1.3. Regional limb perfusion 
Regional limb perfusion has been shown to be effective in delivering antimicrobials under 
pressure to a selected region of the limb through the venous system (Whitehair et ai. 1992; 
Murphey et ai, 1999; Butt et ai. 2001; Scheuch et ai. 2002). In an experimentally induced 
septic arthritis, the mean concentration of gentamicin present in the synovial fluid was 
significantly higher than following intravenous administration (Whitehair et ai. 1992). 
Results showed that regional perfusion with gentamicin was successful in sufficiently 
decreasing the number of micro-organisms present so as to prevent culture of S. aureus 
(Whitehair et ai. 1992). Studies have also investigated intra-osseous perfusion of 
antimicrobials (Butt et ai. 2001; Scheuch et ai. 2002). Whilst this route of administration 
also achieved high concentrations of antimicrobial within the target joint, the 
concentrations were not as high as those achieved using the intravenous route (Butt et ai. 
2001; Scheuch et ai. 2002). 
4.2.3.1.4. Intra-articular use of antimicrobials 
In order to achieve intra-articular antimicrobial concentrations above the MIC for the 
suspected organism, intra-articular administration of antimicrobials is also possible. 
Although initially thought to be contra-indicated due to the chemical synovitis it would 
produce, (Koch 1979; Leitch, 1979; McIlwraith, 1983), more recent studies have shown 
that the beneficial effects of intra-articular administration of appropriate antimicrobials are 
greater than any possible detrimental effects (Stover & Pool, 1985; Lloyd et ai. 1990; 
Schneider & Bramlage, 1991; Mills et ai. 2000). Intra-articular administration of 
aminoglycosides and third generation cephalosporins has also been shown to provide 
higher concentrations of antimicrobial within the synovia, maintaining therapeutic 
concentrations for a longer period of time, compared with intravenous administration of 
antimicrobial (Lloyd et ai. 1990; Mills et ai. 2000). Stover & Pool (1985) demonstrated 
that it could not be the acidic nature of the antimicrobial inducing the characteristic 
synovitis seen, with a greater inflammatory response seen following the intra-articular 
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injection of saline (pH 4.5-7.0) when compared to intra-articular injection of gentamicin 
(pH 3.2). Intra-articular administration of antimicrobials has been included in the 
treatment strategy of many studies investigating septic arthritis in horses (McClure et al. 
1993). Although it is possible to achieve these sustained high concentrations of 
antimicrobials within a joint by daily injection (Cook et al. 1999), the act of introducing a 
needle into a joint not only increases the risk of introducing infectious organisms (Cook et 
al. 1999), but it has also been shown to induce a synovitis (Cook et al. 1999). Alternative 
drug delivery methods have been investigated (Holcombe et al. 1997; Cook et al. 1999; 
Ethell et al. 2000; Lescun et ai. 2000; Summerhays, 2000), including the use of flow-
control tubing and balloon infusers (Adams & Lescun, 2000; Lescun et ai. 2000), to 
provide a continuous infusion of antimicrobial into the joint. Balloon infusers were filled 
with gentamicin, with flow control tubing running from the infuser to an infusion catheter 
within the tibio-tarsal joint (Adams & Lescun, 2000; Lescun et al. 2000). Results 
indicated that use of an infusion system would be an effective way of maintaining a high 
concentration of gentamicin within a joint for a prolonged period of time (Adams & 
Lescun, 2000; Lescun et al. 2000). Although 29% of infusion catheters developed 
complications these were resolved by replacement of either the catheter or the balloon 
infuser, with an air lock of the flow control tubing being the most likely complication. 
Further work showed that a continuous infusion of gentamicin into tibio-tarsal joints for a 
period of five days did not cause significant synovial inflammation or articular cartilage 
damage, with any changes seen improving over a further nine day period (Lescun et al. 
2002). Antimicrobial-impregnated polymethyl methacrylate (PMMA) and antimicrobial-
impregnated hydroxyapatite cement (HAC) has been shown to be effective in providing 
sustained high concentrations of antimicrobials locally when used in human patients, 
whilst maintaining low serum concentrations, thereby limiting the potential for toxic side 
effects (Butson et al. 1996; Tobias et al. 1996; Holcombe et al. 1997; Cook et al. 1999; 
Booth et al. 2001; Farnsworth et al. 2001). Many different antimicrobials have been 
shown to be suitable for combination with both PMMA and HAC in the treatment of 
orthopaedic infections (Holcombe et al. 1997; Bertone, 1999; Ethell et al. 2000), with 
HAC exhibiting a better elution rate and duration of action than PMMA (Ethell et al. 
2000), and where excessive cost may prohibit systemic administration of an antimicrobial 
for prolonged periods, use of an impregnated implant provides a feasible alternative 
(Holcombe et al. 1997; Ethell et al. 2000). The limitation to the use of PMMA beads in 
the treatment of septic arthritis may be that they are non-absorbable and removal of the 
beads is suggested (Summerhays, 2000; Farnsworth et al. 2001), although it can be 
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difficult to determine when these implants should be removed. If beads were left within 
the joint in a freely exercising horse, they could contribute to synovial inflammation and 
cartilage erosion (Summerhays, 2000; Farnsworth et al. 2001). Experimental studies have 
focused on the use of biodegradable drug delivery systems (BDDS) which, whilst 
providing the benefits of sustained high local concentrations of antimicrobials with low 
risk of toxic side effects, would not have the disadvantage of requiring removal at a later 
date (Cook et al. 1999). Collagen sponges were also proposed as a suitable biodegradable 
implant for use in septic arthritis (Summerhays, 2000), providing similar benefits to 
BDDS. 
4.2.3.1.5. Non-steroidal anti-inflammatory drugs 
The judicious use of non-steroidal anti-inflammatory drugs has been advocated in many 
studies on septic arthritis (Leitch, 1979; Rose & Love, 1979; Peremans et al. 1991; Ross et 
al. 1991; Schneider et al. 1992a; Meijer et al. 2000). Whilst they are unable, by 
themselves, to resolve the infection (Bertone et al. 1987a) they are important in both their 
analgesic and anti-inflammatory roles (Peremans et al. 1991; Ross et al. 1991; Ronnas et 
at. 1992a; Schneider et al. 1992a), although over use may mask signs of ongoing sepsis 
within the joint (McIlwraith, 1983; Bertone, 1999). 
4.2.3.2. Surgical therapy 
4.2.3.2.1. Joint lavage 
Distension-irrigation and through-and-through lavage were later considered as alternatives 
to simple aspiration of the synovial fluid, as dilution of both the bacteria and the 
accompanying white cells (which produce lysosomal enzymes) were thought to be an 
impOliant consideration (Rose & Love, 1979; Bertone et al. 1987a,b; Leitch, 1979; 
Schneider et al. 1992a,b; Meijer et al. 2000). Bertone et al. (1987a,b; 1992) performed 
experimental studies inoculating Staphylococcus aureus into the joint in order to induce 
sepsis, to investigate the effect of different treatment modalities. 
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The first study compared the efficacy of administration of systemic antimicrobials with 
either joint lavage, intra-articular and systemic antimicrobials, or joint lavage, arthrotomy, 
intra-articular and systemic antimicrobials. There was also a control group (four joints) 
that received analgesia only following inoculation of bacteria. The conclusions drawn 
were that when no treatment was given, horses were euthanased on humane grounds (pain 
non-responsive to analgesia) within seven days. Using a high dose (double the 
manufacturer's recommended dose) of systemic antimicrobials significantly reduced the 
rate of isolation of Staphylococcus aureus from the joint at the termination of the study, 
although no clinical benefits from using arthrotomy, as opposed to through-and-through 
joint lavage alone, were apparent. This study was both randomised and controlled, thereby 
classifying it as providing class A evidence when using the classification system proposed 
by Yusuf et al (1998), although there was no blinding in the study design. However, the 
numbers in each of the study groups were very low, with only two horses (four joints) in 
each group. The suitability of the control group could also be questioned. The control 
horses were only treated with oral non-steroidal anti-inflammatory drugs, which, if used by 
itself, is not an appropriate treatment for septic arthritis. 
The second study compared two different lavage solutions for their efficacy in resolving 
sepsis, with the horse acting as a self-control (the two tibio-tarsal joints in a horse were 
allocated, one to each treatment group). All horses in the study also received systemic 
antimicrobial therapy and analgesia. Synovial membrane and articular cartilage samples 
collected at necropsy were analysed histologically for evidence of synovitis and articular 
cartilage damage. Results indicated that there was no significant difference in the response 
of the joint between using a neutral-pH, isotonic-balanced electrolyte solution compared to 
a dilute, 0.1 % povidone/iodine solution as lavage solutions. A high proportion of both 
synovial fluid and synovial membrane samples remained culture positive for 
Staphylococcus aureus at the termination of the study. This study was in fact a sub-group 
of the previous study (Bertone et al. 1987a). Similarly, as it is both randomised and 
controlled, it is classified as class A evidence. However, as in the previous study the 
numbers in each of the study groups were low, with only two horses per group. 
The third study (Bertone et al. 1992) investigated the efficacy of arthrotomy versus 
arthroscopy and partial synovectomy for the treatment of experimentally induced 
infectious arthritis. All horses in the study received systemic antimicrobial therapy and 
analgesia. Synovial membrane and articular cartilage samples were collected at necropsy 
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for histologic and histochemical evaluation. Results indicated that arthrotomy eliminated 
the experimentally induced infection faster than arthroscopy and synovectomy, although 
both treatments had eliminated infection from all but a single joint by the termination of 
the study. Again, this study could be classified as class A evidence, as joints were 
randomly assigned to each treatment group. As each horse had one tibio-tarsal joint in 
each group, the horses acted as self-controls. However, although the numbers in each 
study group are slightly higher than previously reported studies (Bertone et al. 1987 a,b), 
the numbers are still low with only four horses in each study group. 
All three of these studies did not find the results from the treatment under investigation 
(arthrotomy; povidone/iodine lavage solution; arthroscopy and synovectomy) significantly 
different from the standard treatment regime used as a comparison. However, a difference 
in outcome that is not found to be statistically significant does not necessarily indicate that 
different treatment regimes are equivalent. The case numbers in each of the study groups 
were very low, therefore the studies may have lacked sufficient power to achieve statistical 
significance. If these studies were repeated with a much larger sample size, the outcome 
may be different. An additional consideration is that these three studies utilised an 
experimental septic arthritis model, induced by the inoculation of S. aureus into the tibio-
tarsal joint. Any extrapolation of results from this study to a practice population should be 
viewed with caution, as a number of important factors (causative organism, bacterial load, 
virulence of organism, joint affected, degree of tissue trauma and bacterial contamination) 
will differ between the study and practice populations. 
The other studies were uncontrolled case series (class C evidence), utilising through-and-
through joint lavage as part of a combination of therapies (Gibson et al. 1991; Ross et al. 
1991; Peremans et al. 1991; Honnas et al. 1992a,b; Schneider et al. 1992a,b; Meijer et al. 
2000). All concluded that thorough lavage of the joint was vital for the successful 
resolution of synovial sepsis. 
Whilst many studies have used polyionic solutions, or lactated ringers solution, when 
lavaging a septic joint, alternatives have been used (Bertone et al. 1987b; Gibson et al. 
1991; Peremans et al. 1991; Honnas et al. 1992a,b; Schneider et al. 1992a,b). The addition 
of povidone/iodine to the lavage solution (Bertone et al. 1987b; Gibson et al. 1991; 
Peremans et al. 1991; Ross et al. 1991; Schneider et al. 1992a) was found to have no 
beneficial effect in reducing the bacterial load when compared to neutral-pH, isotonic-
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balanced electrolyte solutions (Bertone et at. 1987b; Gibson et at. 1991), although there 
was less fibrin found in the joint following treatment with povidone/iodine (Bertone et at. 
1987b). Other additives used have included dimethyl-sulfoxide (DMSO), thought to be 
beneficial through its potent analgesic and anti-inflammatory actions (Honnas et at. 
1992a,b; Bertone, 1999) and antimicrobials (Ross et al. 1991; Schneider et al. 1992a). No 
conclusions were drawn as to whether these solutions were more beneficial than using a 
polyionic solution alone, although it was suggested that incorporating DMSO into the 
lavage solution may have contributed to the successful outcome of those horses in which it 
was used (Honnas et at. 1992a). 
4.2.3.2.2. Arthroscopy and arthrotomy 
Although simple through-and-through lavage may be effective in many cases in the 
treatment of septic arthritis, the needles can rapidly become occluded if fibrin is present 
within the joint (Meijer et al. 2000). Arthroscopy is felt to be superior to lavage in this 
way, as it not only allows good visualisation of the articular surfaces and other synovial 
structures, but also allows removal of fibrin and debridement of any infected areas (Ross et 
at. 1991; Bertone et at. 1992; Honnas et at. 1992a; Schneider et al. 1992a,b; Bertone, 
1999; Meijer et al. 2000; Tremaine, 2000). Synovectomy, to decrease the bacterial load 
and remove excess inflammatory cells sequestered in the synovium, can also be performed 
at this time (Ross et al. 1991; Bertone et al. 1992; Honnas et al. 1992a,b; Schneider et at. 
1992a,b; Bertone, 1999; Meijer et at. 2000; Tremaine, 2000). 
Arthrotomy has been found to be superior to arthroscopic lavage, as it allows continuous 
drainage of fluid from the joint, decreasing the bacterial load faster (Bertone et at. 1992; 
Honnas et at. 1992a; Bertone, 1999) and preventing the discomfort associated with joint 
distension (Gibson et al. 1991; Bertone et at. 1992; Honnas et at. 1992a; Lapointe et at. 
1992 Schneider et al. 1992b; Bertone, 1999). In some instances of open joint injury, 
distension of the joint for arthroscopic evaluation is not possible, leaving arthrotomy as a 
suitable alternative (Honnas et al. 1992a). Although it would appear to be a beneficial 
treatment, studies showed that there was a delayed healing time of the arthrotomy incisions 
(Bertone et al. 1987a; Bertone et at. 1992; Lapointe et al. 1992; Schneider et al. 1992b; 
Bertone, 1999), predisposing them to the formation of exuberant granulation tissue, and 
increasing the risk of ascending infection entering the joint (Belione et al. 1987a; Bertone 
et al. 1992; Honnas et al. 1992a). Synovectomy can also be performed through an 
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arthrotomy incision (Leitch, 1979; Schneider et a11992b) although this will not allow such 
wide access to the joint compared with arthroscopy (Meijer ef al. 2000) 
Although arthrotomy allows passive, open drainage of the joint to occur, closed-suction 
drainage has also been used for continuous removal of excess synovial fluid, bacteria and 
inflammatory products from the joint (Leitch, 1979; Ross ef al. 1991; Honnas et al. 1992a; 
Lapointe et al. 1992). Continuous decompression of the joint increases the comfort of the 
horse, and precludes the need for repeated general anaesthesia to lavage the joint (Ross et 
al. 1991; Honnas ef al. 1992a) 
4.2.4. Outcome 
The prognosis for a successful return to athletic function has been variously described from 
guarded or poor (Martens & Auer, 1980; McIlwraith, 1983; Gibson ef al. 1989; Bowman ef 
al. 1991; Brusie ef al. 1992; Lapointe et al. 1992) to favourable, or even good (Ross et al. 
1991; Schneider et al. 1992a,b; Bertone, 1999; Meijer et al. 2000; Summerhays, 2000; 
Booth et al. 2001). It has been shown that time between onset of sepsis and initiation of 
therapy (Gibson et al. 1989; Peremans et al. 1991; Honnas et al. 1992a), and the joint 
infected (Peremans et al. 1991; Booth et al. 2000) are both influential when considering 
the likely outcome. Whilst it is widely accepted that systemic antimicrobial therapy and 
joint drainage are necessary for the successful resolution of septic arthritis, many different 
treatment regimens exist, and no study has critically evaluated these treatments to see if 
one offers advantages over the others. The majority of studies are retrospective case series 
utilising multiple treatment regimens, rendering it difficult to draw definitive conclusions 
regarding the best method of treatment (Gibson et al. 1989; Schneider et al. 1992a). 
4.3. Study aims 
The purpose of this study was to evaluate critically data from two centres over the last ten 
years, in order to investigate factors associated with survival and return to previous level of 
athletic function following septic arthritis. An additional aim of this study was to evaluate 
appropriate prognostic cut-off values for diagnostic tests in relation to these outcomes. 
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4.4. Materials and methods 
4.4.1. Data retrieval 
The admission records for Bell Equine Veterinary Clinic and Rossdales Equine Hospital 
between 1992 and 2002 were reviewed to identify horses that had been admitted for 
investigation of suspected septic arthritis, and medical records were then retrieved. In 
order to be eligible for inclusion in the study horses had to be at least six months old at the 
time of admission to the hospital. In cases in which septic arthritis was suspected on the 
basis of clinical signs, diagnosis was confirmed on the result of synoviocentesis of the 
affected j oint, where an increased nucleated cell count (upper end of normal reference limit 
for laboratory: 3 x 109 cells/I) in conjunction with an increased total protein concentration 
(upper end of normal reference limit: 15g/l) and the presence of a neutrophilia (>90%) with 
degenerative polymorphonuclear cells on cytological analysis were considered to be 
diagnostic. 
Information retrieved from the medical records included age, sex, breed and athletic use of 
the horse at the time of admission; number and location of affected joints; the suspected 
route of infection; evidence of any radiographic abnormalities at the time of admission; 
time from onset of clinical signs to presentation at the clinic for treatment; the white cell 
count of the synovial fluid at the time of admission to the hospital; results of bacterial 
culture of the synovial fluid; details of antimicrobial therapy and lavage procedures 
performed and whether the horse was discharged from the hospital following treatment. 
The outcomes of interest were whether the horse survived to be discharged from the 
hospital, and whether the horse returned to its' previous, or higher, level of performance. 
4.4.2. Data Analysis 
Variables that were statistically evaluated included age and sex; specific joint infected and 
suspected route of infection; duration of sepsis prior to treatment; synovial white cell count 
at the time of admission and whether there was any evidence of radiographic abnormalities 
at time of admission. Categorical variables with more than two levels were coded as 
indicator variables. 
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Outcomes that were statistically evaluated for each variable included discharge from the 
hospital and whether the horse eventually returned to its previous level, or a higher level, 
of performance. Outcome was determined by evaluation of medical records to determine 
whether the horses were successfully discharged from the hospital. Long term follow up 
was then obtained by means of a questionnaire administered to owners by telephone 
(Appendix 3). The purpose of the questionnaire was to establish the level of athletic 
performance the horse had achieved prior to the occurrence of septic arthritis and whether, 
in the owner's opinion, the horse had been able to return to this level of performance after 
discharge from the hospital. If the owner did not consider the horse to have successfully 
returned to its previous level of performance, it was established whether this was directly 
attributable to the occurrence of septic arthritis, or whether there were other factors that 
had contributed to the eventual outcome. 
Binary logistic regression was used to analyse these data, as both outcomes of interest were 
dichotomous. Two binary logistic regression models were developed using these data. 
Analyses were implemented with the statistical software MINITAB (version 13.31). 
Univariable logistic regression was used to screen all variables, and from this all variables 
with a p-value :s 0.20 were included in a backward elimination process to fit a 
multivariable model. The inclusion criterion for backward elimination was set at p :S 0.05. 
The goodness-of-fit of the models was assessed using the Hosmer-Lemeshow goodness-of-
fit test, to test the null hypothesis that the model was considered to be a good fit, with the 
null hypothesis rejected at a p-value:s 0.05. 
Once the main effects model had been fitted, two-way interaction between variables was 
assessed. Variable selection was determined by biological plausibility. Assessment 
between models was obtained using a likelihood ratio test (LRT) with significance set at p 
:S 0.05. 
A Receiver Operating Characteristic (ROC) curve allows for the evaluation of an 
appropriate cut-off value for a diagnostic test, in order for the test to be a worthwhile 
prognostic indicator. This is done by plotting the sensitivity of a test versus the false 
positive rate calculated at a number of different cut-points, in order to select the optimum 
cut-point for distinguishing between those animals with positive and negative outcomes. 
The closer the ROC curve is to the top left hand corner of the graph, the better the ability 
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of the test to discriminate between those animals with a positive and negative outcome. A 
Two-graph Receiver Operating Characteristic (TG-ROC) curve allows the simultaneous 
evaluation of how both the sensitivity and specificity of a test vary as the cut-point is 
changed. Non-parametric TG-ROC curves were generated to investigate the sensitivity 
and specificity of the nucleated white blood cell count of the synovial fluid at the time of 
admission as a predictor for each outcome of interest, using each observed value of the 
white blood cell count following synovial fluid analysis as a cut-point. 
4.5. Results 
4.5.1. Descriptive statistics 
Three hundred and twenty horses met the criteria for inclusion in the study. One hundred 
and seventy eight horses were male and one hundred and forty-one were female, with the 
sex not recorded in one case. The age at the time of admission was recorded in 314 cases, 
with the age ranging from 6 months old to 30 years old, and the median age was 7 years 
old (inter-quartile range 4 - 11 years old) at the time of admission. The athletic use at the 
time of admission was recorded in all cases, with 103 horses (32.2%) considered to be 
performing at a high athletic level (racing, polo, international eventing, dressage and 
showjumping), 209 horses (65.3%) were general purpose riding horses, and eight (2.5%) 
were used exclusively for breeding. 
Nine of the 320 horses (2.8%; 95% c.r. 1.3 to 5.3; p<O.OOl) had more than one synovial 
structure affected at the time of admission (Table 7). The joint involved was recorded in 
317 cases, with the most commonly affected joint being the tibio-tarsal joint (Table 7). 
The inciting cause of sepsis was recorded in 298 cases (93.1 %); the vast majority of horses 
developing septic arthritis subsequent to a traumatic event (Table 7), and only 1 horse 
developed septic arthritis subsequent to haematogenous spread of organisms from an 
infectious focus elsewhere in the body. Results of the cytological analyses of the synovial 
fluid collected at the time of admission were available in 170 cases (53.1 %). Nucleated 
cell counts on admission (range: 3.9 x 109 cells/l to 285.0 x 109 cells/I; median: 52.0 x 109 
cells/I; inter-quartile range: 21.15 x 109 cells/l to 102.25 x 109 cells/I) exceeded the 
reference limit (3.0 x 109 cells/I) in all cases. 
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The time between onset of clinical signs and presentation at the hospital for treatment was 
recorded in 310 cases (96.9%), with more than 60% of cases being presented at the 
hospital for treatment within 24 hours of the event perceived to have incited sepsis (Table 
7). Radiographs of the affected joint were taken in 298 cases (93.1 %) at the time of 
admission, with abnormalities evident in 58 cases (19.5%; 95% C.l. 15.1 to 24.4; p < 
0.001). Synovial fluid was submitted for bacterial culture and sensitivity prior to the 
administration of any systemic antimicrobials in 121 cases (37.8%), with 75 samples (62%; 
95% C.l. 52.7 to 70.7; p=O.OII) yielding no growth and, of the remaining samples, the 
most common isolate was a pure growth of Staphylococcus aureus (20 cases; 16.5%; 95% 
C.l. 10.4 to 24.4; p < 0.001). 
Table 7: Classification of joint affected, inciting cause of sepsis and time between onset of sepsis and 
initiation of treatment in horses treated for septic arthritis. 
Number % 
> 1 synovial structure affected 9/320 2.8 
Joint involved recorded 317/320 99.1 
Tibio-tarsal joint 98/317 30.9 
Metatarsophalangeal joint 63/317 19.9 
Carpus 49/317 15.5 
Metacarpophalangeal joint 311317 9.8 
Femoropatellar joint +/- 22/317 6.9 
femorotibial joint 
Proximal inter-phalangeal joint 15/317 4.7 
Elbow 14/317 4.4 
Distal inter-phalangeal joint 13/317 4.1 
Navicular bursa 9/317 2.8 
Distal inter-phalangeal joint and 5/317 1.6 
navicular bursa 
Inciting cause of sepsis 298/320 93.1 
recorded 
Trauma 279/298 93.6 
Joint injection or surgery 18/298 6 
Haematogenous spread 11298 0.3 
Time between onset of sepsis 310/320 96.9 
and treatment 
<24 hours 202/310 65.2 
1-7 days 511310 16.5 
>7 days 57/310 18.4 
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4.5.2. Treatment options 
Although all horses were treated with broad-spectrum systemic antimicrobials and joint 
lavage, there was no standardised treatment protocol. The initial joint lavage was 
performed under general anaesthesia in 282 cases (88.1 %), with the remaining horses 
being treated with a standing, through-and-through needle lavage under heavy sedation for 
the intial lavage. Affected joints were usually lavaged on alternate days until a clinical 
improvement was seen, with lavage being performed between one and eleven times 
(median = 1.00 lavage; inter-quartile range: 1 - 2 lavages). Of the 320 horses, 201 (62.8%; 
95% C.l. 57.3 to 68.1; P < 0.001) had only one lavage, along with a course of parenteral 
antimicrobials, with no other treatment necessary to eliminate the infection from the 
affected joint. Other procedures performed included arthroscopy (119, 37.2%; 95% c.r. 
31.5 to 42.7; p<O.OOl); standing lavage after inseliion of a fenestrated drainage tube during 
lavage under general anaesthesia (55, 17.2%; 95% c.r. 13.2 to 21.8; p<O.OOl); insertion of 
an indwelling, continuous antimicrobial infusion system; and insertion of antimicrobial 
impregnated, poly-methyl methacrylate beads, with some horses receiving a combination 
of treatments. Standard practice was to review the antimicrobial regimen if antimicrobial 
sensitivity indicated that the organisms cultured were resistant to the initial antimicrobial 
choice; or if there was a failure to respond to treatment. Horses were discharged from the 
hospital when the clinical signs of infection had resolved, although all horses were still 
receiving systemic antimicrobials at the time of discharge. 
4.5.3. Factors affecting survival 
Of the 320 horses admitted to the hospitals for evaluation and treatment of septic arthritis, 
274 (85.6%) were successfully discharged from the hospitals. Of the 46 horses 
euthanased, six (8.7%) were euthanased whilst under general anaesthesia due to a hopeless 
prognosis for recovery; two (4.3%) were euthanased during hospitalisation due to financial 
constraints; two (4.3%) were euthanased during hospitalisation due to concurrent medical 
problems (development of weight-bearing laminitis in the contralateral limb in one case 
and subluxation of the affected joint in one case); with the remaining 36 cases (78.3%) 
being euthanased during treatment due to non-resolution of sepsis. 
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The synovial white cell count at the time of admission, age of the horse at the time of 
admission, specific joint affected, presence of radiographic changes in the affected joint at 
the time of admission, route of infection, duration from onset of sepsis to commencement 
of treatment, duration of hospitalisation and number of lavages performed during 
hospitalisation were all investigated for their influence on both the short and long-term 
outcome. Univariable binary logistic regression analysis showed that those variables that 
were associated with an increased risk of a horse failing to survive to discharge were time 
from onset of sepsis to admission to the hospital for treatment; the presence of radiographic 
abnormalities at the time of admission; age of the horse at the time of admission; and the 
specific joint involved (Table 8). Those variables found not to be associated with an 
increased risk of a horse failing to survive to be discharged from the hospital included: 
results of cytological analysis of synovial fluid at time of admission; duration of 
hospitalisation; and number of lavages performed (Appendix 4.1). 
Table 8: Variables found to be associated with a decreased likelihood of survival to discharge following 
treatment for septic arthritis. 
Presence of radiographic 
abnormalities 
Coefficient 
-1.20 
S.E. OR 
0.35 0.30 
Duration between onset of sepsis and treatment (referent <24hrs) 
>7ds -l.61 0.37 0.20 
Age (referent <8yrs) 
8-15 yrs -0.84 0.35 
Specific joint affected (referent metatarso-phalangeal joint) 
0.43 
Stifle -2.47 0.86 0.08 
Distal inter-phalangeal -2.64 0.94 0.07 
joint 
Distal inter-phalangeal -3.05 l.l6 0.05 
joint and navicular bursa 
Navicular bursa -3.23 0.98 0.04 
Elbow -2.53 0.93 0.08 
Proximal inter-phalangeal -3.04 0.89 0.05 
joint 
95% CI P 
0.15 - 0.60 0.001 
0.10-0.41 <0.001 
0.22 - 0.85 0.016 
0.02 - 0.46 0.004 
0.01 0.45 0.005 
0.00 - 0.46 0.009 
0.01 - 0.27 0.001 
0.01-0.49 0.006 
0.01 - 0.27 0.001 
A multi variable logistic model was built using backward elimination, with all variables 
with p:S 0.20 at the univariable level included in the analysis. The inclusion criterion for 
backward elimination was set at p :S 0.05. Those variables found to be associated with an 
increased risk of a horse failing to survive to discharge at the multi variable level were the 
presence of radiographic abnormalities at the time of admission; involvement of the stifle, 
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distal inter-phalangeal joint, distal inter-phalangeal joint with concurrent involvement of 
the navicular bursa, navicular bursa, proximal inter-phalangeal joint or elbow, and sepsis in 
the affected joint for more than seven days prior to the initiation of treatment (Table 9). 
Table 9: Variables found to be associated with a decreased likelihood of survival to be discharged 
from the hospital at the multivariable level, following treatment for septic arthritis. 
Coefficient S.E. OR 95% CI P 
Constant 4.28 0.80 <0.001 
Presence of radiographic 
abnormalities -2.49 0.60 0.08 0.03 - 0.27 <0.001 
Duration between onset of sepsis and treatment (referent <24hrs) 
>7ds -2.13 0.53 0.12 0.04 - 0.34 <0.001 
Specific joint affected (referent metatarso-phalangeal joint) 
Stifle -1.89 0.92 0.15 0.02 - 0.92 0.040 
Distal inter-phalangeal joint -2.58 1.02 0.08 0.01 - 0.56 0.012 
Distal inter-phalangeal joint -2.89 1.29 0.06 0.00 - 0.69 0.025 
and navicular bursa 
Navicular bursa -3.25 1.08 0.04 0.00 0.32 0.003 
Elbow -2.24 1.01 0.11 0.01-0.78 0.027 
Proximal inter-phalangeal -3.02 0.97 0.05 0.01-0.33 0.002 
joint 
Interaction terms of significance 
Radiographic abnormalities * 1.21 1.15 3.36 0.35 31.93 0.291 
Durationl-7ds 
Radiographic abnormalities * 2.95 0.89 19.01 3.32 - 108.85 0.001 
Duration >7ds 
The only two-way interaction term that was found to be significant in the final model was 
an interaction between the presence of radiographic abnormalities and the time delay 
between the onset of sepsis and the commencement of treatment (Table 9). The fit of the 
model was evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found 
that the model was a good fit, with insufficient evidence to reject the null hypothesis at p > 
0.05. 
4.5.4. Factors affecting long-term outcome 
Long-term follow up was available in 72% (197/274) cases that survived to be discharged 
from the hospital. Of these 197 cases, 128 (65%) were able to return to their intended use 
as performance horses. A further 17 cases (8.6%) would have been capable ofreturning to 
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their intended use, although they were retired to pasture with no attempt to return to 
exercise as an elective decision of their owners. Thirty-six horses (18.3%) were too lame 
to return to ridden work, but were comfortably retired to pasture, with the remaining 16 
cases (8.1 %) euthanased after discharge from the hospital due to complications directly 
associated with the occurrence of septic arthritis. 
Univariable logistic regression analysis showed that the only variable that was found to be 
associated with an increased risk of a horse being unable to return to the level of athletic 
function attained prior to the onset of sepsis was the presence of radiographic 
abnormalities in the affected joint at the time of admission (Table 10). Other variables 
investigated were not found to be associated with the long-term outcome for horses treated 
for septic arthritis (Appendix 4.2). 
Table 10: Those variables found to be associated with a decreased likelihood of a horse being able to 
return to its' previous level of athletic function following treatment for septic arthritis. 
Presence of radiographic 
abnormalities 
Coefficient 
-1.20 
S.E. 
0.43 
OR 95% CI P 
0.30 0.13 - 0.70 0.005 
A multivariable logistic model was built using backward elimination, with all variables 
with p:s 0.20 at the univariable level included in the analysis. The inclusion criterion for 
backward elimination was set at p :s 0.05. Those variables found to be associated with an 
increased risk of a horse being unable to return to its previous level of athletic function at 
the multivariable level were the presence of radiographic abnormalities in the joint at the 
time of admission and the duration of hospitalisation (Table 11). 
No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit, with insufficient evidence to reject the null hypothesis at p > 0.05. 
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Table 11: Variables found to be associated with a decreased likelihood ofa horse being able to return 
to its previous level of athletic function, at the multivariable level, following treatment for septic 
arthritis. 
Coefficient S.E. OR 95% CI P 
Constant 0.46 0.37 0.213 
Radiographic abnormalities -1.29 0.46 0.27 0.11 0.67 0.005 
at the time of admission 
Duration of hospitalisation (referent <5 ds) 
5-9 ds 1.13 0.51 3.11 1.14 - 8.44 0.026 
4.5.5. Two-graph receiver operating characteristic (TG-ROC) analysis 
4.5.5.1. TG-ROC analysis for survival 
A two graph-receiver operating characteristic (TG-ROC) curve was generated to 
investigate the sensitivity and specificity of the nucleated white blood cell count of the 
synovial fluid at admission as a predictor for whether or not the horse would survive to be 
discharged from the hospital (Figure 1). At a cut-point of 46.91 x 109 cells!l, the 
sensitivity and specificity are both 0.57. Any change in the cut-point to increase the 
sensitivity of the test, would result in a large decrease in the specificity, with the opposite 
also being true. The intermediate range (IR) - 10.00 to 167.00 X 109 cells!l- indicates the 
range of values where the sensitivity and specificity are both below 0.95. For example, 
changing the cut-point to 20.95 x 109 cells!l would increase the sensitivity to 0.8, however 
a concurrent drop in the specificity to 0.2 is also seen, therefore whilst being able to 
identify those horses likely to survive to be discharged with some accuracy, there will also 
be a large number of horses identified as likely to survive that would not be discharged 
successfully. The white blood cell count of the synovial fluid at the time of admission, 
therefore, is a poor predictor of whether the horse will survive to be discharged from the 
hospital. 
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Figure 1: Two graph receiver operating characteristic curve (TG-ROC) showing Sensitivity (Se) and Specificity 
(Sp) the nucleated white blood cell count (WBC) of synovial fluid, as a predictor for survival to discharge. 
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4.5.5.2. TG-ROC analysis for long-term outcome 
An additional TO-ROC curve was generated to investigate whether the white blood cell 
count of the synovial fluid at the time of admission may be a useful predictor of whether a 
horse may be able to return to its original level of athletic function following treatment for 
septic arthritis (Figure 2). At a cut-point of 55.94 x 109 cells/I, the sensitivity and 
specificity are both 0.51. Any change in the cut-point to increase the sensitivity of the test 
would result in a substantial decrease in the specificity, with the opposite also being true. 
The intermediate range (IR) - 9.20 - 200.00 x 109 cells/l - indicates the range of values 
where the sensitivity and specificity are both below 0.90. 
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Figure 2: Two graph receiver operating characteristic curve (TG-ROC) showing Sensitivity (Se) and 
Specificity (Sp) the nucleated white blood cell count (WBC) of synovial fluid, as a predictor for return 
to original level of athletic function. 
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4.6. Discussion 
4.6.1. Class of evidence 
Whilst many retrospective studies investigating the treatment of septic arthritis exist in the 
literature, there is little information on the long-term prognosis for return to athletic 
function in general riding horses, although some information exists for Thoroughbred 
racehorses (Schneider, et at, 1992) and Standardbred racehorses (LaPointe et at. 1992). 
No previous studies have performed a multivariable analysis to identify factors affecting 
either the short or long-term prognosis, allowing consideration of all the variables of 
interest simultaneously, and taking into consideration how these variables may affect one 
another. 
Many of the earlier studies investigating septic arthritis (Schneider et at. 1992; LaPointe et 
al. 1992) were retrospective case series, therefore they would constitute class C evidence 
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using the classification system proposed by Yusuf et al (1998). However, some studies of 
a higher class of evidence do exist. Studies using an experimental model of septic arthritis 
could be classified as providing class A evidence (Bertone, et al. 1987a,b; Bertone et al. 
1988; Bertone et al. 1992; Brusie et al. 1992; Whitehair et al. 1992; Cook et al. 1999), 
although they lack the placebo control and blinding necessary to fulfil all the criteria for 
this classification. However, these studies have commonly used S. aureus as their 
bacterium of choice to induce sepsis, thereby restricting the wider application of their 
results to the general population, where a mixed growth of organisms is typically found in 
septic joints. 
4.6.2. Study limitations 
Despite the large number of horses in the study, the retrospective study design and the fact 
that many horses received more than one antimicrobial and lavage technique, preclude any 
conclusions being drawn regarding the relative efficacy of specific treatment modalities. 
However, the aim of the study was not to compare the relative success associated with one 
specific treatment, but to look at the long-term prognosis of horses that had survived until 
discharge from the hospital. Studies adopting a controlled, prospective design would be 
required to investigate the efficacy of specific treatment regimens. Similarly, attempts to 
examine the effects of the specific joint involved, number of joints and existence of 
concurrent pathology on survival and long-term prognosis should be viewed with caution, 
as this study relies on the retrospective analysis of medical records. 
In addition, the use of a telephone questionnaire introduces bias. Not only have you the 
bias associated with long-term memory recall (3.5.6), but there are also losses to follow up. 
These are inevitable, as people move house, change phone number or prove to be 
impossible to contact despite numerous attempts. It is unknown how significant an effect 
these losses to follow-up may have had on the overall interpretation of results. 
4.6.3. Short-term prognosis 
Survival rates reported here (85.6%) are similar to those reported in previous studies 
(LaPointe et al. 1992; Schneider et al. 1992a; Meijer et al. 2000). As the majority of 
horses included in this study were used primarily for general riding purposes at the time of 
admission to the hospital, it is impossible to quantify their return to athletic activity in 
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terms of either competitive winnings or number of events entered. Follow up information 
was therefore obtained by telephone questionnaire to the owners, as a successful outcome 
following treatment was viewed as whether the horse was able to fulfil the owner's long-
term athletic expectations. 
4.6.4. Factors affecting the outcome 
The most commonly affected joint in our study was the tibio-tarsal joint - a finding that 
concurs with previous studies (Schneider et al. 1992a; Meijer et al. 2000) in which a 
higher incidence of involvement of the larger joints was reported. The statistically 
significant findings that were associated with the joint involved included: involvement of 
the stifle, proximal inter-phalangeal joint, elbow, distal inter-phalangeal joint or navicular 
bursa decreasing the likelihood of the horse surviving to be discharged from the hospital. 
These findings are similar to previously reported findings, where joints that were small, 
with limited surgical access, or of a complex nature, were associated with a poorer 
prognosis for survival (Peremans et al. 1991; Honnas et al. 1992a,b; Booth et al. 2001). 
Similarly, the current study concurred with a previous study (Peremans et ai. 1991) in that 
a significant delay before the onset of treatment (7 days in this study) was associated with a 
poorer prognosis for survival to be discharged from the hospital. It may be expected that a 
longer duration from onset of clinical signs to initiation of treatment would reduce the 
likelihood of that horse either surviving to be discharged from the hospital or returning to 
its original level of athletic function, as prolonged exposure of the articular structure to 
both bacteria and proteolytic enzymes would be expected to deplete the proteoglycans 
from the cartilage matrix, leading to collagen breakdown. However this finding has only 
been sparsely reported (Peremans, et ai. 1991), although many other studies have 
suggested that prompt institution of aggressive treatment may improve the proportion of 
horses with a more favourable outcome. 
At the univariable level the age of the horse was also found to be associated with the risk 
of that horse surviving to be discharged from the hospital in the current study - a finding 
that has not been previously reported. However, age was not found to be a significant 
factor in the multivariable model. Horses less than eight years of age that were treated for 
septic arthritis were found to be significantly more likely to be discharged from the 
hospital than those aged between eight and fifteen years of age. If the age rose above 
fifteen years this was not found to influence the likelihood of survival to discharge, 
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although the low number of horses in this category (27/320; 8.4%) may have led to 
inadequate power to achieve statistical significance. The age of the horse may be expected 
to have a significant influence on both the short and long-term prognosis for horses treated 
for septic arthritis. Older horses would have been more likely to have degenerative 
changes within the joint, with associated inflammation of the synovium. Synovial 
inflammation can compromise the natural defence mechanisms within the synovial cavity, 
with synovial proliferation allowing the sequestration of bacteria within the membrane. 
It may be expected that those horses requiring a greater number of surgical lavages to 
resolve the synovial sepsis would have a poorer prognosis both for survival and return to 
their original level of athletic function, because the articular structure would be exposed to 
bacteria and phagocytic enzymes for a prolonged period of time. However, this finding 
has not been reported in previous studies. The current study did not find that the number 
of surgical lavages performed had an adverse effect on either the likelihood of the horse 
surviving to be discharged from the hospital or returning to its previous level of athletic 
function. The vast majority of horses (62.8%) in this study only required one surgical 
lavage to eliminate the infection from the joint, with low numbers requiring more than one 
lavage. Therefore it may be that there were inadequate numbers to prove statistical 
significance as opposed to this being an unimportant factor. 
The current study found that those horses that were hospitalised for between 5 and 9 days 
were more likely to return to their original level of athletic function than those discharged 
sooner. This finding is in direct contrast to what might be expected, as horses that required 
only one lavage were routinely discharged within 5 days, therefore you might expect these 
horses to have the best prognosis for return to athletic function. Those horses that 
remained in the hospital for more than 5 days did so either because they required more than 
one lavage to eliminate the sepsis, or the wound had not sealed and still communicated 
freely with the joint. 
The presence of radiographic abnormalities within a joint (chip fractures, articular 
fractures, osteomyelitis) will initiate a profound inflammatory response, with degenerative 
joint disease subsequently developing, regardless of the concurrent presence of sepsis. It 
could, therefore, be expected that the presence of radiographic abnormalities detected 
within the affected joint at the time of admission would be associated with a poorer 
prognosis for future soundness. No previous study has investigated whether this could be a 
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significant factor in whether a horse is able to return to athletic activity following treatment 
for septic arthritis. In the current study this was found to be a significant factor both in 
terms of whether the horse survived to be discharged form the hospital, and whether those 
that were discharged were able to return to their original level of athletic function. 
A significant interaction was found to exist between the presence of radiographic 
abnormalities and the time duration between the inciting cause of sepsis and the onset of 
treatment, when considering the likelihood of a horse surviving to be discharged from the 
hospital. 
4.6.5. TG-ROC analysis 
A wide variation was seen in the white blood cell count of the synovial fluid at the time of 
admission, and this study concurred with a previous study (Peremans et at. 1991) in 
finding that the white cell count alone was a poor predictor of both the short and long-term 
prognosis for any horse treated for septic arthritis. If the results of the synovial fluid 
analysis were used as the sole basis on which to recommend whether treatment for septic 
arthritis should be attempted, then the diagnostic test should have a good predictive ability, 
and therefore have a high sensitivity. An additional consideration in the treatment of septic 
arthritis is the high cost involved, not only for the initial treatment but also in the 
subsequent rehabilitation. Where economics can be an important issue, a test with a high 
specificity would also be needed in order to avoid needlessly wasting money on a case that 
has a poor prognosis. Although the white blood cell count of the synovial fluid at the time 
of admission does not appear to be a useful discriminatory test, when taken on its own, 
with regard to either of the outcomes of interest for this study, it is not superseded by any 
other single diagnostic test. To this end the result must be considered in conjunction with 
other contributing factors before a conclusion on either the short or long-term prognosis 
can be reached. 
4.6.6. Classification in the literature pool 
As an uncontrolled case series, the current study would also be classified as providing class 
C evidence. However, the large case numbers in this study, in conjunction with the more 
advanced methods of statistical analysis used, render it a valid addition to the current 
literature pool. 
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Earlier studies that reported the long-term prognosis for horses treated for septic arthritis 
focused on specific study groups: either Thoroughbred or Standardbred racehorses 
(LaPointe et ai. 1992; Schneider et ai. 1992); or horses that received a specific treatment 
regimen (Summerhays, 2000; Booth et ai. 2001). The current study reported both the short 
and long-term prognosis for horses from a study population where the vast majority of 
horses were general purpose riding horses (209/320; 65.3%), and a variety of different 
treatment regimes were used. When considering the population of horses on which this 
study was performed, the results could be more widely extrapolated to other practice 
populations where the vast majority of horses are pleasure horses, when compared to 
previous studies that have a much more specific study population (LaPointe et ai. 1992; 
Schneider et ai. 1992a). 
4.6.7. The benefits of multivariable analysis 
The multivariable logistic regression analysis used in the current study showed that some 
factors identified as significant following univariable analysis were in fact not significant 
in the final model. Similarly, it also identified factors that were not considered significant 
after univariable analysis, that were in fact significant in the final model. In addition, the 
use of multivariable analysis highlighted the interaction that exists between some of the 
factors - a finding which would not have been identified if only univariable analysis was 
performed. The identification of interaction terms is important when considering the final 
model, as it shows how the effect on the final outcome exerted by one variable may also be 
dependent on another variable. 
4.6.8. Conclusion 
The prognosis for survival following early identification and treatment of septic arthritis in 
this particular population of horses was good, with 85.6% (95% C.l. 81.3 - 89.3) of horses 
surviving to be discharged form the hospital. If infection was eliminated from the synovial 
space then 65% (95% C.l. 57.9 - 71.6) of horses successfully discharged returned to their 
original level, or a higher level, of exercise. Therefore, horses that require treatment for 
septic arthritis can be given a fair prognosis for return to full athletic function. However, if 
there is a delay in treatment of more than seven days, evidence of radiographic 
abnormalities in the affected joint, or involvement of the stifle, distal inter-phalangeal 
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joint, proximal inter-phalangeal joint, elbow or the navicular bursa, then a more guarded 
prognosis should be given. 
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Chapter 5 
What is the likelihood that Thoroughbreds treated for septic arthritis will race? 
5.1 Introduction 
Septic arthritis, in both mature horses and neonates, is recognised as a serious clinical 
problem (Bertone et at. 1987a,b; Tulamo et at. 1989; Schneider et at. 1992b; Cook and 
Bertone, 1998; Booth et at. 2001). The potential exists to cause permanent degenerative 
joint disease, irreversible cartilage damage, fibrosis and unsoundness if the infection is not 
rapidly eliminated from the synovial space (Van Pelt & Riley, 1969; Martens & Auer, 
1980; McIlwraith, 1983; Martens et at. 1986; Stoneham, 1997; Waterhouse & Marr, 1997; 
Steel et at. 1999). 
5.2. What is the likelihood that Thoroughbred foals treated for septic arthritis will 
race? 
5.2.1. Introduction 
Septic arthritis in foals, also referred to as joint-ill, was first described in the veterinary 
literature by Rooney in 1962, with reports estimating that between 1-5% of foals may be 
affected (Martens & Auer, 1980). In the neonate, the presentation is often complicated by 
underlying pathology (Martens & Auer, 1980; Schneider et at. 1992a): septic mihritis has 
been frequently described as a common sequel to neonatal septicaemia or failure of passive 
transfer of immunity, with haematogenous spread of organisms (Rooney, 1962; Van Pelt & 
Riley, 1969; Platt, 1973; 1977; Martens & Auer, 1980; McIlwraith, 1983; McClure, 1981; 
Cmier & Martens, 1986; Martens et at 1986; Stoneham, 1997; Hance, 1998; Steel et at. 
1999; Meijer et at. 2000; Tremaine, 2000; White, 2002), although it can develop from 
haematogenous spread with no other signs of systemic disease (Martens & Auer, 1980; 
Carter & Martens, 1986). It has been described as part of the septic arthritis/osteomyelitis 
syndrome (Martens & Auer, 1980; Firth et at. 1985; Martens et al. 1986; Steel et al. 1999; 
Meijer et al. 2000), also associated with neonatal septicaemia. Although less common, it 
can occur following trauma to the joint, or be of iatrogenic origin, subsequent to joint 
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injection or surgery (Van Pelt & Riley, 1969). The clinical signs associated with septic 
arthritis in foals depend on the presence of any underlying pathology. If the joint sepsis is 
of traumatic or iatrogenic origin, or from haematogenous spread without concurrent 
systemic signs of disease, then the most commonly reported clinical signs are (Martens & 
Auer, 1980; Firth, 1983; McIlwraith, 1983; Hance, 1988; Schneider et al. 1992a): 
1. pyrexia, 
2. joint effusion, 
3. oedema over the joint, 
4. heat and pain on palpation of the joint, 
5. either lameness in the affected limb or a reluctance to move. 
If there is an underlying septicaemia with resultant seeding out of bacteria into the joint 
then foals are more likely to present as dull, depressed and recumbent, with septic arthritis 
an incidental finding (Martens & Auer, 1980; McIlwraith, 1983; Carter & Martens, 1986; 
Martens et al. 1986; Stoneham, 1997). It is common for more than one joint to be involved 
(Van Pelt & Riley, 1969; Platt, 1973; Martens & Auer, 1980; McIlwraith, 1983; Carter & 
Martens, 1986; Schneider et al. 1992a; Steel et al. 1999; Meijer et al. 2000). The 
prognosis for recovery from septic arthritis in foals has widely been described as poor or 
unfavourable (Platt, 1977; Martens & Auer, 1980; Firth, 1983; Martens et al. 1986; Brewer 
& Koterba, 1990; Schneider et al. 1992a; Hance et al. 1993; Zamos et al. 1993; Raisis et 
al. 1996; Steel et al. 1999; Meijer et al. 2000), although this is often due to complications 
attributed to underlying disease (Firth, 1983; Brewer & Koterba, 1990; Schneider et al. 
1992a; Steel et al. 1999; Meijer et al. 2000), as opposed to failure to resolve the joint 
sepsis (Steel et al. 1999; Meijer et al. 2000). 
5.2.2. Aetiology of disease 
5.2.2.1. Failure of passive transfer in foals 
Total or partial failure of passive transfer of immunity has been recognised as a 
predisposing factor in the development of a variety of infectious conditions in neonates 
(Martens & Auer, 1980; McClure, 1981; Firth, 1983; Brewer & Mair, 1988; Robinson et 
al. 1993; Raidal, 1996; Hance, 1998; Steel et al. 1999). Colostral antibody temporarily 
protects foals until the immune system is able to respond adequately to challenge by 
environmental pathogens (Jeffcott, 1974; Platt, 1977; Koterba et al. 1984; Carter & 
Chapter 5 115 
Martens, 1986; Brewer & Mair, 1988; Clabough et aZ. 1991; LeBlanc et aZ. 1992; 
Robinson ef aZ. 1993; Stoneham, 1997; Meijer et aZ. 2000). Failure of passive transfer 
occurs when either the foal fails to ingest sufficient colostrum (Jeffcott, 1974; McGuire et 
aZ. 1975; Koterba et aZ. 1984; Jeffcott, 1985; Brewer & Mair, 1988; Clabough et af. 1991), 
the foal ingests colostrum but fails to absorb the antibodies (Jeffcott, 1974; McGuire et af. 
1975; Jeffcott, 1985; Brewer & Mair, 1988; Clabough et aZ. 1991) or there are insufficient 
antibodies present in the colostrum, either through pre-partum loss of colostrum or poor 
quality of colostrum (Jeffcott, 1974; McGuire ef aZ. 1975; Koterba et aZ. 1984; Brewer & 
Mair, 1988; LeBlanc et aZ. 1992). If recognised early, failure of passive transfer of 
immunity can be readily treated by administration of colostrum or transfusion of plasma 
(McGuire et aZ. 1975; Firth, 1983), although it is unknown what quantity of serum 
immunoglobulins should be considered sufficient, thereby not requiring supplementation 
(Brewer & Mair, 1988; Baldwin et aZ. 1989; Baldwin et aZ. 1991; Raidal, 1996). 
The necessity for supplementation is itself a contentious issue (Brewer & Mair, 1988; 
Baldwin ef aZ. 1989; Baldwin et aZ. 1991; Koterba, 1991; Hoffman et aZ. 1992; Raidal, 
1996) as, although total or partial failure of passive transfer predisposes the foal to 
development of infection, it is not absolute that a foal with failure of passive transfer will 
subsequently develop an infection (Brewer & Mair, 1988; Baldwin ef aZ. 1989; Baldwin et 
aZ. 1991; Hoffman et aZ. 1992). Studies have been done that show that many foals with 
apparently low concentrations of serum immunoglobulins remain healthy (Baldwin ef af. 
1989; Baldwin ef aZ. 1991; Koterba, 1991), therefore it is thought that other factors must 
act in conjunction with a low serum immunoglobulin concentration to induce septicaemia 
(Martens & Auer, 1980; Firth, 1983; Baldwin ef aZ. 1989; Baldwin ef aZ. 1991; Koterba, 
1991 ). 
Many infections are caused by the opportunistic invasion of organisms that are ubiquitous 
in the environment of the newborn foal (Platt, 1973; Schneider ef af. 1992a). The 
causative organisms usually gain entrance via the placenta, respiratory and digestive tracts 
or umbilicus (McIlwraith, 1983; Martens & Auer, 1980; Mmiens et aZ. 1986; Meijer et aZ. 
2000; Kettner ef aZ. 2003). Although infection of the umbilicus has been described as the 
most likely cause of haematogenous infection in the neonate (Firth, 1983; McIlwraith, 
1983) its role in the development of septic arthritis is now thought to be overstated (Hance, 
1998), as many foals will have a normal umbilicus on ultrasound evaluation, in the face of 
ongomg sepSIS. Regardless of the initial route of entry of the infectious organism, 
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septicaemia will develop rapidly, spreading to involve multiple organs (Van Pelt & Riley, 
1969; Platt, 1973; Firth, 1983). Apart from the clinical signs seen associated with septic 
shock, pathology will often be found in either one or more of the respiratory tract, gastro-
intestinal tract, umbilicus, bones and joints (Van Pelt & Riley, 1969; Platt, 1973; Martens 
& Auer, 1980; Firth, 1983; Raisis et al. 1996). Once a concurrent infectious process 
develops the prognosis for survival becomes poor (Raisis et al. 1996; Steel et al. 1999; 
Meijer et al. 2000). 
5.2.2.2. Aetiology of septic arthritis 
The vascular system in the bones and joints of foals predisposes them to seed out bacteria 
(McIlwraith, 1983; Martens et al. 1986; Hance, 1998; Meijer et al. 2000; Kettner et al. 
2003). The blood flow in the immature bone has a metaphyseal vascular loop immediately 
prior to the transphyseal vessel, which has low blood flow, allowing bacteria to settle out 
and potentially colonise. The transphyseal vessels disseminate bacteria to the physis, 
epiphysis and synovial membrane (Martens et al. 1986; Hance, 1998; Kettner et al. 2003). 
In addition there are extensive capillary tufts in the synovia that are thought to entrap 
micro organisms, allowing the subsequent colonisation of bacteria (McIlwraith, 1983). 
Septic arthritis is caused by the inoculation of a synovial cavity with bacteria, with viable 
organisms readily becoming established. Normally, synovium is capable of eliminating a 
certain number of bacteria (Gustafson, McIlwraith & Jones, 1989; Hardy, Bertone & 
Malemud, 1998; Tremaine, 2000), although these natural defences can be overcome if: 
1. the bacterial load is overwhelming, 
2. the organism is highly pathogenic and therefore able to adhere to the synovium and 
either bypass or compromise the natural defence mechanisms, 
3. the synovium is compromised (Cook & Bertone, 1998; Tremaine, 2000). 
It has been suggested that the configuration of the capillary tufts in the synovial membrane 
favour entrapment of microorganisms (McIlwraith, 1983; Hance, 1998; Kettner et al. 
2003), thereby predisposing septicaemic foals to develop concurrent septic arthritis. 
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5.2.2.3. Septic arthritis/osteomyelitis syndrome 
One survey revealed that more than 75% of foals diagnosed with septic arthritis also had a 
clinically diagnosed, concomitant osteomyelitis (Martens & Auer, 1980), although later 
studies reported lower numbers of between 33-52% of foals treated for septic arthritis 
having concomitant osteomyelitis (Schneider et at. 1992a; Steel et at. 1999). Septic 
arthritis/osteomyelitis is seen in foals usually less than 60 days of age (Martens et at. 
1986). There is frequently more than one joint involved (Martens et at. 1986; Steel et at. 
1999) and it is commonly the larger joints that are involved, although this is not always the 
case (Martens & Auer, 1980; McIlwraith, 1983). There is generally a site of primary 
sepsis elsewhere in the body (Martens et at, 1986), although it is not always readily 
apparent (Martens & Auer, 1980). 
The septic arthritis/osteomyelitis syndrome is classified according to the location of the 
lesions (Firth, 1983; Martens et at. 1986). A foal with S-type septic arthritis/osteomyelitis 
syndrome characteristically has synovitis without gross evidence of osteomyelitis. Foals 
with E-type have osteomyelitis of the epiphysis at the subchondral bone/cartilage junction. 
Foals with P-type have osteomyelitis directly adjacent to the physis, and a predisposition 
for the formation of these bone lesions has been reported in the lower limbs of foals (Firth, 
1983). It is impossible to differentiate between Sand E-type by clinical signs and synovial 
fluid evaluation (Firth, 1983). The diagnosis of E-type is confirmed by demonstration of 
the characteristic radiographic changes in the epiphysis or affected joints (Firth, 1983). 
The area of diseased bone is generally more extensive than is appreciable radiographically 
(Firth, 1983) and can be so extensive as to have caused loss of extensive areas of articular 
cartilage and epiphyseal bone (Firth, 1983). 
The same joint can have a single type or any combination of types present at anyone time 
(Firth, 1983), although most foals with infectious synovitis also have concurrent bone 
lesions (Firth, 1983; Martens et at. 1986). In the larger joints, bone lesions may be the 
result of local vascular spread from the synovial membrane to the adjacent epiphysis, 
whose vascular supply arises from common vessels (Firth, 1983). It was reported (Firth, 
1983) that no foal was found with an E-type defect in the absence of purulent changes in 
the synovia of the adjacent joint. In P-type defects bone infection may occur before 
involvement of the adjacent joint (Firth, 1983). Once synovial effusion occurs this may be 
the result of either the presence of infection in an adjacent area or of extension of infection 
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from bone to synovial membrane (Firth, 1983). Lesions can be so extensive as to threaten 
to, or have already caused, pathological fracture of the affected bone (Firth, 1983). Whilst 
it is unclear why the predisposition sites in the lower limb for bone lesions occur, it has 
been suggested that it may be linked to trauma, as a history of recent trauma was reported 
in relation to bone infection in children (Firth, 1983). The lower limbs of foals are more 
likely to sustain either external traumatic insults or functional trauma when compared to 
the upper limb, which could then predispose them to the formation of bone lesions (Firth, 
1983). 
5.2.2.4. Synovial response to sepsis 
The response of a synovial structure to invasion by bacteria has been the subject of a large 
body of experimental research, and the sequence of events is well documented (4.2.2.1.). 
5.2.2.5. Bone response to sepsis 
Osteomyelitis develops via the haematogenous route when a bacterial embolus present in 
the circulation settles out to the periphery of metaphyseal veins, causing the development 
of a venous thrombosis (Martens & Auer, 1980; Orsini, 1984; Martens et al. 1986; Hance 
et al. 1993; White, 2002). Feeding capillaries are gradually blocked by the retrograde 
progression of the clot and local marrow necrosis occurs, resulting in a perfect 
environment for the growth and colonisation of bacteria (Mmiens & Auer, 1980; Orsini, 
1984; Martens et al. 1986; Hance et al. 1993). Thrombosis prevents immune defence 
mechanisms from reaching the colonised bacteria. Endosteal blood supply is lost due to 
the thrombosis of the nutrient artery, resulting in sequestrum formation. The dead bone 
becomes separated during necrosis and is surrounded by purulent material (Orsini, 1984; 
White, 2002). It is the osteolysis caused by the cycle of inflammation followed by 
ischaemia and necrosis that is visible radiographically, allowing accurate diagnosis of the 
condition (Martens & Auer, 1980; Hance et al. 1993). 
5.2.2.6. Culture of causative organisms 
It has been widely reported in the literature that bacterial culture from cases of suspected 
septic arthritis is unrewarding (4.2.2.2.). 
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It is recommended that in foals in which septicaemia is suspected, blood cultures be 
performed to identify the causative organism, in order to institute appropriate antimicrobial 
therapy (McIlwraith, 1983; Koterba et al. 1984; Martens et al. 1986; Belione, 1999; 
Tremaine, 2000), with positive blood cultures achieved in approximately 80% of cases that 
were identified as septicaemic (Wilson & Madigan, 1989). It has been reported when 
septicaemic foals with concurrent septic arthritis had both their blood and synovial fluid 
from the affected joint cultured, that in between 50-85% of the cases in which a positive 
culture was obtained, identical organisms were isolated (Vatistas et al. 1993; Steel et al. 
1999). When osteomyelitis is present, culture of any purulent exudates and necrotic 
material is also recommended (Martens & Auer, 1980; Martens et al. 1986), in order to 
increase further the likelihood of achieving a positive culture as microorganisms frequently 
colonise within the bone (Mmiens & Auer, 1980). Studies have found that, whilst a mixed 
growth of bacteria is commonly found when culturing synovial fluid from foals with septic 
mihritis (Schneider et al. 1992a; Bertone, 1999), the bacteria are predominantly 
Enterobacteriaceae, with Escherichia coli being the main isolate (Schneider et al. 1992a). 
This is probably related to the prevalence of these organisms in the environment, 
increasing the likelihood that faecal or soil contamination of compromised surfaces, for 
example an unsealed umbilicus, will result in infection (Platt, 1973; Schneider et al. 
1992a). 
5.2.2.7. Radiography in diagnosis 
It is important when first examining a foal with suspected septic arthritis to identify any 
underlying disease processes and treat these accordingly, in order to eliminate them as a 
source of future pathogens capable of perpetuating the infection, in conjunction with 
treatment of the affectedjoint(s) (Martens & Auer, 1980; McIlwraith, 1983; Stoneham, 
1997; Meijer et al. 2000). Without treatment of any other foci of infection, successful 
resolution of the septic arthritis will not be achieved. Any suspect joints should be 
radiographed for signs of osteomyelitis (Martens & Auer, 1980; Zamos et al. 1993; Raisis 
et al. 1996; Waterhouse & Marr, 1997; Stoneham, 1997; Hance, 1998), with between 33 
and 52% of foals treated for septic arthritis found to have concurrent signs of osteomyelitis 
(Schneider et al. 1992a; Steel et al. 1999), although one survey reported more than 75% of 
foals treated for septic arthritis as having clinically diagnosed concurrent osteomyelitis 
(Martens & Auer, 1980). 
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If no radiographic evidence of osteomyelitis is seen, the joints should be re-radiographed 
every three to five days for the duration of treatment (Martens & Auer, 1980; Firth, 1983; 
Martens et al. 1986; Zamos et al. 1993; Stoneham, 1997; Hance, 1998; White, 2002), as 
there is frequently a latent period between the onset of clinical signs and the development 
of radiographically visible lesions (Zamos et al. 1993; Stoneham, 1997; White, 2002). 
5.2.3. Treatment 
5.2.3.1. Medical Therapy 
5.2.3.1.1. Systemic antimicrobial therapy 
Systemic antimicrobial therapy and lavage of the affected joint are the two most important 
aspects of treatment for septic arthritis (McIlwraith, 1983; Martens et al. 1986; Hance, 
1998). Therapy should only be started once any blood and synovial fluid to be submitted 
for culture has been taken, maximising the likelihood of obtaining a positive culture result 
(FiIih, 1983; Steel et al. 1999). Systemic antimicrobials should then be started 
immediately, without waiting for any culture results. The results of any culture and 
sensitivity can be used later to guide a change in antimicrobial therapy if a clinical 
response to treatment is not seen (Martens & Auer, 1980; Waterhouse & Marr, 1997; Steel 
et al. 1999). 
The antimicrobials selected initially should be broad spectrum (Martens & Auer, 1980; 
McIlwraith, 1983; Koterba, 1991; Hance et al. 1993) although many infections in young 
foals are gram negative (Schneider et al. 1992a; Meijer et al. 2000), mixed bacterial 
infections cannot be ruled out without a positive culture result (Schneider et al. 1992a). 
The antimicrobials should also be bactericidal, as a sick neonate may have a compromised 
immune system (Firth, 1983; Stoneham, 1997), and they must be capable of achieving 
therapeutic concentrations for prolonged periods within both bone and synovia (Stoneham, 
1997). 
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Care must be taken in considering both excretion and metabolism when selecting a suitable 
antimicrobial, as drugs administered at a standard dose can reach nephrotoxic 
concentrations ifrenal compromise exists (Bowman et al. 1991; Stoneham, 1997). Studies 
have shown that neonates, particularly when septic (Bowman et al. 1991; Wichtel et al. 
1992; Green & Conlon, 1993), are prone to developing nephrotoxicity at standard 
antimicrobial dosages (Baggot & Short, 1984; Geor & Brashier, 1991; Wichtel et al. 1992; 
Bertone, 1999), therefore therapeutic monitoring may be appropriate in order to establish 
whether a non-toxic dose achieves therapeutic concentrations (Bowman et al. 1991). 
The first choice of antimicrobials are a penicillin in combination with an aminoglycoside 
(Koterba, 1991; Schneider et al. 1992a; Stoneham, 1997; Waterhouse & Marr, 1997; 
Hance, 1998; Bertone, 1999; Steel et al. 1999; Meijer et al. 2000), although a third 
generation cephalosporin has also been used effectively (Schneider et al. 1992a; Zamos et 
al. 1993; Stoneham, 1997; Bertone, 1999). The use of amikacin in foals has been 
associated with less nephrotoxicity (Koterba, 1991), as well as less resistance amongst 
likely organisms when compared to gentamicin (Brewer & Koterba, 1985; Koterba, 1991). 
Systemic antimicrobial therapy alone may be sufficient if osteomyelitis is diagnosed early 
in its clinical course (Martens & Auer, 1980; Martens et al. 1986; Zamos et al. 1993; 
Kettner et al. 2003), although ischaemia is an important aspect of osteomyelitis and 
microorganisms thrive in the avascular tissue. Once evidence of abscessation, 
sequestration or severe lysis is seen radiographically, surgical decompression will be 
required, with excision of the dead bone and associated infected tissue (Martens & Auer, 
1980; Martens et al. 1986; Zamos et al. 1993; White, 2002). 
Depending on the site of the lesion, surgical debridement may not be feasible (Hance et al. 
1993; Kettner et al. 2003). Instances of osteomyelitis of the femoral condyle have been 
reported where no gross involvement of the articular cartilage was evident, despite changes 
in the synovial fluid suggestive of sepsis, therefore surgical curettage of the lesion would 
require removal of the overlying cartilage, creating additional damage to the joint (Hance 
et al. 1993). Similarly, in P-type osteomyelitis, if the bony lesion is at the centre of the 
growth plate, surgical curettage would result in extensive damage to both the growth plate 
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and adjacent bone (Kettner et al. 2003). Even after successful surgical debridement of a 
lesion and resolution of joint sepsis, foals require a prolonged course of antimicrobials for 
a number of months that extends far beyond the resolution of clinical signs (Martens & 
Auer, 1980; Firth, 1983; Martens et al. 1986; Hance et al. 1993). This is necessary 
because bacteria are capable of surviving for a long time in the bone and physeal cartilage, 
providing an ongoing source of infection (Martens & Auer, 1980; Orsini, 1984; Martens et 
al. 1986). If the antimicrobials are stopped prematurely, the infection will often recur 
(Martens & Auer, 1980; Firth, 1983; Martens et al. 1986). 
5.2.3.1.2. Intra-articular antimicrobials and regional perfusion 
Intra-articular antimicrobial therapy remains controversial in the treatment of septic 
arthritis (4.2.3.1.4.). The use of intra-articular antimicrobials in foals has been only 
infrequently reported (Schneider et al. 1992a; Zamos et al. 1993; Steel et al. 1999), and 
their requirement questioned (Waterhouse & Marr, 1997), as it is likely that multiple organ 
systems are involved in the disease process, and this would necessitate the systemic use of 
antimicrobial therapy (Waterhouse & Marr, 1997). 
Regional perfusion of antimicrobials has been proposed as a viable method of treatment for 
septic arthritis and osteomyelitis in foals (Hance, 1998). Regional perfusion has been 
shown to be effective in delivering antimicrobials under pressure to a selected region of the 
limb through the venous system (Whitehair et al. 1992; Murphey et aI, 1999; Butt et al. 
2001; Scheuch et al. 2002). This allows antimicrobials to reach ischaemic areas by 
diffusion from the surrounding vascular tissue, resulting in higher local concentrations of 
antimicrobials within the bone lesions associated with osteomyelitis (Kettner et al. 2003). 
Regional perfusion has been studied using both the intravenous and intra-osseous route of 
administration of antimicrobials (Whitehair et al. 1992; Kettner et al. 2003). The intra-
osseous route is thought to be advantageous as it does not require serial catheterisation of 
veins (Kettner et al. 2003), and when treating osteomyelitis it is unknown if antimicrobial 
concentrations are as high in bone following intravenous administration of antimicrobials 
when compared to the intra-osseous route (Kettner et al. 2003). 
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5.2.3.1.3. Non-steroidal anti-inflammatory drug therapy 
Anti-inflammatory drug therapy is important in minimising damage to the articular surface 
(Martens & Auer, 1980; Schneider & Bramlage, 1991; Zamos et aZ. 1993; Stoneham, 
1997). Chronically inflamed tissue and the associated by-products can perpetuate cartilage 
destruction even in the absence of sepsis, resulting in the occurrence of degenerative joint 
disease (Martens & Auer, 1980; Martens et aZ, 1986; Meijer et aZ. 2000). Whilst the 
judicious use of non-steroidal anti-inflammatory drugs (NSAIDs) is widely accepted as 
being beneficial in the treatment of septic arthritis in adult horses (Schneider & Bramlage, 
1991; Bertone, 1999), they should only be used with care in the management of foals 
(Martens et aZ. 1986; Stoneham, 1997; Hance, 1998). They are known to contribute to 
gastric ulcer syndrome in foals (Martens et aZ. 1986; Stoneham, 1997; Waterhouse & Marr, 
1997; Hance, 1998), therefore prophylactic anti-ulcer medication is recommended. They 
can induce a profound improvement in the degree of lameness seen in foals (Hance, 1998), 
even if the therapy employed is not being wholly effective, leading to a false sense of 
optimism, and they limit any febrile episodes, which are also an indicator of ongoing sepsis 
(Hance, 1998). 
5.2.3.1.4. Anti-ulcer therapy 
Anti-ulcer medication is recommended in the management of foals with septic arthritis 
(Zamos et aZ. 1993; Stoneham, 1997; Waterhouse & Marr, 1997). Many foals will receive 
NSAIDs as part of their therapy, which are known to be ulcerogenic, and when 'stressed' 
foals are more prone to develop gastric ulcers (Stoneham, 1997; Waterhouse & Marr, 
1997) 
5.2.3.1.5. Therapy for neonatal septicaemia 
If the foal is septicaemic, this must be treated alongside treatment of septic arthritis and 
osteomyelitis. Systemic antimicrobial therapy should be instituted (McClure, 1981), with 
blood cultures confirming organism type and sensitivity. As failure of passive transfer in 
foals is recognised to predispose them to the development of septic conditions, 
immunoglobulin concentrations should be established, with hypogammaglobulinaemic 
foals receiving supplementary administration of antibodies through the intravenous 
transfusion of either plasma or serum (Martens & Auer, 1980; McClure, 1981; Meijer et aZ. 
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2000). It has been shown that clinically ill foals display a significantly lower rise in serum 
immunoglobulin concentrations following treatment with plasma than clinically healthy 
foals (LeBlanc, 1988), therefore a larger volume of plasma may be necessary to increase 
the serum immunoglobulin concentration an acceptable amount. It may be beneficial to 
administer plasma even in foals that were known to have acceptable concentrations of 
circulating immunoglobulins soon after birth, as it has been suggested that infection may 
lower the concentration of circulating immunoglobulins (LeBlanc, 1988) as serum proteins 
leak out into the infected tissues and body cavities (Brewer & Mair, 1988), and it is 
unknown how marked this drop in serum immunoglobulin concentration can be (Robinson 
et ai. 1993). 
5.2.3.2. Surgical Therapy 
5.2.3.2.1. Joint lavage 
Through-and-through lavage using a balanced polyionic solution, although reported to be 
ineffective in removing the fibrin-white blood cell coagulum within the joint (Martens et 
ai. 1986; Schneider et ai. 1992b), is a simple and quick technique frequently used in the 
treatment of septic arthritis in foals (Martens & Auer, 1980; Martens et ai. 1986; 
Stoneham, 1997; Waterhouse & Marr, 1997; Meijer et ai. 2000; Tremaine, 2000; 
Parviainen, 2002). It has the added advantage in the foal that it can be performed on a 
sedated animal in a suitably clean environment (Stoneham, 1997; Waterhouse & Marr, 
1997; Meijer et ai. 2000; Tremaine, 2000), negating the need for serial general anaesthesia 
in an animal that may also have systemic disease (Meijer et ai. 2000), and rendering it a 
suitable treatment option where hospital facilities are not available (Tremaine, 2000). 
There are few reports on the use of lavage solutions other than a balanced, polyionic 
solution, in the treatment of septic arthritis in foals. Studies have cited the use of either a 
0.1 % povidone-iodine solution, or the use of a dimethyl-sulfoxide (DMSO) solution 
(Honnas et ai. 1992a,b; Schneider et ai. 1992a; Zamos et ai. 1993). The addition of 0.1 % 
povidone-iodine has been shown to be no more beneficial than the use of a balanced, 
polyionic solution in the treatment of an experimentally induced septic arthritis in adult 
horses (Bertone, 1987b). The addition of DMSO to an articular lavage solution is thought 
to inhibit prostaglandin production and phagocytic cellular influx (Honnas et al. 1992a; 
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Zamos et al. 1993), although it is unknown if this is any more beneficial than a balanced, 
polyionic solution in the treatment of septic atihritis in foals. 
5.2.3.2.2. Arthroscopy and arthrotomy 
Arthroscopy and arthrotomy are surgical procedures that can be used in conjunction with 
lavage, in situations in which excessive fibrin within the joint interferes with thorough 
lavage using the through-and-through technique (4.2.3.2.2.). It has been suggested that 
arthroscopy should be a suitable first-choice treatment, as it would allow visualisation and 
subsequent curettage of any osteomyelitic lesions, along with removal of fibrin and 
inflammatory debris from the joint (Zamos et al. 1993; Meijer et al. 2000; Tremaine, 
2000). It allows greater visualisation of the joint and the physis when compared to 
arthrotomy (Zamos et al. 1993; Tremaine, 2000), along with the ability to perform 
synovectomy at a site remote to the incision (Zamos et al. 1993; Tremaine, 2000). 
5.2.3.3. Follow up 
When treating osteomyelitis, repeat radiographs can be an effective means of monitoring 
the efficacy of treatment. If the lesion is continuing to progress into adjacent bony tissue 
despite antimicrobial therapy, then the drugs chosen are either not penetrating the lesion 
(Parviainen, 2002), or are not effective against the causative organism (Parviainen, 2002). 
However, if the lesion appears static after approximately 7 days of treatment, this would 
suggest that the antimicrobial regimen is effective (Hance, 1998; Kettner et al. 2003). 
Radiographs can also be used to determine the length of treatment required, based on the 
rate of regression of any bony lesions evident (Hance, 1998). 
5.2.4. Outcome and prognosis 
The outcome for foals with septic arthritis, with or without concurrent osteomyelitis, is 
generally described as poor (Martens & Auer, 1980; Schneider et al. 1992a; Steel et al. 
1999; Meijer et al. 2000). Although young animals have a greater capacity for 
regeneration of articular cartilage than adults (Matiens & Auer, 1980; McIlwraith, 1983) a 
guarded prognosis for future athletic capability is still indicated (Martens & Auer, 1980). 
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Foals are frequently euthanased before successful resolution of joint sepsis due to 
complications attributed to underlying disease processes (Schneider et al. 1992a; Steel et 
al. 1999; Meijer et al. 2000), failure of the joint sepsis to respond to treatment (Koterba et 
al. 1984; Hance et al. 1993; Steel et al. 1999; Meijer et al. 2000), or occurrence of 
musculoskeletal sepsis at other sites during the course of treatment (Koterba et al. 1984; 
Raisis et al. 1996; Steel et al. 1999). An inverse relationship has been described between 
the number of joints affected and the likelihood of recovery from the sepsis (Martens & 
Auer, 1980; Raisis et al. 1996; Steel et al. 1999). Presence of concurrent osteomyelitis, 
hypogammaglobulinaemia and the presence of multi-system disease are all thought 
negatively to influence the prognosis for a favourable outcome from septic arthritis (Firth, 
1983; Bertone, 1999; Steel et al. 1999; Meijer et al. 2000). The treatment of septic arthritis 
and osteomyelitis in foals is complicated by the presence of underlying disease. There are 
few studies in existence that have incorporated large numbers of foals, with the studies that 
have done so being retrospective case series utilising a number of different treatment 
regimens (Schneider et al. 1992a; Steel et al. 1999), rendering it difficult to compare the 
efficacy of individual methods of treatment (Schneider et al. 1992a; Steel et al. 1999). 
5.2.5. Study aims 
The purpose of this study was to evaluate data from an equine hospital over the last 13 
years, and to compare each study group to a suitable control population, so as to 
investigate the likely long term athletic prognosis for Thoroughbred neonates treated for 
septic arthritis. It was hypothesised that the occurrence of septic arthritis in a 
Thoroughbred neonate would significantly reduce the likelihood of that foal starting on a 
racecourse when compared to its siblings. The aim was to test this hypothesis using a 
retrospective study. 
5.2.6. Material and Methods 
5.2.6.1. Power calculation 
The number of foals required (n) for this study, using a significance level of 5%, and study 
power of 80%, was calculated using the standard formula (Snedecor and Cochran, 1980): 
n = [(Za + Zb)/(Po - p,)]2 * (P,Q, + PoQo) 
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where Za, calculated to be 1.96, is the value of Student's t distribution at the specified 
confidence level and Zb, calculated to be -0.842, is the value of Student's t distribution at 
the specified power, with Po being the proportion of Thoroughbred foals that successfully 
start on a racecourse following treatment for septic arhtirits, Qo being (I-Po), PI is the 
proportion of Thoroughbred siblings that start on a racecourse, and QI is (I-PI)' With Po 
estimated to be 40%, based on previously published data (Steel et al. 1999) and PI 
estimated to be 65%, based on statistics published by Weatherbys, the required number of 
foals for the study was, therefore, 67. 
5.2.6.2. Data retrieval 
5.2.6.2.1. Case identification 
The admission records for Rossdales Equine Hospital between 1988 and 2001 were 
reviewed to identify Thoroughbred foals that had been admitted with suspected joint 
pathology, and medical histories were then retrieved. To be eligible for inclusion in the 
study, foals had to be Thoroughbreds, intended for use as racehorses, and had to be less 
than 4 months old at the time of admission. Any Thoroughbred foals which were not 
intended solely as racehorses were excluded from the study. Where septic arthritis was 
suspected on the basis of clinical signs, diagnosis was confirmed on the result of 
synoviocentesis of the affected j oint, in which an increased nucleated cell count (upper end 
of normal reference limit for laboratory: 3 x 109 cells/I) in conjunction with an increased 
total protein concentration (upper end of normal reference limit: 15g/1) and the presence of 
a neutrophilia with degenerative polymorphonuclear cells on cytological analysis were 
considered to be diagnostic. Information retrieved from the medical records included sex, 
evidence of multi-system disease, the number of joints infected, anatomical location of the 
joint(s) involved, the white cell count of the synovial fluid at the time of admission to the 
hospital, and details of antimicrobial therapy and lavage procedures performed. 
5.2.6.2.2. Comparison population identification 
The foaling history of each foal's dam was then reviewed using Weatherbys stud book and 
racing records, in order to obtain the registration details of the affected foal, along with the 
details of two siblings. Two siblings were used as controls wherever possible in order to 
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increase the statistical power of the study. In instances in which mares had produced fewer 
than two live foals in the years prior to the affected foal being born, the closest siblings in 
age born after the affected foal were selected for comparison, provided that they had 
attained racing age within the study period, in order that each foal treated for septic 
arthritis might have two siblings as controls. In the case of mares that had failed to 
produce two other live foals of racing age in the study period, only one sibling was 
available for comparison. 
5.2.6.3. Data Analysis 
5.2.6.3.1. Study group analysis 
Outcomes that were statistically evaluated within the study group included discharge from 
the hospital and whether the foal eventually raced. Outcome was determined by evaluation 
of medical records to determine whether the foals were successfully discharged from the 
hospital. Lifetime race records were then obtained for all the foals that had been 
successfully discharged following treatment for septic arthritis. Race records were 
obtained from when foals were:::: 2 years old until 1st December 2003, and the time from 
birth until the first start and the number of starts were recorded. 
Variables that were statistically evaluated included infection in more than one joint, the 
presence of multi-system disease and the specific joint involved. Analyses of categorical 
variables were conducted for each outcome. Comparisons among groups of discreet data 
were initially made using univariable analyses of odds ratios and 95% confidence intervals, 
along with a X2 test for independence, attributable risk and absolute risk increase. 
5.2.6.3.2. Comparative analysis between study and control groups 
The outcome that was statistically evaluated was whether the foal eventually raced. 
Outcome was determined by obtaining the lifetime race records for all control foals, and all 
the foals that had been successfully discharged following treatment for septic arthritis. 
Race records were obtained from when foals were:::: 2 years old until 1 st December 2003, 
and the time from birth until the first start, and the total number of starts was recorded. 
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To compare the likelihood of a foal starting on a racecourse from the study group with 
their siblings in the control group, data were analysed using conditional logistic regression 
analysis, using the statistical software package PAIRS etc version 0.86, Win PEPI version 
4.0. This analysis allows exposed individuals (those in the study group) to have varying 
numbers of individually matched controls (those in the control group). This matching of 
cases and their siblings thereby clusters data by dam, to test the null hypothesis that septic 
arthritis as a foal did not affect the likelihood of that Thoroughbred foal starting on a 
racecourse, when compared to its siblings. 
Kaplan-Meier survival curves were generated depicting the age at first race of male and 
female foals in both the study group and the control population, and the age at first race of 
the study group and the control population. Survival curves were compared using the Log-
rank test. Differences were considered significant at p < 0.05. 
The attributable risk (AR), indicating the increase in the probability of failing to start on a 
racecourse in the study group, beyond the baseline risk experienced by the control 
population, resulting from the development of septic arthritis was calculated using the 
standard formula (Dohoo et al. 2003): 
AR = (al/nl) - (ao/no) 
Where: 
a I: is number of foals with septic arthritis that failed to start on a racecourse 
n I: is total number of foals with septic arthritis 
ao: is number of control foals that failed to start on a racecourse 
no: is total number of control foals 
The attributable fraction (AF), indicating the proportion of foals in the study group failing 
to start on a racecourse due to the occurrence of septic arthritis, using the standard formula 
(Dohoo et al. 2003): 
AF = [(al/nl) - (ao/no)]/(al/nl) 
Where: 
a I: is number of foals with septic arthritis that failed to start on a racecourse 
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nl: is total number of foals with septic arthritis 
ao: is number of control foals that failed to start on a racecourse 
no: is total number of control foals 
5.2.7. Results 
5.2.7.1. Descriptive statistics 
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Sixty-nine Thoroughbred foals met the criteria for inclusion in the study, thereby satisfying 
the power calculation performed at the outset of the study. Thirty-eight foals were male 
and thirty-one foals were female. Of the 69 foals, five had two affected joints at 
presentation and the remaining 64 foals had only one affected joint. The joint involved 
was recorded in 57 cases and included: femoropatellar joint with or without involvement of 
the femorotibial joint (17 foals), tibiotarsal joint (15), metacarpophalangeal or 
metatarsophalangeal joint (10), radiocarpal joint (6), humeroulnar joint (5), coxofemoral 
joint (2), scapulohumeral joint (1) and distal interphalangeal joint (1). In four of the five 
foals with> 1 joint involved, it was the same joint but in contra-lateral limbs. The specific 
joints affected were not recorded for the fifth foal. Results of the cytological analyses of 
the synovial fluid collected at the time of admission were available for 44 foals. Nucleated 
cell counts on admission (range: 5.0 x 109 cells/l to 194 x 109 cells/I; median: 38 x 109 
cells/I; inter-quartile range: 20.25 x 109 cells/l to 95.50 x 109 cellsll) exceeded the reference 
limit (3.0 x 109 cells/I) in all cases. Duration of clinical signs prior to presentation at the 
hospital was recorded in 51 cases, with clinical signs first being noticed < 24 hours prior to 
admission at the hospital for treatment in 38 cases (74.5%). 
5.2.7.2. Treatment options 
Although all foals were treated with systemic, broad spectrum antimicrobials and joint 
lavage there was no standardised treatment protocol, with the specific antimicrobials and 
lavage technique used varying with the preference of the treating veterinarian. Affected 
joints were usually lavaged on alternate days until a clinical improvement was seen, with 
lavage being performed between one and six times in total (median=l lavage). Standard 
practice was to review the antimicrobial regimen if antimicrobial sensitivity indicated that 
the organisms cultured were resistant to the initial antimicrobial choice, or if there was a 
failure to respond to treatment. Foals were discharged from the hospital when the clinical 
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signs of infection had resolved, although all foals were still receiving antimicrobials at the 
time of discharge. 
5.2.7.3. Factors affecting survival 
Of the 69 foals admitted to the hospital for treatment of septic arthritis, 84.1 % (58/69) 
survived to be discharged from the hospital, with long-term follow-up available for all the 
foals discharged. Of the 11 foals that were euthanased prior to discharge from the hospital, 
one foal was euthanased due to a disease process other than septic arthritis. The remaining 
10 foals were all euthanased due to a failure of the septic arthritis to respond to treatment. 
Three of the five foals with more than one affected joint failed to survive to discharge from 
the hospital. The remaining two foals were successfully discharged but did not race. 
Further statistical analysis to demonstrate an association between the presence of infection 
in more than one joint and either a reduced likelihood of foals surviving to discharge or a 
reduced likelihood of starting on a racecourse was not performed, as there was insufficient 
power to prove a statistically significant difference. 
Eight of 69 foals (11.6%) had evidence of a disease process outside the synovial cavity -
one foal had concurrent osteomyelitis, one had a ruptured bladder, one foal had pneumonia 
and five foals had infected umbilical remnants requiring surgical resection. Of these eight 
foals, four failed to survive until discharge. Of the remaining four that were discharged, 
two failed to race. The presence of multi-system disease was associated with a decreased 
likelihood of the affected foal surviving to be successfully discharged from the hospital 
(O.R. 0.13; 95% c.r. 0.02 to 0.90; p=0.005). However, of those foals successfully 
discharged, the presence of multi-system disease did not affect the likelihood that they 
would start in at least one race compared to the foals treated for septic arthritis that were 
not affected with multi-system disease (O.R. 0.45; 95% C.l. 0.04 to 2.81; p=0.34). 
5.2.7.4. Long-term follow-up 
Twenty-eight foals (40.5%; 95% C.l. 28.9 to 53.1; p=0.148) with septic arthritis 
subsequently started in ::::1 race, and 17 (24.6%) raced:::: 5 times. Thus, 28 of the 58 
(48.3%) foals that were discharged from the hospital following treatment started in a race. 
Of the 130 foals in the control group, 86 (66.2%; 95% C.r. 57.3 to 74.2; p < 0.001) 
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subsequently started in ~1 race, and 69 (53.1 %) raced ~ 5 times. Data analysed using 
combined regression analysis confirmed that the occurrence of septic arthritis as a neonate 
resulted in a Thoroughbred foal being 3.5 times less likely to start on a racecourse 
compared to its siblings prior to the commencement of treatment (O.R. 0.28; 95% c.r. 0.12 
to 0.62, p=O.OOl). If the foal was successfully discharged from the hospital following 
resolution of joint sepsis, it would be 2.8 times less likely to start on a racecourse 
compared to its siblings (O.R. 0.36; 95% C.r. 0.15 to 0.83, p=0.008). Within those foals 
that started on a racecourse at least once, foals that had been treated for septic arthritis 
were no less likely to start ~ 5 times as the sibling population (O.R. 0.38; 95% C.r. 0.14 to 
1.08; p=0.037). 
Calculation of the attributable risk showed that there was an increase by 0.256 in the risk 
of foals in the study group failing to start on a racecourse, beyond the baseline risk of 
failing to start on a racecourse experienced by those foals in the control group, due to the 
occurrence of septic arthritis. Calculation of the attributable fraction showed that in 43% 
of those foals in the study group that failed to start on a racecourse, this failure was due to 
the occurrence of septic arthritis. Therefore, if all the foals in the study group had not 
developed septic arthritis, an additional 43% could have been expected to start on a 
racecourse. 
5.2.7.5. Comparison popUlation 
Two siblings for comparison were identified in 61 cases, with the remaining eight foals in 
the study group only having one sibling available for comparison. Therefore, there were 
130 foals in the control group. 
Of the 130 foals in the control group, 64 were female and 66 were male. A significantly 
larger proportion of the male foals started on a racecourse compared to the female foals 
(O.R. 2.82; 95% C.l. 1.24 to 6.49; p=0.007). In comparison, no statistically significant 
difference was found between the number of male and female foals treated for septic 
arthritis that started on a racecourse (O.R. 1.89; 95% Cl. 0.64 to 5.74; p=0.20). Overall, 
male foals that were treated for septic arthritis were less likely to start on a racecourse 
when compared to the male foals in the control group (O.R. 0.26; 95% C.l. 0.10 to 0.68; 
p=0.002). The same was not found to be true of female foals treated for septic arthritis, 
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when compared to the female population in the control group (O.R. 0.39; 95% C.l. 0.14 to 
1.05; p=0.04). 
5.2.7.6. Survival anlaysis 
Kaplan-Meier survival curves were generated comparing age at first race with the sex of 
the foal, and comparing age at first race between the study and sibling groups. Data from 
foals that failed to start in a race were censored. Log-rank comparison of the survival 
curves confirmed that foals discharged successfully following treatment for septic arthritis 
took significantly longer to appear on a racetrack for the first time compared to the sibling 
population (mean age of study group=1757 days; 95% c.l. 1604 to 1909; mean age of 
sibling group=1273 days; 95% C.l. 1197 to 1349; p=0.0006; Figure 3). 
Within the healthy sibling population male foals appeared on a racetrack at an earlier age 
then female foals (mean age of male foals = 1172 days; 95% C.l. 1074 to 1270; mean age 
of female foals = 1208 days; 95% c.l. 1144 to 1273 p=0.002; Figure 4). However, within 
the study group sex was not statistically associated with the age of the foal at its first race 
(mean age of male foals = 1692 days; 95% C.l. 1487 to 1896; mean age of female foals = 
1333 days; 95% C.l. 1242 to 1424; p=0.24; Figure 4). Although the difference in the mean 
age at first racecourse appearance was greater between male and female foals in the study 
group than in the control group, the sex of the foal in the study group was not found to be 
statistically significant due to the low number of foals in this group providing inadequate 
power to detect a statistically significant difference. 
Chapter 5 134 
1.0""1 
__ Sil:inggroup 
09 -l \\ Stud; goup 
I 
08
1 \1_, ~ 0.7 " ,-:0 , 
'" .0 e 06 
CL 
0.5 
0.4 
0.3 
I 
I 
1000 2000 
Age at first race (days) 
Figure 3: Kaplan-Meier plot of the probability of a Thoroughbred foal not starting on a racecourse, 
for the sibling and study groups. 
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Figure 4: Kaplan-Meier plot of the probability of the sibling and study populations not starting on a 
racecourse, for male and female foals. 
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5.2.8. Discussion 
5.2.8.1. Limitations of the study 
Survival rates reported here for foals treated for septic arthritis are higher than those in 
other reports (Schneider et al. 1992a; Steel et al. 1999; Meijer et al. 2000). This may be 
the result of early recognition and treatment of joint sepsis. All the foals were resident at 
large studs, where the awareness of the importance of adequate colostrum consumption, 
along with thorough daily checks of foals, contributes to a better management regimen. 
The majority of cases were admitted to the hospital by members of the practice rather than 
being a referral population as described by previous reports, in which it might be expected 
that there is a bias towards more severely affected animals. In addition, the practice in 
question is a large, specialist equine hospital, well equipped both in terms of facilities and 
experienced personnel, where staff are familiar with neonatal septic arthritis and are 
therefore able to detect subtle clinical signs of early sepsis. 
Despite the large number of publications in the literature on septic arthritis, limited data are 
available on the prognosis for neonatal septic arthritis (Schneider et al. 1992a; Steel et al. 
1999; Meijer et al. 2000), particularly in an athletic breed such as the Thoroughbred, with 
only two studies extending follow-up beyond discharge from the hospital (Platt, 1977; 
Steel et al. 1999). Although both these studies contain valid data and conclusions, in EBM 
terms they would be classified as providing class C evidence, using the classification 
system proposed by Yusuf et al (1998), as they are case series, using no control groups. 
The purpose of the current study was to investigate the long term prognosis for 
Thoroughbred foals treated for septic arthritis, with the intention of conducting a study that 
would provide a higher class of evidence than those studies already published in the 
literature. By using a retrospective case series as a study design, with older siblings used 
as a comparison population, the current study would be classified as providing class B 
evidence. 
5.2.8.2. Factors affecting long-term prognosis 
Although many studies have examined the efficacy of different treatment regimens in the 
management of septic arthritis, no study has focused on such a specific study group, or 
compared the long-term outcome following treatment for septic arthritis to a suitable 
Chapter 5 136 
control group. The purpose of this study was not to compare the specific treatment 
regimes used and their effect on the long-term prognosis, but to assess whether a 
Thoroughbred foal treated successfully for septic arthritis would race. All foals admitted 
to the hospital for treatment of septic arthritis were matched with two of their siblings of 
racing age as controls, for comparison of the number of starts achieved in their career 
(Mitten et al. 1995). Older siblings were selected where possible. Where two siblings of 
racing age were not available, one sibling was used as a control. Statistics published by 
Weatherbys suggest that approximately 65% of Thoroughbred foals born in one year will 
start at least once on a racecourse - a figure that has not changed over the past decade. Our 
figures showed that 66.2% of the siblings successfully started in at least one race - an 
almost identical result to the predicted average. In comparison, only 48.3% of all foals 
successfully discharged following treatment for septic arthritis started in at least one race 
in their career. This result is higher than two previous studies reporting the long term 
outcome of Thoroughbred foals treated for septic arthritis, in which only 30% (Platt, 1977) 
and 37% (Steel et al. 1999) of foals subsequently raced. The outcome may have been 
better than that previously reported, due to the nature of the study population. They were 
not a true referral population, as reported by Steel et al. (1999), but were resident at large 
studs where all foals were checked on a daily basis. In addition, daily veterinary visits 
were standard practice, allowing for prompt institution of treatment in cases where either 
septicaemia or septic arthritis was suspected. 
Although young animals have a greater capacity for regeneration of articular cartilage than 
adults (Martens & Auer, 1980; McIlwraith, 1983) the severe degenerative changes that 
occur subsequent to infection are likely to have contributed to the higher number of foals 
that failed to race following successful resolution of sepsis, when compared to the sibling 
population. However, it is impossible to ascertain from lifetime racing records alone the 
reason that some of the foals that were discharged from the hospital failed to make at least 
one start on a racecourse. 
Unlike previous studies (Martens & Auer, 1980; Steel et al. 1999), infection of multiple 
joints was not associated with either a reduced likelihood of foals surviving to discharge, 
or a reduced likelihood of racing. However, the total number of foals treated with multiple 
joint involvement was very low (5/69; 7%), compared with previous studies where a 
significantly higher proportion of multiple joint involvement was recorded - 50% 
(Schneider et al. 1992a) and 50.6% (Steel et al. 1999). The very small numbers of foals 
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that had multiple joint involvement in the current study rendered the statistical power too 
small to detect any significant difference. This finding highlights the fact that despite the 
careful study design and a power and sample size calculation being performed at the outset 
of the study, subsequent subdivision of the study group for investigation of different 
variables on the outcomes of interest will lower the power. However, the investigation of 
the affect these variables might have on the outcomes of interest was not the primary aim 
of this study. 
The affected joint (femoropatellar, tibiotarsal joint, metacarpo/metatarsophalangeal) did 
not have a significant effect on either survival to discharge or the long term prognosis. 
Other joints were not affected in sufficient numbers to allow for accurate evaluation. The 
presence of multi-system disease was associated with an increased likelihood of the 
affected foal not surviving to be discharged from the hospital. However, of those foals 
discharged, the presence of multi-system disease did not affect the likelihood that they 
would start in at least one race. 
Despite the large number of foals in the study, the retrospective study design, coupled with 
the fact that many foals received more than one antimicrobial and lavage technique 
precludes any conclusions being drawn regarding the relative efficacy of specific treatment 
modalities. However, the aim of the study was not to compare the relative success 
associated with one specific treatment, but to investigate the long-term prognosis of foals 
that had survived until discharge from the hospital, and whether the occurrence of septic 
arthritis as a neonate would affect the likelihood of them starting on a racecourse. It was 
not possible to draw any conclusions from this study as to whether the occurrence of septic 
arthritis as a neonate affected the racing performance of those foals in the study group. 
However, it would not be possible to investigate this adequately in a retrospective study, 
due to the multiple factors that influence a foal's ability to race successfully. 
Studies adopting a prospective, controlled design are required in order to be able to draw 
any conclusions on the efficacy of specific treatment regimens. Similarly, attempts to 
examine the effects of the joint involved, number of joints and existence of concurrent 
pathology on survival and long-term prognosis should be viewed with caution as this study 
relies on retrospective analysis of medical records. When attempting to draw conclusions 
from the effects of multiple joint involvement or multi-system disease, the very low 
numbers of foals in each of these categories dramatically reduces the power of that 
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component of the study. In order to fully investigate the influence any of these variables 
might have on the outcomes of interest, it would be necessary to design a study that would 
take into consideration the relative prevalence of each of these variables, and an 
appropriate power and sample size calculation should be performed. 
5.2.8.3. Conclusions 
The prognosis for survival following early identification and treatment of septic arthritis in 
this particular population of Thoroughbred neonates is guarded to fair, although it IS 
reduced significantly by the presence of multi-system disease. If the infection IS 
eliminated from the synovial space then almost 50% of foals successfully started in at least 
one race. However, the prognosis for starting in a race, when compared to their siblings, is 
poor. 
5.3. What factors affect the likelihood that mature Thoroughbred racehorses 
treated for septic arthritis will race? 
5.3.1. Routes of infection 
Septic arthritis in adult horses is a serious clinical problem (Bertone et ai. 1987a,b; Tulamo 
et ai. 1989; Schneider et ai. 1992b; Cook and Bertone, 1998; Booth et ai. 2001) which, 
unlike in the neonate, commonly affects only a single joint (Cook and Bertone, 1998). 
There are three recognised routes by which bacteria may become established within a 
synovial cavity (4.2.1.): 
1. trauma 
2. iatrogenic origin 
3. haematogenous spread 
Occasionally, the inciting cause of sepsis if never identified. 
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5.3.2. Prognosis following resolution of sepsis 
The prognosis for a successful return to athletic function has been variously described from 
guarded or poor (Martens & Auer, 1980; McIlwraith, 1983; Gibson et al. 1989; Bowman et 
al. 1991; Brusie et al. 1992; Lapointe et al. 1992) to favourable or even good (Ross et al. 
1991; Schneider et al. 1992a,b; Bertone, 1999; Meijer et al. 2000; Summerhays, 2000; 
Booth et al. 2001). It has been shown that time between onset of sepsis and initiation of 
therapy (Gibson et al. 1989; Peremans et al. 1991; Honnas et al. 1992a), and the joint 
infected (Peremans et al. 1991; Booth et al. 2000) are both influential when considering 
the likely outcome. The main causes of treatment failure are the inability to eliminate the 
causative agent (Bertone et al. 1987a; Schneider et al. 1992a,b; Meijer et al. 2000) and to 
disrupt effectively the vicious cycle of articular cartilage destruction mediated by 
inflammatory products (Orsini, 1984; Stover, 1990; Bertone, 1999). 
Previous studies have frequently reported only short term follow up, with the end point 
commonly being discharge form the hospital. Only three studies (Ross et al. 1991; 
Lapointe et al. 1992; Schneider et al. 1992a) have followed the outcome of horses after 
they have been discharged from the hospital following treatment for septic arthritis. 
Studies have reported that between 41.7% (Honnas et at. 1992) and 85% (Schneider et al. 
1992a) of mature horses treated for septic arthritis were successfully discharged from the 
hospital. Of those studies that reported longer term follow up, it was found that 25% 
(LaPointe et al. 1992) to 56.5% (Schneider et al. 1992a) of horses were able to return to 
their original level of athletic function, with no adverse affects related to the occurrence of 
septic arthritis. No study has followed up a large number of horses over an extended time 
period to assess the long term outcome following treatment for septic arthritis. 
5.3.3. Study aims 
The purpose of this study was to evaluate data from an equine hospital over the last 10 
years, and to compare each study group to a suitable control population, so as to 
investigate the likely long term athletic prognosis for mature Thoroughbred racehorses 
treated for septic arthritis. In this study it was hypothesised that the occurrence of septic 
arthritis in mature Thoroughbred racehorses would significantly reduce the likelihood of 
these horses returning to their previous level of athletic function. The study aim was to test 
this hypothesis using a retrospective study. 
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5.3.4. Material and Methods 
5.3.4.1. Data retrieval 
The admission records for Rossdales Equine Hospital between 1993 and 2002 were 
reviewed to identify mature Thoroughbred horses that had been admitted with suspected 
joint pathology, and medical records were then retrieved. To be eligible for inclusion in 
the study horses had to be Thoroughbreds, either in training or intended for use as 
racehorses, and had to be 2: 6 months old at the time of admission. Any Thoroughbred 
horses which were not intended solely as racehorses were excluded from the study. If age 
was not specified on the medical records, those horses were excluded from the study. In 
cases in which septic arthritis was suspected on the basis of clinical signs, diagnosis was 
confirmed on the result of synoviocentesis of the affected joint, where an increased 
nucleated cell count (upper end of normal reference limit for laboratory: 3 x 109 cells/I) in 
conjunction with an increased total protein concentration (upper end of normal reference 
limit: 15g/l) and the presence of a neutrophilia with degenerative polymorphonuclear cells 
on cytological analysis were considered to be diagnostic. Information retrieved from the 
medical records included age, sex, number of joints infected, anatomical location of 
joint(s) involved, the suspected route of infection, the white cell count of the synovial fluid 
at the time of admission to the hospital, radiographic findings, results of culture of the 
synovial fluid, details of antimicrobial therapy and lavage procedures performed and 
whether the horse was discharged from the hospital following treatment. 
The foaling history of each horse's dam was then reviewed in order to obtain the details of 
two siblings, in order to match the case with two controls for analysis. In situations in 
which mares had produced fewer than two live foals in the years prior to the affected horse 
being born, the closest siblings in age born after the affected horse were selected for 
comparison, provided that they had attained racing age within the study period, in order 
that each horse treated for septic arthritis might have two siblings as controls. In the case 
of mares that had failed to produce two other live foals of racing age in the study period, 
only one sibling was available for comparison. 
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5.3.4.2. Data analysis 
5.3.4.2.1. Study group analysis 
Variables that were statistically evaluated included age, sex, location of affected joint, 
inciting cause of sepsis, evidence of radiographic changes at the time of admission, 
synovial white cell count at the time of admission, duration of onset of sepsis until 
commencement of treatment and the number of lavages performed. Categorical variables 
with more than two levels were coded as indicator variables. 
Outcomes that were statistically evaluated included discharge from the hospital and 
whether the horse started on a race course following treatment for septic arthritis. 
Outcome was determined by evaluation of medical records to determine whether the horses 
were successfully discharged from the hospital. Lifetime race records were then obtained 
for all the horses that had been successfully discharged following treatment for septic 
arthritis. Race records were obtained from when horses were 2: 2 years old until 1 st 
December 2004. For horses in the study group, the highest Official Rating awarded to 
each horse by the British Horseracing Board's handicappers, both before and after 
treatment for septic arthritis, was retrieved. 
Binary logistic regression was used to analyse these data, as both outcomes of interest were 
dichotomous. Analyses were implemented with the statistical software MINITAB (version 
13.31). 
Univariable logistic regression was used to screen all variables, and from this all variables 
with a p-value ::;0.20 were included in a backward elimination process to fit a multivariable 
model. The inclusion criterion for backward elimination was set at p ::; 0.05. The 
goodness-of-fit of the models was assessed using the Hosmer-Lemeshow goodness-of-fit 
test, to test the null hypothesis that the model was a good fit, with the null hypothesis 
accepted at a p-value 2: 0.05. 
Once the main effects model had been fitted, two-way interaction between variables was 
assessed. Variable selection was determined by biological plausibility. Assessment 
between models was obtained using a likelihood ratio test (LRT) with significance set at p 
::; 0.05. 
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5.3.4.2.2. Comparative analysis between study and control groups 
The outcome that was statistically evaluated was whether the horse started on a race course 
following treatment for septic arthritis. Outcome was determined by obtaining lifetime 
race records for all the horses in the control group, and all the horses that had been 
successfully discharged following treatment for septic arthritis. Race records were 
obtained from when horses were ~ 2 years old until 1 st December 2004. For horses in the 
study group, the highest Official Rating awarded to each horse by the British Horseracing 
Board's handicappers, both before and after treatment for septic arthritis, was retrieved. 
The highest lifetime Official Rating awarded was retrieved for each horse in the 
comparison group. Data were then analysed using a general linear model, which allowed a 
univariate analysis of variance to be performed with an unbalanced design, as there was 
more than one control available for comparison with each case. 
Data were also analysed using combined regression analysis, which allows for matching of 
cases and their siblings thereby clustering data by dam, to test the null hypothesis that the 
occurrence of septic arthritis did not affect the likelihood that an umaced Thoroughbred 
would start on a racecourse, when compared to its siblings. Comparison of Official 
Ratings between the study group and their matched controls was made using a general 
linear model. Differences were considered significant at p < 0.05. 
A Wilcoxon signed rank test was used to compare the highest Official Rating achieved 
after resolution of septic arthritis with the highest Official Rating achieved prior to the 
onset of sepsis, for those horses that had raced at least once prior to the onset of sepsis. 
The null hypothesis, that there was no significant difference between the distribution or 
median of the paired samples, was rejected at p-values :s 0.05. 
5.3.5. Results 
5.3.5.1. Descriptive statistics 
Sixty-five mature Thoroughbred horses met the criteria for inclusion in the study. Thirty-
eight horses were male and twenty-seven horses were female. The age at the time of 
admission was recorded for all the horses, and ranged from 1 year old to 12 years old, with 
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the median age being 2 years old (inter-quartile range: 2 to 4 years old). None of the 65 
horses had two or more affected joints at presentation. 
5.3.5.2. Factors affecting survival 
Of the 65 horses admitted to the hospital for treatment of septic arthritis, 87.7% (57/65; 
95% C.l.: 77.2 to 94.5; P < 0.001) survived to be discharged from the hospital, with long-
term follow-up available for all the horses discharged. Of the eight horses that were 
euthanased prior to discharge from the hospital, all horses were euthanased due to a failure 
of the septic arthritis to respond to treatment. Two of the eight horses that were euthanased 
had been successfully discharged from the hospital, then were re-admitted due to a 
recurrence of the synovial sepsis. 
The age and gender of the horse at the time of admission, synovial white cell count at the 
time of admission, specific joint affected, presence of radiographic changes in the affected 
joint at the time of admission, route of infection, duration from onset of sepsis to 
commencement of treatment and number of lavages performed were all investigated for 
each outcome. The only variables found to be associated with an increased risk of a horse 
failing to survive to be discharged from the hospital were the involvement of the proximal 
inter-phalangeal joint and a delay of at least five days between the onset of sepsis and the 
commencement of treatment (Table 12). None of the other variables investigated were 
associated with an increased risk of a horse failing to survive to be discharged (Appendix 
5.1). 
Table 12: Univariable analysis of factors affecting survival of mature Thoroughbred racehorses 
following treatment for septic arthritis. 
Coefficient S.E. OR 95% CI p 
Joint affected (referent metatarso-phalangeal joint) 
Proximal inter- -3.05 1.43 0.05 0.00 - 0.79 0.033 
phalangeal joint 
Delay between onset of sepsis and treatment (referent <ld) 
>5 ds -1.90 0.86 0.15 0.03 - 0.80 0.027 
A multi variable logistic model was built using backward elimination, with all variables 
with p:s 0.20 at the univariable level included in the analysis. The inclusion criterion for 
backward elimination was set at p:S 0.05. The only variable found to be associated with an 
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increased risk of a horse failing to survive to discharge at the multivariable level was a 
delay of more than 5 days between the onset of sepsis and treatment (Table 13). However, 
due to the low number of horses that failed to survive to be discharged from the hospital 
(8/65; 12.3%) the statistical power to detect a significant difference is very small. 
Table 13: Multivariable analysis of factors associated with a decreased likelihood of mature 
Thoroughbred racehorses surviving following treatment for septic arthritis. 
Coefficient S.E. OR 95% CI p 
Constant 2.99 0.92 0.001 
Delay between onset of sepsis and treatment (referent <ld) 
>5 ds -2.68 1.23 0.07 0.01 - 0.77 0.030 
5.3.5.3. Factors affecting long-term prognosis 
Thirty-six horses (55.4%; 95% c.r. 42.5 to 67.7; p=0.457) with septic arthritis started in at 
least one race following discharge from the hospital. Thus, thirty-six of the fifty-seven 
horses (63.2%; 95% C.r. 49.3 to 79.6; p=0.063) that were successfully discharged from the 
hospital went on to start on a racecourse. 
Univariable logistic regression analysis did not find that any of the variables investigated 
were associated with an increased risk of a horse that was successfully discharged 
following treatment for septic arthritis failing to start on a racecourse (Appendix 5.2). 
5.3.5.4. Comparison population 
Of the one hundred and twenty horses in the comparison group, 83 (69.2%; 95% c.r. 60.1 
to 77.3; p < 0.001) subsequently started in 2: 1 race, with the remaining thirty-seven horses 
failing to make a start on a racecourse. Sixty-four of those horses were female and fifty-
six were male. The sex of the horse did not have a significant effect on whether the horse 
would start on a racecourse (OR 0.70; 95% CI 0.29 to 1.64; p= 0.37). A retrospective 
power calculation, with a 5% significance level, showed that with 36/65 (55.4%) horses in 
the study group starting in a race following resolution of septic arthritis, compared to 
83/120 (69.2%) horses in the comparison group, the power of this component of the study 
to detect a significant difference between the two groups was only 37%. However, even if 
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the study design had provided significant power to detect a meaningful difference, it could 
be argued that there may be little clinical significance in the difference in proportions 
(55.4% and 69.2%) of horses starting on a racecourse. 
5.3.5.5. Comparison between study and sibling populations 
5.3.5.5.1. Raced prior to septic arthritis 
Of the sixty-five horses in the study group, thirty-one horses (47.7%) had started in at least 
one race prior to the occurrence of septic arthritis. Of these horses, five (16.1 %, 95% C.r. 
5.0 to 34.0)) were euthanased prior to discharge from the hospital. Of the twenty-six 
horses successfully discharged from the hospital following resolution of the septic arthritis, 
eleven horses (42.3%, 95% C.r. 23.0 to 63.0) went on to make at least one subsequent start 
on a racecourse. Of these eleven horses, only one horse (9.1 %; 95% C.r. 2.0 to 41.3) failed 
to achieve an equal or higher Official Rating awarded by the British Horseracing Board's 
handicappers, compared to the one allocated to it before the occurrence of septic arthritis. 
The highest Official Rating achieved by each horse following resolution of sepsis was 
compared to the highest rating achieved prior to the onset of sepsis using the Wilcoxon 
signed rank test. The highest rating achieved following resolution of sepsis was not found 
to be significantly different to that achieved prior to sepsis, with a p-value >0.05, therefore 
the null hypothesis could not be rejected. However, the limited number of horses available 
limited the power of the study to detect a significant difference. 
5.3.5.5.2. Never raced prior to septic arthritis 
The remaining thirty-four horses in the study group (52.3%) were all in training at the time 
of the occurrence of septic arthritis, but had not made their first start on a racecourse. Of 
these horses, three were euthanased prior to discharge from the hospital, and of those that 
were successfully discharged following resolution of the septic arthritis, twenty-five horses 
(80.6%, 95% C.r. 63.0 to 93.0) went on to make at least one subsequent start on a 
racecourse. Of the fifty-six siblings in the comparison group for these cases, thirty-seven 
horses (66%) made at least one appearance on a racecourse. Data analysed using 
combined regression analysis confirmed that the occurrence of septic arthritis in a mature 
Thoroughbred racehorse, prior to its first start in a race, did not affect the likelihood that it 
would make at least one appearance on a racecourse when compared to its siblings (OR 
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2.75; 95% C.l. 0.72 to 15.6; p=O.II). Of the twenty-five cases that started on a racecourse 
at least once after discharge from the hospital, four horses failed to achieve an Official 
Rating either equal or higher to that awarded by the British Horseracing Board's 
handicappers to its siblings. 
When considering the likelihood of those horses that had already raced prior to the onset of 
septic arthritis returning to the racecourse, compared to the likelihood of those horses that 
had yet to make their first appearance on a racecourse prior to the onset of septic arthritis 
starting in a race, the horses that had yet to make their first appearance on a racecourse 
were significantly more likely to race after resolution of septic arthritis than those that had 
raced prior to the onset of septic arthritis (OR 0.20; 95% c.l. 0.07 to 0.58; p=0.002). 
5.3.5.6. Official Ratings 
Ofthe 36 cases that started in a race after successful treatment for septic arthritis, a general 
linear model was used to compare the highest Official Rating achieved by those cases in 
the study group successfully discharged from the hospital that went on to start on a 
racecourse, with the highest Official Rating achieved by their siblings in the comparison 
population (Table 14; Appendix 3). Whether a horse was a member of the study or control 
population was treated as a fixed effect in the model, whilst the code referring a member of 
the control population to its sibling in the study population was treated as a random effect. 
The model found that the F -statistic was significant, therefore there was a significant 
difference between variances in the study and control groups (Table 14). The coefficient 
indicated that those horses in the study group had, on average, an Official Rating 12.97 
points higher than their siblings in the control group (Appendix 6). 
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Table 14: Comparison of highest Official Rating achieved between study and comparison populations 
of mature Thoroughbred racehorses, using a General Linear Model. 
Degrees of Sequential Adjusted Adjusted F-test p-value 
Freedom Sums of Sums of Means statistic 
Squares Squares Squares 
Case 1 12090 12567 12567 9.43 0.004 
Sibling 35 70520 70520 2015 1.51 0.093 
code 
Error 47 62630 62630 1333 
Total 83 145240 
Where: Case = member of study group; Sibling code = code referring member of control group to 
sibling in study group; Error = difference between observed value of observation and value predicted 
by model 
5.3.6. Discussion 
5.3.6.1. Class of evidence 
Although there have been many studies published in the literature on septic arthritis, only a 
few have reported on the long-term prognosis for those horses successfully discharged 
from a hospital following resolution of sepsis (Ross et ai. 1991; LaPointe et ai. 1992; 
Schneider et ai. 1992a). These three studies have all been case series, which would be 
classified in EBM terms as providing class C evidence using the classification system 
proposed by Yusuf et ai (1998). The aim of this study was not merely to add another 
retrospective study to the literature pool, but to utilise a suitable comparison population, 
thereby reporting on a study providing a higher class of evidence (class B) than those 
previously reported. 
5.3.6.2. Factors affecting the outcome 
Survival rates reported here are similar to those from previous studies (LaPointe et ai. 
1992; Schneider et ai. 1992a; Meijer et ai. 2000). The majority of cases were admitted to 
the hospital by members of the practice rather than being a referral population as described 
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by previous reports, where it might have been expected that there would be a bias towards 
more severely affected animals. 
The most commonly affected joint in our study was the metatarsophalangeal joint - a small 
joint with a relatively simple structure. Previous studies have reported a higher incidence 
of involvement of the larger joints (tibio-tarsal joint) (Schneider et al. 1992a; Meijer ef al. 
2000). The only statistically significant finding associated with the joint affected was that 
involvement of the proximal inter-phalangeal joint was associated with a decreased 
likelihood of surviving to be discharged from the hospital. This is similar to previously 
reported findings, where joints that were small, with limited surgical access, were 
associated with a poorer prognosis for survival (Peremans ef al. 1991; Honnas ef al. 1992; 
Booth ef al. 2001). Similarly, our study concurred with a previous study (Peremans ef al. 
1991) in that a substantial time delay (at least 5 days in this study) was associated with a 
decreased likelihood of surviving to be discharged from the hospital. Although it could be 
expected that a delay between the onset of sepsis and treatment would lead to a poorer 
prognosis for survival, due to the prolonged exposure of the articular structure to both 
bacteria and proteolytic enzymes, this finding has only been sparsely reported (Peremans et 
al. 1991). However, the low numbers of horses presented for treatment more than 24 hours 
after the inciting caurse of sepsis reduces the power of that component of the study. 
5.3.6.3. Limitations of the study 
Despite the large number of horses included in the study, the retrospective study design, 
coupled with the fact that many horses received more than one antimicrobial and lavage 
technique, precludes any conclusions being drawn regarding the relative efficacy of 
specific treatment modalities. However, the aim of the study was not to compare the 
relative success associated with one specific treatment, but to investigate the long-term 
prognosis of horses that had survived until discharge from the hospital, and whether the 
occurrence of septic arthritis would affect the likelihood of them starting on a racecourse 
compared to their siblings. 
Although many studies have examined the efficacy of different treatment regimens in the 
management of septic arthritis, no study has focused on such a specific study group, or 
compared the long-term outcome following treatment for septic arthritis to a suitable 
control group. All horses admitted to the hospital for treatment of septic arthritis were 
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matched with two of their siblings of racing age as controls, for comparison of whether 
they ever started on a racecourse (Mitten et ai. 1995). Older siblings were selected where 
possible. Where two siblings of racing age were not available, one sibling was used as a 
control. Of those horses in the study group that were successfully discharged from the 
hospital, 63.2% started on a racecourse following treatment for septic arthritis - an almost 
identical result to the predicted average (5.2.6.1). However, it is impossible to know from 
medical records and racing records alone how many of these horses were capable of 
returning to racing but did not for other reasons. This could only be determined by long 
term follow up through contact with either the owner or trainer. It is possible that bias 
occurred in the long term follow up, with horses only being returned to training following a 
potentially expensive treatment for septic arthritis if owners or trainers were confident that 
they would be successful on a racecourse. Without direct communication with either the 
owners or trainers it is impossible to establish whether horses were not returned to training, 
and therefore racing, due to complications directly attributable to the occurrence of septic 
arthritis or if there was an ulterior motive. Due to the retrospective nature of the study, and 
the limited case numbers available, the power of this component of the study was low 
(40%). In order to improve the power of the study a larger study population should be 
compared with a suitable control group. However, sufficient case numbers may be 
difficult to recruit without a lengthy study period. 
Evaluation of the official rating issued by the British Horseracing Board's handicappers 
showed that, of the horses that returned to racing, the occurrence of septic arthritis did not 
prevent horses returning to their best previous rating, or a higher rating. Similarly, over 
90% of horses that returned to racing were able to attain a rating either equal to or higher 
than the highest rating achieved by their siblings. Therefore the occurrence of septic 
arthritis, whilst decreasing the likelihood that a mature Thoroughbred will return to racing 
compared to its siblings, does not appear to affect adversely the performance of those 
horses that do make at least one start on a racetrack after successful resolution of synovial 
sepsis. 
5.3.6.4. Conclusions 
The prognosis for survival following early identification and treatment of septic arthritis in 
this particular population of Thoroughbred racehorses is favourable. If the infection is 
eliminated from the synovial space, then almost 65% of horses successfully discharged 
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started in at least one race. In conclusion, the prognosis for starting in a race, following 
resolution of sepsis, is good. 
5.4. Overall Conclusions 
Overall, the prognosis for both surviving to be discharged form the hospital, and starting in 
at least one race, is porr for Thoroughbred neonates treated for septic arthritis. In direct 
contrast, the prognosis for a mature Thoroughbred racehorse treated for septic arthritis is 
much better, being described as favourable, or good, for either surviving to be discharged 
from the hospital or starting in at least one race. 
Chapter 6 
Chapter 6 
Incisional complications following exploratory celiotomy: does a belly band reduce 
the risk? 
6.1. Introduction 
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As the rate of post-operative survival has increased over the last three decades, 
complications following exploratory laparotomy for abdominal pain in the horse have 
become more apparent (Freeman et aI, 2000; French et al. 2002). These post-operative 
complications are corning under increasing scrutiny as their relative importance increases 
in terms of the overall cost of treatment and the length of time to recovery. 
6.2. Complications following exploratory laparotomy 
The main postoperative complications documented following colic surgery include 
(Ducharme et al. 1983; Hunt et al. 1986; Phillips and Walmsley, 1993; Freeman et al. 
2000; French et al. 2002; Proudman et al. 2002; Mair and Smith, 2005a,b): 
1. incisional infection, herniation and dehiscence 
2. jugular vein thrombophlebitis 
3. post-operative ileus 
4. recurrent episodes of colic 
5. post-operative shock 
6. laminitis 
7. colitis/diarrhoea 
8. septic peritonitis 
The nature of post-operative complications identified in these studies was similar, although 
there was variation in the prevalence of the complications between different studies. Some 
of this variability may be due to the changes in the peri- and post-operative management of 
horses undergoing colic surgery, along with the trend towards earlier referral and surgery, 
which has occurred over the last two decades. 
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6.2.1. Morbidity associated with complications 
Although many post-operative complications are amenable to medical management, some 
of these complications are potentially life-threatening. The most common causes of 
euthanasia in the immediate post-operative period include: anastomotic leakage 
(MacDonald et al. 1989); septic peritonitis (Phillips and Walmsley, 1993); post-operative 
pain (Mair and Smith, 2005a) and shock (Ducharme et al. 1983). In some instances of 
post-operative pain, the decision for euthanasia was based on economic constraints (Mair 
and Smith, 2005a), instead of proceeding to a repeat laparotomy. 
Even with complications associated with low mortality, the increased post-operative 
morbidity results in an increase in the length of hospitalisation of the patient (Mair and 
Smith, 2005a,b), both increasing the overall cost of the treatment (Mair and Smith, 
2005a,b) and prolonging the eventual return to work. There has also been a direct link 
recognised between some of the more minor complications, for example incisional 
infections, and some of the more serious complications, for example incisional herniation 
(Gibson et al. 1989). 
For these reasons, much research is now being directed at the identification of risk factors 
contributing to post-operative complications (Kobluk et al. 1989; Roussel et al. 2001; 
French et al. 2002; Morton and Blikslager, 2002; Proudman et al. 2002), and strategies that 
may help avoid these complications developing (Galuppo et al. 1999; Coomer et ai. 2005). 
6.3. Incisional complications following exploratory laparotomy 
6.3.1. Classification of colic surgery 
Using the classification system proposed by the Committee on Trauma of the National 
Research Council (1964), few colic surgeries are classified as clean surgical procedures, 
with many procedures being classified as clean-contaminated or even contaminated, 
depending on the lesion identified. With the classification of a procedure as either clean-
contaminated or contaminated, the increased likelihood of possible exposure of the incision 
to a source of contamination is likely to contribute to this increased rate of incisional 
infections seen after an emergency celiotomy (Phillips & Walmsley, 1993; Honnas & 
Cohen, 1997). 
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6.3.2. Incidence of incisional complications 
A higher incidence of incisional complications following clean-contaminated emergency 
surgical procedures has been reported in Equidae compared to other species, with rates of 
5% (Vasseur et at. 1985; Vasseur et at. 1988) and 15% (Desrochers et at. 1996) reported 
for small animals and cattle respectively, compared to 24% in horses (Ingle-Fehr et at. 
1997). Incisional complications, ranging from oedema and drainage to more serious 
complications including infection and acute dehiscence, occur relatively commonly 
following exploratory celiotomy (Kobluk et at. 1989). Some studies have associated this 
high incidence rate with intra-operative incisional trauma, primarily from the manipulation 
and evacuation of the large colon (Phillips and Walmsley, 1993). 
6.3.3. Drainage from an incision 
Any form of drainage from the celiotomy incision is now frequently considered to be 
synonymous with incisional infection, even when a bacterial culture of the fluid has not 
been performed. Previous studies (Kobluk et at, 1989; Honnas and Cohen, 1997) have 
shown that a large proportion of celiotomy incisions that are draining any fluid, be it 
serous, sera-sanguineous or purulent, will yield a positive bacterial culture. 
Incisional drainage may not just be evidence of incisional infection, but can also be a 
precursor to the more serious incisional complications that could occur (herniation or 
dehiscence), as previous studies (French et at. 2002; Mair and Smith, 2005) have found 
that these complications have frequently been associated with prior incisional drainage. 
6.3.4. Incisional infections 
The prevalence of incisional infections after celiotomy incisions in horses is variable, with 
propOliions fram 4% (Mair, 2003; Mair and Smith, 2005b), to 9.9% (Kobluk et at. 1989), 
24% (Ingle-Fehr et at. 1997),25.4% (Honnas & Cohen, 1997) and 27% (Wilson, Baker & 
Boero, 1995) reported. Although there is wide variation in these figures, there was also a 
difference in classification of the definition of 'wound infection', ranging from any 
incisional drainage (Wilson, Baker & Boero, 1995; Ingle-Fehr et at. 1997), through 
purulent incisional drainage with associated heat and pain on palpation (Mair and Smith, 
Chapter 6 154 
2005b) to positive bacterial culture (Honnas & Cohen, 1997), which may account for some 
of the variation. Similarly, whilst some studies were restricted to celiotomies for colic 
(Kobluk et al. 1989; Honnas & Cohen, 1997; Mair, 2003; Mail' and Smith, 2005b) other 
studies included all forms of abdominal surgery (Wilson, Baker & Boero, 1995), which 
would alter the expected rate of incisional complications. 
An increased occurrence of incisional complications was also reported following repeat 
celiotomies (Kobluk et al. 1989; Phillips and Walmsley, 1993; Mair, 2003; Mair and 
Smith, 2005b), from between 57% (Mail' and Smith, 2005b) and 87.5% (Kobluk et al. 
1989) reported. 
6.3.5. Risk Factors for Incisional Complications 
Many studies have identified risk factors that could contribute to the overall likelihood of 
incisional complications following exploratory laparotomy, including: manipulation of the 
gastro-intestinal tract traumatising the incisional edges (McIlwraith, 1978; Phillips & 
Walmsley, 1993; Honnas & Cohen, 1997); exposure of the incision to potential sources of 
contamination during either routine enterotomy or gastro-intestinal resection (Phillips & 
Walmsley, 1993; Honnas & Cohen, 1997); use of certain suture materials when closing the 
linea alba, specifically polyglactin 910 (Honnas and Cohen, 1997) and the development of 
post-operative endotoxaemia predisposing to infection. Although these have all been 
identified as potential risk factors, their contribution to the overall incidence of incisional 
complications has not been either investigated or quantified. 
6.3.5.1. Suture Material 
Polyglactin 910, a braided suture material, has been reported to be the suture material of 
choice when closing the abdomen, unless an excessive amount of contamination has 
occurred (Ducharme, et al. 1992). In cases of excessive contamination, it is thought that 
this multifilament braided material will provide crevices where bacteria can survive and 
remain protected from both the host immune response, and the effect of any systemic 
antimicrobials administered. 
In one study, the use of polyglactin 910 in the closure of the linea alba was associated with 
a greater number of wound infections using both univariable and multivariable analyses, 
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when compared to polydioxanone and polyglycolic acid (Honnas and Cohen, 1997). It 
was proposed that the contamination resulting from an enterotomy may leave sufficient 
numbers of bacteria remaining in the abdomen to contaminate the suture material, thereby 
allowing establishment of post-operative wound infections (Honnas and Cohen, 1997). 
6.3.5.2. Suture Pattern 
The use of a near-far-far-near suture pattern when closing the linea alba was reported in 
one study to be associated with an increased incidence of incisional complications (Kobluk 
et al. 1989). The authors proposed that the dead space created when undermining tissue to 
place the sutures contributed to this increased occurrence of incisional infection (Kobluk, 
et al. 1989). 
A later study that investigated the influence of suture pattern as a factor in the development 
of incisional infection did not find the use of a near-far-far-near suture pattern statistically 
associated with an increased incidence of incisonal complications (Honnas and Cohen, 
1997. In this study, no undermining of tissues occurred prior to the placement of the 
sutures, thereby minimising the dead space created at the incision. It was proposed that 
this lack of dead space when using this suture pattern helped avoid the development of 
incisonal infection (Honnas and Cohen, 1997). A more recent study (Mair and Smith, 
2005b) found that when the fascial tissues were dissected from the linea alba prior to 
closure, the horse was almost four times more likely to experience post-operative wound 
complications than those where no dissection occurred, although all horses in this study 
had their linea alba closed using a simple continuous suture pattern. This report concurs 
with the earlier studies (Kobluk et al. 1989; Honnas and Cohen, 1997) in which it was 
proposed that the increased incidence of complications may be associated with the 
undermining of tissues and creation of dead space, as opposed to the specific suture pattern 
used. 
6.3.5.3. Repeat Celiotomy 
Horses that undergo a second laparotomy early in the post-operative period (prior to 
discharge from the hospital) are recognised to have a significantly higher likelihood of 
developing post-operative incisional complications than those horses that underwent a 
single surgical procedure (Kobluk et al. 1989; Phillips and Walmsley, 1993; Freeman et al. 
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2002; Mair and Smith, 2005b). It has been proposed that the increased incidence of 
incisional infection following repeat laparotomy has been caused by the transfer of bacteria 
from the raw edges of the wound and diminished resistance in the friable and oedematous 
tissues (Freeman et ai. 2002). 
In one large retrospective study, the prevalence of incisional drainage following a repeat 
laparotomy was 57%, compared to only 29% following a single laparotomy (Mair and 
Smith, 2005b). Similarly, the likelihood of developing an incisional hernia increased 
following a repeat laparotomy, from 7.2% to 25% (Mair and Smith, 2005b). 
6.3.6. Means of reducing complications 
Previous studies have indicated a number of factors that may contribute to the high 
prevalence of post-operative complications following exploratory laparotomy. However, 
no study has evaluated the efficacy of specific strategies to reduce the incidence of 
incisional complications. It has been suggested that the use of a protective belly band 
(abdominal bandage) will reduce environmental contamination of the ventral abdominal 
incision, as well as providing increased support of the incision and a more optimal 
environment for wound healing, thereby leading to a reduction in the prevalence of post-
operative incisional complications. However, to date no prospective study has been 
designed specifically to investigate this matter. 
6.4. Study Aim 
The aim of this controlled, randomised study was to test the hypothesis that the use of a 
belly band following colic surgery through a celiotomy incision would significantly reduce 
the prevalence of post-operative incisional complications. 
6.5. Materials and Methods 
6.5.1. Power Calculation 
Based on previously published data (Mair and Smith, 2005b), in which the prevalence of 
incisional complications at Bell Equine Veterinary Clinic following exploratory 
laparotomy over a ten year period was found to be 26%, the number of horses required for 
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this study, using a significance level of 5% and a study power of 80%, was calculated 
using MINITAB®. This revealed that in order to show a significant reduction in the 
prevalence of complications, so that it was comparable to the complication rate of 5% 
identified in small animals following clean-contaminated surgery, it would be necessary to 
have 46 horses in each group, therefore 92 horses in total in the study. 
6.5.2. Inclusion Criteria 
Horses admitted to Bell Equine Veterinary Clinic between December 2003 and July 2005 
were eligible for inclusion in the study if they fulfilled the following criteria: 
1. They underwent an exploratory celiotomy for the investigation of abdominal pain 
2. They recovered successfully from anaesthesia 
3. They were not euthanased prior to discharge from the hospital 
Horses that were undergoing a repeat celiotomy prior to discharge from the hospital were 
excluded from the study. 
6.5.3. Randomisation 
A table of random numbers was used to generate the randomisation data, for allocation of 
horses to one of two study groups. Horses either had an Elastoplast belly band applied 
immediately after recovery from general anaesthesia (study group), or the celiotomy 
incision was left uncovered, with no further form of intervention following recovery from 
anaesthesia (control group). All horses were subject to the same peri- and post-operative 
management. 
6.5.4. The belly band 
An Elastoplast belly band was used instead of one of the commercial elastic belly bands 
available, as it has been the author's experience at the clinic that they did not provide a 
good fit to the majority of the caseload, who encompassed a wide variety of sizes and 
shapes. The belly band consisted of two gamgee pads, one placed on the ventral midline 
incision and one on the dorsal spine to protect against pressure sores, before Elastoplast 
was wrapped around the abdomen, covering the entire length of the incision. 
Chapter 6 158 
6.5.5. Data collection 
The outcomes of interest for the study were: whether there was any evidence of post-
operative swelling at the surgical site; any drainage from the surgical site, along with the 
nature of the drainage; partial or complete dehiscence of the surgical site; pyrexia; and 
hernia formation, defined for this study as both a palpable and visible defect in the ventral 
body wall (Appendix 8). 
Variables evaluated for each outcome included: age, sex and weight of horse; heart rate 
and haematocrit at presentation; degree of abdominal pain at presentation and duration of 
colic signs; duration of general anaesthetic; duration of the surgical procedure; primary 
lesion identified; anatomical location of primary lesion; length of surgical incision; 
whether an enterotomy or resection was performed; degree of contamination of the 
abdomen during surgery; suture pattern used for closure of deep tissues, sub-cutaneous 
tissues and skin; suture material used in closure of each layer; whether the linea alba was 
lavaged with sterile saline prior to closure of the subcutaneous tissues and skin; whether 
crystalline sodium benzylpenicillin was applied to the linea alba prior to the closure of the 
subcutaneous tissues and skin; whether a belly band was applied following recovery from 
general anaesthesia (Appendix 8). Male horses were not routinely catheterised prior to an 
exploratory laparotomy being performed. In order to prevent urine contamination of the 
incision, the prepuce was packed with sterile swabs and a purse-string suture pattern used 
to close the prepuce. Horses had a urinary catheter placed to empty the bladder 
immediately prior to entering the recovery box. 
Data were recorded at four key points during the study (Appendix 7). When horses entered 
into the study, a pre-operative assessment was carried out, recording the name, signalment 
and weight of the horse; rectal temperature, heart rate and respiratory rate; evidence of 
endotoxaemia; degree of abdominal discomfort displayed; duration of colic signs; along 
with the results of any haematological or biochemical analysis of blood if these were 
performed (Appendix 7). During the peri- and immediate post-operative period, a surgery 
report was completed, including such information as the primary lesion identified; 
anatomical location of the primary lesion whether an enterotomy or resection was 
performed; degree of contamination of the abdomen during surgery; duration of both 
general anaesthesia and surgery; length of incision made; the suture materials and suture 
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patterns used during closure of the individual tissue layers; whether the linea alba was 
lavaged with sterile saline or had crystalline sodium benzylpenicillin applied prior to 
closure of the subcutaneous tissues and skin (Appendix 7). 
Once the horse had recovered successfully from general anaesthesia, it was assessed daily 
for any of the outcomes of interest in the study (Appendix 7), with a final assessment for 
any of the outcomes of interest being performed when the horse was discharged from the 
hospital. The post-operative assessment was not performed by the surgeon involved with 
the case, but by the team of staff responsible for the daily care of the horse, in order to 
remove any bias that may have occurred from a surgeon assessing their own work. 
6.5.6. Post-operative management 
Once the horse had recovered successfully from general anaesthesia, the iodophore 
impregnated self-adhesive drape (loban 2, 3M Health Care) used to protect the incision 
during the recovery period was removed. Horses that had been assigned to the study group 
had an Elastoplast belly band applied, and those horses assigned to the control group had 
no further form of intervention. 
In the post-operative period, all horses received a 4 day course of intravenous systemic 
antimicrobials (sodium benzylpenicillin and gentamicin), supplemented in some cases with 
oral metronidazole. Intravenous flunixin meglumine was administered for 48 hours post-
operatively at 1.1mg/kg, before the dose was reduced for a further 48 hours to O.25mg/kg. 
All horses received intravenous fluid therapy for 24 hours post-operatively, supplemented 
where necessary with either calcium or potassium. Some horses received intravenous 
hypermune plasma in addition to the fluid therapy, and some horses received intravenous 
fluid therapy for longer than 24 hours. In some cases, the intravenous fluids were 
supplemented with the pro kinetic drug lignocaine hydrochloride. 
6.5.7. Assessment of incision 
In the control group, the celiotomy incision was inspected daily, and evidence of any 
swelling, oedema, pain on palpation, discharge (including the nature of the discharge), 
dehiscence or herniation was noted. In the study group belly bands were changed 24 hours 
post-operatively, then every 48 hours until the horse was discharged from the hospital, 
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unless they required changing sooner due to loosening, slipping, external contamination or 
strike through. Once the horse had been discharged from the hospital, the belly band was 
changed after 7 days, and then removed 14 days after discharge. When the belly band was 
changed, the incision was inspected for any evidence of swelling, oedema, pain on 
palpation, discharge (including the nature of the discharge), dehiscence or herniation, and 
the gamgee pad was examined for any evidence of incisional drainage. 
6.5.8. Follow-up information 
Follow up telephone interviews with the horses' caretakers were conducted at 14 days, 30 
days and 3 months post-discharge. At this time, it was ascertained whether there had been 
any oedema, drainage from the incision (including the nature of the drainage), dehiscence 
or herniation. 
These time points were chosen to reflect both the findings from earlier studies, and the 
post-operative management of the patients. An earlier study found that the most likely 
time for the onset of incisional drainage was approximately 2 weeks post-discharge from 
the hospital (Galuppo et al. 1999); therefore assessment of the incision at 14 days post-
discharge would allow the assessment of the number of incisions that developed 
complications in the immediate post-discharge period. Horses were routinely confined to a 
stable with in-hand walking for the first 30 days post-discharge, before beginning small 
paddock turnout. At 30 days the skin incision should have healed, although the linea alba 
will not have regained its full strength by this point. The final post-operative assessment 
was made at 3 months post-discharge, when the skin incision should have completely 
healed, and it is at this time that horses are beginning to return to light ridden work 
following their rehabilitation. 
6.5.9. Data Analysis 
Binary logistic regression was used to analyse these data, as all outcomes of interest were 
dichotomous. Categorical variables with more than two levels were coded as indicator 
variables. Analyses were implemented using the statistical software MINIT AB (version 
13.31). 
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Univariable logistic regression was used to screen all variables, and from this all variables 
with a p-value :s 0.20 were included in a backward elimination procedure to fit a 
multi variable model. The inclusion criterion for backward elimination was set at p:S 0.05. 
Once the main effects model had been fitted, two-way interaction between variables was 
assessed. Variable selection was determined by biological plausibility. Assessment 
between models was obtained using a likelihood ratio test (LRT) with significance set at p 
:S 0.05. The goodness-of-fit of the models was assessed using the Hosmer-Lemeshow 
goodness-of-fit test, with the model considered to be a good fit with a p-value > 0.05. 
The nature of the incisional discharge (serous, sero-sanguinous, purulent) was considered 
to be a nominal variable. Therefore, in order to investigate whether the use of a belly band 
post-operatively influenced the type of incisional drainage seen, nominal logistic 
regression analysis was used. 
A decision analysis was performed to evaluate whether the additional expense of using a 
belly band outweighed the expense of a horse developing a post-operative incisional 
infection. 
6.6. Results 
6.6.1. Descriptive Statistics 
Eighty-five horses met the inclusion criteria for the study: 38 in the study group (belly 
bands) and 47 in the control group (no belly bands). The age of the horses in the study 
group ranged from 8 months old to 30 years old, and in the control group the age ranged 
from 8 months old to 32 years old (Table 16). Overall there were 48 male horses in the 
study (35 in the control group and 13 in the study group) and 37 female horses (12 in the 
control group and 25 in the study group) (Table 15). 
The signs of abdominal discomfort each horse was exhibiting at the time of presentation to 
the clinic for evaluation were qualified as mild, moderate or severe (Table 15). The 
duration of signs of abdominal discomfort ranged from 2 hours to 60 days in the study 
group (see table 16) and from 3 hours to 60 days in the control group (Table 16). On initial 
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examination, the heart rate ranged from 32 to 96 bpm (Table 16), and the haematocrit from 
19.3 to 52.0% in the study group (Table 16). In the control group, the heart rate ranged 
from 36 to 100 bpm (Table 16), and the haematocrit ranged from 23.1 to 56.0% (Table 16). 
An emergency midline laparotomy was performed in all cases for the investigation of 
abdominal discomfort. At surgery the primary lesion identified involved the large bowel in 
the majority of cases in both the study and control groups (Table 15). In one case no 
primary pathology could be identified (Table 15). In the study group the most commonly 
identified primary lesion was a large colon torsion (Table 15). In the control group no one 
primary lesion predominated, with the most frequently identified lesions being: large colon 
torsion; strangulating lesion of the small intestine; and non-strangulating lesion of the 
small intestine (Table 15). Only one horse overall presented with an inflammatory 
infiltrate of the bowel wall (Table 15). Three horses (all in the study group) had full 
thickness biopsy samples of the bowel wall taken during surgery (Table 15), and a further 
20 horses had a resection of either the caecum or small bowel performed at surgery (Table 
15). The length of resected intestine ranged from O.2m to 5.5m (Table 16). 
The duration of general anaesthesia ranged from 65-180 minutes (Table 16), and the 
duration of surgery ranged from 40-160 minutes (Table 16) in the study group, and in the 
control group the duration of general anaesthesia ranged from 60 - 205 minutes (Table 16), 
and the duration of surgery from 40 - 190 minutes (Table 16). The incision made on the 
ventral midline ranged from 20 to 35cm in length in the study group, and from 16 to 35cm 
in the control group. During surgery the degree of contamination of the abdomen and 
visceral surfaces was assessed by the surgeon and judged to be mild in the majority of 
cases in both the study and control groups (Table 15), with severe contamination only 
recorded in one case (Table 15). 
The linea alba was closed in all cases using double-stranded, 5 metric polyglactin 910, in a 
simple continuous pattern. In 54 cases (63.5%; Table 15), a sub-cutaneous suture layer 
was placed, using 3.5 metric polyglactin 910 in a simple continuous pattern, and the skin 
was closed in all cases using 2 metric polyglactin 910 in a simple continuous pattern. The 
linea alba was lavaged using a sterile saline solution in 51 cases (60%; Table 15) prior to 
closure of the sub-cutaneous and skin layers, and in 5 cases (5.9%; Table 15) crystalline 
sodium benzylpenicillin was applied to the linea alba prior to closure of the sub-cutaneous 
and skin layers. 
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Table 15: Descriptive variables investigated for an association with an increased risk of the 
development of post-operative incisional complications following exploratory laparotomy, for both the 
study and control groups. 
Stud~ Grou~ {n=38) Control Grou~ (n=47) 
No. 0/0 No. 0/0 
Gender 
Male 13 34.2 35 74.5 
Female 25 65.8 12 25.6 
Level of abdominal discomfort 
Mild 12 31.6 18 38.3 
Moderate 13 34.2 16 34.0 
Severe 13 34.2 13 27.7 
Evidence of endotoxaemia at 11 28.9 15 31.9 
admission 
Location of primary lesion 
Large Intestine 23 60.5 22 46.8 
Small Intestine 14 36.8 20 42.6 
Caecum 1 2.6 4 8.5 
No pathology identified 0 0 1 2.1 
Primary lesion identified 
Large bowel displacement 7 18.4 6 12.8 
Large colon torsion 15 39.5 7 14.9 
Large colon impaction 1 2.6 4 8.5 
Physical obstruction of colon 1 2.6 6 12.8 
Inflammatory infiltrate of bowel 1 2.6 0 0 
wall 
Entrapment of small intestine in 3 7.9 6 12.8 
epiploic foramen 
Strangulating lesion of small 5 13.2 7 14.9 
intestine 
Non-strangulating lesion of 5 13.2 7 14.9 
small intestine 
Distension and loss of motility 0 0 3 6.4 
with no obvious obstruction 
Full thickness biopsy performed 
Large bowel 2 5.3 0 0 
Small intestine 1 2.6 0 0 
Resection performed 
Caecum 0 0 2 4.3 
Small intestine 6 15.8 12 25.5 
Table continued overleaf 
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Table 15 (continued): 
Study Group (n=38) Control Group (n=47) 
No. % No. % 
Pelvic flexure enterotomy 34 89.5 37 78.7 
performed 
Degree of contamination of visceral surfaces 
Mild 37 97.4 37 78.7 
Moderate 1 2.6 9 19.1 
Subcutaneous suture layer 25 65.8 29 61.7 
placed 
Incision lavaged with sterile 27 71.1 24 51.1 
saline 
Crystalline sodium 4 10.5 2.1 
benzylpenicillin applied to 
incision 
Table 16: Descriptive variables of interest for all cases undergoing an exploratory laparotomy for the 
investigation of abdominal discomfort 
Stud~ Grou~ {n=38} Control GrouE {n=47} 
Median Inter-quartile Median Inter-quartile 
Range Range 
Age (years) 12 6-16 9 5 -16 
Duration of 6 5 -17 8 6 -18 
abdominal 
discomfort prior 
to presentation 
(hrs) 
Heart rate at 51 41.5 - 60 48 40 -61.5 
presentation 
(bpm) 
Haematocrit at 33.7 28.8 - 38.0 32.5 29.3 - 38.55 
presentation (%) 
Length of 0.4 0.1 - 0.8 2.0 1.0 -4.0 
intestine resected 
(m) 
Duration of 100 80 - 117.50 110 95 - 140 
general 
anaesthesia (mins) 
Duration of 80 60-95 85 70 -115 
surgery (mins) 
Length of incision 30 25 -30 30 25 -30 
(cm) 
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6.6.2. Analysis of data 
6.6.2.1. Overall analysis of data 
When considering all of the data for the entire follow-up period as one dataset, with the 
dichotomous outcome of whether the horse developed some form of incisional drainage, 
acute partial or total incisional dehiscence, or incisional hernia formation, it was found that 
12/38 horses in the study group (31.6%; 95% C.l. 17.5 to 48.7), compared to 36/47 horses 
in the control group (76.6%; 95% C.l. 62.0 to 87.7). It was considered to be a normal 
finding for horses in both the study and control groups to have a very small volume of 
sero-sanguinous discharge in the 12 hours immediately following recovery from general 
anaesthesia. Therefore, as long as there was no further incisional drainage and no other 
incisional complication developed, these horses were excluded from this analysis. 
There was an absolute risk reduction (ARR) of the likelihood of developing a post-
operative incisional complication of 45% when using a belly band, compared to not using a 
belly band in the post-operative period. Therefore, it would be necessary to treat 2.2 
horses with a belly band in order to prevent one horse developing any of these unwanted, 
and potentially both serious and expensive, post-operative incisional complications. 
6.6.2.2. Hospitalisation data 
6.6.2.2.1. Descriptive Statistics 
Complications recorded during hospitalisation included: pyrexia, incisional swelling, 
incisional drainage and one horse had partial dehiscence of the skin sutures (Table 17). Of 
the 15 horses that were pyrexic during hospitalisation, 6115 (40%) also had incisional 
drainage. 
No horse in the study group had an acute dehiscence of the skin incision during 
hospitalisation (Table 17). Of the five horses that were pyrexic during hospitalisation, two 
horses (40%) also had incisional drainage. One horse in the control group had acute 
dehiscence of the skin incision during hospitalisation (Table 17). Of the 10 horses in the 
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control group that were pyrexic during hospitalisation, seven horses (70%) also had 
incisional drainage. 
At the time of discharge more than 80% of horses had experienced some form of incisional 
complication (Table 18), with the formation of pitting oedema around the incision being 
the most common complication (69/85; 81.2%). Incisional drainage had resolved prior to 
discharge on more than 50% of the cases, with only 21 horses (24.7%) experiencing some 
form of incisional drainage at the time of discharge from the hospital. Of those horses that 
were pyrexic during hospitalisation, 6115 (40%) had drainage from their incision at the 
time of discharge. 
Table 17: Complications recorded during hospitalisation for all horses undergoing an exploratory 
laparotomy for the investigation of abdominal discomfort 
All Cases (n=85) Study Group Control Group 
(n=38} (n=47} 
No. % No. 0/0 No. % 
Pyrexia 15 17.6 5 13.2 10 21.3 
Swelling 64 75.3 24 63.2 40 85.1 
Oedema 69 81.2 25 65.8 44 93.6 
Drainage 49 57.6 19 50.0 31 66.0 
Serous 7 14.3 4 21.1 1 3.2 
Sera-sanguinous 26 53.1 9 47.4 17 54.8 
Purulent 16 32.7 6 31.6 10 32.3 
Dehiscence l.l 0 0.0 2.1 
Pain 1.1 0 0.0 2.1 
Incisional complications were recorded in 71.1 % of horses in the study group (Table 18). 
Of the five horses that were pyrexic during hospitalisation, only one horse had incisional 
drainage at discharge. Of the 19 horses that had some form of incisional drainage during 
hospitalisation, only five horses (26.3%) still had drainage at discharge, with the majority 
of these horses (80%) having purulent drainage. Horses that had purulent incisional 
drainage during hospitalisation were more likely to still have incisional drainage at 
discharge than those with either serous or sero-sanguineous discharge (p=0.007). 
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Incisional complications were recorded in 91.5% of horses in the control group (Table 18), 
including acute dehiscence of the skin incision in one case. When considering the 10 
horses that had been pyrexic during hospitalisation, five had incisional drainage at 
discharge. Of the 31 horses that had some form of incisional discharge during 
hospitalisation, 51.6% still had incisional drainage at discharge, with the most common 
type of drainage being purulent (56.3%). Horses that had purulent drainage during 
hospitalisation were significantly more likely to still have incisional drainage at discharge 
than those with either serous or sero-sanguinous drainage (p=O.009). The horse that had an 
acute dehiscence of the skin incision had had purulent drainage from the incision prior to 
dehiscence. 
Table 18: Incisional complications recorded at discharge for all horses undergoing an exploratory 
laparotomy for the investigation of abdominal discomfort 
All Cases (n=85) Study Group Control Group 
(n=38) (n=47) 
No. % No. % No. % 
Swelling 61 71.8 22 57.9 39 83.0 
Oedema 63 74.1 24 63.2 39 83.0 
Drainage 21 24.7 5 13.2 16 34.0 
Sera-sanguinous 8 38.1 1 20.0 7 43.8 
Purulent 13 61.9 4 80.0 9 56.3 
Dehiscence 1.1 0 0.0 2.1 
Pain 3 3.3 2.6 2 4.2 
6.6.2.2.2. Factors affecting the likelihood of the development of incisional 
complications 
6.6.2.2.2.1. During Hospitalisation 
When considering all the cases in the study, univariable binary logistic regression analysis 
showed that the only variables associated with an increased risk of a horse developing 
incisional drainage during hospitalisation were the duration of either the general 
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anaesthetic or surgery, or the length of the incision. No other variables were found to be 
significant (Appendix 9.1). 
A multi variable logistic model was built using backward elimination, with all variables 
with p:S0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :S 0.05. The only factor that was found to be associated 
with an increased risk of a horse developing incisional drainage during hospitalisation was 
the duration of surgery (Table 19). 
Table 19: Variables found to be associated with an increased risk of a horse having incisional drainage 
during hospitalisation following multivariable logistic regression 
Coeffic S.E. Adjusted O.R. 95% c.1. p 
Constant -0.13 0.30 0.66 
Duration of surgery (referent <85mins) 
>85mins 1.16 0.47 2.51 1.03 - 6.12 0.043 
Univariable nominal logistic regression was performed to investigate whether the use of a 
belly band would influence the nature of the incisional drainage (serous, sero-sanguinous 
or purulent). It was found that the use of a belly band during hospitalisation was not 
associated with the risk of a horse developing incisional drainage, or the nature of that 
drainage (Appendix 9.2). 
Univariable binary logistic regression analysis showed that, when considering all the 
possible incisional complications together, the use of a belly band significantly reduced the 
likelihood of a horse having anyone incisional complication at discharge from the hospital 
(Appendix 9.3). 
6.6.2.2.2.2. Discharge from the hospital 
When considering all the cases, univariable binary logistic regression analysis showed that 
the variables that were associated with an increased risk of a horse having incisional 
drainage at the time of discharge from the hospital included: duration of colic prior to 
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presentation, presence of endotoxaemia, involvement of the small intestine, duration of 
either general anaesthesia or surgery and length of incision. No other variables were found 
to be significant (Appendix 9.4). 
A multi variable logistic model was built using backward elimination, with all variables 
with p ~ 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p ~ 0.05. The factors that were found to be associated 
with an increased risk of a horse having incisional drainage at the time of discharge from 
the hospital were: duration of general anaesthesia; and whether a subcutaneous suture 
layer was used (Table 20). 
Table 20: Variables found to be associated with an increased risk of a horse having incisional drainage 
at the time of discharge from the hospital, following multivariable logistic regression 
Coeffic S.E. Adjusted O.R. 95% C.I. P 
Constant -1.30 0.49 0.008 
Duration of general anaesthesia (referent <110mins) 
>110mins 2.61 0.70 13.67 3.45 - 54.21 <0.001 
Subcutaneous -1.67 0.71 0.19 0.05 - 0.76 0.019 
suture layer 
No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit. 
Univariable nominal logistic regression was performed to investigate whether the use of a 
belly band was associated with the nature of the incisional drainage (sero-sanguinous or 
purulent). It was found that the use of a belly band was not associated with the risk of a 
horse having incisional drainage, or the nature of that drainage, at the time of discharge 
from the hospital (Appendix 9.5). 
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6.6.2.3. Fourteen day follow-up data 
6.6.2.3.1. Descriptive Statistics 
At 14 days post-discharge from the hospital, five of the 85 cases (5.9%) had been 
euthanased, two from the study group and three from the control group, all due to a 
recurrence of colic. Follow-up information was available for all of the remaining 80 
horses. Incisional complications were still present in 90% of horses. Incisional 
complications recorded included oedema, drainage and acute dehiscence of the skin 
incision (Table 21). The skin incision had completely healed in 48.8% of cases, although 
30 of these horses (76.9%) still had significant oedema associated with the site of the 
incision. Of the nine horses that had acute dehiscence of the skin incision, five of these 
(55.6%) had not had any incisional drainage at discharge. 
Incisional complications were recorded in 77.8% of cases in the study group (Table 21). 
The skin incision had healed completely in 69.4% of cases, although 17 of these (68%) still 
had oedema associated with the site of the incision. Two of the three horses that had acute 
dehiscence of the skin incision had a history of incisional drainage at the time of discharge 
from the hospital. 
Table 21: Incisional complications recorded at 14 days after discharge in both the study and control 
groups. 
All cases (n=80) StudX GrouQ (n=36} Control GrouQ {n=44} 
No. % No. % No. % 
Swelling 3 3.8 2 5.6 2.3 
Oedema 68 85 26 72.2 42 95.5 
Drainage 41 51.3 11 30.6 30 68.1 
Dehiscence 9 11.3 3 8.3 6 13.6 
Heal 39 48.8 25 69.4 14 31.8 
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In the control group incisional complications were recorded in all cases (Table 21). The 
skin incision had completely healed in 31.8% of cases, although 13 of these (92.9%) still 
had significant oedema associated with the site of the incision. Of the six horses that had 
acute dehiscence of the skin incision, three had prior incisional drainage recorded at the 
time of discharge from the hospital. 
6.6.2.3.2. Factors affecting the likelihood of the development of incisional 
complications at 14 days post-discharge from the hospital 
Univariable binary logistic regression analysis showed that the variables that were 
associated with an increased risk of a horse having incisional drainage at 14 days post-
discharge included: the duration of colic prior to presentation; length of incision; whether 
a belly band was used; if the incision had drained during hospitalisation or at discharge, 
and the nature of that drainage; and if there was oedema associated with the incision either 
during hospitalisation or at discharge. No other variables were found to be significant 
(Appendix 9.6). 
A multi variable logistic model was built using backward elimination, with all variables 
with p :S 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :S 0.05. Those factors that were found to be associated 
with an increased risk that a horse would have incisional drainage at 14 days post-
discharge included: duration of colic prior to presentation; heart rate at presentation; 
primary lesion identified; whether a belly band was used; and whether the horse was 
pyrexic during hospitalisation (Table 22). 
No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit. 
Univariable binary logistic regression analysis showed that the only variables that were 
associated with an increased risk of a skin incision having dehisced by 14 days post 
discharge were: whether the horse was pyrexic during hospitalisation; whether a 
subcutaneous suture layer was used; and whether the incision was draining at the time of 
discharge from the hospital. No other factors were found to be significant (Appendix 9.7). 
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Table 22: Variables found to be associated with the risk of a horse having incisional drainage at 
fourteen days post-discharge following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% C.I. P 
Constant 0.66 1.00 0.513 
Duration of colic signs prior to presentation (referent <8hrs) 
8-24hrs 2.35 0.91 10.50 1.75 - 62.85 0.010 
>24hrs 2.59 1.15 13.29 1.39 - 126.67 0.025 
Heart rate at presentation (referent <40bpm) 
>60bpm 3.35 1.13 28.38 3.09 -260.19 0.003 
Primary lesion identified at surgery (referent displacement) 
Large bowel -3.68 1.60 0.03 0.00 - 0.58 0.022 
obstruction 
Small intestinal -3.58 1.39 0.03 0.00 - 0.43 0.010 
strangulation 
Use of a belly band -2.59 0.82 0.08 0.02 - 0.37 0.002 
Pyrexic during 2.76 1.21 15.85 1.49-168.41 0.022 
hospitalisation 
A multivariable logistic model was built using backward elimination, with all variables 
with p::; 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p ::; 0.05. Those factors that were found to be associated 
with the risk of a skin incision having dehisced by 14 days post-discharge were: whether 
the primary lesion involved the small intestine; if a pelvic flexure enterotomy was 
performed; use of a subcutaneous suture layer; and whether the incision was draining at the 
time of discharge form the hospital (Table 23). 
Table 23: Variables found to be associated with the risk of a sl{in incision having dehisced by fourteen 
days post-discharge, following multivariable logistic regression. 
Coefficient 
Constant 2.39 
Affected bowel (referent large bowel) 
Small Intestine -4.18 
Pelvic flexure 
enterotomy performed 
Subcutaneous suture 
layer 
Incisional drainage at 
discharge 
-3.64 
-3.00 
2.34 
S.E. 
1.68 
1.76 
1.61 
1.26 
1.03 
Adjusted O.R. 95% c.1. P 
0.157 
0.02 0.00 - 0.48 0.018 
0.03 0.00 -0.62 0.024 
0.05 0.00 - 0.58 0.017 
10.37 1.37 - 78.31 0.023 
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No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit. 
Univariable binary logistic regression analysis showed that the variables that were 
associated with the risk of a skin incision having not healed by 14 days post discharge 
were: the duration of colic prior to presentation; the length of the incision; whether a belly 
band was used; whether there had been any incisional drainage either during 
hospitalisation or at discharge, and the nature of that drainage; and whether there was any 
oedema associated with the incision either during hospitalisation or at discharge. No other 
factors were found to be significant (Appendix 9.8). 
A multi variable logistic model was built using backward elimination, with all variables 
with p:S 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :S 0.05. The factors that were found to be associated 
with an increased risk that an incision would not have healed by 14 days post-discharge 
included: the duration of colic prior to presentation; the heart rate at presentation; the 
primary lesion identified; whether a belly band was used; and whether the horse had been 
pyrexic during hospitalisation (Table 24). 
Table 24: Variables found to be associated with a decreased likelihood of the skin incision having 
healed by fourteen days post-discharge, following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% c.1. P 
Constant -0.66 l.00 0.5l3 
Duration of colic signs prior to presentation (referent <8hrs) 
8-24hrs -2.35 0.91 0.10 0.02 -0.57 0.010 
>24hrs -2.59 1.15 0.08 0.01 - 0.72 0.025 
Heart rate at presentation (referent <40bpm) 
>60bpm -3.35 1.13 0.04 0.00 - 0.32 0.003 
Primary lesion identified at surgery (referent displacement) 
Large bowel 3.68 1.60 39.69 l.72 - 916.44 0.022 
obstruction 
Small intestinal 3.58 1.39 35.70 2.33 - 546.16 0.010 
strangulation 
Use of a belly band 2.59 0.82 l3.28 2.69 - 65.65 0.002 
Pyrexic during -2.76 1.21 0.06 0.01 - 0.67 0.022 
hospitalisation 
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No two-way interaction terms were found to be significant in the final model. The fit of 
the model was evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was 
found that the model was a good fit. 
6.6.2.4. Thirty day follow-up data 
6.6.2.4.1. Descriptive statistics 
A further seven horses (8.8%) had been euthanased by 30 days after discharge from the 
hospital, five from the study group and two from the control group. Follow-up information 
was available for all of the remaining 73 cases. Incisional complications recorded at this 
time included: oedema, drainage, acute dehiscence and formation of granulation tissue 
where an incision was healing by second intention (Table 25). The skin incision had 
completely healed in 53.4% of cases, although 32 of these cases (82.1%) still had oedema 
associated with the site of the incision. Of the 10 cases where the skin incision had 
dehisced, one horse had formed a large bed of healthy granulation tissue as the wound 
attempted to heal by second intention. 
In the study group the skin incision had completely healed in 74.2% of cases (Table 25), 
although there was still oedema associated with the site of the incision in 19 cases (82.6%). 
Of the five horses where the skin incision had dehisced, one horse (20%) had formed a 
large bed of healthy granulation tissue where the wound was beginning to heal by second 
intention. 
The skin incision had completely healed in 38.1 % of cases in the control group (Table 25), 
although there was still oedema associated with the site of the incision in 13 cases (81.3%). 
Of the five horses that had acute dehiscence of the skin incision, none of these cases 
showed evidence of formation of a healthy granulation bed, indicative of the process of 
healing by second intention. 
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Table 25: Incisional complications recorded 30 days after discharge in both the study and control 
groups. 
All Cases {n=73) Stud~ GrouE (n=31) Control GrouE (n=42) 
No. 0/0 No. % No. 0/0 
Granulating 1.4 3.2 0 0 
Oedema 63 86.3 24 77.4 39 92.9 
Drainage 34 46.6 8 25.8 26 6l.9 
Dehiscence 10 13.7 5 16.1 5 I l.9 
Heal 39 53.4 23 74.2 16 38.1 
6.6.2.4.2. Factors affecting the likelihood of the development of incisional 
complications at 30 days post-discharge 
Univariable binary logistic regression analysis showed that the variables that were 
associated with an increased risk of having incisional drainage at 30 days post discharge 
were: the level of pain on presentation; the duration of colic prior to presentation; the 
length of the incision; whether the horse was pyrexic during hospitalisation; whether a 
belly band was used; whether the incision was draining either during hospitalisation, at the 
time of discharge from the hospital or at 14 days post-discharge, and the nature of the 
drainage; and whether there was any oedema associated with the incision either during 
hospitalisation or at discharge. No other factors were found to be significant (Appendix 
9.9). 
A multivariable logistic model was built using backward elimination, with all variables 
with p:s 0.20 at the univariable level included in the analysis. The inclusion criterion for 
backward elimination was set at p :s 0.05. Those factors found to be associated with the 
risk of incisional drainage at 30 days post-discharge included: whether incisional oedema 
had been present during hospitalisation; whether the incision was draining at the time of 
discharge from the hospital; and whether the incision was draining at 14 days post-
discharge (Table 26). 
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Table 26: Variables found to be associated with the risk of having incisional drainage at thirty days 
post-discharge, following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% c.1. p 
Constant -4.14 1.45 0.004 
Oedema during 2.78 1.39 16.19 1.07 - 244.44 0.044 
hospitalisation 
Incisional drainage at 2.04 0.85 7.67 1.46 - 40.42 0.016 
discharge 
Incisional drainage at 1.78 0.63 5.95 1.74-20.41 0.005 
fourteen days post-discharge 
No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit. 
Univariable binary logistic regression analysis showed that the variables that were 
associated with the risk of the skin incision having dehisced by 30 days post discharge 
were: the weight of the horse; the duration of colic prior to presentation; whether there was 
involvement of the small intestine; if a subcutaneous suture layer was used; if there was 
any purulent incisional drainage during hospitalisation; and whether the skin incision had 
dehisced by 14 days post-discharge. No other factors were found to be significant 
(Appendix 9.10). 
A multi variable logistic model was built using backward elimination, with all variables 
with p:S 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :S 0.05. The only factors found to be associated with an 
increased risk of a skin incision having dehisced by 30 days post-discharge was: the weight 
ofthe horse; and whether a subcutaneous suture layer had been used (Table 27). 
No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit. 
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Table 27: Variables found to be associated with an increased risk of the skin incision having dehisced 
by thirty days post-discharge, following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% C.I. P 
Constant -l.98 0.77 0.010 
Weight of horse at induction (referent <500kgs) 
>5001{gs 1.95 0.89 7.04 1.24 -40.00 0.028 
Subcutaneous suture layer -2.04 0.80 0.13 0.03 - 0.62 0.011 
Univariable binary logistic regression analysis showed that the variables that were 
associated with an increased risk of the skin incision having not healed by 30 days post 
discharge were: the level of pain on presentation; the duration of colic prior to 
presentation; the length of the incision; whether the horse was pyrexic during 
hospitalisation; whether a belly band was used; whether there was purulent incisional 
drainage during hospitalisation, or oedema associated with the incision during 
hospitalisation; if there was any incisional drainage at discharge and the nature of that 
drainage; if there was oedema associated with the incision at discharge; and whether there 
was any incisional drainage evident 14 days post-discharge. No other factors were found 
to be significant (Appendix 9.11). 
A multivariable logistic model was built using backward elimination, with all variables 
with p:s 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :s 0.05. Those factors found to be associated with the 
risk of a skin incision having not healed by 30 days post-discharge included: degree of pain 
on presentation; duration of colic prior to presentation; use of a belly band; and whether 
there had been any incisional drainage at 14 days post-discharge (Table 28). 
No two-way interaction terms were found to be significant. The fit of the model was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test, and it was found that the 
model was a good fit. 
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Table 28: Variables found to be associated with the decreased likelihood of the sldn incision having 
healed by thirty days post-discharge, following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% c.1. 
Constant 2.40 1.06 
Pain on presentation (referent mild) 
Severe -2.98 1.21 0.05 0.00- 0.55 
Duration (referent <8hrs) 
8-24hrs -2.21 0.99 0.11 0.02 - 0.76 
Belly Band 2.16 0.83 8.60 1.70 43.58 
Drainage at 14d -2.49 0.79 0.08 0.02 - 0.39 
6.6.2.5. Three month follow-up data 
6.6.2.5.1. Descriptive Statistics 
p 
0.023 
0.014 
0.026 
0.009 
0.002 
One further horse (1.4%), from the control group, was euthanased between 30 days and 3 
months post-discharge from the hospital, and one horse (1.4%), also from the control 
group, was lost to follow-up. Follow-up information was available for the remaining 71 
cases. Incisional complications recorded included: hernia formation, drainage and 
dehiscence (Table 29). At this time the skin incision had completely healed in 95.8% of 
cases, with the skin having not healed in only three horses. Two of these horses had 
formed a healthy bed of granulation tissue as the wound healed by second intention. 
However, the third horse showed no evidence of granulation tissue formation at this stage, 
with the wound still draining purulent material. Of the 10 horses that had developed an 
incisional hernia, nine cases had incisional drainage at 30 days post-discharge, whist the 
remaining horse had had incisional drainage at 14 days post-discharge. 
The skin incision had completely healed in 96.8% of cases in the study group (Table 29), 
leaving only one case where the incision had yet to heal. This horse still had purulent fluid 
draining from his wound, with no evidence of granulation tissue formation. Two horses 
(6.5%) had developed an incisional hernia, both of which had had fluid draining from their 
incision at 30 days post-discharge. 
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Table 29: Incisional complications recorded 3 months after discharge in both the study and control 
groups. 
All cases (n=71) Study Group (n=31_) __ {:ontrol Group (n=40) 
No. % No. % No. % 
Hernia 10 14.1 2 6.5 8 20.0 
Drainage 1.4 3.2 o 0.0 
Granulating 2 2.8 o 0.0 2 5.0 
Dehiscence 3 4.2 3.2 2 5.0 
Heal 68 95.8 30 96.8 38 95.0 
At this time the skin incision was completely healed in 95% of cases in the control group 
(Table 29). The remaining two horses no longer had any incisional drainage and both had 
formed healthy beds of granulation tissue, as the wounds healed by second intention. Eight 
horses (20%) had developed an incisional hernia, with seven of these horses (87.5%) 
having a history of incisional drainage at 30 days post-discharge. The eighth horse did not 
have incisional drainage at 30 days, but incisional drainage had been present at 14 days 
post -discharge. 
6.6.2.5.2. Factors affecting the likelihood of the development of incisional 
complications at 3 months post-discharge 
Univariable binary logistic regression analysis showed that the variables that were 
associated with an increased risk of the skin incision having failed to heal by 3 months post 
discharge were: whether there was any dehiscence of the skin incision at either 14 or 30 
days post-discharge. No other factors were found to be significant (Appendix 9.12). 
A multi variable logistic model was built using backward elimination, with all variables 
with p:s 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :s 0.05. The only factor found to be associated with the 
risk of the skin incision having failed to heal by 3 months post-discharge was: whether the 
skin incision had dehisced by 14 days post-discharge (Table 30). 
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Table 30: Variables found to be associated with the decreased likelihood of the skin incision having 
healed by three months post-discharge, following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% c.1. p 
Constant 4.13 1.01 <0.001 
Dehiscence at 14ds -3.03 1.30 0.05 0.00- 0.62 0.020 
Univariable binary logistic regression analysis showed that the variables that were 
associated with an increased risk of the formation of an incisional hernia by 3 months post 
discharge were: whether there was any dehiscence of the skin incision at either 14 or 30 
days post-discharge. No other factors were found to be significant (Appendix 9.13). 
A multivariable logistic model was built using backward elimination, with all variables 
with p:S 0.20 at the univariable level included in the analysis. The inclusion criteria for 
backward elimination was set at p :S 0.05. The only factor found to be associated with an 
increased risk of the formation of an incisional hernia by 3 months post-discharge was: 
whether the incision was draining at 30 days post-discharge (Table 31). 
Table 31: Variables found to influence likelihood of formation of incisional hernia by three months 
post-discharge, following multivariable logistic regression. 
Coefficient S.E. Adjusted O.R. 95% c.1. p 
Constant -3.56 1.01 <0.001 
Drainage at 30ds 2.58 1.09 13.12 1.56 - 110.48 0.018 
6.6.2.6. Decision analysis 
A decision analysis was performed to investigate whether the cost of using a belly band 
was greater than the cost of the necessary treatment when a horse developed a post-
operative incisional infection (Table 32). The assumptions made were that the treatment 
was for a 500kgs horse, requiring a 5 day course of oral antimicrobials (Norodine and 
Baytril) in order to resolve an incisional infection. 
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Table 32: Decision analysis comparing cost of using a belly band with that of the treatment of a post-operative incisional infection. 
Problem Decision Outcome Probability Cost (£) Probability x Cost Assumptions for 500kgs horse 
(£) 
Belly Incisional 0.32 -2(87.66)-(34.30)- -140.59 5ds Norodine (trimethoprim 
Band infection (90.72)-2(30.00)- sulphonamide) = £34.30 
2(39.50) 
None 0.68 -2(87.66)-(30.00)- -166.48 5ds Baytril (enrofloxacin) = £90.72 
(39.50) 
Total £307.07 
Incisional Examination fee = £30.00 
infection 
None Incisional 0.77 -(34.30)-(90.72)- -203.30 Visit for veterinary attention= £39.50 
infection 2(30.00)-2(39.50) 
None 0.23 -(30.00)-(39.50) -15.99 Elastoplast belly band = £87.66 
Total £219.29 
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When considering all of the data for the entire follow-up period as one dataset, it was 
found that 12 of the 38 horses in the study group developed a post-operative incisional 
complication. Therefore, the probability that a horse would develop a post-operative 
incisional complication was 0.32. In the control group 36 of 47 horses developed a post-
operative incisional complication, resulting in a probability of developing a post-operative 
incisional complication of 0.77. 
The decision analysis showed that the costs incurred when a horse that was wearing a belly 
band developed an incisional complication were less than those incurred in a horse without 
a belly band, when taking into consideration the probability of the likely outcomes. 
6.7. Discussion 
6.7.1. Sample size and Power 
The power calculation performed at the outset of the study found that 92 horses were 
needed, 46 in each group, in order to have sufficient power to detect a statistically 
significant, clinically meaningful outcome, defined as a reduction in complications from 
26% to less than 5%. Although this number was not achieved, the final number of horses 
emolled in the study was close to that identified in the original power study. In addition, 
the magnitude of the difference found for the prevalence of incisional complications 
between the study and control groups was greater than anticipated in the study design, such 
that a statistically significant difference was identified between the study and control 
groups, even though slightly fewer horses were recruited to the study than originally 
considered necessary. 
6.7.2. Using a belly band 
The current study has found that using a belly band, although not 100% effective at 
preventing complications, did reduce both the incidence and the severity of incisional 
complications following colic surgery. Those horses that had a belly band applied 
following colic surgery had the risk of developing a post-operative incisional complication 
reduced by 45%, when compared to those horses that did not have a belly band applied. 
Expressed in another way, in the parlance of EBM, it would only be necessary to apply a 
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belly band to 2.2 horses in order to prevent one horse developing post-operative incisional 
complications. 
By 14 days post-discharge, horses in the study group were significantly less likely to have 
any incisional complications than those in the control group. More specifically, it was 
found that using a belly band reduced the likelihood of incisional drainage at this time by 
more than twelve times. In addition, those horses that were wearing a belly band were 
more than twelve times more likely to have a healed skin incision by 14 days post-
discharge than those in the control group. An incision that continues to drain for a 
prolonged period post-discharge is a complication that is both unsightly and unwanted for 
the owner, who has already invested a large amount of both time and money in electing to 
have an exploratory laparotomy performed. In addition, a draining incision may be a 
precursor to more serious complications such as hernia formation, which can be more than 
a visible blemish. Once the skin incision has healed, this will protect the deeper tissue 
layers from contamination and ascending infection. 
In order to quantify the advantages of using a belly band further, a cost-benefit analysis 
should be performed, to answer the question: does the additional expense of a belly band 
cost less than the additional expense of an incisional infection, with all the associated costs 
(antimicrobials, veterinary attention), based on the associated probabilities that these 
events will occur. The decision analysis performed confirmed that the cost of a belly band 
was less than the cost of treating an incisional infection, even without taking into account 
the additional cost that could be incurred with more serious complications such as an 
incisional hernia repair. 
In this study the horses had three different belly bands applied during hospitalisation alone, 
with at least one more applied after discharge. In retrospect, it may not have been 
necessary to change the belly band so frequently. However, as it was unknown how the 
use of a belly band would influence the likelihood of developing incisional complications, 
it was vital to check the incision on a regular basis for the welfare of the horse. In future, 
the use of a washable, reusable belly band would allow regular inspections of the incision 
with no increase in cost, provided it proves as effective as those used in this study. 
However, the commercially available reusable belly bands that have been used in the past 
at the participating clinic frequently slipped back, exposing the incision to sources of 
external contamination. They were also a poor fit for many of the horses, which could lead 
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to urine contamination of the wound and the formation of pressure sores. More companies 
are now producing washable, reusable belly bands, and with the increased choice on the 
market there are now more suitable options that are applicable to a wider range of shapes 
and sizes of horse. 
6.7.3. Factors affecting the outcome 
6.7.3.1. Factors affecting the likelihood of post-operative incisional complications 
Earlier studies have investigated many factors that might influence the likelihood of a 
horse surviving after undergoing colic surgery, including: duration of colic prior to referral 
(Reeves et al. 1986; Phillips and Walmsley, 1993; Mair and Smith, 2005a); evidence of 
endotoxaemic shock on presentation (Mair and Smith, 2005a); severity of pain on 
presentation and heart rate (Morton and Blikslager, 2002; Proudman et al. 2002; Mair and 
Smith, 2005a); duration of surgery (Honnas and Cohen, 1997; Mair and Smith, 2005a); and 
the nature of the primary lesion identified (Ducharme et al. 1983; Pascoe et al. 1983; Mair 
and Smith, 2005a). Only a few of these studies have identified factors that may be 
associated with the occurrence of post-operative incisional complications (Turner et al. 
1978; Kobluk, et al. 1989; Phillips and Walmsley, 1993; Honnas and Cohen, 1997; Ingle-
Fehr et al. 1997; French et al. 2002; Coomer et al. 2005; Mair and Smith, 2005). 
Factors that were investigated by these earlier studies to establish whether they influenced 
the likelihood of the occurrence of post-operative incisional complications included: 
1. duration of colic signs (Honnas and Cohen, 1997; French et al. 2002), although no 
relationship between duration of signs and post-operative complications was 
identified 
2. evidence of endotxaemia (Turner et aI, 1978), where endotoxaemia was recognised 
to predispose horses to developing post-operative incisional complications 
3. involvement of the large intestine and caecum (Phillips and Walmsley, 1993) was 
associated with an increased incidence of incisional complications 
4. performing a pelvic flexure enterotomy, which has been variably reported to either 
increase (Honnas and Cohen, 1997), or not affect (Kobluk, et al. 1989; Phillips and 
Walmsley, 1993; Mair and Smith, 2005b), the likelihood of a horse developing 
incisional complications 
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5. post-operative pyrexia (Ingle-Fehr, et al. 1997), where a positive correlation was 
identified between pyrexia and the development of incisional drainage 
6. use of a subcutaneous suture layer (Coomer, et al. 2005) 
The current study concurred with earlier studies when it found that clinical signs of 
endotoxaemia at presentation, prolonged duration of general anaesthesia ( > 11 Omins) and 
post-operative pyrexia were all associated with an increased incidence of post-operative 
incisional complications. An excessive duration of general anaesthesia has been shown to 
increase the likelihood of developing incisional complications even in healthy individuals 
(Romatowski 1989; MacDonald et al. 1994; Brown et al. 1997; Beal et al. 2000). General 
anaesthesia can induce hypoxia, hypotension and cold, all of which individually are known 
to cause an increase rate of incisional infections. However, a number of factors will 
influence the overall length of surgery, including the nature of the lesion identified and the 
surgical techniques required. In the current study longer durations of both general 
anaesthesia and surgery were associated with an increased likelihood of developing 
incisonal drainage. This is probably a reflection of the severity of the lesion identified at 
surgery, and the degree of manipulation of the gastro-intestinal tract to correct the problem. 
Pyrexia was associated with an increased likelihood of incisional drainage in the follow-up 
period, and a decreased likelihood of the incision having healed. Even if the source of the 
post-operative pyrexia is not an incisional infection, active infections at sites remote from 
the surgical site have been found to increase the incidence of incisional infections 
(Romatowski, 1989). 
However, unlike the earlier studies, the current study did not find that performing a pelvic 
flexure enterotomy or use of a subcutaneous suture layer were associated with an increased 
incidence of incisional complications. In addition, the current study contradicted an earlier 
study as it found that when the primary lesion identified at surgery involved the small 
intestine there was an increased likelihood of the development of post-operative incisional 
complications, compared to lesions involving the large intestine. 
The current study identified a relationship between the duration of colic signs prior to 
presentation and the occurrence of post-operative incisional complications - a relationship 
which earlier studies failed to identify. Unlike these earlier studies, the current study found 
that those horses that were presented at the hospital for evaluation within 8 hours of first 
exhibiting colic signs were significantly less likely to develop incisional drainage or 
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dehiscence of the skin incision than those horses presented between 8 and 24 hours after 
first displaying signs of colic, and the skin incision was more likely to have healed by 14 
days in those horses presented rapidly. 
The current study also found that: those horses whose heart rate was elevated above 60bpm 
were significantly more likely to experience incisonal drainage and delayed incisional 
healing in the post-operative period, compared to those horses with a heart rate below 
40bpm on presentation; and that those horses that were showing signs of severe pain on 
presentation were more likely to have longer term incisional complications than those 
horses showing lesser signs of abdominal discomfort, and there was a decreased likelihood 
of the incision having healed by thirty days. The delayed healing process and apparently 
increased likelihood of incisional complications is probable a reflection of the degree of 
compromise to their cardiovascular status at the time of presentation. Heart rate is also a 
good reflection of the degree of cardiovascular compromise, therefore you would expect 
heart rate to influence the outcome in a manner similar to endotoxaemic shock. 
6.7.3.2. Incisional complications 
Oedema associated with the incision was the most common complication noted after 
surgery, lasting in nearly all cases (86.3%) for more than 30 days after discharge, even 
though many of the skin incisions (53.4%) had completely healed by this time. 
Incisional drainage that occurred during hospitalisation appeared to be transient in many 
cases, with more than 50% of those cases resolving prior to discharge from the hospital. 
However, by 14 days post-discharge the number of horses that had incisional drainage had 
doubled, with nearly all cases having resolved by 3 months post-discharge. These findings 
would suggest that the biggest risk period for developing incisional drainage is in the first 
2 weeks after surgery, a finding that concurs with that of an earlier study (Honnas and 
Cohen, 1997). Where horses had purulent incisional drainage, they were more likely to 
have complications longer into the follow-up period than those with either sero-sanguinous 
or no drainage (Appendices 7 and 10). Purulent incisional drainage in the early post-
operative period was also associated with an increased likelihood of dehiscence of the skin 
incision (Appendix 11) and incisional hernia formation (Appendix 14). 
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6.7.4. Incisional drainage 
By 14 days post-discharge, 51 % of horses still had incisional drainage, with 46% of these 
incisions still draining at 30 days post-discharge. However, in the study group only 31 % 
of horses had incisional drainage at 14 days post-discharge, compared to 68% in the 
control group, and by 30 days only 26% of horses in the study group had incisional 
drainage, compared to 62% in the control group. 
Following univariable analysis, using a belly band was found to significantly reduce the 
likelihood that the incision would be draining at either 14 or 30 days post-discharge from 
the hospital. If the incision is not draining, there is no need for systemic antimicrobials, 
thereby reducing the cost to the client and protecting the horse from the possible unwanted 
side-effects of long-term antimicrobial use. 
6.7.5. Incisional healing 
Once the skin incision has healed, it provides an impermeable barrier to protect the deeper 
tissues against ascending infection and contamination. By 14 days post-discharge from the 
hospital the skin incision was completely healed in almost 50% of cases (Table 21). 
However, when considering those horses in the study group, almost 70% of the skin 
incisions had healed, compared to only 30% in the control group. Multivariable analysis 
found that, when considering all other factors, using a belly band increased the likelihood 
of a skin incision having healed by 14 days post-discharge by more than twelve times. 
Following univariable analysis, using a belly band was found to increase the likelihood of 
a skin incision having healed by either 14 or 30 days post-discharge. 
6.7.6. Hernia Formation 
This study concurred with earlier studies (Mair and Smith, 2005b) where it was found that 
those horses that had incisional drainage were significantly more likely to develop an 
incisional hernia. However, this study only found incisional drainage at either 14 or 30 
days post-discharge to be a significant factor in whether a hernia would develop. Horses 
that had incisional drainage either during hospitalisation or at discharge were not more 
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likely to develop a hernia than those with no drainage, unless the drainage was purulent in 
nature. The current study also found that a longer duration of anaesthesia increased the 
likelihood of hernia formation. Whilst there would not appear to be a direct link between 
general anaesthesia and hernia formation, it is worth noting that the length of anaesthesia 
was also a significant factor in the development of incisional drainage either during 
hospitalisation (Appendix 2) and at discharge (Table 20). Excessive duration of general 
anaesthesia has also been reported to delay the healing of incisions (Chapter 7) which 
could contribute to incisional hernia formation. 
6.7.7. Study limitations 
Although this was both a randomised and controlled trial, there were still substantial 
limitations to the study. Whilst the horses remained hospitalised, their care and assessment 
could be standardised. However, once the horses had been discharged there was a heavy 
reliance on owner compliance when following post-operative care instructions. To 
illustrate this point it may be worth noting that one of the horses in the study group was 
turned out early in the rehabilitation period, leading to soiling of the belly band and 
subsequent fly strike of the incision. This resulted in the development of purulent drainage 
and dehiscence of the skin incision. If the owner had followed the post-operative care 
instructions it is highly unlikely that this would have been the eventual outcome. 
Similarly, one horse was euthanased on the advice of a referring veterinarian as it had 
developed a purulent incisional discharge. Outcomes such as these highlight the need for 
further education of both clients and veterinarians in the management of horses following 
colic surgery, along with the possible complications that may occur. These cases highlight 
the fact that in spite of a careful study design, providing what would be classified as class 
A evidence using the system proposed by Yusuf et at. (1998), events beyond the control of 
the study can have an effect on the final outcome. 
6.7.8. Class of evidence 
Until now, there has only been one published study investigating the efficacy of a specific 
strategy to reduce the incidence of incisonal complications following colic surgery 
(Coomer et at. 2005), and this only featured preliminary results. Many earlier studies have 
been retrospective analyses of case records, attempting to identify factors that may 
contribute to either the survival rate or post-operative complication rate in horses following 
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colic surgery (Kobluk et al. 1989; Phillips and Walmsley, 1993; Honnas and Cohen, 1997; 
Mair and Smith. 2005). Whilst identifying important areas for future research, these 
studies do not provide such robust evidence as that which can be generated by prospective 
studies. Therefore, in EBM terms they are considered to be a relatively poor class of 
evidence (class C) (Yusuf et al. 1998). 
The current study would be considered to provide class A evidence (Yusuf et al. 1998), 
although it was not possible to introduce blinding into the study design. 
6.7.9. Conclusion 
Although incisional complications continue to be a problem following an exploratory 
celiotomy for colic, the proportion of horses affected and the severity of the complications 
appear to be significantly reduced by the use of a belly band. There was an absolute risk 
reduction in the likelihood of developing post-operative incisional complications of 45% 
when using a belly band in the post-operative period, compared to those cases where no 
belly band was used. 
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Chapter 7 
Investigation into the prevalence of post-operative complications following elective 
surgical procedures. 
7.1. Introduction 
Drainage from an ostensibly clean surgical incision is an unwanted sequel to any surgical 
procedure, both for the surgeon and the patient (Romatowski, 1989). It has long been 
recognised that surgical intervention in animals can have associated complications, ranging 
from anaesthetic complications to problems directly associated with the surgical procedure. 
Incisional infections are one of the most common complications associated with elective 
surgical procedures in animals (Orsini, 1992; Speirs, 1992), despite rigid adherence to 
aseptic techniques, and many clients will attribute this unsatisfactory outcome to 
carelessness on the part of the surgeon (Romatowski, 1989), regardless of whether the 
actual procedure was a success. 
Infection has been defined as "the successful attachment and multiplication of micro-
organisms on or within a host that result in a measurable host response" (Trostle & 
Hartmann, 1992). The majority of studies in human surgery that have investigated the 
occurrence of surgical infections have focused primarily on the development of incisional 
infections, using large scale epidemiological surveys to allow physicians to quantify risk 
factors for infection in a wide range of surgical procedures (Romatowski, 1989). An 
overall infection rate of 4.7% has been reported, with a rate of 1.5% reported for clean 
surgical procedures in one prospective study of 62,939 wounds (Cruse & Foord, 1980). 
Other studies have reported comparable rates of 1.6% and 1.9% for clean surgical 
procedures (Leissner, 1976; Olson et ai. 1984). Due to the large number of animals 
required, and financial constraints, such large-scale studies have not been performed in 
small animal surgery (Romatowski, 1989; Brown et ai. 1997), although the limited studies 
that are available report incisional infection rates that are comparable to those reported for 
human medicine - ~ 2.5% - 4.8% for clean surgical procedures (Vasseur et ai. 1985; 
Vasseur et ai. 1988; Brown et ai. 1997; Beal et ai. 2000) and an overall rate of 5.1% -
5.5% (Vasseur et ai. 1985; Vasseur et ai. 1988; Brown et ai. 1997). Although much 
research has been conducted on specific problems in small animals, little has been reported 
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in the equine literature, with the majority of reports focusing on complications associated 
with emergency celiotomies and different types of colic surgery (Kobluk et al. 1989; 
Honnas & Cohen, 1997; Ingle-F ehr et al. 1997), where it has been recognised that the 
development of an incisional infection will significantly increase the likelihood of the 
subsequent development of an incisional hernia (Gibson et al. 1989; Honnas & Cohen, 
1997; Ingle-Fehr et al. 1997; Mail', 2003). The incidence of incisional infections has been 
sparsely reported in elective equine surgery, with rates of 1.43% - 8.1 % reported for clean 
surgical procedures (Macdonald et al. 1994; Smith & Ross, 2002). Studies considering the 
incidence of infection for celiotomy incisions have reported rates of between 4% - 25.4% 
(Kobluk et al. 1989; Honnas & Cohen, 1997; Ingle-Fehr et al. 1997; Mail', 2003). 
However, no differentiation is made between clean, clean-contaminated or contaminated 
procedures, which would also be expected to influence the infection rates. 
Although extrapolation from data from the human to the veterinary literature may not be 
precisely appropriate, surgical infection control techniques that have been developed in 
human hospitals are applicable across the species (Romatowski, 1989). A number of 
factors have been found in the human literature to influence the occurrence of incisional 
infections, including malnutrition, obesity, old age and active infection at sites distant from 
the surgical incision (Romatowski, 1989). 
7.2. Surgical wound classification 
In 1964, a committee appointed by the National Research Council defined four general 
categories of surgery, based on the expected degree of bacterial contamination, ranging 
from clean surgery to dirty surgery. A clean surgical procedure was defined as: "an 
elective procedure in which the wound is closed to heal by primary intention and without 
mechanical drainage, trauma, inflammation, or break in aseptic technique. The respiratory, 
alimentary, genitourinary, and oropharyngeal tracts are not entered." A clean-
contaminated procedure is where: "the surgeon enters the respiratory, alimentary, or 
genitourinary tract under controlled conditions and without unusual contamination." 
If all other factors are equal, the incidence of wound infection would be expected to 
increase as the degree of bacterial contamination increased (Romatwoski, 1989; Holmberg, 
1985; Laitinen, 2001). It has been established that there is excessive variation within these 
broad categories, as surgical procedures within the same category can vary widely in their 
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associated post-operative infection rates (Vasseur et al. 1985; Vasseur et al. 1988; 
Romatowski, 1989; Macdonald et al. 1994; Brown et ai, 1997). However, these categories 
provide vital information for a wound infection surveillance programme, and results of 
surveys can provide benchmark data for future comparison (Vasseur et al. 19895; 
Romatowski, 1989; Brown et ai, 1997). 
All surgical wounds, despite the best aseptic techniques, are invariably contaminated to 
some degree, but only a small percentage of these wounds become infected, as a healthy 
patient is able to resist the attempts of bacteria to grow in living tissue (Hackett et al. 1983; 
Romatowski, 1989). 
7.3. Wound healing 
7.3.1. Host response to a wound 
The basic response to any wound is the inflammatory process - a cascade of events 
initiated by the injury (Silver, 1982; Lees et al. 1989). The predominant cells in the early 
stages of inflammation are polymorphonuclear leukocytes, whose primary role is the 
destruction of any infective organisms (Silver, 1982). In a clean wound these can 
effectively eliminate bacteria within four hours (Silver, 1982; Lees et al. 1989), when they 
will then be superseded by monocytes and macrophages, which have a wider range of 
functions than polymorphs, playing an essential role in wound healing (Silver, 1982). 
Necrotic tissue and foreign material is phagocytosed and removed from the wound (Lees et 
al. 1989; Johnston, 1990) by the macrophages, or multinucleate giant cells formed by 
coalescence of monocytes (Johnston, 1990), although if organisms or debris are lying 
within large masses of dead tissue they will be protected from the action of these cells 
(Lees et al. 1989; Johnston, 1990). In surgical incisions, surrounding tissue trauma must 
be minimised, in order to prevent non-viable tissue acting as a reservoir for bacterial 
proliferation (Johnston, 1990). 
Once haemostasis has been achieved, the primary objective of wound healing is to re-
establish the integrity of the epidermis (Silver, 1982) - not only is it important in forming a 
barrier to prevent the evaporation of water, but it also forms a barrier to the entry of 
organisms (Silver, 1982). In a simple incision with little dead space or dehydration of 
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tissues, the epithelial cells will migrate directly across the wound under the scab, joining 
up with cells migrating in from the other side (Silver, 1982). Depending on the size of the 
wound, this process can be complete within thirty-six hours (Silver, 1982). If there is an 
open wound, where dehydration of the surface tissue has occurred, the epithelial cells must 
cut through the underlying dermal connective tissue (Silver, 1982) - a process which is 
both energy consuming and slow (Silver, 1982). The cell migration rate, as it is an energy-
dependant process, will also vary according to the supply of oxygen available (Silver, 
1982; Johnston, 1990). In tissues, if the blood supply is inadequate due to trauma, cell 
migration rates will be significantly reduced (Silver, 1982; Johnston, 1990). 
In a surgical wound, especially if it has been sutured, the same steps in wound healing 
occur (Johnston, 1990), although as there is minimal dead space, minimal tissue damage 
and good approximation of the wound edges healing is much more rapid (Johnston, 1990). 
Minimal debridement of the wound by inflammatory cells is required before epithelial cells 
are able to migrate across the intra-incisional clot beneath the scab (Johnston, 1990). 
7.3.2. Inhibition of wound healing 
A number of factors can affect the rate of wound healing. Hard exercise and other stresses 
will reduce the rate of wound healing, by increasing the concentrations of circulating 
glucocorticoids and by mechanical breakdown of newly formed collagen with resultant 
pulling open of the wound (Silver, 1982). Cold will also have a negative effect on the rate 
of wound healing, by causing a reduction in the metabolic rate and vasoconstriction, 
therefore reducing the blood supply to the wound (Silver, 1982; Johnston, 1990; Beal et al. 
2000). Hypovolaemia will exert a similar influence (Silver, 1982; Lees et al. 1989; 
Johnston, 1990). In animals mechanical irritation through self-trauma is an important 
consideration, as it will prolong the inflammatory response (Silver, 1982), necessitating 
either good bandaging, or restraint of the animal. Nutrition is also important at both 
extremes of the scale, with delayed wound healing evident in both obese and malnourished 
animals (Silver, 1982; Lees et al. 1989; Johnston, 1990; Brown et al. 1997). 
Local tissue injury will affect the rate of wound healing (Johnston, 1990). Although some 
trauma is inevitable, an excess of trauma to the tissues will increase the amount of debris 
that must be removed by phagocytosis and will decrease the activity of the phagocytic cells 
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(Johnston, 1990). The inflammatory phase of healing will be prolonged, with an increase 
in the possibility of the development of infection (Johnston, 1990). Excessive tissue 
trauma will also promote the formation of seromas and haematomas between the tissue 
layers, preventing proper apposition of the tissues and interfering with the blood supply to 
the wound edges (Johnston, 1990). Seromas and haematomas allow bacterial proliferation, 
whilst inhibiting the normal host response to bacteria. Prolonged exposure of tissues, 
associated with a long surgical time, will result in dessication of the tissue and delayed 
healing (Johnston, 1990) - this is thought to be a contributing factor in the increased 
incidence of incisional infections that are seen in long operative procedures (Johnston, 
1990; Brown et al. 1997). The experience of the surgeon has been shown to have a 
significant effect on the incidence of wound infections, with the rate of infection 
decreasing as the surgeon's experience increases (Vasseur et al. 1988; Hofmann et al. 
1999). It is thought that surgical experience results in a decrease both in local tissue 
trauma and duration of surgery (Vasseur et al. 1988; Hofmann et al. 1999). 
Old age has been recognised in human surgery to have a negative effect on the rate of 
wound healing, thereby increasing the likelihood of the development of an incisional 
infection (Lees et al. 1989; Romatowski, 1989). It is an area that has been poorly 
investigated in veterinary surgery, although it is a risk factor cited in many veterinary 
surgical textbooks. In the only study in the veterinary literature where it was investigated 
as a risk factor, a statistically significant difference in wound infection rates with respect to 
age of the animal was not reported (Brown et al. 1997). No data have been reported in the 
equine literature on the influence of age on the incidence of incisional complications. 
It has long been recognised that the presence of infectious organisms in a wound will have 
a deleterious effect on the rate of repair of that wound. These organisms should be killed 
off by the polymorphs and phagocytes, which are attracted to the wound in the early stages 
of inflammation and wound healing. If these organisms survive and multiply they inhibit 
healing by (Silver, 1982): 
1. stimulating excessive inflammatory exudates leading to waterlogging tissues; 
consuming oxygen vital to tissue repair 
2. attracting excessive numbers of phagocytic cells, which not only deplete the 
available oxygen levels but also release lytic enzymes causing further tissue 
destruction 
3. produce toxins which kill cells directly 
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4. inhibiting epithelialisation by killing epithelial cells and washing them off the 
wound surface through excessive exudates. 
General anaesthesia can induce hypoxia, hypotension and cold, all of which are known 
individually to cause an increased rate of incisional infections. Excessive depth of 
anaesthesia, or prolonged total anaesthetic time (Romatowski, 1989; Macdonald et at. 
1994; Brown et at. 1997; Beal et at. 2000) will contribute to an increased rate of inc isiona I 
infection. 
7.3.3. Sources of bacterial contamination 
Bacteria causing wound contamination can be either endogenous or exogenous in origin 
(Galuppo et at. 1999). Endogenous factors include resident and transient bacterial flora of 
the skin (Galuppo et at. 1999). Bacterial virulence and host resistance are also considered 
endogenous factors (Galuppo et at. 1999). Exogenous factors include operating room 
contamination, recovery room contamination and surgical site preparation (Galuppo et at. 
1999). 
Although endogenous bacteria are widely reported as being the predominant cause of 
incisional infections (Osuna et at. 1990), studies have shown that positive cultures from 
incisional and intra-operative swabs do not show a good correlation with the subsequent 
development of infection (Holmberg, 1985; Ingle-Fehr et at. 1997; Whittem et at. 1999). 
7.3.4. Routes of infection 
The basic tenets of aseptic surgery - disinfection of both the surgeon and the surgical site, 
sterilisation of instruments, sterile technique - have been established in human surgery 
since 1895. This had led, by the 1910s, to the reduction of surgical infection rates at some 
institutions to a level equivalent to those reported today in the medical literature 
(Romatowski, 1989). Largely due to economic considerations, aseptic technique was not 
adopted in the veterinary profession until the mid-1940s in small animal surgery 
(Romatowski, 1989), with large animal surgery lagging behind still further. With strict 
adherence to the principles of surgery, contamination of the wound can be minimised, 
therefore removing the reliance on antimicrobials. 
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The condition of the wound at the end of surgery and the degree of bacterial contamination 
that has occurred are the primary determinants for post-operative infection (Honnas & 
Cohen, 1997). Traumatic tissue handling, excessive use of electrocautery causing 
charring, inappropriate selection of suture materials and inadequate haemostasis leading to 
haematoma formation are among the factors that reduce resistance to infection. They all 
result in increased dead space between the tissue layers of the wound and excessive loss of 
potentially viable tissue (Kobluk et at. 1989; Honnas & Cohen, 1997), increasing the 
likelihood of the development of wound infection (Kobluk et at. 1989; Honnas & Cohen, 
1997). Traumatised tissue will support bacterial growth, whilst having impaired host 
defences, along with a reduced oxygen content promoting the proliferation of anaerobic 
bacteria. 
7.3.5. Natural host resistance to infection 
Whether bacteria in a wound cause infection depends on the number and type of 
microorganisms present (Hackett et at. 1983; Holmberg, 1985; Kobluk et at. 1989; Lees et 
at. 1989; Trostle & Hartmann, 1992; Honnas & Cohen, 1997), as well as on the local and 
general resistance of the patient (Hackett et at. 1983; Kobluk et at. 1989; Lees et at. 1989; 
Trostle & Hartmann, 1992; Honnas & Cohen, 1997), and the degree of tissue destruction 
present (Kobluk et at. 1989; Honnas & Cohen, 1997). In order for infection to develop in a 
closed wound, not compromised by other systemic or local factors, a minimal number of 
bacteria must be present (Hackett et at. 1983; Lees et at. 1989), with 105 or more 
organisms/g of tissue being the critical tissue level of viable bacteria necessary to cause 
infection (Hackett et at. 1983; Lees et at. 1989). 
Normal host defence mechanisms are a combination of humoral factors present in the 
wound fluid and phagocytic cells that migrate into the wound. The wound fluid is a 
serosanguinous exudate that contains antimicrobial substances which have been shown to 
inhibit the growth of bacteria. However, an excess of this wound fluid will also promote 
the incidence of post-operative infection, as it hinders migration of phagocytic cells. The 
phagocytic cells are the single most important host defence against incisional infection. 
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7.4. Celiotomy incisions in horses 
The prevalence of incisional infections after celiotomy incisions in horses is variable, with 
rates of 4% (Mail', 2003), 9.9% (Kobluk et al. 1989),24% (Ingle-Fehr et al. 1997),25.4% 
(Bonnas & Cohen, 1997) and 27% (Wilson, Baker & Boero, 1995) reported. Although 
there is wide variation in these figures, there was also a difference in classification of the 
definition of "wound infection", ranging from any incisional drainage (Wilson, Baker & 
Boero, 1995; Ingle-Fehr et al. 1997) to positive bacterial culture (Bonnas & Cohen, 1997), 
which may account for some of the variation. Similarly, whilst some studies were 
restricted to celiotomies for colic (Kobluk et al. 1989; Bonnas & Cohen, 1997; Mail', 2003) 
other studies included all forms of abdominal surgery (Wilson, Baker & Boero, 1995), 
which would alter the expected rate of incisional complications. An increased incidence of 
incisional complications was also reported following repeat celiotomies (Kobluk et al. 
1989; Mail', 2003), although only one study gave a numerical value to the increased 
incidence, with a rate of 87.5% (Kobluk et al. 1989) reported. 
Few colic surgeries are classified as clean surgical procedures, with many being classified 
as clean-contaminated or contaminated procedures. The possible exposure of the incision 
to a source of contamination, along with trauma to the incisional borders caused during 
exteriorisation and manipulation of the gastro-intestinal tract, are likely to contribute to this 
increased rate of incisional infection (Phillips & Walmsley, 1993; Bonnas & Cohen, 1997). 
Depending on the type of lesion discovered during an exploratory celiotomy, colicking 
horses are often sick and endotoxaemic, which will also increase the likelihood of the 
development of an incisional infection. 
7.5. Post-operative pyrexia 
It has been reported in the human literature that development of a post-operative fever is a 
positive predictor of bacterial infection (Mellors et al. 1988), with a likelihood of 16% of 
incisional infection with the occurrence of post-operative fever (Mellors et al. 1988). The 
occurrence of post-operative pyrexia has only been reported in one study in the equine 
literature, where a positive correlation was found between post-operative pyrexia and the 
development of incisional drainage (Ingle-Fehr et al. 1997). It was reported that 62% of 
horses that underwent a ventral midline celiotomy became febrile during their 
hospitalisation (Ingle-Fehr et al. 1997). Of those horses that became pyrexic during 
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hospitalisation, 29% subsequently developed incisional drainage (Ingle-Fehr et al. 1997). 
Although multiple factors were put forward as the possible cause of this pyrexia, no 
investigation was performed to identify if these suggestions were accurate (Ingle-Fehr et 
al. 1997). 
7.6. The prophylactic use of antimicrobials in clean surgical procedures - a 
contentious issue 
7.6.1. The use of antimicrobials 
The prophylactic use of antimicrobials in clean surgical procedures remains a controversial 
point in small animal veterinary surgery (Holmberg, 1985; Vasseur et al. 1985; Whittem et 
al. 1999). Whilst large, prospective studies in human surgery have established that 
antimicrobial prophylaxis is not routinely necessary in clean surgical procedures (Vasseur 
et al. 1985), and can in fact be detrimental (Vasseur et al. 1985; Lizan-Garcia et al. 1997), 
conflicting data has been reported in the veterinary literature (Holmberg, 1985; Vasseur et 
al. 1985; Whittem et al. 1999). Improper use of prophylactic antimicrobial therapy has 
been observed to contribute to the development of superinfections, resistant bacterial 
species and nosocomial infections (Holmberg, 1985; Van den Bogaard & Weidema, 1985; 
Vasseur et al. 1985). Although several reports in the veterinary literature concurred with 
the finding that routine use of antimicrobial prophylaxis in clean procedures was 
unnecessary (Holmberg, 1985; Vasseur et al. 1985; Brown et al. 1997), few controlled 
studies have been reported (Holmberg, 1985; Vasseur et al. 1985) and the theory remains 
controversial (Whittem et al. 1999). The limited number of studies that have compared the 
prevalence of incisional infections in clean procedures, both with and without 
antimicrobial prophylaxis, have found both for (Holmberg, 1985; Vasseur et al. 1985) and 
against (Vasseur et al. 1988; Whittem et al. 1999) this theory, with different studies 
reporting a widely variable prevalence of incisional infection (Holmberg, 1985; Vasseur et 
al. 1985; Whittem et al. 1985). In the equine literature no controlled studies have been 
performed to investigate the incidence of incisional infection in clean surgical procedures 
without the use of prophylactic antimicrobials. All surgical centres that have published 
data routinely use prophylactic antimicrobials for all surgical procedures, although the 
antimicrobial protocols employed vary between the institutions. 
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Numerous studies in human surgery have confirmed the significant reduction in wound 
infection associated with the prophylactic use of antimicrobials in clean-contaminated 
surgical procedures (Romatowski, 1989). 
7.6.2. Potential side effects associated with prophylactic antimicrobial use 
The prophylactic use of antimicrobials is not without its risks (Van den Bogaard & 
Weidema, 1985). Side effects include drug toxicity, allergic reactions and the evolution of 
bacterial resistance (Van den Bogaard & Weidema, 1985; Rosin et al. 1993). 
Superinfection by resistant strains, as well as non-susceptible bacteria, has also been 
reported (Van den Bogaard & Weidema, 1985). In both human and small animal surgery it 
has been recommended that, where prophylactic antimicrobials are used, careful selection 
and dosage of antimicrobials should be employed (Van den Bogaard & Weidema, 1985; 
Rosin et al. 1993), targeting the antimicrobial at the suspected bacterial contaminants and 
utilising as narrow a spectrum of antimicrobial as possible (Van den Bogaard & Weidema, 
1985; Rosin et al. 1993). The antimicrobials should also be used for a short period of time 
only - twenty-four hours is a time period that has frequently been cited in the literature 
(Van den Bogaard & Weidema, 1985; Whittem et al. 1999). 
Whilst reactions have been documented in the equine literature to specific antimicrobials 
(Baker & Leyland, 1973; Cook, 1973; White & Prior, 1982; Blue et a1.1987; Dick & 
White, 1987; Sweeney et al. 1991; Mahrt, 1992; McConnico et al. 1992; Riond et at. 1992; 
van Duijkeren et al. 1994), little appears to have been repOlied as to the prevalence of 
adverse reactions to prophylactic antimicrobials used during clean surgical procedures. 
Adverse reactions that have been reported in commonly used antimicrobials include severe 
colitis following oxytetracycline administration (Baker & Leyland, 1973; Cook, 1973; 
White & Prior, 1982); local irritation after intra-muscular administration of ceftiofur 
sodium (Mahrt, 1992); severe cardio-vascular abnormalities, collapse and death after 
administration of doxycycline (Riond et al. 1992); cardiac irregularities and sudden death 
following intravenous administration of trimethoprim-sulphonamide (Dick & White, 1987; 
van Duijkeren et al. 1994); inappetance associated with oral metronidazole (Sweeney et al. 
1991); and immune-mediated haemolytic anaemia associated with administration of 
penicillin (Blue et at. 1987; McConnico et at. 1992; Robbins et at. 1993). 
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7.7. Conclusion 
The integrity of an incision remains a vital factor in the recovery of a horse from any 
surgical procedure. Little information is currently available in the equine literature 
regarding the incidence of incisional infections, and any risk factors that may increase the 
occurrence of what is a potentially life-threatening complication (Kobluk et al. 1989; 
Honnas & Cohen, 1997). 
7.8. Study aims 
Due to the lack of information on the subject of complications following elective equine 
surgery in the literature to use as a suitable comparison, a true clinical audit could not be 
performed. The purpose of this study, therefore, was to investigate the elective surgical 
case load at three private surgical facilities, in order to identify risk factors that may 
predispose horses to developing incisional complications. If any alterable peri operative 
risk factors could be identified, steps could then be taken to decrease the development of 
incisional drainage and infection. An additional aim of this study was to provide 
benchmark data for future comparison, and identify and complications associated with 
prophylactic antimicrobial use. 
7.9. Materials and Methods 
7.9.1. Inclusion criteria 
Any horse admitted to the three participating private equine hospitals during the study 
period for an elective surgical procedure under general anaesthesia that fulfilled all of the 
inclusion criteria, were eligible for inclusion in the study. The study period of interest was 
from the 1 st October 2003 until the 30th September 2004. The risk period under 
investigation was from the time that the surgical procedure was performed until the horse 
was discharged from the hospital. 
The inclusion criteria for this study were: 
1. the surgical procedure had to be considered elective and, for the purpose of this 
study, 'elective' was defined as a procedure that could be postponed up to twenty-
four hours without having a detrimental effect on the outcome 
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2. the procedure had to be performed under general anaesthesia 
3. there had to be at least one full thickness skin incision, although this incision did 
not have to have a primary closure 
4. the skin at the surgical site must be intact and free from any gross pathology prior 
to the induction of anaesthesia 
5. there must be no evidence of concurrent systemic infection or localised infection at 
the surgical site. 
Prior to the commencement of the study, all surgical procedures were defined by an equine 
surgeon as either clean or clean-contaminated; and if any degree of post-operative swelling 
or incisional drainage was considered normal for a particular procedure this was identified, 
with the amount of expected swelling or drainage quantified. 
7.9.2. Data collection 
The outcomes of interest for the study were (Appendix 11): 
1. whether there was any evidence of post-operative swelling at the surgical site, and 
whether this could be considered a normal finding for that procedure 
2. any drainage from the surgical site, along with the nature of the drainage, and 
whether this was a normal or abnormal finding for this procedure 
3. partial or complete dehiscence of the surgical site 
4. pyreXIa 
5. diarrhoea 
6. catheter site infection or jugular thrombus formation associated with an intravenous 
catheter. 
Variables evaluated for each outcome included (Appendix 11): 
1. age, sex and weight of horse 
2. haematological abnormalities prior to induction 
3. whether the surgical site was clipped prior to induction, and if so how long before 
induction 
4. whether the surgical site was shaved at preparation 
5. if there was evidence of a local skin reaction after preparation of surgical site 
6. duration of general anaesthetic 
7. duration of the surgical procedure 
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8. classification of surgical procedure performed 
• clean vs. clean-contaminated 
9. type of surgical procedure performed 
• orthopaedic or soft tissue 
10. specific procedure performed 
11. anatomical location of surgical procedure 
12. number of full thickness skin incisions made 
13. length of surgical incision 
14. suture pattern used for closure of deep tissues, subcutaneous tissues and skin 
15. suture material used in closure of each layer 
16. volume of dead space left at the end of surgery 
17. whether a dressing was used post-operatively, and the type of dressing used post-
operatively 
18. whether systemic antimicrobials were administered prior to induction of 
anaesthesia, and if so, the systemic antimicrobials used. 
Data were recorded at four key points during the study (Appendix 10). 
1. When horses entered into the study a pre-operative assessment was carried out, 
recording: 
• the name, signalment and weight of the horse 
• rectal temperature, heart rate and respiratory rate 
• the results of any routine haematological or biochemical analyses of blood 
if they were performed. 
2. During the peri- and immediate post-operative period, a surgery report was 
completed, including such information as: 
• the surgical procedure performed 
• the nature of the surgical procedure performed as defined by the National 
Research Council 
• identity of the surgeon 
• whether the surgical site was clipped or shaved, including whether this had 
occurred prior to induction for anaesthesia and if so, how long before 
induction 
• whether there was any evidence of local skin reaction following the 
preparation of the surgical site 
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• duration of both general anaesthesia and surgery 
• length and site of incision made 
• the suture materials and suture patterns used during closure of the individual 
tissue layers 
• the volume of dead space left after surgery 
• whether an indwelling drain had been placed, and if so what type of drain 
• and the nature of any dressings used to protect the incision post-operatively 
3. Once the horse had recovered successfully from general anaesthesia it was assessed 
daily for any of the outcomes of interest in the study. 
4. A final assessment for any of the outcomes of interest was performed when the 
horse was discharged from the hospital. 
The post-operative assessment was not performed by the surgeon involved with the case, 
but by the team of staff responsible for the daily care of the horse, in order to remove any 
bias that may occur from a surgeon assessing their own work. 
7.9.3. Data Analysis 
Binary logistic regression was used to analyse these data as all outcomes of interest were 
dichotomous. Categorical variables with more than two levels were coded as indicator 
variables, using the quartiles to define the parameters of each indicator variable. Analyses 
were implemented using the statistical software MINITAB (version 13.31). 
Univariable logistic regression was used to screen all variables, and from this all variables 
with a p-value :S0.20 were included in a backward elimination procedure to fit a 
multivariable model. The inclusion criterion for backward elimination was set at p:S 0.05. 
Once the main effects model had been fitted, two-way interaction between variables was 
assessed. Variable selection was determined by biological plausibility. Assessment 
between models was obtained using a likelihood ratio test (LRT) with significance set at p 
:S 0.05. 
The goodness-of-fit of the models was assessed using the Hosmer-Lemeshow goodness-of-
fit test, to test the null hypothesis that the model was considered to be a good fit, with the 
null hypothesis rejected at a p-value:s 0.05. 
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7.10. Results 
7.10.1. Descriptive statistics 
7.10.1.1. All cases 
Four hundred and thirty-three horses were found to be eligible for inclusion in the study. 
There were 139 female horses, 156 geldings and 138 entire male horses in the study, with 
an age range of between 3 days old and 19 years old at the time of admission to the 
hospital (median: 5 years old; inter-quartile range: 2 to 9 years old). 
Table 33: Classification, according to National research Council, of all elective surgical procedures 
performed. 
Classification Procedure Number Percentage {%) 
Total 433 100 
Clean 376/433 86.8 
Orthopaedic 272/376 72.3 
Arthroscopy/Tenoscopy 110/272 40.4 
Neurectomy 57/272 21.0 
Fracture repair 47/272 17.3 
Desmotomy 25/272 9.2 
Other orthopaedic 33/272 12.1 
procedures 
Soft Tissue 104/376 27.7 
Castration 711104 68.2 
Laparotomy 1011 04 9.6 
Enucleation 51104 4.8 
Myectomy 4/104 3.8 
Other soft tissue 141104 13.5 
procedures 
Clean-Contaminated 57/433 13.2 
Laryngoplasty 23/57 40.4 
Sinus surgery 12/57 21.1 
Dental surgery 7157 12.3 
Penile surgery 7/57 12.3 
Other procedures 8/57 14.0 
Three hundred and seventy six horses (86.8%) underwent a clean surgical procedure, and 
the remaining 57 horses (13.2%) underwent a clean-contaminated surgical procedure. Of 
the clean surgical procedures performed, 272 (72.3%) were orthopaedic procedures and 
104 horses (27.7%) underwent a soft tissue procedure (Table 33). 
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Post-operative complications recorded during hospitalisation for the 433 surgical 
procedures performed included: pyrexia (10, 2.3%; 95% C.l. 1.1 to 4.2); diarrhoea (7, 
1.6%; 95% C.l. 0.7 to 3.3); incisional swelling considered abnormal for the surgical 
procedure performed (93, 21.5%; 95% C.l. 17.7 to 25.7); incisional drainage considered 
abnormal for the surgical procedure performed (101, 23.3%; 95% C.l. 19.4 to 27.6); and 
partial or total dehiscence of the incision (7, 1.6%; 95% c.l. 0.7 to 3.3). Other 
complications recorded included: a pronounced pain response on palpation of the surgical 
site (15, 3.5%; 95% C.l. 2.0 to 5.6); and seroma or haematoma formation at the surgical 
site (10, 2.3%; 95% c.l. 1.1 to 4.2). (Table 34). 
7.10.1.2. Clean surgical procedures 
Three hundred and seventy six clean surgical procedures were performed (Table 33). 
There were 128 female horses, 118 geldings and l30 entire male horses. The age at 
admission ranged from 3 days old to 19 yrs (median: 4.0 yrs; inter-quartile range: 2 to 9 
years old). Post-operative complications recorded during hospitalisation in all clean 
surgical procedures included: pyrexia, diarrhoea, incisional swelling, discharge from the 
surgical site and either partial or total dehiscence of the surgical site (Table 34). Other 
complications recorded included: a pronounced pain response on palpation of the surgical 
site, and seroma or haematoma formation at the surgical site (Table 34). 
Seven horses undergoing clean surgical procedures were euthanased during the period of 
hospitalisation: five cases (1.3%) due to complications attributable to general anaesthesia 
in the horse (malignant hyperthermia (n=l), pleuropneumonia (n=l), myopathy (n=3)); one 
case (0.3%) due to implant failure; and one case (0.3%) due to the results of 
histopathologcial analysis. Of those cases that survived to be discharged from the hospital, 
complications recorded at discharge included: swelling, considered to be abnormal for that 
surgical procedure (39, 10.4%) drainage from the surgical site, considered to be abnormal 
for that surgical procedure (17, 4.5%); and partial or total dehiscence of the surgical site (5, 
1.3%). Three horses (0.8%) were still observed to show a marked pain response on 
palpation of their surgical site at the time of discharge from the hospital (Table 35). 
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7.10.1.3. Clean-contaminated surgical procedures 
Fifty seven horses underwent a surgical procedure that was classified as clean-
contaminated (Table 33). There were 11 female horses, 38 geldings and eight entire male 
horses. The age at the time of admission ranged from 2 months old to 18 yrs (median: 7 
yrs; inter-quartile range: 3.25 to 11 years old). Post-operative complications recorded for 
all clean-contaminated surgical procedures included: pyrexia, diarrhoea, incisional 
swelling, discharge from the surgical site, and partial or total dehiscence of the surgical site 
(Table 34). Other complications recorded included: a marked pain response on palpation 
of the surgical site, and seroma or haematoma formation at the surgical site (Table 34). 
Two horses undergoing clean-contaminated surgical procedures were euthanased during 
hospitalisation, at the request of their owners for reasons unrelated to either general 
anaesthesia or the surgical procedure itself. Of those horses that survived to be discharged 
from the hospital, complications recorded at discharge included: swelling; drainage from 
the surgical site, considered to be abnormal for that surgical procedure (2, 3.5%); and 
partial or total dehiscence of the surgical site (2,3.5%). (Table 35). 
7.10.1.4. Orthopaedic procedures 
Two hundred and seventy two orthopaedic procedures were performed during the study. 
There were 111 female horses, 111 geldings and 50 entire male horses. The age at the time 
of admission ranged from 3 days old to 19 years (median: 6 yrs; inter-quartile range: 3 to 
10 years old). 
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Table 34: Post-operative complications recorded during hospitalization following an elective surgical procedure. 
Pyrexia Diarrhoea Swelling Abnormal Drainage Abnormal Dehiscence Pain Seromal 
Swelling Drainage Haematoma 
No. % No. 0/0 No. 0/0 No. 0/0 No. % No. % No. % No. % No. % 
All surgical 10 2.3 7 1.6 166 38.3 93 21.5 120 27.7 101 23.3 7 1.6 15 3.5 10 2.3 
procedures 
Clean 8 2.1 6 1.6 145 38.6 82 21.8 99 26.3 78 20.7 5 1.3 l3 3.5 9 2.4 
Orthopaedic 4 1.5 4 1.5 87 32.0 81 29.8 76 27.9 72 26.5 3 1.1 9 3.3 4 1.5 
Soft Tissue 4 3.8 2 1.9 58 55.8 1.0 23 22.1 6 5.8 2 1.9 4 3.8 5 4.8 
Clean- 2 3.5 1.8 21 36.8 11 19.3 27 47.4 23 40.4 2 3.5 2 3.5 1.8 
contaminated 
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Table 35: Post-operative complications recorded at discharge from the hospital following an elective surgical procedure. 
Swelling Abnormal Drainage Abnormal Dehiscence Pain PTS 
Swelling Drainage 
No. 0/0 No. % No. % No. % No. % No. % No. 0/0 
All surgical procedures 99 22.9 39 9.0 49 11.3 19 4.4 7 1.6 3 0.7 9 2.1 
Clean 91 24.2 39 10.4 35 9.3 17 4.5 5 1.3 3 0.8 7 1.9 
Orthopaedic 40 14.7 39 14.3 20 7.4 16 5.9 3 1.1 0.4 4 1.5 
Soft Tissue 51 49.0 0 0 15 14.4 1.0 2 1.9 2 1.9 3 2.9 
Clean-contaminated 8 14.0 0 0 14 24.6 2 3.5 2 3.5 0 0 2 3.5 
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7.10.1.5. Soft tissue procedures 
One hundred and four soft-tissue procedures were performed during the study. There were 
17 female horses, 7 geldings and 80 entire male horses. The age at the time of admission 
ranged from 3 weeks old to 14 years (median: 2yrs; inter-quartile range: 1.86 to 4 years 
old). 
7.10.2. Analysis of all data 
7.10.2.1. All cases 
When considering data from all the surgical procedures performed, binary logistic 
regression at the univariable level showed that the only variable found to be associated 
with an increased risk of a horse developing pyrexia post-operatively was the use of the 
suture material PDS in the closure of the deep layer of the surgical incision (Appendix 
12.1). 
No variables were found to be associated with whether a horse undergoing an elective 
surgical procedure developed post-operative diarrhoea. 
Univariable analyses using binary logistic regression were then performed for each of the 
incisional outcomes: abnormal swelling; abnormal drainage and either partial or complete 
incisional dehiscence (Appendix 12.6). 
A multivariable logistic model was then built using backward elimination, for each 
outcome of interest. All variables with p :s 0.20 at the univariable level were included in 
the analyses, with the inclusion criterion for backward elimination set at p :s 0.05. 
In the multi variable model, no variables were found to be associated with an increased risk 
of a horse developing post-operative diarrhoea. Those variables that were found to be 
associated with an increased risk of a horse developing post-operative pyrexia were: 
whether a laparotomy had been performed, and whether a horse developed post-operative 
incisional swelling that was considered abnormal for that procedure (Table 36). 
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Those variables found to be associated with an increased risk of the occurrence of either 
partial or total dehiscence of the surgical incision were: the length of the incision, and 
whether a deep suture layer was used (Table 37). No two-way interaction terms were 
found to be significant in the final model. 
Table 36: Logistic regression analysis of factors associated with the development of post-operative 
pyrexia following an elective surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% c.1. P 
(Constant) -4.26 1.33 0.001 
Surgical procedure performed (referent arthroscopy and tenoscopy) 
Laparotomy 3.57 1.59 35.55 1.59 - 796.51 0.024 
Development of abnormal 
incisional swelling 
2.15 0.96 8.58 1.31 - 56.20 0.025 
Table 37: Logistic regression analysis of factors associated with the development of either partial or 
total incisional dehiscence following an elective surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% c.1. P 
(Constant) -5.02 0.71 <0.001 
Length of surgical incision (referent <5cm) 
>10cm 2.56 0.93 12.99 2.10 - 80.39 0.006 
Those variables found to be associated with an increased risk of a horse developing post-
operative incisional swelling, considered to be abnormal for the surgical procedure 
performed, included: the age of the horse; the duration of general anaesthesia; the suture 
pattern used to close the skin; the suture material used in closure of the deep and 
subcutaneous layers; antimicrobial used; surgical procedure performed; and whether there 
was either partial or total incisional dehiscence (Table 38). Significant interaction was 
found to occur between the age of the horse, and the use of vicryl in the closure of the 
subcutaneous layer compared to the referent category of no closure of the subcutaneous 
layer. 
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Table 38: Logistic regression analysis of factors associated with the development of post-operative 
incisonal swelling considered to be an abnormal finding for the specific surgical procedure performed, 
following an elective surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% C.I. P 
(Constant) 1.34 1.49 
Age of horse at induction, in comparison to:::; 2 yrs old 
3 - 5yrs old 1.00 0.57 
6 - 9yrs old 1.59 0.67 
Duration of general anaesthesia (referent < 60mins) 
2110mins 1.17 0.57 
Suture material used in closure of deep layer (referent none) 
2.73 
4.90 
3.21 
Vicryl -1.76 0.50 0.17 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl 1.87 0.85 6.46 
0.90 - 8.26 
1.31- 18.38 
1.05 - 9.80 
0.06 - 0.46 
1.23 - 34.02 
Antimicrobials administered prior to induction (referent no antimicrobials given) 
0.369 
0.076 
0.018 
0.041 
<0.001 
0.028 
Procaine penicillin or -2.81 1.38 0.06 0.00 - 0.90 0.042 
sodium penicillin 
Procaine penicillin -2.97 1.44 0.05 0.00 - 0.87 0.040 
and gentamicin 
Sodium penicillin -3.64 1.47 0.03 0.00 - 0.55 0.018 
and gentamicin 
Antimicrobials other -4.63 1.72 0.01 0.00 - 0.29 0.007 
than peniciIIin +/-
gentamicin 
Surgical procedure performed (referent arthroscopy and tenoscopy) 
Other orthopaedic -3.06 1.08 0.05 
procedure 
Other soft tissue -2.85 1.25 0.06 
procedure 
3-5yrs * Vicryl in 
subcutaneous layer 
-2.08 0.92 0.13 
0.01- 0.39 0.005 
0.01- 0.67 0.022 
0.02 -0.75 0.023 
Those variables found to be associated with an increased risk of the development of post-
operative incisional drainage considered to be an abnormal finding for the specific surgical 
procedure performed included: gender of the horse; duration of surgical procedure; 
clipping of surgical site prior to induction; classification of surgical procedure; and 
antimicrobials used (Table 39). No two-way interaction terms were found to be 
significant. 
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Table 39: Logistic regression analysis of factors associated with the development of post-operative 
incisonal drainage considered to be an abnormal finding for the specific surgical procedure performed, 
following an elective surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% c.1. p 
(Constant) -1.00 0.93 
Gender of horse (referent female) 
Entire male -1.59 0.50 
Duration of surgical procedure (referent <30 mins) 
30-50 mins 0.87 0.42 
>65 mins 0.96 0.45 
Surgical site clipped prior to induction (referent not clipped) 
0.20 
2.39 
2.60 
>24hrs 1.38 0.34 3.99 
Classification of surgical procedure (referent clean) 
Clean-contaminated 1.37 0.41 3.95 
Antimicrobials given prior to induction (referent no antimicrobials given) 
Antimicrobial other 
0.08 - 0.54 
1.05 - 5.41 
1.08- 6.26 
2.03 -7.85 
1.77 - 8.78 
0.287 
0.001 
0.038 
0.033 
<0.001 
0.001 
than penicillin +/- -3.32 1.41 0.04 0.00 - 0.58 0.019 
gentamicin 
The fit of the models were evaluated using the Hosmer-Lemeshow goodness-of-fit test, 
and it was found that the models were a good fit. 
7.10.3. Clean surgical procedures 
Univariable analyses using binary logistic regression were performed for each outcome of 
interest (Appendices 12.2 and 12.7). Following a clean surgical procedure, no variables 
were found to be associated with an increased risk of a horse developing post-operative 
diarrhoea. 
After the backward elimination of variables for data from all the clean surgical procedures, 
no variables were found to be associated with an increased risk of a horse developing post-
operative diarrhoea. Those variables that were found to be associated with an increased 
risk of horses developing post-operative pyrexia included: the weight of the horse; the 
length of the surgical incision; and the suture material used to close the deep layer of the 
incision (Table 40). No two-way interaction terms were found to be significant. 
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Table 40: Logistic regression analysis of factors associated with the development of post-operative 
pyrexia following a clean surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% C.I. P 
(Constant) 
Age of horse (referent < 2 yrs) 
> 9 yrs 
-5.71 1.55 
3.42 1.41 
Anatomical location of surgical incision (referent distal limb ) 
30.69 
Head and neck 2.91 1.35 18.28 
Abnormal incisional 
swelling 
3.28 1.39 26.46 
<0.001 
1.93 - 488.49 0.015 
1.29 - 258.24 0.032 
1.74 - 402.98 0.018 
Those variables found to be associated with an increased risk of a horse developing post-
operative incisional swelling that was considered to be abnormal for the specific surgical 
procedure performed included: the duration of general anaesthesia; the type of dressing 
used; the suture material used in the closure of the deep and subcutaneous layers; and the 
surgical procedure performed (Table 41). No two-way interaction terms were found to be 
significant in the final model. 
Those variables found to be associated with an increased risk of a horse developing post-
operative incisional drainage that would be considered an abnormal finding for the specific 
surgical procedure included: whether the surgical site was clipped prior to induction; and 
the suture material used in the closure of the skin (Table 42). No two-way interaction 
terms were found to be significant in the final model. 
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Table 41: Logistic regression analysis of factors associated with the development of post-operative 
incisional swelling considered to be abnormal the surgical procedure following a clean surgical 
procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% C.1. P 
(Constant) -3.25 0.92 
Duration of general anaesthesia (referent <6Omins) 
> 11 Omins 1. 71 0.60 5.50 
Type of dressing used (referent none) 
C~ ~~ 
Bandage 1.84 
1.41 
0.85 
Suture material used in closure of deep layers (referent none) 
29.95 
6.32 
Vicryl -1.73 0.54 0.18 
Suture material used in closure of subcutaneous layers (referent none) 
Vicryl 1.42 0.60 4.14 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Fracture -3.37 1.19 0.03 
Other orthopaedic -2.68 0.91 0.07 
procedure 
<0.001 
1.70-17.86 0.005 
1.88 - 476.33 0.016 
1.20- 33.20 0.029 
0.06 - 0.52 0.001 
1.28 -13.37 0.018 
0.00- 0.35 0.005 
0.01 - 0.41 0.003 
Table 42: Logistic regression analysis of factors associated with the development of post-operative 
incisional drainage considered to be abnormal for the specific surgical procedure, following a clean 
surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% C.I. P 
(Constant) -1.16 0.33 <0.001 
Surgical site clipped prior to induction of general anaesthesia (referent not clipped) 
Clipped >24hrs prior to 1.19 0.31 3.30 1.78 - 6.11 <0.001 
induction 
Suture material used in closure of the skin (referent none) 
Vicryl -2.13 0.67 0.12 0.03 - 0.44 0.001 
The only variable found to be associated with an increased risk of a horse developing 
partial of total incisional dehiscence was the anatomical location of the surgical procedure 
(Table 43). 
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Table 43: Logistic regression analysis of factors associated with the development of partial or total 
incisional dehiscence, following a clean surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% c.1. P 
(Constant) -4.67 0.71 <0.001 
Length of incision (referent <5 cm) 
>10 cm 2.99 0.94 19.84 3.15 -125.05 0.001 
7.10.4. Clean-contaminated surgical procedures 
Univariable logistic regression analysis showed that no single variable was associated with 
an increased risk of a horse developing post-operative pyrexia or diarrhoea following a 
clean-contaminated surgical procedure (Appendix 12.3). Univariable logistic regression 
analysis was then performed for each of the incisional outcomes (swelling, abnormal 
swelling, drainage from the incision, abnormal drainage and either partial or complete 
incisional dehiscence). (Appendix 12.8). 
A multi variable logistic model built using a backward elimination procedure for each of 
the outcomes of interest. No variables were found to be associated with an increased risk 
of a horse developing post-operative pyrexia, diarrhoea, or partial or total incisional 
dehiscence. 
Table 44: Logistic regression analysis of factors associated with the development of post-operative 
swelling considered to be abnormal for the surgical procedure, following a clean-contaminated surgical 
procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% C.I. P 
(Constant) 
Abnormal post-operative 
incisional drainage 
-1.50 
1.85 
0.65 
0.82 6.38 
Suture material used in closure of the deep layer (referent none) 
Vicryl -2.26 0.89 0.10 
0.020 
1.29 - 31.57 0.023 
0.02 - 0.60 0.011 
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Those variables found to be associated with an increased risk of a horse developing post-
operative incisional swelling considered to be abnormal for the specific surgical procedure 
performed included: the suture material used in closure of the deep layer; and whether 
there was any post-operative incisional drainage (Table 44). No two-way interaction terms 
were found to be significant in the final model. 
Those variables found to be associated with an increased risk of a horse developing post-
operative incisional drainage considered to be abnormal for the surgical procedure 
performed were: the age of the horse; and whether post-operative incisional swelling 
considered to be an abnormal finding for the surgical procedure occurred (Table 45). No 
two-way interaction terms were found to be significant in the final model. 
Table 45: Logistic regression analysis of factors associated with the development of post-operative 
incisional drainage considered to be abnormal for the surgical procedure, following a c1ean-
contaminated surgical procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% c.1. p 
(Constant) -1.88 0.77 0.015 
Age of horse (referent <3 yrs) 
>11 yrs 3.31 1.34 27.26 1.96 - 378.46 0.014 
Abnormal post-operative 1.93 0.82 6.88 1.37 - 34.45 0.019 
incisional swelling 
The fit of the models were evaluated using the Hosmer-Lemeshow goodness-of-fit test, 
and it was found that the models were a good fit. 
7.10.5. Orthopaedic procedures 
Univariable binary logistic regression was performed for each outcome of interest 
(Appendices 12.4 and 12.9). 
Following backward elimination of variables for all orthopaedic procedures no variables 
were found to influence the likelihood of a horse developing post-operative pyrexia, 
diarrhoea or partial or total dehiscence of the surgical incision. 
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Those variables found to be associated with an increased risk of a horse developing post-
operative incisional swelling considered to be an abnormal finding for the surgical 
procedure performed included: the gender and weight of the horse; the suture material used 
in the closure of the deep and subcutaneous layers; and the surgical procedure performed 
(Table 46). Significant interaction was found to occur between the gender of the horse, 
and the weight of the horse at induction. 
Those variables found to be associated with an increased risk of a horse developing post-
operative incisional drainage that is considered to be abnormal for the surgical procedure 
performed were the duration of general anaesthesia and whether the surgical site was 
clipped greater than twenty-four hours prior to induction of general anaesthesia (Table 47). 
No two-way interaction terms were found to be significant in the final model. 
The fit of the models were evaluated using the Hosmer-Lemeshow goodness-of-fit test, 
and it was found that the models were a good fit. 
Table 46: Logistic regression analysis of factors associated with the development of post-operative 
incisional swelling considered to be abnormal for the surgical procedure performed, following an 
orthopaedic surgical procedure. 
Factor Coefficient S.E. Adjusted O.R_. ... 95% c.1. p 
(Constant) -1.00 0.50 0.043 
Gender of horse (referent female) 
Gelding 1.44 1.17 4.20 0.42 - 41.84 0.221 
Weight of horse (referent <400kgs) 
400 - 600 kgs 1.27 0.54 3.56 1.23 -10.30 0.019 
Suture material used in closure of the deep layer (referent none) 
Vicryl -1.55 0.55 0.21 0.07 - 0.62 0.005 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl 1.67 0.63 5.31 1.53 -18.39 0.009 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Fracture repair -1.77 0.69 0.17 0.04 - 0.67 0.011 
Other orthopaedic -2.69 0.94 0.07 0.01- 0.43 0.004 
procedure 
Gelding * 400-600 kgs -2.77 1.24 0.06 0.01- 0.71 0.026 
Chapter 7 218 
Table 47: Logistic regression analysis of factors associated with the development of post-operative 
incisional drainage considered to be abnormal for the surgical procedure, following an orthopaedic 
surgical procedure. 
Factor Coefficient S.E. Ad,justed O.R. 95% c.1. p 
(Constant) -2.29 0.43 <0.001 
Duration of general anaesthesia (referent <75 mins) 
> 115 mins 1.13 0.50 3.09 1.17-8.17 0.023 
Surgical site clipped prior to induction of general anaesthesia (referent not clipped) 
Clipped >24 hrs prior to 1.40 0.34 4.06 2.10 -7.85 <0.001 
induction 
7.10.6. Soft Tissue procedures 
Univariable binary logistic regression analysis was carried out for all outcomes of interest 
(Appendices 12.5 and 12.1 0). Following backward elimination of variables for each 
outcome of interest, no variables were found to be associated with an increased risk of: a 
horse developing post-operative diarrhoea; either post-operative incisional swelling or 
drainage considered to be an abnormal finding for the specific surgical procedure 
performed; or partial or total incisional dehiscence. The only variable found to be 
associated with an increased risk of a horse developing post-operative pyrexia was the type 
of dressing applied to the surgical site (Table 48). 
Table 48: Logistic regression analysis of factors associated with the development of post-operative 
pyrexia following an elective soft tissue procedure. 
Factor Coefficient S.E. Adjusted O.R. 95% c.1. p 
(Constant) -2.74 0.73 <0.001 
Type of dressing used (referent none) 
Adhesive dressing or stent 2.34 1.17 10.33 1.05 - 102.08 0.046 
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7.11. Discussion 
7.11.1. Class of evidence 
No prospective study has previously been reported in the equine veterinary literature, 
investigating the prevalence of complications following clean and clean-contaminated 
elective surgery. Complication rates following clean, elective orthopaedic surgical 
procedures have been sparsely reported (Macdonald et al. 1994), as have those following 
specific clean and clean-contaminated elective procedures (Smith & Ross, 2002). A 
practitioner survey of castration complications has also been reported in the equine 
veterinary literature (Moll et al. 1995). These studies would be considered to provide 
class C (Macdonald et al. 1994; Smith & Ross, 2002) or even class D (Moll et al. 1995) 
evidence, using the classification system proposed by Yusuf et al. 1998. In contrast, many 
of those studies published in the small animal literature are of a higher classification: 
class A (Holmberg, 1985; Vasseur et al. 1985; Osuna et al. 1990) and class B (Brown et 
al. 1997; Heldmann et al. 1999; Beal et al. 2000). 
More information is available on complications associated with emergency exploratory 
celiotomies in horses (Gibson et al. 1989; Kobluk et al. 1989; Honnas & Cohen, 1997; 
Ingle-Fehr et al. 1997; Mail', 2003; Mail' and Smith, 2005a,b). These studies would 
predominantly be classified as class C evidence (Kobluk et al. 1989; Honnas & Cohen, 
1997; Ingle-Fehr et al. 1997; Mail', 2003; Mail' and Smith, 2005a,b), as they are 
retrospective case series. 
7.11.2. Normal or abnormal? 
Although the development of swelling at the surgical site, along with any form of drainage 
from the incision, could be considered an unwelcome sequel to any surgery, they are 
widely accepted as being an incidental finding following certain procedures. The purpose 
of leaving a castration site open is to allow free drainage of fluid in the post-operative 
period, preventing the accumulation of secretions that are associated with the inhibition of 
phagocytic cells and the increased incidence of incisional infections; therefore some sero-
sanguinous discharge would be considered perfectly normal following a castration and 
would not be considered as a complication. However, if this drainage was noted 
following a fracture repair, this would be an abnormal finding, and may be indicative of an 
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underlying infection. A similar story is true with swelling around the surgical site - any 
surgical incision will result in some degree of trauma to, and contamination of, the skin 
edges thereby inducing an inflammatory response, however it is when this inflammatory 
response becomes marked that it will begin to interfere with wound healing and natural 
host-resistance to infection. One problem encountered in this study was a method of 
differentiating between those post-operative findings that could be considered normal for 
that specific surgical procedure and those that were considered to be true complications. 
In order to address this issue, a surgeon who was not involved in the study was asked to 
identify those procedures where post-operative swelling or surgical site drainage could be 
a normal feature, and then quantify that which would be considered normal and that which 
would be considered abnormal. If this had not occurred, the reported prevalence of 
incisional complications such as swelling and surgical site drainage would have been 
significantly higher than the value reported herein. 
7.11.3. Types of Outcome 
A distinction must be made between those complications directly associated with the 
surgical procedure, and those that could be attributed to general anaesthesia, 
hospitalisation and systemic antimicrobial therapy. Those complications attributed to 
hospitalisation, anaesthesia and the administration of systemic antimicrobials include post-
operative pyrexia and diarrhoea. In contrast, those complications directly associated with 
the surgical procedure include: swelling of the surgical site; drainage from the incision; 
and partial or total dehiscence of the incision. 
7.11.3.1. Hospitalisation Complications 
7.11.3.1.1. Post-operative Pyrexia 
Post-operative pyrexia has been reported in the human literature to be a positive predictor 
of bacterial infection (Mellors et al. 1988). The prevalence of post-operative pyrexia has 
only been reported in one study in the equine literature, where a positive correlation was 
found between post-operative pyrexia and the development of incisional drainage (Ingle-
Fehr et al. 1997), although this study was investigating complications following midline 
celiotomies for the investigation of abdominal pain. 
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In our study the prevalence of post-operative pyrexia was low and the only positive 
correlations that were identified between the development of pyrexia and surgical site 
complications were: the age of the horse, with horses over nine years of age undergoing a 
clean surgical procedure more likely to develop post-operative pyrexia than those in the 
referent category of less than 2 years old (Table 40); the location of the surgical incision 
when a horse underwent a clean surgical procedure (Table 40); the surgical procedure 
performed, with horses undergoing a laparotomy more likely to become pyrexic than those 
undergoing arthroscopy or tenoscopy (Table 36); and the occurrence of incisional swelling 
that was considered to be an abnormal finding for the specific surgical procedure 
performed would increase the likelihood of a horse developing post-operative pyrexia 
(Tables 36 and 40). However, one hospital contributed the vast majority of cases to this 
study, and it was standard practice at this hospital not to take the rectal temperature of 
horses unless they had undergone a surgical procedure involving placement of an implant 
(fracture repair, laryngoplasty) or the horse was displaying clinical signs of systemic 
disease (inappetance, lethargy). Taking this into account, the true prevalence of post-
operative pyrexia in the population of interest may have been much higher than that 
recorded in this study if it remained at the sub-clinical level, without the horse displaying 
signs of systemic disease. Therefore it is not possible to investigate accurately whether 
post-operative pyrexia could be a positive predictor for surgical site complications. The 
prevalence of post-operative pyrexia was found to be 10/433 (2.3%), however a more 
accurate figure would be obtained if you were to only consider those cases where the 
rectal temperature was taken twice daily, which would result in a prevalence of 101162 
(6.2%). 
7.11.3.1.2. Post-operative diarrhoea 
In both human and small animal surgery it has been recommended that, where 
prophylactic antimicrobials are used, careful selection and dosage of antimicrobials should 
be employed (Van den Bogaard & Weidema, 1985; Rosin et ai. 1993; Seim, 1997), 
utilising as narrow a spectrum of antimicrobial as possible (Van den Bogaard & Weidema, 
1985; Rosin et ai. 1993; Seim, 1997). The antimicrobials should also be used for a short 
period of time only - twenty-four hours is a time period that has frequently been cited in 
the literature (Van den Bogaard & We idem a, 1985; Whittem et at. 1999). These 
recommendations were made in order to reduce the possibility of drug toxicity, allergic 
reaction and the evolution of resistant strains of bacteria. 
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All three hospitals that participated in this study routinely used broad-spectrum 
prophylactic antimicrobials in the post-operative period, for longer than the recommended 
twenty-four hours. Whilst reactions have been documented in the equine literature to 
specific antimicrobials (Baker & Leyland, 1973; Cook, 1973; White & Prior, 1982; Blue 
et al.1987; Dick & White, 1987; Sweeney et al. 1991; Mahrt, 1992; McConnico et al. 
1992; Riond et al. 1992; van Duijkeren et al. 1994), very few horses developed 
complications in this study that could be attributed to the use of prophylactic 
antimicrobials, with only 7 horses (1.6%) developing diarrhoea in the post-operative 
period. No single factor was found to influence the likelihood that a horse would develop 
post-operative diarrhoea. 
7.11.3.2. Incisional Complications 
Those factors that were found to influence the prevalence of post-operative incisional 
complications in the human literature included: old age (Lees et al. 1989; Romatowski, 
1989), long surgical time (desiccation of wound edges) (Johnston, 1990), general 
anaesthesia time (excessive depth or prolonged total time) (Johnston, 1990; Brown et al. 
1997; Seim, 1997), hypoxia (Romatowski, 1989; Macdonald et al. 1994; Brown et al. 
1997; Beal et al. 2000), hypotension (Romatowski, 1989; Macdonald et al. 1994; Brown 
et al. 1997; Beal et al. 2000), cold (Silver, 1982; Johnston, 1990; Beal et al. 2000), 
experience of the surgeon (traumatisation of tissues, duration of surgery) (Vasseur et al. 
1988; Hofmann et al. 1999), malnutrition, obesity, and active infection at sites remote 
from the surgical incision. Those factors found to contribute to the prevalence of post-
operative incisional complications in the small animal veterinary literature include: cold 
(Silver, 1982), hypovolaemia (Silver, 1982; Romatowski, 1989; Macdonald et al. 1994; 
Brown et al. 1997; Beal et al. 2000), malnutrition or obesity (Silver, 1982; Lees et al. 
1989; Johnston, 1990; Brown et al. 1997), mechanical irritation through self-trauma 
(Silver, 1982), and general anaesthesia and surgery times (Romatowski, 1989; Macdonald 
et al. 1994; Brown et al. 1997; Beal et al. 2000). The only study that investigated the 
effect of old age on the prevalence of post-operative incisional complications did not 
report a statistically significant difference in complication rates with respect to the age of 
the animal (Brown et al. 1997). 
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In the equine veterinary literature, those factors that have been reported to affect the 
prevalence of post-operative complications in elective surgical procedures include: 
classification of surgical procedure (MacDonald et at. 1994), duration of surgery 
(MacDonald et at. 1994), the use of pre-operative antimicrobials (MacDonald et at. 1994), 
and the gender of the patient (MacDonald et at. 1994). Variables not found to be 
associated with the incidence of post-operative infection included the age of the patient 
(MacDonald et at. 1994), and the training level of the primary surgeon (MacDonald et at. 
1994). 
The current study found that when considering all the data, those factors that exerted an 
influence on the prevalence of post-operative complications included: 
1. the age and gender of the horse 
2. the duration of general anaesthesia and the duration of the surgical procedure 
3. the use of antimicrobials prior to induction 
4. whether the surgical site was clipped prior to induction 
5. the specific surgical procedure performed 
6. the classification of the surgical procedure performed, as classified by the National 
Research Council 
7. the length of the surgical incision made 
8. the suture materials used in the closure of the incision 
9. the suture patterns used in the closure of the incision 
The weight of the horse, type of dressing used to cover the surgical incision, and the 
anatomical location of the surgical incision were significant when considering specific 
types of surgical procedure (those classified as clean or orthopaedic procedures). 
7.11.4. Variables of interest 
7.11.4.1. Weight 
Both obesity and malnutrition have been reported to delay wound healing (Silver, 1982; 
Johnston, 1990; Brown et at. 1997) and to contribute to an increase occurrence of 
incisional infections (Silver, 1982; Johnston, 1990; Brown et at. 1997). In this study 
every horse was weighed prior to induction of anaesthesia. However, the weight alone is 
not an accurate guide to the overall body condition of the animal, due to the wide range of 
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sizes and types of horse that this study encompasses. The weight recorded is merely an 
index of the total body mass of each horse. 
This study found that the weight of the horse was only an important factor when 
considering orthopaedic procedures, when horses weighing more than 600kgs were more 
likely to develop post-operative incisional swelling that was considered to be an abnormal 
finding for the specific surgical procedure performed (Table 46). Significant interaction 
was found to occur between the gender of the horse and the weight of the horse. 
7.11.4.2. Gender 
A previous study found that female horses were almost three times as likely to develop 
incisional infections post-operatively as male horses (MacDonald et ai. 1994). It was 
postulated that this may be the result of a hormonal influence on neutrophil function. 
However, due to the retrospective nature of the study it was impossible to ascertain 
whether or not this was merely conjecture. 
The current study concurred with the previously reported findings, as male horses were 
found to be significantly less likely to develop post-operative complications following an 
elective surgical procedure than female horses, in particular if they underwent an 
orthopaedic procedure (Tables 39 and 46). When considering horses undergoing 
orthopaedic procedures, significant interaction was found to occur between the weight of 
the horse and the gender of the horse (Table 46). 
7.11.4.3. Age 
Old age has been recognised in human surgery to have a negative effect on the rate of 
wound healing post-operatively, thereby increasing the likelihood of developing incisional 
complications (Lees et ai. 1989; Romatowski, 1989). Although sparsely reported in the 
veterinary literature, those studies that have investigated the effect of age on the likelihood 
of developing post-operative incisional complications have not found it to be a significant 
factor (MacDonald, et ai. 1994; Brown et ai. 1997). 
In the current study the increasing age of the animal was found to be a significant factor 
for the development of post-operative incisional complications following either clean-
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contaminated or orthopaedic procedures (Tables 38, 40 and 45). Older horses were more 
than twenty-seven times more likely to develop post-operative incisional drainage 
following a clean-contaminated procedure than their younger counterparts. This may be a 
feature unique to this particular population, as the majority of horses that underwent a 
clean-contaminated surgical procedure were older than the reference age group. 
The caseload of one hospital was primarily young, fit Thoroughbred racehorses in 
training, and this hospital provided most of the data for the study. The referent group 
when investigating whether age was a significant factor in the development of post-
operative complications was the first quartile, which was :s 2 years of age. Young, fit 
horses such as these could be expected to heal faster than their older counterparts, who 
may have sub-clinical health problems that could compromise their healing potential. 
7.11.4.4. Pre-operative antimicrobials 
In direct contrast to an earlier study (MacDonald et al. 1994), an increased likelihood of 
developing post-operative incisional complications was not seen following the 
administration of antimicrobials prior to induction. When considering the data for all 
surgical procedures, it was found that the administration of antimicrobials prior to 
induction would significantly reduce the likelihood of the horse developing post-operative 
incisional swelling or drainage, considered to be an abnormal finding for the specific 
surgical procedure performed (Tables 38 and 39). 
7.11.4.5. Clean vs. Clean-contaminated 
As long ago as 1964, when a committee appointed by the National Research Council 
defined four general categories of surgery, based upon the expected degree of bacterial 
contamination, it has been recognised that the nature of the surgical procedure will 
influence the likelihood that post-operative complications will develop (Romatowski, 
1989; Holmberg, 1985; MacDonald et al. 1994; Brown et al. 1997; Laitinen, 2001). 
Although it has been established that there is excessive variation within the broad 
categories defined by the National Research Council, it is still accepted that the expected 
rate of complications for a clean surgical procedure will be lower than that for a clean-
contaminated surgical procedure (MacDonald et al. 1994; Brown et al. 1997), as the 
exposure of the surgical incision to possible sources of contamination, and the resultant 
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bacterial load, increases. The results of this study supported this theory, with those horses 
undergoing a clean-contaminated surgical procedure almost four times more likely to 
develop post-operative incisional complications than those horses that underwent a clean 
surgical procedure (Table 39). 
7.11.4.6. Pre-operative preparation 
Preparation of the skin pre-operatively can influence the prevalence of post-operative 
complications. Close clipping and shaving of the surgical site is thought to cause 
microtrauma to the skin barrier, producing small cuts in which bacteria could colonise, 
thus predisposing patients to post-operative wound infection (Brown et at. 1997; Smith 
and Ross, 2002). In small animal surgery clipping the surgical site within four hours of 
induction of anaesthesia was found to increase the likelihood of post-operative incisional 
complications three-fold, compared to clipping the site after induction of anaesthesia 
(Brown et at. 1997). 
In the current study, clipping the surgical site was found to affect the likelihood of 
developing post-operative incisional complications for all surgical procedures (Tables 39 
and 42), and in particular those horses that underwent an orthopaedic surgical procedure 
(Table 47). This finding may be due to the fact that many horses undergoing orthopaedic 
surgery had the affected area clipped for the performance of diagnostic regional or 
synovial anaesthesia, or an ultrasonographic examination, prior to the decision of 
performing a surgical intervention was made. In many cases this would occur at least 
twenty-four hours prior to the surgery being performed. When exposed to a typical stable 
environment, this would allow bacteria to populate any abrasions created in the otherwise 
impermeable skin barrier, prior to a surgical incision being made. Shaving the surgical 
site at the time of skin preparation could be expected to cause further superficial trauma to 
the skin surface. However, shaving was only found to be significant following univariable 
analysis, but not after the final model was constructed. Not every horse undergoing an 
orthopaedic procedure had the surgical site shaved, with this routinely performed only for 
neurectomies and tenoscopies. 
Horses undergoing either soft tissue or clean-contaminated surgical procedures were only 
infrequently clipped prior to induction for anaesthesia. No horse undergoing either a soft-
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tissue or clean-contaminated surgical procedure had the surgical site shaved at the time of 
skin preparation. 
7.11.4.7. Duration of Anaesthesia 
The duration of anaesthesia is thought to increase the likelihood of developing incisional 
complications through a number of mechanisms. General anaesthesia can induce hypoxia, 
hypotension and hypothermia, each of which individually is known to cause an increased 
rate of incisional infections, by causing a reduction in the metabolic rate and 
vasoconstriction (Silver, 1982; Johnston, 1990). Excessive depth of anaesthesia or 
prolonged total anaesthetic time (Romatowski, 1989; Macdonald et al. 1994; Brown et al. 
1997; Beal et al. 2000) will also contribute to an increased rate of incisional infection. 
When considering data from all surgical procedures performed, and procedures classified 
as clean or orthopaedic, the current study found that when the duration of general 
anaesthesia exceeded 110 minutes, this was associated with a significant increase in the 
likelihood of the development of post-operative incisional swelling or drainage, 
considered to be abnormal for the surgical procedure performed (Tables 38, 41 and 47). 
This finding concurs with previous studies (Romatowski, 1989; Macdonald et al. 1994; 
Brown et al. 1997; Beal et al. 2000) where it was found that a prolonged total anaesthetic 
time contributed to an increased rate of incisional infection. 
When the duration of surgery exceeded the reference value of 30 minutes, this was found 
to significantly increase the likelihood of developing incisional swelling or drainage 
(Table 39). A longer surgical procedure will automatically result in a longer duration of 
general anaesthesia. However, longer surgical procedures also result in increased 
handling of the tissues, and potentially increased trauma to the tissues through excessive 
handling and desiccation. This may also have contributed to the increase in post-operative 
incisional complications associated with longer surgical procedures (Johnston, 1990; 
Brown et al. 1997). 
7.11.4.8. Suture Materials and Patterns 
The ideal suture material, with a high tensile strength and eliciting minimal tissue reaction 
without inducing an environment favourable to bacterial growth (Blackford and 
Chapter 7 228 
Blackford, 1999) does not exist. Many suture materials exist, each with their own 
associated advantages and disadvantages. Whilst much is known about the chemical 
composition and tensile strength of individual suture materials, there is a paucity of 
information in the equine literature about their performance in vivo (Turner and 
McIlwraith, 1989), leading to extrapolation of data from the human and small animal 
literature. 
It has been reported that the use of polyglactin 910 (Vicryl) has been associated with an 
increased risk of incisional complications (Honnas and Cohen, 1997), although the study 
that reported this was a retrospective case series, only providing class C evidence, and 
later studies have not concurred with this finding. 
In the current study, the use of polyglactin 910 (Vicryl) in the closure of the deep or skin 
layers was found to significantly decrease the likelihood of the development of unwanted 
sequelae to an elective surgical procedure (Tables 38, 41, 42, 44 and 46), a finding in 
direct contrast to that reported previously (Honnas and Cohen, 1997). However, the use of 
Vicryl in the closure of the subcutaneous tissue layer was associated with an increased 
likelihood of the development of post-operative incisional swelling, compared to those 
incisions where no subcutaneous suture layer was placed (Tables 38, 41 and 46). This 
finding may support the theory currently being investigated that the use of a subcutaneous 
suture layer will lead to an increase in post-operative incisional complications, due to 
increased tissue handling and an increase in the quantity of foreign material within a 
surgical incision (Coomer et al. 2005). 
The most commonly used suture patterns are simple continuous and simple interrupted, 
with the continuous pattern recommended for tissues that are elastic, and that are not 
subject to a lot of tension (Turner and McIlwraith, 1989). In the current study, no 
associations were found between the suture pattern used and any of the outcomes of 
interest. 
7.11.4.9. Dead Space 
Studies in both the human and the veterinary literature have recognised that large volumes 
of dead space left after surgery increase the risk of incisional complications (Lees et al. 
1989). Dead space potentiates incisional infection due to the accumulation of tissue fluid 
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in the dead space (Lees et al. 1989), which will prevent the migration of phagocytic cells. 
These cells are the primary host defence against the development of incisional infection. 
In the current study the volume of dead space left after surgery was not found to be a 
significant factor in the development of post-operative complications in any of the final 
models constructed. 
7.11.5. Sources of bacterial contamination 
Previous studies investigating the prevalence of incisional complications in equine surgery 
have recognised the contribution of the recovery room environment to the bacterial load 
(Smith and Ross, 2002). Unlike in both human and small animal surgery, it is impossible 
to accurately control a horse during the recovery period. Ineffectual attempts to stand 
prematurely can result in excessive trauma to the surgical site, leading to an exaggerated 
inflammatory response, local tissue trauma and partial or total dehiscence of the incision 
(Silver, 1982). Trauma is not the only factor in the recovery room environment that will 
contribute to the overall bacterial load. A strong positive correlation has been identified 
between the recovery room environment and the prevalence of incisional infections, with 
recovery room hygiene and maintenance considered to be important contributing factors 
(Galuppo et al. 1999; Smith and Ross, 2002). Poorly disinfected drains, or cracks in the 
padded lining to the recovery room, have proven to be ideal breeding grounds for bacteria, 
which in turn will readily colonise fresh surgical incisions. The incision can be protected 
to some degree by the application of a padded dressing, although this is not always either 
appropriate or feasible, depending on the nature of the surgical procedure and the site of 
the incision. 
Using a dressing not only protects the incision from sources of trauma and bacterial 
contamination, but will also provide an improved environment for wound healing (Silver, 
1982). A dressing will prevent evaporation and help keep the surface of the wound moist, 
allowing the epithelium to move straight along the damaged surface of the connective 
tissue, or even migrate straight through the wound exudates (Silver, 1982). However, a 
balance must be struck as an excess of this wound exudate will slow down the migration 
of the phagocytic cells, promoting the incidence of post-operative infection (Rosin et al. 
1993). 
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In the current study the use of a protective dressing post-operatively was found to 
significantly increase the likelihood of a horse developing an abnormal amount of post-
operative incisional swelling following a clean surgical procedure (Table 41). This is an 
unexpected finding, which may be due to the fact that those incisions most susceptible to 
either external trauma or where excessive tissue handling has occurred were preferentially 
covered by surgeons, for example casting of limbs following fracture repair, in 
comparison to those incisions where relatively few complications were anticipated, and 
therefore the incision was left uncovered. 
7.11.6. Study Limitations 
The risk period was under investigation was defined as running from the time of the 
surgical procedure being performed, until the horse was discharged from the hospital. It 
has been reported that most incisional complications occur approximately 14 days post-
operatively in horses that have undergone and exploratory laparotomy (Galuppo et at. 
1999), therefore it is possible that complications were potentially missed due to the short 
risk period under investigation. However, it was important to the study that all horses 
were evaluated at the end of the risk period by an impartial observer, and this would not 
have been possible in all cases if the risk period extended beyond the point of discharge 
from the hospital. 
7.11.7. Conclusion 
The results of our study showed that the prevalence of post-operative complications 
following an elective surgical procedure was higher than that previously reported, both 
when comparing results to the human literature and the veterinary literature, with almost 
25% of horses undergoing a surgical procedure experiencing a complication. When 
looking exclusively at the prevalence of incisional complications, the prevalence reported 
was 23.3%. This figure is higher than that previously reported when compared to both the 
human and the veterinary literature. All post-operative complications appeared to be 
transient, with the majority resolving prior to the horse's discharge from the hospital, 
although no data is available on whether horses experienced any complications subsequent 
to discharge from the hospital. 
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Chapter 8 
Conclusions and General Discussion 
The purpose of this research was to perform a series of studies that would investigate a 
number of surgical conditions in the horse, both elective and emergency procedures, 
focusing on different aspects of sepsis. The sepsis ranged from intra-synovial sepsis that 
would require a form of surgical intervention in order to have a successful outcome, to 
sepsis as a direct result of a form of surgical intervention. 
All the areas investigated were of a direct relevance to the general equine practitioner, and 
were also amenable to an EBM approach. There is a paucity of information available in 
the equine veterinary literature covering the investigation of the prevalence of 
complications following elective surgery (Macdonald et ai. 1994; Smith & Ross, 2002), 
and in particular what factors may contribute to the development of post-operative 
complications. Similarly, when looking at complications arising from emergency surgery, 
whilst previous studies have hypothesised about factors that may either increase or 
decrease the risk of developing these complications (Turner et ai. 1978; Kobluk, et ai. 
1989; Phillips and Walmsley, 1993; Honnas and Cohen, 1997; Ingle-Fehr et al. 1997; 
French et al. 2002; Coomer et ai. 2005; Mair and Smith, 2005), no study has previously 
been published that investigates the influence of any risk factors on the prevalence of 
complications, or the success of any preventive measures to reduce the prevalence. 
In contrast, when investigating the literature available on synovial sepsis in the horse, there 
is a wealth of information (Van Pelt & Riley, 1969; Koch, 1979; Leitch, 1979; Morris, 
1980; McIlwraith, 1983; Stover & Pool, 1985; Martens et ai. 1986; Bertone et al. 1987a,b; 
Lloyd et al. 1990; Peremans et ai. 1991; Ross et ai. 1991; Honnas et al. 1992a,b; Schneider 
et ai. 1992a,b; Whitehair et ai. 1992; McClure et ai. 1993; Holcombe et al. 1997; Cook et 
al. 1999; Murphey et ai. 1999; Lescun et al. 2000; Adams & Lescun, 2000; Meijer et ai. 
2000; Summerhays, 2000; Booth et ai. 2001; Butt et ai. 2001; Scheuch et ai. 2001). 
However, much of this information is conflicting and of a 'poor quality' of evidence in 
EBM terms. The majority of studies are retrospective, with low case numbers (Van Pelt & 
Riley, 1969; Ross et al. 1991; Honnas et ai. 1992a,b; Schneider et ai. 1992b; Lescun et ai. 
2000; Adams & Lescun, 2000; Summerhays, 2000; Booth et ai. 2001; Meijer et ai. 2000), 
which limits the conclusions that can be drawn from the results, with many conclusions 
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being based on personal experience and anecdote rather than strongly supported by factual 
evidence. Those studies that exist that are of a prospective nature, for example the clinical 
trials performed by Bertone et al. (1987a,b), contain only small case numbers and focus on 
a very specific study population in which synovial sepsis was caused by inoculation of the 
synovial structure with S. aureus, thereby limiting the application of the findings to a wider 
population. 
The studies reported here have made estimates of the likelihood of horses with either septic 
arthritis or septic digital tenosynovitis surviving, and going on to return to their previous, 
or anticipated, level of exercise. It was found that the presence of multi-system disease in 
neonatal Thoroughbreds treated for septic arthritis significantly reduced the likelihood that 
the foal would survive to be discharged from the hospital, compared to those foals with no 
disease process outside the synovial cavity. It was not possible to investigate whether 
involvement of more than one joint had an adverse effect on survival, as there was 
insufficient power to support a statistically significant effect. It was also found that the 
occurrence of septic arthritis in neonatal Thoroughbreds significantly reduced the 
likelihood of those foals going on to make at least one start on a racecourse, with those 
foals being 3.5 times less likely to start on a racecourse when compared to their siblings. 
When considering mature Thoroughbred racehorses treated for septic arthritis, only one 
factor was found to influence survival in the final model: a delay of more than five days 
between the onset of sepsis and commencement of treatment, with those horses being 
thirteen times less likely to survive than horses where treatment was started earlier. The 
occurrence of septic arthritis in a mature Thoroughbred racehorse did not reduce the 
likelihood of that horse starting on a racecourse when compared to its siblings, or of 
achieving an Official Rating issued by the British Horseracing Board's handicappers equal 
to either the highest rating achieved prior to the onset of sepsis in cases in which horses 
had raced previously, or equal to the highest rating achieved by their siblings. 
When considering the overall population of mature horses treated for septic arthritis, it was 
found that the presence of radiographic abnormalities at the time of admission; a delay of 
more than seven days between the onset of sepsis and the commencement of treatment; and 
involvement of the stifle, elbow, proximal inter-phalangeal joint, distal inter-phalangeal 
joint or navicular bursa significantly decreased the likelihood that the horse would survive 
to be discharged from the hospital. The single factor that was found to influence the 
likelihood of horses being able to return to their previous level of athletic function 
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following the successful resolution of septic arthritis was whether there were any 
radiographic abnormalities evident in the affected joint at the time of admission for 
treatment. The only factor found to influence the likelihood of horses treated for septic 
digital tenosynovitis either surviving to be discharged from the hospital, or returning to 
their previous level of performance, was a delay in more than seven days between the onset 
of sepsis and the commencement of treatment. 
These four studies were all retrospective studies, and therefore susceptible to many of the 
disadvantages commonly associated with these designs. Missing data in the case records 
are always a potential problem in this type of study, although did not affect the statistical 
analyses performed in the studies. Due to the wide variation in the treatment regimens 
employed, it was impossible to draw any conclusions regarding the relative efficacy of 
specific treatment modalities, although this was never the primary aim of these studies. In 
order to be able to draw conclusions about the relative efficacy of different treatment 
regimens it would be necessary to perform a controlled, prospective study, with sufficient 
case numbers to achieve statistical significance for medically meaningful outcomes. In 
addition, all long-term follow-up information was obtained by telephone questionnaire to 
the horses' caretakers. It was not possible to contact the caretaker of every horse in these 
studies, leading to the exclusion of some data from the final analyses. In those cases in 
which it was possible to contact the horse's caretaker, all information obtained was reliant 
on the ability of the caretaker to recall relevant events accurately and without bias, and it 
was up to the caretaker to decide subjectively whether they thought the horse had been able 
to return to its previous level of performance. In some cases there was a time lag of ten 
years between the horse being treated and follow-up information being obtained. 
However, at the outset of these studies, it was decided that a successful outcome would be 
the ability of the horse to satisfy the owner's long-term athletic expectations following 
treatment. As many horses were used primarily for general purposes at the time of 
admission to the hospital, it was impossible to quantify their return to athletic activity in 
terms of either competitive winnings or number of events entered. 
The final two studies investigated the prevalence of complications following elective 
surgical procedures, and whether the use of a belly band would reduce the occurrence of 
incisional complications following an exploratory celiotomy for the investigation of 
abdominal pain. It was found that those horses that had an exploratory laparotomy 
Chapter 8 234 
performed as an elective surgical procedure were 35 times more likely to develop post-
operative pyrexia than horses undergoing the referent surgical procedure (arthroscopy or 
tenoscopy), and those risk factors found to influence the likelihood of a horse experiencing 
either partial or total incisional dehiscence in the risk period of interest were: having an 
incision that exceeded 5cm in length, compared to the referent value of less than 5cm; and 
whether the incision had a simple continuous suture pattern used in the closure of the deep 
tissue layers, compared to the referent value of no closure in the deep tissue layer. Those 
variables found to influence the likelihood of a horse developing post-operative incisional 
swelling, considered to be abnormal for the surgical procedure performed, included: the 
gender of the horse; the age of the horse; the duration of general anaesthesia; the suture 
pattern used to close the skin; the suture material used in closure of the deep and 
subcutaneous layers; the antimicrobials used; the surgical procedure performed; and 
whether either partial or total incisional dehiscence occurred during the risk period. Those 
variables found to influence the likelihood of the development of post-operative incisional 
drainage, considered to be an abnormal finding for the specific surgical procedure 
performed, included: the gender of the horse; duration of the surgical procedure; clipping 
of the surgical site prior to induction; classification of surgical procedure; and the 
antimicrobials used. 
The use of an elastoplast belly band following an exploratory laparotomy for the 
investigation of abdominal pain was found to significantly reduce the likelihood of a horse 
developing post-operative incisional complications, with the risk of post-operative 
incisional complications reduced by 45% when compared to those horses in which no 
further form of intervention was used following recovery from general anaesthesia. In 
addition, it was found that in those horses that wore belly bands, the skin incision was 
more than twelve times more likely to have healed by 14 days post-discharge than those 
horses that did not wear belly bands. An incision that continues to drain for a prolonged 
period post-discharge is a complication that is both unsightly and unwanted for the owner, 
who has already invested a large amount of both time and money in electing to have an 
exploratory laparotomy performed. A draining incision is also a precursor to more serious 
complications such as incisional hernia formation, which can be more than just a visible 
blemish. Once the skin incision has healed, it will protect the deeper tissue layers from 
contamination and ascending infection. 
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All of the individual studies reported here were conducted in busy private practices. The 
questions formulated were directly relevant to practitioners, and were questions that had 
been faced by members of these practices countless times. Reviews of the available 
literature confirmed that no answers to these questions were immediately forthcoming and, 
therefore, they were suitable areas for further research. All data were collected as part of 
the normal case recording carried out on a daily basis for hospitalised patients, with 
minimal extra time required for the noting of results in case records. The study 
populations were the general populations encountered by each of the three private 
practices. As the studies were carried out in three general practice populations of horses, 
the results obtained should be broadly applicable to the horse population of the United 
Kingdom as a whole. An important subset of the practice population was identified at one 
practice, where there was a higher level of athletic expectation for Thoroughbred 
racehorses compared to the other practice populations. As a result, further analysis of this 
subset was also performed. 
The subsequent collation and analysis of the data was time consuming, and required the 
acquisition of skills in statistical analysis. However, once these skills have been acquired, 
it would be possible to perform these analyses whilst working in a private practice, 
although time away from clinical duties would be beneficial. This demonstrates that it is 
possible to conduct good quality, practice-based clinical research, although a suitable 
support structure allowing the acquisition of further statistical skills and a reduction in 
clinical duties would be advantageous. It is with this aim in mind that the Cambridge 
Infectious Disease Consortium created their clinical research outreach programme, with 
the added incentive of a financial reimbursement for all participating practices to cover the 
expense encountered when employing a locum veterinarian. Indeed, if more practices 
were to adopt a similar approach, it may encourage many young veterinarians to venture 
into becoming involved in clinical research, without having to leave a clinical position for 
one in academia, especially if suitable sustainable partnerships between practices and 
interested academic departments could be maintained. 
It could be argued that it does not have to be a veterinarian that performs the literature 
reviews, collection and collation of data, or the subsequent analysis of these data. In this 
way it would not be necessary for clinicians to take time away from their clinical duties in 
order for practice-based research to be perfOlmed. However, it is the veterinarian who is 
able to identify questions that are directly relevant to their practice population, where no 
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answer currently exists. There is also much to be gained by a clinician in performing a 
literature review of the relevant area, both in terms of increasing their existing knowledge 
base, but also in appreciating fully how to review studies, recognising both their 
advantages and their short-comings. This appreciation of study design and statistical 
analysis can then be transferred to future articles read in veterinary journals, allowing the 
clinician to appraise them and decide whether they are of a good quality of evidence, in 
EBM terms, and whether the results are directly relevant to the clinician's individual 
practice population. Similarly, by learning how to perform some simple statistical 
analyses, a greater understanding, not only of the results of the clinician's own research, 
but also of the results reported in the published literature, can be achieved. 
The results provided by the studies performed here all answered a clinically relevant 
question, and the results are directly applicable to the intended end user: the general equine 
practitioner. In addition, they have provided a higher 'class' of evidence in EBM terms 
than was previously available. Although only one study could be classified as providing 
class A evidence, when using the classification system proposed by Yusuf et al. (1998), the 
other studies were all classified as class B evidence, thereby still providing a valuable 
addition to the current literature pool. The next step would be to conduct randomised trials 
investigating the efficacy of the different treatment regimens employed in these studies. 
However, in order to achieve sufficient case numbers, it would be necessary to either have 
a lengthy study period, or conduct a multi-centre study. Conducting a multi-centre study 
would require a considerable level of commitment from the participating practices, relying 
on the goodwill of the participants to agree on and adhere to a particular treatment 
regimen, then collect the relevant data accurately. As has already been demonstrated in the 
medical profession (Cruse & Foord, 1980), multi-centre studies are likely to be the best 
way forward for veterinary clinical research, in order to achieve sufficient case numbers to 
provide answers that are directly relevant to practice-based clinical situations. 
One apparent shortcoming of the current study was the lack of opportunity to discuss the 
findings of the individual studies with practitioners, and gain feedback from them on how 
relevant they perceived the results to be to their practice situation. The fifth, and final, step 
in the application of the principles of EBM is the critical evaluation of the outcome of all 
the preceding steps. Although the current study performed self-evaluation, a more rigorous 
test of the applicability of the results to the intended target audience would have been the 
dissemination of the results to such an audience. A review of the results by practitioners 
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would then have provided a more accurate assessment of whether the underlying aim of the 
study had been achieved: the application of the principles of EBM to equine practice, in 
order to generate, and then answer, clinically relevant questions. 
Although many in academia have been keen to embrace the principles of Evidence-Based 
Medicine, general practitioners are still left questioning the necessity of such an approach. 
The question of whether the application of EBM to a common problem will actually 
change the outcome is a valid one, and one that must be addressed. Evidence-based 
medicine will be perceived to be of little relevance to the equine practitioner if the studies 
performed and the results obtained cannot be applied to general practice (Mair, 2001; Mair 
and Cohen, 2003; Marr, 2003). In fact, this approach would be a direct contraindication of 
the original ethos of EBM. It must be remembered that EBM should be answering 
questions relevant to an individual's situation and therefore the questions that are 
addressed must pertain to general practice for a practitioner to be able to utilise the results 
(Mair, 2001; Mair and Cohen, 2003; Marr, 2003). 
There h,!-s recently been encouragement for general practitioners to contribute to future 
research, either by providing the questions that are relevant to practice, thereby giving 
researchers guidance as to where to focus future research, or by participating in practice-
based research. In reality, many of the veterinarians who hold an active interest in research 
work are already in academic institutions, in order to gain access to a wide range of 
facilities and funding opportunities that enable high quality research to be conducted. 
Those practitioners that are keen to participate in clinical research are often at a loss as to 
how to start when planning a practice-based research project, and any aspirations to 
publish in a prestigious, peer-reviewed journal are often shelved at the prospect of having 
to undertake the rigours of the writing and peer-review process. The peer-review process 
is to ensure that only high quality, relevant research is published, yet this may leave many 
practitioners feeling that any contribution they may have to make would be inadequate in 
such a forum. 
Currently, the results of research utilising the principles of EBM are published in 
veterinary journals, having been subjected to the peer-review process. However, it could 
be asked whether journals really are the most appropriate vehicle for disseminating new, 
and potentially ground-breaking, research. Many such journals have a long backlog of 
accepted manuscripts, leading to a substantial delay between the research being conducted 
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and the results being disseminated to a target audience. Theoretically, this delay could lead 
to the results being out-of-date by the time they are published, even though they are being 
published as some of the most up-to-date and applicable results in their field. This delay in 
publication and dissemination of results is the anathema of the ethos of EBM. The medical 
profession has addressed this problem by the creation and utilisation of on-line journals for 
research following the principles of EBM, allowing the results to be both rapidly and 
widely disseminated to the target audience. However, with no on-line EBM journals 
available to the veterinary profession, at the current time it would be appear that printed 
journals are the most efficient way for results to be communicated to the profession as a 
whole. 
In order for the results of a manuscript to reach its target audience, it must be published in 
an appropriate journal. If a practitioner were to attempt to read all the journals available-
both the general and specialised - there would be insufficient time both to review and 
digest all the relevant results on top of a normal workload. In addition, there would be a 
substantial cost incurred in subscribing to the plethora of publications that are available. 
As a rule, general practitioners are more likely to read one of the many broad-spectrum 
journals available to the profession, as opposed to a specialist, or scientific, journal if they 
wish to keep abreast of all the new developments. To this end, research must then be 
published in a journal appropriate to the intended target audience. However, authors may 
be attracted to the more specialised journals for the publication of their research, in 
particular in light of research assessment exercises and impact factor pressures, thereby 
taking that information away from the readership for which it was intended. 
If it is to be accepted that journals are, at this time, the most appropriate method for the 
communication of relevant research to the profession, then how manuscripts are accepted 
for publication must itself be reviewed. Many journals utilise the peer-review system, 
where manuscripts are passed on to members of the profession with a specific interest in 
that field, for review. The onus is then on the reviewer to decide whether the manuscript is 
suitable for publication, and whether any amendments should be made. Journals rely on 
the goodwill of reviewers to add to their normal workload by taking on such 
responsibilities. An obvious flaw in the review process is that there is no formal training in 
either how to review a manuscript appropriately or the understanding of statistical 
techniques, with many learning through personal experience. The potential also exists for 
the introduction of deliberate bias into the review process, or a reviewer's judgement being 
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influenced by personal interests. Without any standardisation of the review process, this 
results in a wide variation in the personal opinion of reviewers when considering the same 
manuscript. In addition, there is inevitably a delay until reviewers can find an appropriate 
break in their workload to examine the manuscript thoroughly and prepare a report. This 
delay will add to the delay faced by a manuscript awaiting publication, thereby increasing 
the time-lag between the submission of research and the dissemination of that research to 
the wider population. 
The Equine Veterinary Journal launched a section dedicated to Clinical Evidence Articles 
in November 2003, in order to disseminate results of clinically relevant studies rapidly, 
addressing common and important diseases and promote the principles of EBM within the 
veterinary profession (Rossdale et al. 2003). Since the launch of the Clinical Evidence 
section in the Equine Veterinary Journal, only eight articles have been published that fulfil 
the inclusion criteria for this section (Edwards et al. 2003; Barakzai et al. 2004; Johnston 
et al. 2004; Smith et al. 2004; Proudman et al. 2005a,b; Smith et al. 2005; Valverde et al. 
2005), whilst the General Articles section of the journal continues to be inundated with 
manuscripts. This poor response to an avenue offering fast-track publication for 
manuscripts fulfilling the inclusion criteria must be queried. It could be that the rigorous 
inclusion criteria, along with the stringent requirements on the overall length of the 
manuscript, are prohibitive. The main criterion is that the article must address a clinically 
relevant question, which is clearly defined at the outset. Furthermore, a sample size 
calculation must be performed at the outset of the study to ensure that there will be 
sufficient power to detect a statistically significant difference for a medically meaningful 
outcome. The case definition criteria and outcomes of interest must be unambiguous, 
rigorously applied and explicitly reported at all stages of the study. Controls, 
randomisation and blinding should be utilised as appropriate, and reported accordingly, 
and appropriate analytical methods applied to the data. Authors may believe that it is not 
possible to fulfil all these inclusion criteria in sufficient detail, and still produce a 
manuscript that conforms to the length of general articles. Another possible explanation is 
the lack of clinical research that is submitted. The majority of articles submitted from 
academic institutions are reporting results of bench or basic science research. This is 
unlikely to be wholly because they believe that these areas are more worthy, or interesting, 
to research than questions that are more pressing to general practitioners. Academic 
institutions must attract funding from the research councils or charities to support their 
research interests, and inevitably, the sources of this funding to some extent dictate the 
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nature of the research undertaken. Funding for basic science research is, generally, more 
widely available and the findings of such research are, generally, more amenable to 
publication in high impact factor journals, which greatly influence the rating of the 
scientists and their institute. Hence, clinically orientated research faces many difficulties 
in gaining points with basic science. 
It could be argued that it takes time to: 
1. identify an area suitable for, and in need of, further research, 
2. design an appropriate study, 
3. implement this study, collecting all the relevant data, 
4. process these data, 
5. interpret and present these data in a comprehensible fashion. 
Despite these difficulties, the initiative of the Equine Veterinary Journal is to be applauded 
and it is to be hoped that the volume of well-founded research will start to grow steadily 
over the coming years. In the meantime, many of the early studies have re-investigated 
areas that have already been covered extensively in the literature. These studies have not 
contradicted their earlier counterparts, but have reinforced the findings of prior research, as 
well as contributing new results to the literature pool. This finding should encourage 
further implementation of the principles of EBM in veterinary research, instead of shying 
away from it with the fear that a 'new science' may disprove widely accepted, long-
standing beliefs. The Equine Veterinary Journal has itself been proactive in encouraging 
the use of the principles ofEBM in future research, and promoting the understanding of the 
principles of EBM, both through the Clinical Evidence section, and the Clinical Evidence 
Notebook, launched in May 2005. The Notebook was intended to complement research 
articles and address a wide range of issues relating to the collection, analysis and 
interpretation of data of clinical relevance (Marr and Rossdale, 2005). 
The current study should be viewed as 'the tip of the iceberg', demonstrating that it is 
entirely possible to conduct modest, practice-based clinical studies within private practices, 
and generating worthwhile results from these studies that are applicable to a wider 
audience. The knowledge gained from this, and hopefully other future studies, will 
provide answers to questions that are directly relevant to equine practitioners. In addition 
to providing a good quality of evidence to support the most up-to-date and relevant 
knowledge, they provide substance to support clinical decision making. In this way, the 
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veterinary profession can be seen to be demonstrating a commitment to best practice and 
effective self-regulation. 
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Appendix 1 
Survey of horse owners to obtain long-term follow-up of horses treated for septic 
digital tenosynovitis - Questionnaire 
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What is the likelihood that a horse treated for septic digital tenosynovitis will return 
to its previous level of athletic function? 
Horse: Owner: 
What best describes the intended use of the horse at the time of purchase? 
Breeding ~ Eventing ~ Polo § 
General Purpose Show jumping Hunting 
Showing Flat racing Team chasing 
Dressage Jump racing 
What best describes the use of the horse at the time of the injury? 
Breeding ~ Eventing ~ Polo 
General Purpose Show jumping Hunting 
Showing Flat racing Team chasing 
Dressage Jump racing 
§ 
Has the horse returned to the same type of work after the injury? 
Yes D 
No LJ 
If no, is the reason directly attributable to the injury (ie lameness associated with the 
tendon or tendon sheath) or is it due to any other umelated injuries/illnesses? 
Related D 
Umelated LJ 
Has the horse returned to the same level of work after the injury? 
Yes D 
No D 
If no, is the reason directly attributable to the injury (ie lameness associated with the 
tendon or tendon sheath) or is it due to any other umelated injuries/illnesses? 
Related D 
Umelated D 
Has the horse attained its originally intended use after the injury? 
Yes D 
No D 
If no, is the reason directly attributable to the injury (ie lameness associated with the 
tendon or tendon sheath) or is it due to any other umelated injuries/illnesses? 
Related D 
Umelated D 
Have there been any long term/recurrent lameness problems associated with the initial 
injury? 
Yes 
No B 
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Appendix 2 
Univariable analysis of factors influencing short and long term prognosis following 
treatment for septic digital tenosynovitis. 
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Appendix 2.1: Univariable analysis of factors influencing likelihood of survival following treatment for 
septic digital tenosynovitis 
Coefficient S.E. 
Age of horse at presentation (referent <5 yrs) 
5-10 yrs -2.04 l.l1 
10 -14 yrs 19 10163 
> 14 yrs -0.89 1.27 
Gender of horse (referent female) 
Male 0.106 0.646 
Limb affected (referent forelimb) 
Hindlimb -0.28 0.67 
Location of wound (referent fetlock) 
Pastern -0.36 0.72 
Foot 20 28097 
Adjusted O.R. 95% C.I. p 
0.14 
OCJ 
0.41 
1.11 
0.76 
0.69 
OCJ 
0.01- 1.15 
0.00 - OCJ 
0.03 4.89 
0.31 - 3.95 
0.20 -2.79 
0.17-2.84 
0.00 - OCJ 
0.067 
0.998 
4.80 
0.869 
0.675 
0.611 
0.999 
Delay between onset of sepsis and commencement of treatment (referent <24 hrs) 
1-7ds 20 11295 OCJ 0.00 - OCJ 0.999 
>7 ds -0.76 0.89 0.47 0.08 - 2.67 0.391 
Appendix 2.2: Univariable analysis of factors affecting likelihood of return to previous level of 
performance following treatment for septic digital tenosynovitis 
Coefficient S.E. 
Age of horse at presentation (referent <5 yrs) 
5-10 yrs l.l0 0.68 
10 -14 yrs 0.81 0.70 
> 14 yrs 0.29 0.67 
Gender of horse (referent female) 
Male 0.41 0.47 
Limb affected (referent forelimb) 
Hindlimb -0.55 0.48 
Location of wound (referent fetlock) 
Pastern 0.07 0.49 
Foot -21 17307 
Adjusted O.R. __ . 95% c.1. p 
3.00 
2.25 
1.33 
1.50 
0.57 
1.07 
OCJ 
0.80 - 11.31 
0.57 - 8.82 
0.36 -4.93 
0.59 - 3.80 
0.22 - 1.47 
0.41 - 2.83 
0.00 - OCJ 
0.105 
2.45 
0.666 
3.89 
0.249 
0.889 
0.999 
Delay between onset of sepsis and commencement of treatment (referent <24 hrs) 
1-7ds -2.08 0.83 0.13 0.02 - 0.63 0.012 
>7ds 1.14 l.l3 3.12 0.34-28.73 0.314 
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Appendix 3 
Survey of horse owners to obtain long-term follow-up of horses treated for septic 
arthritis - Questionnaire 
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What is the likelihood that a mature horse treated for septic arthritis will be able to 
return to its' previous level of athletic performance? 
Horse: Owner: Clinic: 
What best describes the intended use of the horse at the time of purchase? 
Breeding ~ Eventing ~ Polo H 
General Purpose Show jumping Hunting 
Showing Flat racing Team chasing 
Dressage Jump racing 
What best describes the use of the horse at the time of the injury? 
Breeding ~ Eventing ~ Polo 
General Purpose Show jumping Hunting 
Showing Flat racing Team chasing 
Dressage Jump racing 
H 
Has the horse returned to the same type of work after the injury? 
Yes D 
No 0 
If no, is the reason directly attributable to the injury (ie lameness associated with that joint) 
or is it due to any other unrelated injuries/illnesses? 
Related D 
Unrelated 0 
Has the horse returned to the same level of work after the injury? 
Yes D 
No D 
If no, is the reason directly attributable to the injury (ie lameness associated with that joint) 
or is it due to any other unrelated injuries/illnesses? 
Related D 
Unrelated D 
Has the horse attained its originally intended use after the injury? 
Yes D 
No D 
If no, is the reason directly attributable to the injury (ie lameness associated with that joint) 
or is it due to any other unrelated injuries/illnesses? 
Related D 
Unrelated D 
Have there been any long term/recurrent lameness problems associated with the initial 
injury? 
Yes 
No B 
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Appendix 4 
Univariable analysis of factors influencing short and long term prognosis following 
treatment for septic arthritis. 
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Appendix 4.1: Univariable logistic regression analysis of factors affecting survival following treatment 
for septic arthritis 
Coefficient S.E. OR 95% CI P 
Rads -1.20 0.35 0.30 0.15 - 0.60 0.001 
Duration (referent <24hrs) 
1-7ds -0.21 0.50 0.81 0.31-2.14 0.670 
>7ds -1.61 0,37 0.20 0.10 0.41 <0.001 
Age (referent <8yrs) 
8-15 yrs -0.84 0.35 0.43 0.22 - 0.85 0.016 
>15 yrs -0.94 0.50 0.39 0.15-1.03 0.058 
Specific joint affected (referent metatarso-phalangeal joint) 
Carpus -1.28 0.86 0.28 0.05 - 1.51 0.138 
Stifle -2.47 0.86 0.08 0.02 0.46 0.004 
Hock -1.39 0.79 0.25 0.05 -l.l6 0.076 
Metacarpo- -0.81 1.03 0.44 0.06 - 3,32 0.429 
phalangeal joint 
Distal inter- -2.64 0.94 0.07 0.01 - 0.45 0.005 
phalangeal joint 
Distal inter- -3.05 l.l6 0.05 0.00 - 0.46 0.009 
phalangeal joint 
and navicular 
bursa 
Navicular bursa -3.23 0.98 0.04 0.01 - 0.27 0.001 
Elbow -2.53 0.93 0.08 0.01-0.49 0.006 
Proximal inter- -3.04 0.89 0.05 0.01- 0.27 0.001 
phalangeal joint 
Route of infection (referent trauma) 
Iatrogenic -0.99 0.56 0,37 0.13 -1.11 0.076 
Haematogenous 20.00 00 0.00 -00 1.000 
Synovial white cell count (referent <21 x 109 cells/I) 
21-71 -0.51 0.54 0.60 0.21 - 1.74 0.349 
71-102 0.25 0.76 1.28 0.29 - 5.62 0.746 
>102 0.00 0.62 1.00 0.29 - 3,39 1.000 
Duration hospitalisation (referent <5ds) 
5-9 ds 22.00 00 0.00 -00 0.996 
9-12 ds 22.00 00 0.00 - 00 0.996 
>12 ds 22.00 00 0.00 - 00 0.996 
Number lavages performed (referent 1) 
2-4 0.35 0.36 1.42 0.69 - 2.90 0.338 
>4 -1.23 0.76 0.29 0.07 -1.29 0.104 
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Appendix 4.2: Univariable logistic regression analysis of factors affecting likelihood of return to 
original athletic function following treatment for septic arthritis 
Coefficient S.E. OR 95% CI Q 
Rads -1.20 0.43 0.30 0.13 -0.70 0.005 
Duration (referent <24hrs) 
1-7ds -0.07 0.45 0.93 0.39 - 2.23 0.867 
>7ds -0.82 0.42 0.44 0.19 - 1.01 0.052 
Age (referent <8yrs) 
8-15 yrs -0.12 0.35 0.89 0.45 - 1.74 0.728 
>15 yrs -0.61 0.52 0.54 0.19-1.51 0.242 
Specific joint affected (referent metatarso-phalangeal joint) 
Carpus 0.12 0.47 1.13 0.45 - 2.84 0.803 
Stifle 0.41 0.74 1.50 0.35 - 6.38 0.583 
Hock 0.33 0.41 1.39 0.62-3.11 0.424 
Metacarpo- -0.12 0.57 0.88 0.29 -2.68 0.827 
phalangeal joint 
Distal inter- 0.12 0.91 1.13 0.19-6.76 0.898 
phalangeal joint 
Distal inter- -1.27 1.26 0.28 0.02 3.32 0.314 
phalangeal joint 
and navicular 
bursa 
Navicular bursa 0.81 1.16 2.25 0.23 -21.70 0.483 
Elbow 0.12 1.26 1.13 0.10 - 13.29 0.926 
Proximal inter- -2.19 1.13 0.11 0.01 - 1.04 0.054 
phalangeal joint 
Route of infection (referent trauma) 
Iatrogenic -0.76 0.60 0.47 0.14-1.52 0.208 
Haematogenous -22.00 00 0.00 0.00 -00 0.999 
Synovial white cell count (referent <21 x 109 cells/I) 
21-71 -0.50 0.57 0.61 0.20 - 1.87 0.386 
71-102 -0.38 0.67 0.69 0.19-2.54 0.572 
>102 -0.63 0.60 0.53 0.16 - 1.72 0.294 
Duration hospitalisation (referent <5ds) 
5-9 ds 0.95 0.50 2.58 0.97 - 6.87 0.057 
9-12 ds -0.15 0.46 0.86 0.35 - 2.14 0.747 
>12 ds -0.15 0.46 0.86 0.35 - 2.14 0.747 
Number lavages performed (referent 1) 
2-4 -0.17 0.32 0.84 0.45 - 1.57 0.595 
>4 -2.14 1.14 0.12 O.oJ - 1.09 0.059 
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Appendix 5 
Univariable analysis of factors influencing short and long term prognosis in mature 
Thoroughbred racehorses following treatment for septic arthritis. 
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Appendix 5.1: Univariable analysis of factors affecting survival in mature Thoroughbred racehorses 
following treatment for septic arthritis 
Coefficient S.E. OR 95%CI P 
Gender (referent 0.85 0.86 2.34 0.44 - 12.62 0.321 
male) 
Radiographic 20 20140 CIJ 0.00 - CIJ 0.999 
abnormalities at 
admission 
Duration (referent <24hrs) 
1- 5ds -0.80 1.24 0.45 0.04 - 5.06 0.518 
>5ds -1.90 0.86 0.15 0.03 - 0.80 0.027 
Age (referent :'S2yrs) 
3-4 yrs 0.32 0.89 1.38 0.24 -7.94 0.719 
>4 yrs 0.73 1.15 2.07 0.22-19.63 0.527 
Specific joint affected (referent metatarso-phalangeal joint) 
Carpus 19 8104 CIJ 0.00 - CIJ 0.998 
Stifle -2.35 1.60 0.10 0.00-2.18 0.141 
Hock -0.97 1.34 0.38 0.03 - 5.27 0.472 
Metacarpo- -0.56 1.31 0.57 0.04 -7.44 0.669 
phalangeal joint 
Distal inter- 19 17507 CIJ 0.00 - CIJ 0.999 
phalangeal joint 
Distal inter- 19 30324 CIJ 0.00 - CIJ 0.999 
phalangeal joint 
and navicular 
bursa 
Navicular bursa -0.97 1.34 0.38 0.03 - 5.27 0.472 
Proximal inter- -3.05 1.43 0.05 0.00 0.79 0.033 
phalangeal joint 
Route of infection (referent trauma) 
Iatrogenic -0.02 1.15 0.98 0.10-9.39 0.984 
Haematogenous 20 39965 CIJ 0.00 - CIJ 1.000 
Synovial white cell count (referent <50 ) 
50 -120 21 11854 CIJ 0.00 - CIJ 0.999 
>120 0.41 1.30 1.50 0.12 - 19.24 0.755 
Number lavages performed (referent 1) 
>1 0.00 0.87 1.00 0.18-5.53 1.000 
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Appendix 5.2: Univariable analysis of factors affecting likelihood of racing in mature Thoroughbred 
racehorses, following treatment for septic arthritis 
Coefficient S.E. OR 95% CI P 
Gender (referent -0.84 0.58 0.43 0.14 - 1.34 0.146 
male) 
Radiographic -1.79 1.20 0.17 0.02 -1.74 0.134 
abnormalities at 
admission 
Duration (referent <24hrs) 
1- 5ds -0.77 0.89 0.46 0.08 -2.63 0.384 
>5ds -0.49 0.84 0.62 0.12-3.19 0.563 
Age (referent :S2yrs) 
2-4 yrs -21 8655 0.00 0.00 -00 0.998 
>4 yrs -21 8655 0.00 0.00 - 00 0.998 
Specific joint affected (referent metatarso-phalangeal joint) 
Carpus -0.33 0.72 0.72 0.18 - 2.92 0.643 
Stifle 21 25687 00 0.00 -00 0.999 
Hock 0.48 1.25 1.62 0.14 18.58 0.700 
Metacarpo- -0.21 1.03 0.81 0.11- 6.04 0.835 
phalangeal joint 
Distal inter- 0.07 1.31 1.08 0.08 - 14.08 0.955 
phalangeal joint 
Navicular bursa 0.48 1.25 1.62 0.14-18.58 0.700 
Proximal inter- -22 26303 0.00 0.00 - 00 0.999 
phalangeal joint 
Route of infection (referent trauma) 
Iatrogenic -0.44 0.84 0.64 0.12-3.30 0.596 
Haematogenous -22 26726 0.00 0.00 -00 0.999 
Synovial white cell count (referent <50) 
50-120 0.45 0.80 1.57 0.33 - 7.48 0.570 
>120 -0.11 0.89 0.89 0.16-5.11 0.899 
Number lavages performed (referent 1) 
>1 -1.00 0.65 0.37 0.10-1.33 0.126 
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Appendix 6 
General Linear Model comparing highest Official Rating achieved by mature 
Thoroughbred racehorses treated for septic arthritis, and the comparison population. 
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Term Coefficient S.E. p 
Constant 54.08 4.23 <0.001 
Case/Sib 
Case -12.97 4.23 0.004 
Sib code 
1 37.24 20.95 0.082 
2 -54.08 25.44 0.039 
3 11.91 20.95 0.572 
4 21.94 35.99 0.545 
5 -34.08 25.44 0.187 
6 27.94 35.99 0.441 
7 -3.42 20.95 0.871 
8 10.58 20.95 0.616 
9 -5.76 20.95 0.785 
10 44.24 20.95 0.040 
11 13.92 25.44 0.587 
12 15.24 20.95 0.470 
13 8.92 25.44 0.727 
14 -5.58 25.44 0.827 
15 9.42 25.44 0.713 
16 31.42 25.44 0.223 
17 -22.09 20.95 0.297 
18 26.91 20.95 0.205 
19 -16.58 25.44 0.518 
20 -5.06 35.99 0.889 
21 -67.06 35.99 0.069 
22 22.91 20.95 0.280 
23 42.91 20.95 0.046 
24 28.91 20.59 0.174 
25 -14.08 25.44 0.582 
26 -49.76 20.95 0.022 
27 -30.08 25.44 0.243 
28 -4.58 25.44 0.858 
29 15.92 25.44 0.535 
30 -49.76 20.95 0.022 
31 26.92 25.44 0.295 
32 -0.76 20.95 0.971 
33 -49.76 20.95 0.022 
34 -4.58 25.44 0.858 
35 29.92 25.44 0.245 
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Appendix 7 
Incisional complications following exploratory celiotomy: does a belly band reduce 
the risk? - Data collection forms 
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Sheet 1 
Case details 
Horse name: Owner name: Date of surgery: 
Age: Sex: M F MN Breed: 
Use: Weight (kgs): 
Duration of signs of abdominal discomfort prior to induction: 
Severity of discomfort prior to induction: mild / moderate / severe 
Evidence of endotoxaemia present prior to induction: Y / N 
Pre-op. rectal temperature (0C), heart rate (bpm) and respiratory rate (bpm): 
T: P: R: 
Rectal findings: 
Pre-op. haematology: 
WBC: 
Neutrophils: 
Hct: 
TP: 
Pre-op. antibiotics: 
Drugs Total Dose 1M /IV I PO 
Pre-op. analgesia: 
Drugs Total Dose 1M /IV IPO 
Any evidence of pre-existing site of infection? 
YIN 
Skin wound remote to surgical site 
Nasal discharge 
Diarrhoea 
Appendix 7 
Surgery Report Form 
Date: 
Horse name: 
Duration of anaesthesia (mins): 
Sheet 2 
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Surgeon: Nurse: 
Owner name: 
Duration of surgery (mins): 
Surgical scrub solution used: pevidine / hibiscrub Duration of surgical scrub (mins): 
Evidence of local skin reaction following surgical clip & scrub: Y / N 
Surgical report (to include: nature of lesion found including anatomical location, any gut resected 
including site of resection, reason for resection, length of resection and type of anastomosis performed, 
viability and motility of gut prior to closure of abdomen): 
Degree of peritoneal contamination: mild / moderate / severe 
Length of incision (cm): 
to linea: Y / N 
Linea lavaged after closure: Y / N Crystapen applied 
Suture material (select as appropriate): Deep layer closure (select as appropriate): 
continuous c=J interrupted: simple 
cruciate 
mattress 
near-far 
far-near 
other: 
,--------, Vicryl § SIZE: 
Polysorb 
Biosyn 
PDS 
other: 
Subcutaneous closure (select as appropriate): 
continuous c::::::::J interrupted: sim~le [8 
crucJate 
mattress 
other: 
Skin closure (select as appropriate): 
continuous c::::::::J interrupted: 
Drain inserted: Y / N 
simple 
cruciate 
mattress 
other: 
[8 
Suture material (select as appropriate): 
Vicryl EJ SIZE: 
other: 
Suture material (select as appropriate): 
Vicryl FJ SIZE: 
Nylon 
Prolene 
Staples 
~ 
'"0 
ci. 
o 
I 
tl 
o 
0... 
2 
3 
4 
5 
6 
7 
1;j 
<!) 
::r:: 
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Sheet 3 
Horse name: Owner name: 
Belly band applied: Y / N 
Type of belly band used: Elasticated / Elastoplast 
Daily wound assessment (answer yes/no as appropriate): 
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Q a 
Did horse receive any antibiotics other than Crystapen and Gentamicin: Y / N 
If yes, please state which antibiotics and reason for change: 
AM 
T(°C) 
P(bpm) 
R(bpm) 
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PM 
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P(bpm) 
R(bpm) '" ] .~ 
~ 
..... 
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Sheet 4 
Discharge Sheet 
Horse name: Owner name: 
Date of discharge: 
Was horse pyrexic at any time during hospitalistion? Y / N 
Was pyrexia attributed to (please check box as appropriate): 
Respiratory tract infection 
Gastro-intestinal tract infection 
Wound infection 
Thrombophlebitis of jugular 
r----ll vein 
Catheter site infection 
Pyrexia of unknown origin 
Wound assessment at discharge - any evidence of (please check box as appropriate): 
Heat 
Pain on palpation 
Swelling 
Pitting oedema 
f------j 
Discharge from incision 
Partial dehiscence of 
incision 
Total dehiscence of incision 
Please attach copies of results of all bloodwork, and any other laboratory 
investigations performed during hospitalization, to this sheet. 
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Appendix 8 
Incisional complications following exploratory celiotomy: does a belly band reduce 
the risk? Definitions of outcomes 
Appendix 8 
Definitions of outcomes 
Post operative period 
262 
• defined as starting immediately following recovery of the horse from general 
anaesthesia, ie. post-op. day 1 is the same day as the surgical procedure. 
Pyrexia 
• identified by twice daily assessment of rectal temperature. 
• rectal temperature> 39°C at anyone time. 
Jugular thrombosis 
• identified by observation and palpation of the ventral neck of the horse on a daily 
basis. 
• swelling of, or palpable thrombus formation within, jugular vein in which an intra-
venous catheter has been placed during hospitalization, ideally confirmed as 
narrowing or complete obstruction of jugular vein by the use of ultrasound. 
Catheter site infection 
• identified by observation and palpation of the catheter insertion site on a daily 
basis. 
• localized swelling, heat or abscess formation, without associated thrombosis of 
underlying vessel, in the skin directly around the site of insertion of an intra-venous 
catheter, ideally confirmed by the use of ultrasound. 
Diarrhoea 
• identified by twice daily inspection of faeces. 
• loose faeces for 2: 24 hours. 
Respiratory tract infection 
• rectal temperature elevated >39 °c, associated with any two of the following 
criteria identifying the respiratory tract as the source of the pyrexia: nasal discharge 
(serous/purulent); increased respiratory rate; increased lung sounds on thoracic 
auscultation. 
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Gastro-intestinal tract infection 
• rectal temperature elevated >39 °C, associated with diarrhoea of >24 hours 
duration. 
Pyrexia of unknown origin 
• rectal temperature elevated >39 °C, associated with non-specific signs of illness 
(eg. lethargy, inappetance), where no infectious cause is identified. 
Definition of surgical terms 
Anaesthesia time 
• defined as the time from induction to the time that the gaseous anaesthetic agent 
was turned off. 
Surgery time 
• defined as the time from the first surgical incision until all surgical intervention 
(suturing, application of dressing, etc) had ceased. 
Peritoneal contamination 
• defined as any material from the lumen of the gastro-intestinal tract entering the 
peritoneal cavity. 
• Mild - small particles of ingesta seen on the serosal surface of the gut, easily 
removed by lavage (eg after an enterotomy incision) 
• Moderate - some ingesta seen on the serosal surface of the gut, where the amount 
renders it unlikely that all contamination will be removed following lavage. 
• Severe frank contamination of abdomen with significant quantities of ingesta, or 
evidence of peritonitis already present at time of closure of incision. 
Identification and definition of complications during hospitalisation 
Pain 
• Mild - occasional pawing, may lie quietly in sternal/lateral recumbancy with no 
repeated attempts to roll. 
administration of analgesia. 
Responds readily, for prolonged periods, to 
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• Moderate - intermittent episodes of pawing and lieing down to roll, however when 
roused into a standing position will stand quietly. Responds well to analgesia, 
however only for a short time (hours). 
• Severe - persistent pawing and rolling. Hard to maintain in a standing position, 
with administration of analgesia resulting in a poor response « Ihr). 
Endotoxaemia 
• defined as exhibiting any two of the three following signs when being assessed 
prior to surgery: congested mucous membranes with prolonged capillary refill 
time, significantly elevated heart rate (>50 bpm), significantly elevated haematocrit 
(>50111). 
Drainage from incision 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• any fluid seen to be leaking from the surgical site. 
Serous drainage 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• clear, straw coloured fluid leaking from incision. 
Serosanguinous drainage 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• clear, blood tinged fluid leaking from incision. 
Purulent drainage 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• cloudy, cellular fluid leaking from incision. 
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Heat 
• identified by palpation of the surgical incision at every dressing change. If no 
dressing is used then the wound will be assessed on a daily basis. 
• incision palpably warmer compared to either temperature of surrounding skin, or to 
a comparable region, ie with a skin incision on neck, compare to other side of neck. 
Pain on palpation of wound 
• identified by gentle palpation of the surgical incision at every dressing change. If 
no dressing is used then the wound will be assessed on a daily basis 
• horse flinches or makes an attempt to move away when incision is palpated 
Swelling of incision 
• identified by observation of the surgical incision at every dressing change. If no 
dressing is used then the wound will be assessed on a daily basis. 
• margins of incision raised above level of surrounding skin more than would be 
anticipated with the suture pattern used. 
Oedema of incision 
• identified by observation and palpation of the surgical incision at every dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• margins of incision raised above level of surrounding skin more than would be 
anticipated with the suture pattern used, and when digital pressure is applied to this 
area a visible indent remains for >5secs. 
Partial wound dehiscence 
• identified by observation of the surgical incision at every dressing change. If no 
dressing is used then the wound will be assessed on a daily basis. 
• disruption ofless than 75% of the surgical wound. 
Total wound dehiscence 
• identified by observation of the surgical incision at every dressing change. If no 
dressing is used then the wound will be assessed on a daily basis. 
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• disruption of at least 75% of the surgical wound. 
Serornalhaernatorna 
• identified by observation and palpation of surgical incision on a daily basis. 
• localized, fluid filled pocket in area of surgical wound. 
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Appendix 9 
Univariable analysis of factors affecting the likelihood of the development of post-
operative incisional complications following exploratory celiotomy 
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Appendix 9.1: Univariable analysis of factors affecting liI{elihood of the development of incisional 
drainage during hospitalisation following exploratory laparotomy for the investigation of abdominal 
discomfort 
Factor Coefficient S.E. O.R. 95% C.1. P 
Age (referent <5 yrs) 
5 -10 yrs 0.53 0.62 1.69 0.50 - 5.68 0.395 
10 -16 yrs -0.17 0.61 0.85 0.26 - 2.78 0.783 
>16 yrs 0.37 0.63 1.45 0.42 - 4.96 0.553 
Gender (referent male) 
Female -0.73 0.47 0.48 0.19 - 1.21 0.120 
Weight (referent <500kgs) 
>500 kgs 0.77 0.46 2.17 0.88 - 5.35 0.094 
Pain on presentation (referent mild) 
Moderate 1.02 0.55 2.76 0.94 - 8.07 0.064 
Severe 0.90 0.55 2.47 0.84 -7.30 0.102 
Duration (referent <8hrs) 
8-24hrs -0.17 0.53 0.85 0.30 - 2.39 0.754 
>24hrs -0.79 0.59 0.46 0.14-1.45 0.183 
Endotoxic 0.93 0.51 2.53 0.92 6.94 0.071 
Heart rate (referent <40 bpm) 
40-60 bpm 0.47 0.52 1.60 0.58 - 4.43 0.367 
>60 bpm 1.20 0.66 3.31 0.90 - 12.13 0.071 
Haematocrit (referent <33.2%) 
>33.2% 0.37 0.46 1.45 0.59 - 3.54 0.418 
Affected bowel (referent large bowel) 
Small intestine 0.39 0.46 1.47 0.59 - 3.66 0.403 
Caecum 21 11168 00 0.00 -00 0.998 
Primary lesion (referent displacement) 
Torsion -0.37 0.72 0.69 0.17-2.81 0.602 
Impaction -0.88 1.08 0.42 0.05 - 3.43 0.416 
Obstruction -0.18 0.95 0.83 0.14 - 5.40 0.848 
IBD -22 25141 0.00 0.00 - 00 0.999 
EFE 0.78 0.98 2.19 0.32 - 15.04 0.426 
Strangulating SI 0.22 0.84 1.25 0.24 - 6.44 0.790 
Non strangulating -0.47 0.81 0.63 0.13-3.07 0.562 
SI 
LI distension 21 14418 00 0.00 - 00 0.999 
Resection 0.40 0.51 1.49 0.55 - 4.03 0.433 
Enterotomy 0.06 0.59 1.06 0.33 - 3.38 0.921 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes 1.23 0.51 3.41 1.25 - 9.30 0.016 
Appendix 9.1 continued overleaf 
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Appendix 9.1 contd. 
Factor Coefficient S.E. O.R. 95% C.I. P 
Duration of surgery (referent <85 minutes) 
>85 minutes 1.16 0.47 3.20 1.26 - 8.11 0.014 
Length of incision (referent <28cm) 
>28 cms 0.92 0.45 2.51 1.03 - 6.12 0.043 
Contamination of abdomen (referent mild) 
Moderate 2.06 1.08 7.85 0.95 - 65.14 0.056 
Severe 21 24886 00 0.00-00 0.999 
Lavage LA -0.03 0.45 0.97 0.40 - 2.34 0.940 
Crystapen on LA -0.79 0.94 0.45 0.07 -2.87 0.401 
Subcutaneous -0.11 0.46 0.90 0.36 - 2.23 0.817 
suture layer 
Belly band -0.72 0.45 0.49 0.20 - 1.18 0.112 
Pyrexia 0.43 0.60 1.54 0.48 - 4.98 0.472 
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Appendix 9.2: Nominal logistic regression to investigate whether the use of a belly band influenced 
either whether a horse would develop incisional drainage or the nature of the drainage, during 
hospitalisation following an exploratory laparotomy for the investigation of abdominal discomfort 
Coefficient S.E. O.R. 95% C.I. P 
-_._ ........ _-
Sero-sanguinous (referent purulent) 
-0.13 0.66 0.88 0.24 3.22 0.850 
Serous (referent purulent) 
0.80 0.92 2.22 0.36 - 13.54 0.386 
None (referent purulent) 
0.57 0.62 l.76 0.53 - 5.92 0.358 
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Appendix 9.3: Variable that influences likelihood of development of incisional complications at 
discharge from the hospital, subsequent to an exploratory laparotomy, following univariable binary 
logistic regression 
Use of a belly 
band 
Coefficient 
1.67 
S.E. 
0.70 
O.R. 95% c.1. p 
0.19 0.05 - 0.75 O.oI8 
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Appendix 9.4: Univariable analysis of factors affecting likelihood of incisional drainage at discharge 
from the hospital, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. p 
Age (referent <5 yrs) 
5 -10 yrs -0.50 0.72 0.61 0.15 -2.48 0.487 
10 -16 yrs 0.27 0.65 1.31 0.37 -4.67 0.679 
>16 yrs -0.79 0.77 0.46 0.10 - 2.07 0.309 
Gender (referent male) 
Female -0.32 0.55 0.73 0.25-2.14 0.563 
Weight (referent <500kgs) 
>500 kgs 0.36 0.51 1.44 0.53 3.90 0.475 
Pain on presentation (referent mild) 
Moderate 0.09 0.65 1.09 0.31-3.89 0.893 
Severe 0.81 0.62 2.25 0.67 -7.56 0.189 
Duration (referent <8hrs) 
8-24hrs 1.38 0.58 3.96 1.27 - 12.30 0.017 
>24hrs 0.17 0.75 1.19 0.27 - 5.20 0.820 
Endotoxic 1.05 0.53 2.85 1.01 - 8.02 0.047 
Heart rate (referent <40 bpm) 
40-60 bpm -0.85 0.67 0.43 0.11- 1.60 0.207 
>60 bpm 1.10 0.67 3.00 0.81 - 11.08 0.099 
Haematocrit (referent <33.2%) 
>33.2% 0.78 0.54 2.18 0.75 - 6.31 0.152 
Affected bowel (referent large bowel) 
Small intestine 1.11 0.55 3.02 1.03 - 8.85 0.044 
Caecum 1.26 1.00 3.52 0.49 - 25.10 0.209 
Primary lesion (referent displacement) 
Torsion -0.24 0.86 0.78 0.14 -4.24 0.778 
Impaction -20 12953 0.00 0.00 -00 0.999 
Obstruction -0.59 0.127 0.56 0.05 - 6.63 0.642 
IBD -20 28963 0.00 0.00 -00 0.999 
EFE 1.43 0.94 4.17 0.66 -26.29 0.129 
Strangulating SI 0.87 0.88 2.38 0.42 - 13.39 0.325 
Non strangulating -0.30 1.02 0.74 0.10-5.49 0.769 
SI 
LI distension 0.51 1.39 1.67 0.11 - 25.43 0.713 
Resection 0.94 0.54 2.57 0.90 -7.34 0.078 
Enterotomy -0.20 0.65 0.82 0.23 - 2.95 0.758 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes 2.04 0.57 7.67 2.52 23.30 <0.001 
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Appendix 9.4, contd. 
Factor Coefficient S.E. O.R. 95% c.1. p 
Duration of surgery (referent <85 minutes) 
>85 minutes 1.74 0.58 5.67 1.83 - 17.60 0.003 
Length of incision (referent <28cm) 
>28 cms 1.58 0.61 4.84 1.06 - 16.03 0.010 
Contamination of abdomen (referent mild) 
Moderate 1.34 0.70 3.80 0.97 -14.86 0.055 
Severe 23 35550 00 0.00 -00 0.999 
Lavage LA -0.10 0.51 0.90 0.33 - 2.45 0.838 
Crystapen on LA -21 13013 0.00 0.00 00 0.999 
Subcutaneous -0.72 0.52 0.49 0.18-1.34 0.162 
suture layer 
Belly band -1.23 0.57 0.29 0.10 - 0.90 0.132 
Pyrexia 0.86 0.60 2.36 0.72 -7.68 0.155 
Drainage during 21 4918 00 0.00 -00 0.997 
hospitalisation 
Oedema during 0.92 0.81 2.52 0.52 -12.24 0.252 
hospitalisation 
Nature of drainage (referent none) 
Serous 0 12048 1.00 0.00 -00 1.000 
Sero-sanguinous 21 4918 00 0.00 -00 0.997 
Purulent 23 4918 00 0.00 -00 0.996 
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Appendix 9.5: Nominal logistic regression to investigate whether the use of a belly band influenced 
either whether a horse had incisional drainage, or the nature of the drainage, at discharge from the 
hospital following an exploratory laparotomy 
Coefficient S.E. O.R. 95% c.1. p 
Sero-sanguinous (referent purulent) 
-l.l4 1.23 0.32 0.03 - 3.56 0.355 
None (referent purulent) 
0.88 0.65 2.40 0.67 - 8.62 0.180 
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Appendix 9.6: Univariable analysis of factors affecting likelihood of incisional drainage at fourteen 
days post-discharge subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. ~ 
Age (referent <5 yrs) 
5-10 yrs 0.36 0.64 1.43 0.41-5.01 0.577 
10 -16 yrs -0.18 0.62 0.83 0.25 - 2.80 0.768 
>16 yrs -0.72 0.64 0.49 0.14-1.70 0.260 
Gender (referent male) 
Female 0.04 0.47 1.04 0.41 - 2.62 0.939 
Weight (referent <500I{gs) 
>500 kgs 0.11 0.45 1.12 0.46 -2.72 0.807 
Pain on presentation (referent mild) 
Moderate 0.54 0.55 1.71 0.59 - 5.02 0.326 
Severe 0.05 0.54 1.05 0.36 - 3.05 0.921 
Duration (referent <8hrs) 
8-24hrs 1.25 0.58 3.50 1.13 10.80 0.029 
>24hrs 0.81 0.61 2.25 0.68 -7.42 0.183 
Endotoxic 0.80 0.51 2.24 0.82 - 6.10 0.116 
Heart rate (referent <40 bpm) 
40-60 bpm -0.04 0.52 0.96 0.34 - 2.67 0.933 
>60 bpm 1.04 0.67 2.84 0.76 - 10.58 0.121 
Haematocrit (referent <33.2%) 
>33.2% 0.37 0.46 1.45 0.59 3.61 0.420 
Affected bowel (referent large bowel) 
Small intestine -0.13 0.47 0.88 0.35 - 2.22 0.790 
Caecum 1.39 1.16 4.00 0.41 - 38.84 0.232 
Primary lesion (referent displacement) 
Torsion -1.30 0.75 0.27 0.06 1.19 0.084 
Impaction -0.81 1.17 0.44 0.05 - 4.37 0.487 
Obstruction -0.81 1.01 0.44 0.06 - 3.24 0.424 
lBD -22 24381 0.00 0.00-00 0.999 
EFE -0.59 0.90 0.56 0.10 - 3.25 0.514 
Strangulating Sf -0.81 0.83 0.44 0.09 - 2.28 0.330 
Non strangulating -1.22 0.88 0.30 0.05 -1.67 0.168 
SI 
Lf distension 20 14077 00 0.00 -00 0.999 
Resection -0.19 0.49 0.82 0.31-2.17 0.697 
Enterotomy -0.65 0.61 0.52 0.16 1.73 0.288 
Duration of general anaesthesia (referent <11 Ominutes) 
>110 minutes 0.88 0.48 2.42 0.94 - 6.24 0.068 
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Appendix 9.6, contd. 
Factor Coefficient S.E. O.R. 95% c.1. p 
Duration of surgery (referent <85 minutes) 
>85 minutes 0.57 0.46 1.78 0.73 - 4.34 0.208 
Length of incision (referent <28cm) 
>28 ems 1.03 0.47 2.79 1.12 - 6.94 0.028 
Contamination of abdomen (referent mild) 
Moderate 0.43 0.69 1.54 0.40 - 5.96 0.528 
Severe 21 24390 CIJ 0.00 - CIJ 0.999 
Lavage LA -0.33 0.46 0.72 0.29 - 1.76 0.466 
Crystapen on LA -0.49 0.94 0.62 0.10 - 3.90 0.606 
Subcutaneous -0.25 0.47 0.78 0.31 - 1.95 0.597 
suture layer 
Belly band -1.58 0.49 0.21 0.08 - 0.53 0.001 
Pyrexia 1.35 0.70 3.87 0.98 - 15.34 0.054 
Drainage during 1.26 0.48 3.53 1.38 - 9.oI 0.008 
hospitalisation 
Nature of drainage (referent none) 
Serous 1.39 0.94 4.00 0.63 25.32 0.141 
Sero-sanguinous 0.61 0.54 1.85 0.63 - 5.37 0.260 
Purulent 2.64 0.84 14.00 2.69 -72.82 0.002 
Oedema during 2.16 0.80 8.67 1.79 - 41.88 0.007 
hospitalisation 
Drainage at 2.77 0.79 15.98 3.39 -75.25 <0.001 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous 2.47 1.10 11.77 1.36-102.16 0.025 
Purulent 3.00 1.08 20.18 2.45 - 165.98 0.005 
Oedema at 2.18 0.68 8.81 2.31 - 33.57 0.001 
discharge 
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Appendix 9.7: Univariable analysis of factors affecting likelihood of having dehiscence of skin incision 
at fourteen days post-discharge, subsequent to exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. p 
Age (referent <5 yrs) 
5-10yrs 0.63 0.97 1.88 0.28 12.61 0.518 
10 -16 yrs 0.57 0.97 1.76 0.26 11.83 0.558 
>16 yrs -0.59 1.27 0.56 0.05 - 6.66 0.643 
Gender (referent male) 
Female -0.02 0.75 0.98 0.23 - 4.26 0.978 
Weight (referent <500kgs) 
>500 kgs 1.57 0.84 4.83 0.93 - 24.95 0.060 
Pain on presentation (referent mild) 
Moderate 0.98 0.91 2.67 0.45 - 15.96 0.283 
Severe 0.65 0.96 1.91 0.29 12.44 0.499 
Duration (referent <8hrs) 
8-24hrs 1.25 0.82 3.50 0.70 - 17.40 0.126 
>24hrs 0.77 0.97 2.15 0.32 -14.32 0.427 
Endotoxic 0.24 0.75 1.28 0.29 - 5.60 0.748 
Heart rate (referent <40 bpm) 
40-60 bpm -0.53 0.76 0.59 0.13-2.62 0.486 
>60 bpm -1.16 1.17 0.31 0.03 - 3.08 0.319 
Haematocrit (referent <33.2%) 
>33.2% 0.75 0.75 2.12 0.49 - 9.22 0.314 
Affected bowel (referent large bowel) 
Small intestine -1.10 0.84 0.33 0.06 - 1.73 0.191 
Caecum -21 18353 0.00 0.00 - 00 0.999 
Primary lesion (referent displacement) 
Torsion -1.05 0.99 0.35 0.05 -2.46 0.292 
Impaction 1.20 1.20 3.33 0.32 - 34.83 0.315 
Obstruction -21 16754 0.00 0.00 00 0.999 
IBD -21 41038 0.00 0.00 - 00 1.000 
EFE -0.88 1.25 0.42 0.04 -4.81 0.483 
Strangulating SI -21 11847 0.00 0.00 - 00 0.999 
Non strangulating -0.99 1.24 0.37 0.03 - 4.23 0.424 
SI 
LI distension -21 23693 0.00 0.00 - 00 0.999 
Resection -1.28 1.09 0.28 0.03 -2.36 0.241 
Enterotomy -1.00 0.78 0.37 0.08 - 1.69 0.198 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes -0.17 0.75 0.85 0.19 3.67 0.824 
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Appendix 9.7, contd. 
Factor Coefficient S.E. O.R. 95% c.1. p 
Duration of surgery (referent <85 minutes) 
>85 minutes -0.64 0.75 0.53 0.12 -2.29 0.394 
Length of incision (referent <28cm) 
>28 ems 2.00 l.09 7.35 0.87 - 6l.88 0.066 
Contamination of abdomen (referent mild) 
Moderate -0.17 l.l2 0.85 0.09 -7.60 0.882 
Severe -20 41277 0.00 0.00 Cf) l.000 
Lavage LA -0.21 0.71 0.81 0.20 - 3.30 0.773 
Crystapen on LA 0.74 l.l8 2.09 0.21-2l.l1 0.531 
Subcutaneous -2.05 0.84 0.l3 0.02 - 0.67 0.Dl5 
suture layer 
Belly band -0.55 0.75 0.58 0.13-2.48 0.459 
Pyrexia l.71 0.76 5.51 1.24 - 24.43 0.025 
Drainage during l.00 0.84 2.71 0.53 - 13.98 0.233 
hospitalisation 
Nature of drainage (referent none) 
Serous -20 16851 0.00 0.00 - Cf) 0.999 
Sero-sanguinous 0.75 0.95 2.11 0.33 - 13.72 0.433 
Purulent l.64 0.93 5.17 0.93 - 32.00 0.078 
Oedema during 0.58 l.l0 l.79 0.21 - 15.61 0.597 
hospitalisation 
Drainage at 1.46 0.73 4.30 l.03 - 17.92 0.045 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous 1.52 0.97 4.58 0.69 - 30.49 0.115 
Purulent 1.42 0.84 4.13 0.80 - 21.30 0.091 
Oedema at l.00 l.l0 2.72 0.32 - 23.24 0.361 
discharge 
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Appendix 9.8: Univariable analysis of factors affecting likelihood of skin incision having healed by 
fourteen days post-discharge, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. p 
Age (referent <5 yrs) 
5-10 yrs -0.36 0.64 0.70 0.20 - 2.45 0.577 
10 -16 yrs 0.18 0.62 1.20 0.36 - 4.04 0.768 
>16 yrs 0.72 0.64 2.06 0.59-7.21 0.260 
Gender (referent male) 
Female -0.04 0.47 0.96 0.38 - 2.44 0.939 
Weight (referent <500kgs) 
>500 kgs -0.11 0.45 0.89 0.37 - 2.18 0.807 
Pain on presentation (referent mild) 
Moderate -0.54 0.55 0.58 0.20 - 1.71 0.326 
Severe -0.05 0.54 0.95 0.33 2.74 0.921 
Duration (referent <8hrs) 
8-24hrs -1.25 0.58 0.29 0.09 - 0.88 0.029 
>24hrs -0.81 0.61 0.44 0.13-1.47 0.183 
Endotoxic -0.80 0.51 0.45 0.16 - 1.22 0.116 
Heart rate (referent <40 bpm) 
40-60 bpm 0.04 0.52 1.05 0.37 -2.92 0.933 
>60 bpm -1.04 0.67 0.35 0.09 1.32 0.121 
Haematocrit (referent <33.2%) 
>33.2% -0.37 0.46 0.69 0.28 - 1.71 0.420 
Affected bowel (referent large bowel) 
Small intestine 0.l3 0.47 l.l3 0.45 - 2.85 0.790 
Caecum -1.39 l.l6 0.25 0.03 - 2.43 0.232 
Primary lesion (referent displacement) 
Torsion 1.30 0.75 3.66 0.84 - 15.91 0.084 
Impaction 0.81 1.17 2.25 0.23-22.14 0.487 
Obstruction 0.81 1.01 2.25 0.31-16.41 0.424 
IBD 22 24381 00 0.00 - 00 0.999 
EFE 0.59 0.90 1.80 0.31 - 10.52 0.514 
Strangulating SI 0.81 0.83 2.25 0.44 - 11.52 0.330 
Non strangulating 1.22 0.88 3.37 0.60 - 19.01 0.168 
SI 
LI distension -20 14077 0.00 0.00 - 00 0.999 
Resection 0.19 0.49 1.21 0.46 - 3.20 0.697 
Enterotomy 0.65 0.61 1.91 0.58 - 6.32 0.288 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes -0.88 0.48 0.41 0.16-1.07 0.068 
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Appendix 9.8, contd. 
Factor Coefficient S.E. O.R. 95% C.I. P 
Duration of surgery (referent <85 minutes) 
>85 minutes -0.57 0.46 0.56 0.23 - l.38 0.208 
Length of incision (referent <28cm) 
>28 ems -1.03 0.47 0.36 0.14-0.89 0.028 
Contamination of abdomen (referent mild) 
Moderate -0.43 0.69 0.65 0.17 -2.50 0.528 
Severe -21 24390 0.00 0.00 - 00 0.999 
Lavage LA 0.33 0.46 1.40 0.57 - 3.43 0.466 
Crystapen on LA 0.49 0.94 1.62 0.26 - 10.29 0.606 
Subcutaneous 0.25 0.47 1.28 0.51-3.20 0.597 
suture layer 
Belly band 1.58 0.49 4.87 1.88 - 12.61 0.001 
Pyrexia -l.35 0.70 0.26 0.07 - 1.02 0.054 
Drainage during -1.26 0.48 0.28 0.11 - 0.72 0.008 
hospitalisation 
Nature of drainage (referent none) 
Serous -1.39 0.94 0.25 0.04 - 1.58 0.141 
Sero-sanguinous -0.61 0.54 0.54 0.19 - 1.58 0.260 
Purulent -2.64 0.84 0.07 0.01 - 0.37 0.002 
Oedema during -2.16 0.80 0.12 0.02 - 0.56 0.007 
hospitalisation 
Drainage at -2.77 0.79 0.06 0.01 - 0.29 <0.001 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous -2.47 1.10 0.08 0.01- 0.74 0.025 
Purulent -3.00 1.08 0.05 0.01-0.41 0.005 
Oedema at -2.18 0.68 0.11 0.03 - 0.43 0.001 
discharge 
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Appendix 9.9: Univariable analysis of factors affecting liI{elihood of incisional drainage at thirty days 
post-discharge, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. p 
Age (referent <5 yrs) 
5 - 10 yrs 0.56 0.67 1.75 0.47 - 6.45 0.403 
10-16 yrs 0.68 0.68 1.96 0.52-7.41 0.319 
>16 yrs 0.00 0.68 1.00 0.26 - 3.82 1.000 
Gender (referent male) 
Female -0.16 0.50 0.85 0.32 - 2.26 0.750 
Weight (referent <500kgs) 
>500 kgs 0.50 0.48 1.65 0.64 - 4.23 0.297 
Pain on presentation (referent mild) 
Moderate 0.36 0.58 1.43 0.46 - 4.47 0.540 
Severe 1.46 0.61 4.29 1.29 - 14.26 0.018 
Duration (referent <8hrs) 
8-24hrs 1.48 0.61 4.37 1.32 - 14.50 0.016 
>24hrs -0.36 0.68 0.69 0.18 - 2.64 0.592 
Endotoxic 0.88 0.53 2.40 0.85 - 6.79 0.099 
Heart rate (referent <40 bpm) 
40-60 bpm -0.29 0.55 0.75 0.26-2.19 0.598 
>60 bpm 0.13 0.67 1.14 0.31 - 4.25 0.842 
Haematocrit (referent <33.2%) 
>33.2% 0.27 0.49 1.31 0.50 - 3.42 0.585 
Affected bowel (referent large bowel) 
Small intestine 0.32 0.49 1.37 0.53 - 3.60 0.517 
Caecum 0.32 1.05 1.37 0.17 10.82 0.762 
Primary lesion (referent displacement) 
Torsion 0.76 0.83 2.13 0.42 - 10.78 0.359 
Impaction 2.08 1.34 8.00 0.58 - 110.27 0.120 
Obstruction -0.63 1.29 0.53 0.04 - 6.66 0.625 
IBD -20 24509 0.00 0.00 -00 0.999 
EFE 1.27 1.02 3.56 0.48 - 26.28 0.214 
Strangulating SI 1.32 0.90 3.73 0.65 - 21.58 0.141 
Non strangulating 0.58 0.94 1.78 0.28 - 11.12 0.538 
SI 
LI distension 22 14159 00 0.00 - 00 0.999 
Resection 0.19 0.53 1.21 0.43 - 3.38 0.719 
Enterotomy -0.57 0.64 0.57 0.16 - 1.99 0.375 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes 0.66 0.50 1.94 0.73 - 5.14 0.183 
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Appendix 9.9, contd. 
Factor Coefficient S.E. O.R. 95% c.1. p 
Duration of surgery (referent <85 minutes) 
>85 minutes 0.32 0.48 l.37 0.54 - 3.49 0.503 
Length of incision (referent <28cm) 
>28 cms l.03 0.49 2.80 l.06 -7.39 0.037 
Contamination of abdomen (referent mild) 
Moderate l.l7 0.74 3.23 0.76 -13.68 0.111 
Severe 22 24476 CIJ 0.00 - CIJ 0.999 
Lavage LA 0.12 0.48 l.l2 0.44 2.88 0.808 
Crystapen on LA -l.0 1 l.l8 0.36 0.04 - 3.67 0.391 
Subcutaneous -0.95 0.50 0.39 0.14 - l.04 0.060 
suture layer 
Belly band -l.54 0.52 0.21 0.08 - 0.59 0.003 
Pyrexia l.90 0.82 6.66 1.33 - 33.45 0.021 
Drainage during 0.93 0.49 2.53 0.96 - 6.66 0.061 
hospitalisation 
Nature of drainage (referent none) 
Serous 0 0.95 l.00 0.16 - 6.42 l.000 
Sero-sanguinous 0.79 0.58 2.20 0.70 - 6.91 0.177 
Purulent 1.48 0.66 4.40 l.20 - 16.17 0.026 
Oedema during 2.56 l.08 12.96 1.57 - 106.73 0.017 
hospitalisation 
Drainage at 2.37 0.69 10.67 2.75 4l.42 0.001 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous 22 9992 CIJ 0.00 - CIJ 0.998 
Purulent l.90 0.72 6.67 l.63 - 27.27 0.008 
Oedema at l.64 0.69 5.17 1.33 - 20.12 O.oI8 
discharge 
Drainage at 14d 2.47 0.57 1l.88 3.86 - 36.56 <0.001 
Oedema at 14d 0.60 0.90 l.83 0.31 10.67 0.502 
Dehiscence at 14d 22 8653 CIJ 0.00 - CIJ 0.998 
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Appendix 9.10: Univariable analysis of factors affecting likelihood of skin incision having dehisced by 
thirty days post-discharge, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. p 
Age (referent <5 yrs) 
5 -10 yrs 1.80 1.15 6.07 0.63 58.22 0.118 
10 -16 yrs 1.22 1.21 3.40 0.32 36.27 0.311 
>16 yrs 0.00 1.46 1.00 0.06 17.33 1.000 
Gender (referent male) 
Female 0.29 0.70 1.33 0.34 - 5.24 0.681 
Weight (referent <500kgs) 
>500 kgs 1.68 0.83 5.38 1.05 - 27.50 0.043 
Pain on presentation (referent mild) 
Moderate 1.19 0.89 3.29 0.57 - 18.83 0.181 
Severe 0.68 0.96 1.97 0.30 - 13.01 0.480 
Duration (referent <8hrs) 
8-24hrs 1.77 0.78 5.85 1.28 - 26.79 0.023 
>24hrs 0.05 1.20 1.06 0.10 11.12 0.964 
Endotoxic 0.07 0.74 1.07 0.25 4.61 0.926 
Heart rate (referent <40 bpm) 
40-60 bpm -1.14 0.79 0.32 0.07 -1.50 0.148 
>60 bpm -0.65 0.91 0.52 0.09 - 3.14 0.478 
Haematocrit (referent <33.2%) 
>33.2% 0.34 0.70 1.40 0.36 - 5.49 0.629 
Affected bowel (referent large bowel) 
Small intestine -2.20 1.09 0.11 0.01- 0.93 0.043 
Caecum -21 18749 0.00 0.00 -00 0.999 
Primary lesion (referent displacement) 
Torsion 0.55 0.94 1.73 0.27 - 10.97 0.560 
Impaction 1.50 1.27 4.50 0.37 - 54.16 0.236 
Obstruction -21 15308 0.00 0.00 - 00 0.999 
IBD -21 37498 0.00 0.00 - 00 1.000 
EFE -0.29 1.33 0.75 0.05 -10.23 0.829 
Strangulating SI -21 10825 0.00 0.00 - 00 0.998 
Non strangulating -21 11858 0.00 0.00 - 00 0.999 
SI 
LI distension -21 21649 0.00 0.00 - 00 0.999 
Resection -1.36 1.09 0.26 0.03-2.18 0.213 
Enterotomy 0.64 1.11 1.90 0.22 - 16.61 0.560 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes -0.32 0.74 0.73 0.17-3.09 0.666 
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Appendix 9.10, contd. 
Factor Coefficient S.E. O.R. 95% C.1. P 
Duration of surgery (referent <85 minutes) 
>85 minutes -0.78 0.74 0.46 0.11- 1.93 0.287 
Length of incision (referent <28cm) 
>28 cms 0.62 0.74 1.87 0.44 -7.89 0.396 
Contamination of abdomen (referent mild) 
Moderate -0.42 1.11 0.65 0.07 - 5.81 0.703 
Severe -20 37731 0.00 0.00 - CI) 1.000 
Lavage LA 0.49 0.74 1.64 0.39 6.94 0.502 
Crystapen on LA 0.80 1.21 2.22 0.21 23.75 0.509 
Subcutaneous -1.69 0.74 0.19 0.04 0.79 0.023 
suture layer 
Belly band 0.35 0.68 l.42 0.37 - 5.42 0.605 
Pyrexia 1.08 0.79 2.95 0.63 -13.78 0.170 
Drainage during 1.16 0.83 3.20 0.63 - 16.29 0.161 
hospitalisation 
Nature of drainage (referent none) 
Serous 1.03 1.32 2.80 0.21-37.03 0.434 
Sero-sanguinous 0.39 l.04 1.47 0.19-1l.39 0.710 
Purulent 1.85 0.91 6.36 1.07 - 37.81 0.042 
Oedema during 0.64 1.11 1.90 0.22 - 16.61 0.560 
hospitalisation 
Drainage at 1.25 0.70 3.50 0.89 - 13.84 0.074 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous 0.67 1.19 l.96 0.19 20.26 0.572 
Purulent 1.47 0.76 4.36 0.98 19.42 0.054 
Oedema at 1.03 1.10 2.81 0.33 - 24.04 0.345 
discharge 
Drainage at 14d 21 6471 CI) 0.00 - CI) 0.997 
Oedema at 14d -1.30 0.94 0.27 0.04 - 1.73 0.167 
Dehiscence at 14d 4.97 1.22 144.67 13.20 - <0.001 
1585.70 
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Appendix 9.11: Univariable analysis offactors affecting likelihood of skin incision having healed by 
thirty days post-discharge, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% C.1. p 
Age (referent <5 yrs) 
5-10 yrs -0.56 0.67 0.57 0.15 -2.12 0.403 
10 - 16 yrs -0.68 0.68 0.51 0.13 - 1.92 0.319 
>16 yrs 0.00 0.68 1.00 0.26 - 3.82 1.000 
Gender (referent male) 
Female 0.16 0.50 1.17 0.44 - 3.09 0.750 
Weight (referent <500kgs) 
>500 kgs -0.50 0.48 0.61 0.24 - 1.55 0.297 
Pain on presentation (referent mild) 
Moderate -0.36 0.58 0.70 0.22-2.19 0.540 
Severe -1.46 0.61 0.23 0.07 - 0.78 0.018 
Duration (referent <8hrs) 
8-24hrs -1.48 0.61 0.23 0.07 0.76 0.016 
>24hrs 0.36 0.68 1.44 0.38 5.47 0.592 
Endotoxic -0.88 0.53 0.42 0.15 1.18 0.099 
Heart rate (referent <40 bpm) 
40-60 bpm 0.29 0.55 1.33 0.46 - 3.89 0.598 
>60 bpm -0.13 0.67 0.88 0.24 - 3.26 0.842 
Haematocrit (referent <33.2%) 
>33.2% -0.27 0.49 0.76 0.29 -2.00 0.585 
Affected bowel (referent large bowel) 
Small intestine -0.32 0.49 0.73 0.28 - 1.90 0.517 
Caecum -0.32 1.05 0.73 0.09 - 5.72 0.762 
Primary lesion (referent displacement) 
Torsion -0.76 0.83 0.47 0.09 - 2.37 0.359 
Impaction -2.08 1.34 0.13 0.01 - 1.72 0.120 
Obstruction 0.63 1.29 1.87 0.15 - 23.40 0.625 
IBD 20 24509 00 0.00 -00 0.999 
EFE -1.27 1.02 0.28 0.04 - 2.08 0.214 
Strangulating SI -1.32 0.90 0.27 0.05 - 1.55 0.141 
Non strangulating -0.58 0.94 0.56 0.09 - 3.52 0.538 
SI 
LI distension -22 14159 0.00 0.00 - 00 0.999 
Resection -0.19 0.53 0.83 0.30 - 2.32 0.719 
Enterotomy 0.57 0.64 1.76 0.50 - 6.18 0.375 
Duration of general anaesthesia (referent <110minutes) 
>110 minutes -0.66 0.50 0.52 0.19 - 1.37 0.183 
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Factor Coefficient S.E. O.R. 95% c.1. p 
Duration of surgery (referent <85 minutes) 
>85 minutes -0.32 0.48 0.73 0.29 - 1.85 0.503 
Length of incision (referent <28cm) 
>28 cms -l.03 0.49 0.36 0.14 - 0.94 0.037 
Contamination of abdomen (referent mild) 
Moderate -l.l7 0.74 0.31 0.07 - l.31 0.111 
Severe -22 24476 0.00 0.00-00 0.999 
Lavage LA -0.12 0.48 0.89 0.35-2.28 0.808 
Crystapen on LA l.01 l.l8 2.75 0.27 - 27.76 0.391 
Subcutaneous 0.95 0.50 2.58 0.96 - 6.90 0.060 
suture layer 
Belly band 1.54 0.52 4.67 1.69 - 12.92 0.003 
Pyrexia -l.90 0.82 0.15 0.03 - 0.75 0.021 
Drainage during -0.93 0.49 0.40 0.15-l.04 0.061 
hospitalisation 
Nature of drainage (referent none) 
Serous 0 0.95 l.00 0.16 - 6.42 l.000 
Sero-sanguinous -0.79 0.58 0.45 0.14-1.43 0.177 
Purulent -1.48 0.66 0.23 0.06 - 0.84 0.026 
Oedema during -2.56 l.08 0.08 0.01 - 0.64 0.017 
hospitalisation 
Drainage at -2.37 0.69 0.09 0.02 0.36 0.001 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous -22 9992 0.00 0.00 00 0.998 
Purulent -l.90 0.72 0.15 0.04 - 0.61 0.008 
Oedema at -l.64 0.69 0.19 0.05 0.75 0.018 
discharge 
Drainage at 14d -2.47 0.57 0.08 0.03 - 0.26 <0.001 
Oedema at 14d -0.60 0.90 0.55 0.09-3.19 0.502 
Dehiscence at 14d -22 8653 0.00 0.00-00 0.998 
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Appendix 9.12: Univariable analysis of factors affecting likelihood of skin incision having healed by 
three months post-discharge, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% C.I. P 
Age (referent <5 yrs) 
5 -10 yrs -20 15964 0.00 0.00 -co 0.999 
10 -16 yrs -21 15964 0.00 0.00 -co 0.999 
>16 yrs 0 22261 0.00 0.00 - co 1.000 
Gender (referent male) 
Female 21 13164 co 0.00 -co 0.999 
Weight (referent <500kgs) 
>500 kgs -21 10819 0.00 0.00 -co 0.998 
Pain on presentation (referent mild) 
Moderate -0.87 1.26 0.42 0.04 -4.96 0.491 
Severe 20 14033 co 0.00 -co 0.999 
Duration (referent <8hrs) 
8-24hrs -21 10407 0.00 0.00 co 0.998 
>24hrs -21 10407 0.00 0.00 - co 0.998 
Endotoxic 20 14364 co 0.00 - co 0.999 
Heart rate (referent <40 bpm) 
40-60 bpm 0.58 1.44 1.79 0.11 - 30.27 0.687 
>60 bpm -0.31 1.46 0.74 0.04 -12.82 0.834 
Haematocrit (referent <33.2%) 
>33.2% 0.92 1.25 2.50 0.22 - 29.01 0.464 
Affected bowel (referent large bowel) 
Small intestine -0.28 1.44 0.76 0.05 - 12.63 0.846 
Caecum -2.51 1.54 0.08 0.00 - 1.65 0.102 
Primary lesion (referent displacement) 
Torsion -20 15414 0.00 0.00 -co 0.999 
Impaction 0 29848 1.00 0.00 co 1.000 
Obstruction 0 25945 1.00 0.00 co 1.000 
IBD 0 53394 1.00 0.00 -co 1.000 
EFE -21 15414 0.00 0.00 -co 0.999 
Strangulating SI 0 21339 1.00 0.00 -co 1.000 
Non strangulating 0 22336 1.00 0.00 - co 1.000 
SI 
LI distension -22 15414 0.00 0.00 -co 0.999 
Resection -0.25 1.25 0.78 0.07 - 9.06 0.839 
Enterotomy 1.07 1.27 2.90 0.24 - 35.07 0.402 
Duration of general anaesthesia (referent <11 Ominutes) 
>110 minutes 0.11 1.25 1.12 0.10-12.96 0.930 
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Appendix 9.12, contd. 
Factor Coefficient S.E. O.R. 95% c.1. p 
Duration of surgery (referent <85 minutes) 
>85 minutes 0.54 1.25 1.72 0.15 - 19.92 0.663 
Length of incision (referent <28cm) 
>28 cms -21 11822 0.00 0.00 - OCJ 0.999 
Contamination of abdomen (referent mild) 
Moderate 20 20815 OCJ 0.00 - OCJ 0.999 
Severe -43 1000000 0.00 0.00 OCJ 1.000 
Lavage LA -0.21 1.25 0.81 0.07 - 9.36 0.864 
Crystapen on LA 20 32911 OCJ 0.00 - OCJ 1.000 
Subcutaneous 1.30 1.25 3.67 0.32 42.55 0.299 
suture layer 
Belly band 0.46 1.25 1.58 0.14 18.26 0.715 
Pyrexia -1.07 1.27 0.34 0.03-4.17 0.402 
Drainage during -21 12223 0.00 0.00 OCJ 0.999 
hospitalisation 
Nature of drainage (referent none) 
Serous 0 29521 1.00 0.00 - OCJ 1.000 
Sero-sanguinous -20 12223 0.00 0.00 - OCJ 0.999 
Purulent -21 12223 0.00 0.00 - OCJ 0.999 
Oedema during -20 19001 0.00 0.00 - OCJ 0.999 
hospitalisation 
Drainage at -22 9128 0.00 0.00 - OCJ 0.999 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous -21 7089 0.00 0.00 - OCJ 0.998 
Purulent -21 7089 0.00 0.00 - OCJ 0.998 
Oedema at -20 16456 0.00 0.00 - OCJ 0.999 
discharge 
Drainage at 14d -21 11458 0.00 0.00 - OCJ 0.999 
Oedema at 14d 1.84 1.31 6.30 0.48-82.10 0.160 
Dehiscence at 14d -3.03 1.30 0.05 0.00 0.62 0.020 
Oedema at 30d 1.19 1.28 3.28 0.27 - 39.97 0.352 
Drainage at 30d -21 10678 0.00 0.00 - OCJ 0.998 
Dehiscence at 30d -2.71 1.28 0.07 0.01 - 0.82 0.035 
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Appendix 9.13: Univariable analysis of factors affecting likelihood of incisional hernia formation by 
three months post-discharge, subsequent to an exploratory laparotomy 
Factor Coefficient S.E. O.R. 95% c.1. P 
Age (referent <5 yrs) 
5-10 yrs 0.62 0.95 l.86 0.29 - 11.90 0.514 
10 -16 yrs -0.96 1.28 0.38 0.03 -4.69 0.452 
>16 yrs 0.26 0.99 1.30 0.19 9.02 0.791 
Gender (referent male) 
Female -0.94 0.83 0.39 0.08 - 2.01 0.261 
Weight (referent <500kgs) 
>500 kgs 0.90 0.75 2.46 0.56-10.81 0.233 
Pain on presentation (referent mild) 
Moderate l.67 1.16 5.33 0.55 - 5l.88 0.149 
Severe l.95 1.14 7.06 0.76 - 65.99 0.087 
Duration (referent <8hrs) 
8-24hrs 0.03 0.77 1.03 0.23 -4.66 0.968 
>24hrs -0.60 1.14 0.55 0.06 - 5.l3 0.600 
Endotoxic l.08 0.70 2.93 0.74-11.56 0.124 
Heart rate (referent <40 bpm) 
40-60 bpm 0.35 0.89 1.42 0.25 8.l1 0.696 
>60 bpm 0.75 0.99 2.12 0.31 14.73 0.445 
Haematocrit (referent <33.2%) 
>33.2% 0.30 0.78 1.34 0.29 - 6.18 0.704 
Affected bowel (referent large bowel) 
Small intestine 0.29 0.69 1.33 0.35 5.l3 0.676 
Caecum -20 21240 0.00 0.00 - co 0.999 
Primary lesion (referent displacement) 
Torsion 0.69 1.23 2.00 0.18 2 .. 06 0.571 
Impaction 1.20 1.56 3.33 0.16 -70.91 0.440 
Obstruction -20 18395 0.00 0.00 - co 0.999 
IBD -20 36789 0.00 0.00 - co 1.000 
EFE l.61 1.36 5.00 0.35 - 71.90 0.237 
Strangulating SI 0.69 1.30 2.00 0.16-25.76 0.595 
Non strangulating 0.l1 1.49 l.l1 0.06 -20.49 0.944 
SI 
LI distension -20 21240 0.00 0.00 - co 0.999 
Resection 0.06 0.75 l.06 0.24 - 4.58 0.939 
Enterotomy 0.61 1.11 l.84 0.21-16.17 0.584 
Duration of general anaesthesia (referent <11 Ominutes) 
>110 minutes 1.73 0.75 5.63 1.30 - 24.37 0.021 
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Appendix 9.13, contd. 
Factor Coefficient S.E. O.R. 95% c.1. P 
Duration of surgery (referent <85 minutes) 
>85 minutes 1.20 0.74 3.31 0.78 - 14.09 0.106 
Length of incision (referent <28cm) 
>28 ems 0.68 0.74 1.97 0.46 - 8.36 0.359 
Contamination of abdomen (referent mild) 
Moderate 0.60 0.89 1.82 0.32-10.37 0.499 
Severe -20 36789 0.00 0.00 CfJ 1.000 
Lavage LA -0.19 0.70 0.83 0.21-3.27 0.789 
Crystapen on LA -20 18395 0.00 0.00 - CfJ 0.999 
Subcutaneous -0.19 0.70 0.83 0.21-3.27 0.789 
suture layer 
Belly band -1.35 0.83 0.26 0.05 - 1.32 0.104 
Pyrexia 0.47 0.88 1.59 0.29 - 8.90 0.595 
Drainage during 1.22 0.83 3.38 0.66 - 17.26 0.144 
hospitalisation 
Nature of drainage (referent none) 
Serous 0.96 1.32 2.60 0.20 - 34.46 0.469 
Sero-sanguinous 0.37 1.05 1.44 0.19 - 11.22 0.725 
Purulent 1.87 0.92 6.50 1.08 - 39.12 0.041 
Oedema during 20 10620 CfJ 0.00 - CfJ 0.998 
hospitalisation 
Drainage at 1.26 0.71 3.54 0.89 - 14.12 0.074 
discharge 
Nature of drainage (referent none) 
Sero-sanguinous 0.61 1.19 1.84 0.18-19.05 0.609 
Purulent 1.53 0.77 4.60 1.01-20.91 0.048 
Oedema at 21 9499 CfJ 0.00 - CfJ 0.998 
discharge 
Drainage at 14d 2.30 1.09 9.96 1.19 - 83.69 0.034 
Oedema at 14d 20 15019 CfJ 0.00 - CfJ 0.999 
Dehiscence at 14d 0.79 0.90 2.21 0.38 - 12.89 0.379 
Drainage at 30d 2.58 1.09 13.12 1.56 -110.48 0.018 
Dehiscence at 30d 1.77 0.78 5.89 1.29 - 26.95 0.022 
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Appendix 10 
Investigation into the prevalence of post-operative complications following elective 
surgical procedures - Data Collection forms 
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Sheet 1 
Clinic ID: 
Case details 
Horse name: Owner name: Date of surgery: 
Age: Sex: M F MN Breed: 
Use: 
Approx. height (hh): Weight (kgs): 
Pre-op. rectal temperature (0C), heart rate (bpm) and respiratory rate (bpm): 
T: P: R: 
Pre-op. haematology normal: YIN 
Pre-op. antibiotics: 
Drugs Total Dose 1M /IV IPO 
Pre-op. analgesia: 
Drugs Total Dose 1M /IV IPO 
Any evidence of pre-existing site of infection? 
YIN 
Skin wound remote to surgical site 
Nasal discharge 
Diarrhoea 
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Clinic ID: 
Surgery Report Form 
Date: 
Horse name: 
Sheet 2 
Surgeon: 
Owner name: 
Site of surgery: induction or recovery room / clean surgical suite / dirty surgical suite 
Duration of anaesthesia (mins): Duration of surgery (mins): 
Evidence of local skin reaction following surgical clip & scrub: Y / N 
Surgical scrub solution used: pevidine / hibiscrub / other 
Surgical spirit used after scrub: Y / N 
Surgical procedure: Length of incision (cm): 
Site of incision (please check box): 
F.limb prox. II Hindquarters Neck I Inguinal 
region 
F.limb dist. Flank Chest I Sheath 
/penis 
Thorax 
H.limb prox. Ventral abdomen 
H.limb dist. 
Head HHOOf 
Dorsal spine Perineum/ 
vulva 
Deep layer closure (select as appropriate): 
continuous c=J interrupted simple 
cruciate 
mattress 
near-far 
far-near 
other: 
J-----l polysorb 
Sut~~:;;ateria~1 (select as appropriate): 
biosyn 
PDS 
other: 
Subcutaneous closure (select as appropriate): Suture material (select as appropriate): 
continuous C:=J interrupted simple ~ vicryl § 
cruciate polysorb 
mattress other: 
other: 
Skin closure (select as appropriate): Suture material (select as appropriate): 
continuous C:=J interrupted sim~le ~ vicryl ~ 
cruclate nylon 
mattress prolene 
other: staples 
Drain inserted: Y / N Type of drain: penrose / multi-lumen 
Volume of dead space left: small / moderate / large 
Wound dressing: bandage / cast / stent / adhesive dressing / no dressing 
Sheet 3 
Clinic ID: 
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Sheet 4 
Clinic ID: 
Horse name: Owner name: 
Daily horse assessment and treatment: 
AM PM 
<J) <J) 
TeC) .::l Dose/ cd Dose/ cd TeC) .::l Dose/ cd Dose/ cd .- Q) 'r;; Q) ci. ..... <J) ..... P(bpm) 0 Q) 0 P(bpm) 0 Q) 0 0 ;§ route oJ) route ~g ~ route OJ) route ~g I C;; C;; ..... <J) ~ R(bpm) 1:: of of R(bpm) of of o cd s:: .- >- s:: .- >-P-."d ~ admin. ~ admin. Oc.....- ~ admin. ~ admin. 0,--, 
1 V V V V 
2 V V :V V 
3 V :V V V 
4 V V V V 
5 IV V IV V 
6 V V V V 
7 V V V V 
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Sheet 5 
Clinic ID: 
Discharge Sheet 
Horse name: Owner name: 
Date of discharge: 
Was horse pyrexic at any time during hospitalistion? Y / N 
Was pyrexia attributed to (please check box as appropriate): 
Respiratory tract infection 
Gastro-intestinal tract infection 
Wound infection 
Thrombophlebitis of jugular 
\-----11 vein 
Catheter site infection 
Pyrexia of unknown origin 
Wound assessment at discharge - any evidence of (please check box as appropriate): 
Heat 
Pain on palpation 
Swelling 
I-----j 
Discharge from incision 
Pmtial dehiscence of 
incision 
Total dehiscence of incision 
296 
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Appendix 11 
Investigation into the prevalence of post-operative complications following elective 
surgical procedures - Definitions of outcomes 
Appendix 11 
Definitions of outcomes 
Wound infection defined as the presence of at least two of the following three criteria: 
• wound drainage 
• pain on palpation 
• localized heat on palpation 
Post operative period 
• defined as starting immediately following recovery of the horse from general 
anaesthesia, ie. post-op. day 1 is the same day as the surgical procedure. 
Pyrexia 
• identified by twice daily assessment of rectal temperature. 
• rectal temperature> 39°C at anyone time. 
Jugular thrombosis 
298 
• identified by observation and palpation of the ventral neck of the horse on a daily 
basis. 
• swelling of, or palpable thrombus formation within, jugular vein in which an intra-
venous catheter has been placed during hospitalization, ideally confirmed as 
narrowing or complete obstruction of jugular vein by the use of ultrasound. 
Catheter site infection 
• identified by observation and palpation of the catheter insertion site on a daily 
basis. 
• localized swelling, heat or abscess formation, without associated thrombosis of 
underlying vessel, in the skin directly around the site of insertion of an intra-venous 
catheter, ideally confirmed by the use of ultrasound. 
Diarrhoea 
• identified by twice daily inspection of faeces. 
• loose faeces for ::::: 24 hours. 
Respiratory tract infection 
• rectal temperature elevated >39 °c, associated with any two of the following 
criteria identifying the respiratory tract as the source of the pyrexia: nasal discharge 
(serous/purulent); increased respiratory rate; increased lung sounds on thoracic 
auscultation. 
Gastro-intestinal tract infection 
• rectal temperature elevated >39 °c, associated with diarrhea of>24 hours duration. 
Pyrexia of unknown origin 
• rectal temperature elevated> 39°C, associated with non-specific signs of illness 
(eg. lethargy, inappetance), where no infectious cause is identified. 
Definition of surgical terms 
Hoof 
• all tissue distal to coronary band on both fore and hindlimbs 
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Proximal forelimb 
• from the level of the distal radius to the proximal border of the scapula. 
Distal forelimb 
• forelimb distal to, and including, the carpus, although excluding the hoof. 
Proximal hindlimb 
• from the level of the distal tibia to the level of the greater trochanter of the femur. 
Distal hindlimb 
• hindlimb distal to, and including, the tarsus, although excluding the hoof. 
Hindquarters 
• area extending from tuber coxae to tail-head, incorporating gluteal muscle mass, 
semitendinosus and semimembranosus muscles. 
Flank 
• area extending from caudal aspect of last rib to the level of the tuber coxae, 
including the abdominal oblique muscles. 
Ventral abdomen 
• area from xiphoid process to sheath/mammary glands that is on ventral aspect of 
body 
Thorax 
• area delineated by ribcage, excluding pectoral region and dorsal spine. 
Chest 
• area between the forelimbs, incorporating the pectoral musculature, extending 
dorsally to the base of the jugular furrow. 
Neck 
• area extending from poll to withers and from the cranial border of the wings of the 
atlas to the cranial border of the scapula. 
Anaesthesia time 
• defined as the time from induction to the time that the gaseous anaesthetic agent 
was turned off. In the case of total intravenous anesthesia, the end point was the 
time that all external stimuli had ceased (surgery, application of dressing, etc). 
Surgery time 
• defined as the time from the first surgical incision until all surgical intervention 
(suturing, application of dressing, etc) had ceased. 
Identification and definition of complications during hospitalisation 
Drainage from incision 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• any fluid seen to be leaking from the surgical site. 
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Serous drainage 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• clear, straw coloured fluid leaking from incision. 
Serosanguinous drainage 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• clear, blood tinged fluid leaking from incision. 
Purulent drainage 
• identified by visual inspection of the surgical incision at every bandage/dressing 
change. If no dressing is used then the wound will be assessed on a daily basis. 
• cloudy, cellular fluid leaking from incision. 
Heat 
• identified by palpation of the surgical incision at every dressing change. Ifno 
dressing is used then the wound will be assessed on a daily basis. 
300 
• incision palpably warmer compared to either temperature of surrounding skin, or to 
a comparable region, ie with a skin incision on neck, compare to other side of neck. 
Pain on palpation of wound 
• identified by palpation of the surgical incision at every dressing change. If no 
dressing is used then the wound will be assessed on a daily basis 
• horse flinches or makes an attempt to move away when incision is palpated 
Swelling of incision 
• identified by observation of the surgical incision at every dressing change. Ifno 
dressing is used then the wound will be assessed on a daily basis. 
• margins of incision raised above level of surrounding skin more than would be 
anticipated with the suture pattern used. 
Strike through on bandage 
• identified by observation of the dressing/bandage prior to every dressing change. 
• fluid has leaked through to the outermost layer of the dressing/bandage covering 
the surgical wound. 
Bandage/dressing slipped or chewed 
• identified by observation of the dressing/bandage prior to every dressing change. 
• integrity of the outer layers of the bandage has been disrupted, or the 
bandage/dressing has slipped in such a way as to expose part, or all, of the surgical 
site. 
Partial wound dehiscence 
• identified by observation of the surgical incision at every dressing change. Ifno 
dressing is used then the wound will be assessed on a daily basis. 
• disruption ofless than 75% of the surgical wound. 
Total wound dehiscence 
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• identified by observation of the surgical incision at every dressing change. Ifno 
dressing is used then the wound will be assessed on a daily basis. 
• disruption of at least 75% of the surgical wound. 
Seromalhaematoma 
• identified by observation and palpation of surgical incision on a daily basis. 
• localized, fluid filled pocket in area of surgical wound. 
Volume of dead space left at surgery 
• assessed by surgeon at time of surgical procedure. 
301 
• perfect tissue apposition cannot be achieved, leaving an unoccupied space within 
tissue layers in the surgical field. 
• subjectively quantified as: 
small space left only between tissue/fasciallayers 
moderate small space left within surgical field, eg laryngoplasty 
large tissues surrounding surgical field cannot be adequately 
apposed, eg myectomy incision 
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Appendix 12 
Univariable analysis of factors affecting the likelihood of the development of post-
operative complications following elective surgical procedures 
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Appendix 12.1: Comparison of hospitalisation related outcomes by variable for all elective surgical 
procedures 
P~rexia Diarrhoea 
p OR 95% CI P OR 95% CI 
Age (referent < 2 yrs) 
2 - 6 yrs 0.918 1.11 0.15 8.22 0.481 2.38 0.21-26.63 
6 - 9 yrs 0.573 1.79 0.24 - 13.38 0.817 1.39 0.09 -22.50 
> 9 yrs 0.272 3.26 0.51 20.87 0.245 3.87 0.40 37.75 
Gender (referent female) 
M 0.850 0.86 0.18 - 4.05 0.648 1.52 0.25 - 9.25 
MN 0.770 0.79 0.17-3.72 0.918 0.90 0.13-6.49 
Weight (referent <400kgs) 
400-600 I{gs 0.897 1.12 0.20 6.33 
>600 kgs 0.124 5.10 0.64 -40.57 
Duration of GA (referent < 60 mins) 
60-90 mins 0.887 0.87 0.12 - 6.40 0.819 1.24 0.20 -7.52 
90 -110 mins 0.787 1.41 0.12 16.58 0.999 0.00 0.00 - CIJ 
> 110 mins 0.349 2.31 0.40 13.29 0.854 1.20 0.17-8.72 
Duration of Sx (referent < 30 mins) 
30 - 50 mins 0.473 2.32 0.23 - 23.14 0.318 3.07 0.34 -27.89 
50 -65 mins 0.642 1.95 0.12 - 32.80 0.999 0.00 0.00 - CIJ 
> 65 mins 0.184 4.56 0.49-42.65 0.466 2.46 0.22 -27.52 
Length of incision (referent <Scm) 
5-10cm 0.596 1.49 0.34 - 6.55 
>10cm 0.249 2.77 0.49 - 15.68 
>1 incision 0.844 1.05 0.64 - 1.72 
Volume of dead space left (referent small) 
Moderate 0.926 1.06 0.29 - 3.94 0.892 1.13 0.20 - 6.23 
Large 0.999 0.00 0.00 - CIJ 0.352 2.89 0.31 26.85 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 0.999 0.00 0.00 - CIJ 
>24hrs 0.849 0.23 0.14-10.65 
Dressing used 
YIN 
0.727 0.79 0.21-2.92 
Type of dressing used (referent no dressing used) 
Cast 0.752 1.33 0.23 -7.68 
Bandage 0.784 0.78 0.14 - 4.46 
Adhesive 0.251 2.88 0.47 -17.47 
dressingl stent 
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Appendix 12.1, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Classification of surgical procedure (referent clean) 
Clean- 0.899 0.90 0.18 - 4.45 
contaminated 
Type of clean surgical procedure (referent orthopaedic) 
Soft tissue 0.213 2.50 0.59 10.57 
Suture material used in closure of deep layer (referent none) 
Vicryl/polysorb 0.668 0.73 0.17-3.15 
PDS/biosyn 0.033 8.10 1.18 - 55.40 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.998 0.00 0.00 - 00 
PDS/biosyn 0.998 0.00 0.00 - 00 
Suture material used in closure of skin (referent none) 
Staples 0.812 0.76 0.08 -7.41 
Nylon/prolene 0.999 0.00 0.00 - 00 
Vicryl/polysorb 0.724 1.55 0.14 - 17.44 
PDS/biosyn 0.221 5.91 0.34-
101.60 
Type of antimicrobials used prior to induction (referent none used) 
Procaine 0.99 0.00 0.00 - 00 1.00 1.00 
penicillin or 
sodium penicillin 
Procaine 0.99 0.00 0.00 - 00 1.00 1.00 
penicillin and 
gentamicin 
Sodium penicillin 0.99 0.00 0.00 - 00 1.00 1.00 
and gentamicin 
Other 0.99 0.00 0.00 - 00 1.00 1.00 
combination 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Neurectomy 0.645 1.93 
Fracture repair 0.824 0.76 0.06 - 8.88 0.549 2.35 
Desmotomy 0.415 3.40 0.18 - 64.69 0.294 4.50 
Other 0.998 0.00 0.00 - 00 0.999 0.00 
orthopaedic 
procedure 
Castration 0.998 0.00 0.00 - 00 0.355 3.13 
Laparotomy 0.112 8.50 0.61 1.000 0.00 
118.64 
Enucleation 0.341 4.25 0.22 - 83.52 1.000 0.00 
Other soft tissue 0.226 4.86 0.38 - 62.63 0.999 0.00 
procedure 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.12 31.42 
0.14 - 38.35 
0.27 -74.52 
0.00 - 00 
0.28 - 35.18 
0.00 - 00 
0.00 - 00 
0.00 - 00 
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Appendix 12.1, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Laryngoplasty 0.859 0.77 0.05 -13.27 0.999 0.00 
Sinus & Dental 0.999 0.00 0.00 - CIJ 0.212 6.00 
Penile 
Other clean-
contaminated 
procedure 
0.999 
0.999 
0.00 0.00 - CIJ 
0.00 0.00 - CIJ 
1.000 
l.000 
Anatomical location of surgical procedure (referent distal limb) 
0.00 
0.00 
Proximal limb 0.999 0.00 0.00 - CIJ 0.999 0.00 
Body 0.105 8.63 0.64 0.999 0.00 
116.54 
Head & neck 0.397 l.86 0.44 -7.89 0.849 0.81 
Ventral 0.607 0.56 0.06 - 5.19 0.827 l.21 
abdomen, 
inguinal & penis 
Abnormal 
drainage for the 
surgical 
procedure 
Partial or total 
incisional 
dehiscence 
Abnormal 
swelling for the 
surgical 
procedure 
0.790 
0.063 
0.81 0.16 - 3.97 0.571 0.54 
l.000 0.00 
3.56 0.93 - 13.55 0.652 1.46 
0.00 - CIJ 
0.36 
100.30 
0.00 - CIJ 
0.00 - CIJ 
0.00 - CIJ 
0.00 - CIJ 
0.09 - 7.34 
0.22 -6.73 
0.06 -4.54 
0.00 - CIJ 
0.28 -7.67 
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Appendix 12.2: Clean surgical procedures - hospitalisation outcome by variable 
P~rexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Age (referent < 2 yrs) 
2 - 6 yrs 0.788 1.47 0.09 -24.35 0.424 2.68 0.24 - 30.05 
6 - 9 yrs 0.246 4.27 0.37 -49.68 0.999 0.00 0.00 - 00 
> 9 yrs 0.046 10.85 1.04 - 0.190 4.60 0.47-45.01 
113.17 
Gender (referent female) 
M 0.718 0.71 0.11 - 4.48 0.666 1.49 0.24 - 9.06 
MN 0.615 1.53 0.29 - 8.11 0.625 0.55 0.05 6.12 
Weight (referent <400kgs) 
400-600 I<gs 0.964 1.04 0.17 - 6.48 
>600 kgs 0.010 24.00 2.14-
269.12 
Duration of GA (referent < 60 mins) 
60 -90 mins 0.874 0.85 0.11 - 6.36 0.870 0.85 0.12 - 6.13 
90-110 mins 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 
> 110 mins 0.599 1.65 0.26-10.51 0.796 1.30 0.18-9.43 
Duration of Sx (referent < 30 mins) 
30 - 50 mins 0.487 2.27 0.22 - 22.87 0.461 2.35 0.24 -22.97 
50-65 mins 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 
> 65 mins 0.311 3.32 0.33 33.80 0.399 2.83 0.25 - 31.84 
Length of incision (referent <5cm) 
5-10cm 0.104 3.71 0.76 - 18.01 0.245 2.78 0.50 - 15.56 
>10cm 0.493 2.22 0.23 - 21.90 0.999 0.00 0.00 - 00 
>1 incision 0.606 0.69 0.16 - 2.88 0.654 1.48 0.27-8.18 
Volume of dead space left (referent small) 
Moderate 0.422 1.84 0.41 8.18 0.670 1.45 0.26 - 8.06 
Large 1.000 0.00 0.00 - 00 1.000 0.00 0.00 - 00 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 1.000 0.00 0.00 - 00 0.999 0.00 0.00 - 00 
>24hrs 0.715 1.51 0.17-13.66 0.621 0.58 0.07 - 5.04 
Type of dressing used (referent no dressing used) 
Cast 0.732 1.42 0.19-10.76 0.632 1.81 0.16 20.78 
Bandage 0.866 0.84 0.11- 6.26 0.781 0.77 0.13-4.71 
Adhesive 0.251 3.36 0.42 - 26.72 0.999 0.00 0.00 - 00 
dressing/ stent 
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Appendix 12.2, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Type of clean surgical procedure (referent orthopaedic) 
Soft tissue 0.213 2.50 0.59 - 10.57 0.761 1.30 
Suture material used in closure of deep layer (referent none) 
Vicryl/polysorb 0.727 0.73 0.13-4.17 
PDS/biosyn 0.020 11.50 1.48 - 89.66 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.998 0.00 0.00 - 00 
PDS/biosyn 0.998 0.00 0.00 - 00 
Suture material used in closure of skin (referent none) 
Staples 0.999 0.00 0.00 - 00 
Nylon/prolene 1.000 1.00 0.00 - 00 
Vicryl/polysorb 0.999 0.00 0.00 - 00 
PDS/biosyn 0.999 0.00 0.00 - 00 
Type of antimicrobials used prior to induction (referent none used) 
Procaine 0.999 0.00 0.00 - 00 1.000 0.00 
penicillin or 
sodium penicillin 
Procaine 0.999 0.00 0.00 - 00 1.000 0.00 
penicillin and 
gentamicin 
Sodium penicillin 0.999 0.00 0.00 - 00 1.000 0.00 
and gentamicin 
Other 1.000 0.00 0.00 - 00 1.000 0.00 
combination 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Neurectomy 0.645 1.93 
Fracture repair 0.824 0.76 0.06 8.88 0.549 2.35 
Desmotomy 0.415 3.40 0.18 - 64.69 0.294 4.50 
Other 0.999 0.00 0.00 - 00 0.999 0.00 
orthopaedic 
procedure 
Castration 0.999 0.00 0.00 - 00 0.355 3.13 
Laparotomy 0.341 4.25 0.22 - 83.52 1.000 0.00 
Enucleation 0.341 4.25 0.22 - 83.52 1.000 0.00 
Other soft tissue 0.226 4.86 0.38 62.63 0.999 0.00 
procedure 
0.24 - 7.23 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.12-31.42 
0.14 - 38.35 
0.27 -74.52 
0.00 - 00 
0.28 35.18 
0.00 - 00 
0.00 - 00 
0.00 - 00 
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Appendix 12.2, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Anatomical location ofsurgical procedure (referent distal limb) 
Proximal limb 0.999 0.00 0.00 - CfJ 0.999 0.00 
Body 1.000 0.00 0.00 - CfJ 0.999 0.00 
Head & neck 0.077 4.31 0.86 - 2l.74 0.999 0.00 
Ventral 0.773 0.72 0.08 - 6.75 0.748 1.33 
abdomen, 
inguinal & penis 
Abnormal 
drainage for the 
surgical 
procedure 
Partial or total 
incisional 
dehiscence 
Abnormal 
swelling for the 
surgical 
procedure 
0.602 
0.027 
0.57 0.07 - 4.82 0.999 0.00 
1.000 0.00 
5.26 1.21 - 22.89 0.502 1.80 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.24 - 7.38 
0.00 - CfJ 
0.00 - CfJ 
0.32 - 10.01 
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Appendix 12.3: Clean-contaminated procedures - hospitalisation outcome by variable 
P~rexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Age (referent < 3 yrs) 
3 -7 yrs 0.831 0.73 0.04 13.45 0.999 0.00 0.00 - CIJ 
7 -11 yrs 0.999 0.00 0.00 - CIJ 1.000 1.00 0.00 - CIJ 
> 11 yrs 0.999 0.00 0.00 - CIJ 1.000 1.00 0.00 - CIJ 
Gender (referent female) 
M 0.653 2.00 0.10 41.01 1.000 1.00 0.00 - CIJ 
MN 0.999 0.00 0.00 - CIJ 0.999 0.00 0.00 - CIJ 
Weight (referent <400kgs) 
400-600 kgs 1.000 0.00 0.00 - CIJ 
>600 kgs 1.000 1.00 0.00 - CIJ 
Duration of GA (referent < 67 mins) 
67 - 97 mins 1.000 1.00 0.00 - CIJ 0.999 0.00 0.00 - CIJ 
97 -117 mins 0.999 0.00 0.00 - CIJ 1.000 1.00 0.00 - CIJ 
> 117 mins 0.999 0.00 0.00 - CIJ 1.000 1.00 0.00 - CIJ 
Duration of Sx (referent < 40 mins) 
40 - 65 mins 0.999 0.00 0.00 - CIJ 0.999 0.00 0.00 - CIJ 
65-80 mins 1.000 1.00 0.00 - CIJ 1.000 1.00 0.00 - CIJ 
>80 mins 0.999 0.00 0.00 - CIJ 1.000 1.00 0.00 - CIJ 
Length of incision (referent <Scm) 
5-10cm 0.999 0.00 0.00 - CIJ 0.999 0.00 0.00 - CIJ 
>IOcm 0.653 2.00 0.10-41.01 1.000 1.00 0.00 - CIJ 
>1 incision 1.000 0.00 0.00 - CIJ 1.000 0.00 0.00 - CIJ 
Volume of dead space left (referent small) 
Moderate 0.097 0.07 0.00 - 1.62 1.000 0.00 0.00 - CIJ 
Large 0.999 0.00 0.00 - CIJ 1.000 0.00 0.00 - CIJ 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 0.999 0.00 0.00 - CIJ 1.000 0.00 0.00 - CIJ 
>24hrs 1.000 0.00 0.00 - CIJ 1.000 0.00 0.00 - CIJ 
Type of dressing used (referent no dressing used) 
Cast 1.000 0.00 0.00 - CIJ 
Bandage 
Adhesive 1.000 0.00 0.00 - CIJ 1.000 0.00 0.00 - CIJ 
dressingl stent 
Suture material used in closure of deep layer (referent none) 
Vicryll polysorb 0.727 0.60 0.03 -10.51 
PDS/biosyn 1.000 0.00 0.00 - CIJ 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.999 0.00 0.00 - CIJ 
PDS/biosyn 1.000 1.00 0.00 - CIJ 
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Appendix 12.3, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Suture material used in closure of skin (referent none) 
Staples 1.000 1.00 0.00 - 00 
Nylon/prolene 1.000 0.00 0.00 - 00 
Vicryl/polysorb 0.999 0.00 0.00 - 00 
PDS/biosyn 
Type of antimicrobials used prior to induction (referent none used) 
Procaine 0.999 0.00 0.00 - 00 1.000 0.00 
penicillin or 
sodium penicillin 
Procaine 0.196 0.14 0.01 2.80 1.000 1.00 
penicillin and 
gentamicin 
Sodium penicillin 0.999 0.00 0.00 - 00 1.000 1.00 
and gentamicin 
Other 1.000 1.00 
combination 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Laryngoplasty 1.000 0.00 0.00 - 00 1.000 1.00 
Sinus & Dental 1.000 0.00 0.00 - 00 1.000 0.00 
Penile 1.000 0.00 0.00 - 00 1.000 1.00 
Other c1ean- 1.000 0.00 0.00 - 00 1.000 1.00 
contaminated 
procedure 
Anatomical location of surgical procedure (referent distal limb) 
Proximal limb 1.000 1.00 0.00 - 00 1.000 1.00 
Body 1.000 0.00 0.00 - 00 1.000 0.00 
Head & neck 0.999 0.00 0.00 - 00 1.000 0.00 
Ventral 
abdomen, 
inguinal & penis 
Abnormal 
drainage for the 
surgical 
procedure 
Partial or total 
incisional 
dehiscence 
Abnormal 
swelling for the 
surgical 
procedure 
0.701 
1.000 
0.999 
1.75 0.10 - 30.59 0.999 0.00 
0.00 0.00 - 00 1.000 0.00 
0.00 0.00 - 00 0.999 0.00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00-00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
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Appendix 12.4: Clean orthopaedic procedures - hospitalisation outcome by variable 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Age (referent < 3 yrs) 
3 - 6 yrs 0.999 0.00 0.00 - 00 0.998 0.00 0.00 - 00 
6 -10 yrs 0.999 0.00 0.00 - 00 1.000 1.00 0.00 - 00 
> 10 yrs 0.524 2.25 0.19 27.31 0.998 0.00 0.00 - 00 
Gender (referent female) 
M 0.323 3.45 0.30 -40.32 0.931 1.11 0.10-12.56 
MN 0.771 1.52 0.09 - 25.44 0.579 0.50 0.05 - 5.65 
Weight (referent <400kgs) 
400-600 kgs 0.999 0.00 0.00 - 00 
>600 kgs 0.998 0.00 0.00 - 00 
Duration of GA (referent < 75 mins) 
75 -100 mins 0.999 0.00 0.00 - 00 0.953 0.92 0.06 - 14.99 
100 - 115 mins 1.000 1.00 0.00 - 00 0.999 0.00 0.00 - 00 
> 115 mins 0.999 0.00 0.00 - 00 0.509 2.26 0.20 -25.57 
Duration of Sx (referent < 35 mins) 
35-55 mins 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 
55 - 65 mins 1.000 1.00 0.00 - 00 1.000 1.00 0.00 - 00 
> 65 mins 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 
Length of incision (referent <Scm) 
5-10cm 0.098 8.56 0.67-
108.50 
>10cm 0.999 0.00 0.00 - 00 
>1 incision 0.999 0.00 0.00 - 00 
Volume of dead space left (referent small) 
Moderate 0.088 9.11 0.72 
115.48 
Large 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 1.000 0.00 0.00 - 00 
>24hrs 0.999 0.00 0.00 - 00 
Type of dressing used (referent no dressing used) 
Cast 0.999 0.00 0.00 - 00 
Bandage 0.999 0.00 0.00 - 00 
Adhesive 1.000 1.00 0.00 - 00 
dressingl stent 
Suture material used in closure of deep layer (referent none) 
Vicryll polysorb 0.999 0.00 0.00 - 00 
PDS/biosyn 1.000 0.00 0.00 - 00 
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Appendix 12.4, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.998 0.00 0.00 - CfJ 
PDS/biosyn 0.998 0.00 0.00 - CfJ 
Suture material used in closure of skin (referent none) 
Staples 1.000 0.00 0.00 - CfJ 
Nylon/prolene 1.000 1.00 0.00 - CfJ 
Vicryl/polysorb 1.000 1.00 0.00 - CfJ 
PDS/biosyn 1.000 1.00 0.00 - CfJ 
Type of antimicrobials used prior to induction (referent none used) 
Procaine 1.000 0.00 0.00 - CfJ 1.000 0.00 
penicillin or 
sodium penicillin 
Procaine 1.000 1.00 0.00 - CfJ 1.000 1.00 
penicillin and 
gentamicin 
Sodium penicillin 1.000 0.00 0.00 - CfJ 1.000 0.00 
and gentamicin 
Other 1.000 1.00 0.00 - CfJ 1.000 1.00 
combination 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Neurectomy 0.645 1.93 
Fracture repair 0.824 0.76 0.06 - 8.88 0.549 2.35 
Desmotomy 0.415 3.40 0.18-64.69 0.294 4.50 
Other 0.999 0.00 0.00 - CfJ 0.999 0.00 
orthopaedic 
procedure 
Anatomical location of surgical procedure (referent distal limb) 
Proximal limb 0.999 0.00 0.00 - CfJ 0.999 0.00 
Body 1.000 0.00 0.00 - CfJ 1.000 0.00 
Head & neck 1.000 0.00 0.00 - CfJ 1.000 0.00 
Abnormal 0.856 1.24 0.12 - 12.65 0.999 0.00 
drainage for the 
surgical 
procedure 
Partial or total 1.000 0.00 
incisional 
dehiscence 
Abnormal 0.048 10.42 1.02 - 0.393 2.37 
swelling for the 106.04 
surgical 
procedure 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.12 - 31.42 
0.14 - 38.35 
0.27 -74.52 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.00 - CfJ 
0.33 -17.10 
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Appendix 12.5: Clean soft-tissue procedures - hospitalisation outcome by variable 
P~rexia 
P OR 95%CI P 
Age (referent < 2 yrs) 
2 - 3 yrs 1.000 1.00 0.00 - 00 0.999 
3 - 4 yrs 1.000 1.00 0.00 - 00 1.000 
> 4 yrs 0.999 0.00 0.00 - 00 1.000 
Gender (referent female) 
M 0.998 0.00 0.00 - 00 0.999 
MN 0.683 1.60 0.17 -15.27 1.000 
Weight (referent <400kgs) 
400-600 kgs 0.792 0.71 0.06 - 8.67 
>6001{gs 1.000 0.00 0.00 - 00 
Duration of GA (referent < 50 mins) 
50-60 mins 0.910 0.85 0.05 - 15.16 0.673 
60 -70 mins 0.173 11.00 0035- 0.999 
345.08 
> 70 mins 0.892 1.22 0.07 -22.40 0.999 
Duration of Sx (referent < 28 mins mins) 
28 -39 mins 0.999 0.00 0.00 - 00 0.793 
39 -45 mins 0.327 3.67 0.27 -49.29 0.999 
> 45 mins 0.892 1.22 0.07 -22.40 0.999 
Length of incision (referent <5cm) 
5-10cm 0.714 1.60 0.13 - 19.84 
>10cm 0.644 2.00 0.11-37.83 
>1 incision 0.999 0.00 0.00 - 00 
Volume of dead space left (referent small) 
Moderate 0.227 0.27 0.03 -2.27 
Large 1.000 0.00 0.00 - 00 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 
>24hrs 1.000 0.00 0.00 - 00 
Type of dressing used (referent no dressing used) 
Adhesive 0.046 10.33 1.05 -
dressingl stent 102.08 
Suture material used in closure of deep layer (referent none) 
Vicryll polysorb 0.678 0.58 0.05 7.43 
PDS/biosyn 0.590 2033 0.11 - 50.99 
Diarrhoea 
OR 95% CI 
0.00 0.00 - 00 
1.00 0.00 - 00 
1.00 0.00 - 00 
0.00 0.00 - 00 
1.00 0.00 - 00 
0.55 .003 - 9.12 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.69 0.04 -11.51 
0.00 0.00 - 00 
0.00 0.00 - 00 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.999 0.00 0.00 - 00 
PDS/biosyn 0.999 0.00 0.00 - 00 
Appendix 12.5 continued overleaf 
313 
Appendix 12 
Appendix 12.5, contd. 
Pyrexia Diarrhoea 
P OR 95% CI P OR 95% CI 
Suture material used in closure of skin (referent none) 
Staples 0.999 0.00 0.00 - if.) 
Nylon/prolene 1.000 1.00 0.00 - if.) 
Vicryl/polysorb 0.999 0.00 0.00 - if.) 
PDS/biosyn 0.999 0.00 0.00 - if.) 
Type of antimicrobials used prior to induction (referent none used) 
Procaine 0.999 0.00 0.00 - if.) 1.000 0.00 
penicillin or 
sodium penicillin 
Procaine 0.999 0.00 0.00 - if.) 1.000 1.00 
penicillin and 
gentamicin 
Sodium penicillin 0.999 0.00 0.00 - if.) 1.000 1.00 
and gentamicin 
Other 1.000 1.00 0.00 - if.) 1.000 1.00 
combination 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Castration 0.998 0.00 0.00 - if.) 0.999 0.00 
Laparotomy 0.923 0.88 0.06 - 12.98 1.000 1.00 
Enucleation 0.923 0.88 0.06 - 12.98 1.000 1.00 
Other soft tissue 
procedure 
Anatomical location of surgical procedure (referent distal limb) 
Proximal limb 
Body 1.000 0.00 
Head & neck 0.104 7.20 0.67 -77.83 0.999 0.00 
Ventral 
abdomen, 
inguinal & penis 
Abnormal 0.999 0.00 0.00 - if.) 1.000 0.00 
drainage for the 
surgical 
procedure 
1.000 0.00 
Partial or total 
incisional 
dehiscence 
Abnormal 1.000 0.00 0.00 - if.) 1.000 0.00 
swelling for the 
surgical 
procedure 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
0.00 - if.) 
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Appendix 12.6: Comparison of incisional complications by variable, for all elective surgical procedures. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Age (referent < 2 yrs) 
2 - 6 yrs 0.151 1.70 0.82 - 3.52 0.140 1.89 0.81- 4.41 0.869 l.l8 0.16 - 8.53 
6 - 9 yrs 0.007 2.65 1.30 - 5.41 <0.001 6.92 3.19 -14.99 0.762 0.69 0.06 -7.71 
> 9 yrs 0.001 3.32 1.67 - 6.60 <0.001 7.42 3.47 -15.87 0.816 1.27 0.18-9.14 
Gender (referent female) 
M <0.001 0.24 0.13 - 0.47 <0.001 0.15 0.07 - 0.36 0.648 1.52 0.25 - 9.25 
MN 0.087 0.64 0.38 - 1.07 0.032 1.73 1.05 -2.85 0.918 0.90 0.13 - 6.49 
Weight (referent <400 kgs) 
400-600 kgs 0.084 1.80 0.92 - 3.51 0.034 2.06 1.06 -3.99 0.539 0.58 0.11 - 3.24 
>600 kgs 0.040 2.54 1.05 - 6.16 0.040 2.54 1.05 - 6.16 0.978 0.97 0.09 -10.95 
Duration of GA (referent < 60 mins) 
60 - 90 mins 0.002 3.49 1.59 -7.66 0.008 2.65 1.30 - 5.41 0.999 0.00 0.00 - OCJ 
90-110 mins <0.001 4.67 2.01-10.82 <0.001 4.09 1.90- 8.78 1.000 1.00 0.00 - OCJ 
> 110 mins <0.001 4.88 2.17 -10.97 <0.001 3.73 1.78-7.83 0.000 0.00 0.00 - OCJ 
Duration of Surgery (referent < 30 mins) 
30 - 50 mins 0.362 1.36 0.70 -2.61 0.013 2.30 1.19 - 4.42 0.735 1.52 0.14-16.94 
50 -65 mins 0.262 1.57 0.71 - 3.43 0.228 1.65 0.73 - 3.73 0.999 0.00 0.00 - OCJ 
> 65 mins 0.004 2.67 1.36 - 5.25 0.001 3.25 1.62 - 6.49 0.466 2.46 0.22 -27.52 
Length of incision (referent < Scm) 
5-10cm 0.002 0.29 0.14- 0.63 0.185 0.66 0.36 - 1.22 0.203 3.61 0.50 -25.99 
>10cm 0.179 0.54 0.22 - 1.33 0.529 1.27 0.60 -2.69 0.006 12.99 2.10 - 80.39 
>1 incision <0.001 2.83 1.73 -4.62 0.207 1.34 0.85-2.10 0.091 0.16 0.02 -1.34 
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Appendix 12.6, contd. 
Abnormal swelling Abnormal drainage 
p OR 95% CI P OR 
Volume of dead space left (referent small) 
Moderate <0.001 0.10 0.04- 0.26 0.002 0.39 
Large 0.930 0.96 0.39 - 2.39 0.008 3.09 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 0.376 1.62 0.56 -4.69 0.654 1.30 
>24hrs 0.022 1.92 1.10 -3.35 <0.001 3.84 
Surgical site shaved 0.902 1.04 0.53 -2.08 <0.001 3.74 
Type of dressing used (referent none used) 
Cast 0.001 4.92 1.86 -12.97 0.073 0.16 
Bandage <0.001 4.81 2.52 - 9.17 0.009 1.96 
Adhesive /stent 0.018 2.86 1.19- 6.85 0.980 0.01 
Classification of surgical procedure performed (referent clean) 
Clean-contaminated 0.654 0.85 0042 - 1.72 0.002 2.57 
Suture pattern used in closure of deep layer (referent no deep closure) 
Simple interrupted 0.008 0.14 0.03 -0.60 0.116 0.37 
Simple continuous <0.001 0.18 0.10 - 0.32 0.696 1.10 
MattresslNear-far Far- 0.999 0.00 0.00 - 00 0.690 0.64 
near 
Suture pattern used in closure of subcutaneous layer (referent no closure) 
Simple interrupted 0.107 0.50 0.21-1.16 0.599 0.79 
Simple continuous <0.001 0.29 0.18 - 0.48 0.609 0.88 
MattresslNear-far Far- 1.000 0.00 0.00 - 00 0.999 0.00 
near 
95% CI 
0.21- 0.71 
1.35 -7.07 
0041-4.09 
2.26 - 6.53 
2.07 - 6.75 
0.02 - 1.19 
1.18-3.25 
0046 -2.24 
1.43 -4.61 
0.11- 1.28 
0.69 - 1.73 
0.07 - 5.63 
0.33 - 1.89 
0.55 - 1.43 
0.00 - 00 
P 
00415 
0.002 
0.999 
0.714 
0.888 
0.999 
0.288 
0.777 
0.245 
0.999 
0.137 
X 
0.346 
0.332 
1.000 
Dehiscence 
OR 
2.27 
19.02 
0.00 
0.67 
1.17 
0.00 
0040 
0.73 
2.68 
0.00 
0.20 
x 
3.84 
2.91 
0.00 
95% CI 
0.32 -16.29 
3.02 - 119.90 
0.00 - 00 
0.08 - 5.79 
0.14 - 9.88 
0.00 - 00 
0.07-2.19 
0.08 - 6.64 
0.51-14.17 
0.00 - 00 
0.02-1.67 
X 
0.23 - 62.82 
0.34-25.16 
0.00 - 00 
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Appendix 12.6, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
P OR 95% CI p OR 95% CI P OR 95% CI 
Suture pattern used in closure of skin (referent none) 
Simple interrupted 0.335 1.38 0.72 - 2.67 0.004 0.44 0.25-0.77 0.732 1.45 0.17 -12.24 
Simple continuous 0.026 0.09 0.01- 0.75 0.003 0.20 0.07 - 0.57 0.999 0.00 0.00 - <Xl 
Cruciate 0.999 0.00 0.00 - <Xl 0.404 0.38 0.04 - 3.64 X X X 
MattresslNear-far Far- 0.999 0.00 0.00 - <Xl 0.999 0.00 0.00 - <Xl X X X 
near 
Suture material used in closure of deep layer (referent none) 
Vicryl/ polysorb <0.001 0.17 0.09- 0.30 0.990 1.00 0.64-1.56 0.742 0.78 0.17-3.51 
PDS/biosyn 0.174 0.23 0.03 - 1.90 0.396 0.40 0.05 - 3.29 1.000 0.00 0.00 - <Xl 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb <0.001 0.33 0.20 - 0.53 0.539 0.86 0.54-1.38 0.296 3.11 0.37 -26.08 
PDSlbiosyn 0.221 0.27 0.03 -2.22 0.991 0.99 0.19 - 5.13 1.000 0.00 0.00 - <Xl 
Suture material used in closure of skin (referent none) 
Staples 0.123 1.68 0.87 - 3.27 0.010 0.47 0.27 - 0.83 0.998 1.00 0.00 - <Xl 
Nylon/prolene 0.731 0.68 0.08 - 6.15 0.578 0.62 0.11-3.41 0.998 1.00 0.00 - <Xl 
Vicryl/polysorb 0.003 0.10 0.02 - 0.45 <0.001 0.14 0.05-0.34 0.998 1.00 0.00 - <Xl 
PDS/biosyn 0.362 0.37 0.04- 3.13 0.882 1.10 0.32 - 3.83 1.000 0.00 0.00 - <Xl 
Type of antimicrobials administered prior to induction of anaesthesia (referent none) 
Procaine 0.914 1.09 0.22 - 5.38 0.513 0.62 0.15-2.56 1.000 0.00 0.00 - <Xl 
penicillin/Sodium 
penicillin 
Procaine penicillin and 0.700 0.71 0.13-3.96 0.782 0.81 0.18 - 3.61 1.000 0.00 0.00 - <Xl 
gentamicin 
Sodium penicillin and 0.908 1.11 0.20 - 6.05 0.556 0.63 0.14-2.92 1.000 1.00 0.00 - <Xl 
gentamicin 
Other combination 0.122 0.13 0.01- 1.71 0.039 0.08 0.01- 0.87 1.000 1.00 0.00 - <Xl 
Appendix 12.6 continued overleaf 
Appendix 12 
Appendix 12.6, contd. 
Abnormal swelling Abnormal drainage 
p OR 95% CI p OR 95% CI 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Neurectomy 0.007 0.35 0.17 - 0.76 
Fracture repair 0.045 0.45 0.21- 0.98 
Desmotomy 0.291 1.60 0.67 - 3.83 
Other orthopaedic 0.002 0.10 0.02 - 0.43 
procedure 
Castration 0.995 0.00 0.00 - CIJ 
Laparotomy 0.998 0.00 0.00 - CIJ 
Enucleation 0.999 0.00 0.00 - CIJ 
Other soft tissue 0.020 0.09 0.01- 0.68 
procedure 
Laryngoplasty 0.045 0.31 0.10 - 0.98 
Sinus & Dental 0.051 0.28 0.08 - 1.01 
Penile 0.999 0.00 0.00 - CIJ 
Other clean- 0.390 1.97 0.42 - 9.23 
contaminated 
procedure 
Anatomical location of surgical incision (referent distal limb) 
Proximal limb 0.828 1.08 0.54 - 2.l8 
Body 0.093 0.17 0.02 - 1.34 
Head & neck 0.012 0.39 0.19 - 0.82 
Ventral abdomen, <0.001 0.03 0.00 - 0.18 
inguinal & penis 
0.001 3.19 
0.309 0.62 
0.148 1.99 
0.434 0.66 
0.995 0.00 
0.769 0.79 
0.362 2.36 
0.609 0.71 
0.673 1.25 
0.068 2.58 
0.052 4.72 
0.052 4.72 
0.978 0.99 
0.273 0.43 
0.783 1.09 
<0.001 0.18 
1.60- 6.35 
0.25 - 1.56 
0.78 - 5.07 
0.23 - 1.89 
0.00 - CIJ 
0.16-3.89 
0.37 - 14.95 
0.l9-2.65 
0.44 -3.52 
0.93 -7.12 
0.99 -22.56 
0.99 -22.56 
0.48 -2.05 
0.09 -1.96 
0.60 - 1.99 
0.08- 0.44 
p 
0.645 
0.999 
0.999 
0.382 
0.998 
0.999 
1.000 
0.038 
0.999 
0.212 
0.050 
1.000 
0.999 
0.006 
0.236 
0.878 
Dehiscence 
OR 95% CI 
1.93 
0.00 
0.00 
3.48 
0.00 
0.00 
0.00 
13.50 
0.00 
6.00 
18.00 
0.00 
0.00 
17.92 
3.31 
1.21 
0.l2 - 31.42 
0.00 - CIJ 
0.00 - CIJ 
0.21 - 57.32 
0.00 - CIJ 
0.00 - CIJ 
0.00 - CIJ 
1.16 - 157.58 
0.00 - CIJ 
0.36 - 100.30 
1.00 - 324-
27 
0.00 - CIJ 
0.00 - CIJ 
2.32 - 138.40 
0.46 -23.95 
0.11-13.49 
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Appendix 12.6, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Abnormal incisional 0.005 2.05 1.24-3.38 X X x 0.237 2.49 0.55 - 11.34 
drainage 
Partial or total 0.185 2.78 0.61 - 12.66 0.237 2.49 0.55 - 11.34 X x X 
incisional dehiscence 
Abnormal incisional X x X 0.005 2.05 1.24-3.38 0.185 2.78 0.61 - 12.66 
swelling 
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Appendix 12.7: Clean surgical procedures - incisional outcome by variable 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Age (referent < 2 yrs) 
2 - 6 yrs 0.105 1.87 0.88 -4.01 0.261 1.70 0.67 -4.30 0.778 1.33 0.18-9.62 
6 - 9 yrs 0.009 2.72 1.28- 5.74 <0.001 6.71 2.95 -15.25 0.999 0.00 0.00 - OCJ 
> 9 yrs 0.001 3.61 1.74 -7.48 <0.001 6.23 2.74-14.17 0.808 0.74 0.07 - 8.31 
Gender (referent female) 
M <0.001 0.22 0.11- 0.43 <0.001 0.16 0.06 - 0.39 0.666 1.49 0.24 - 9.06 
MN 0.054 0.57 0.32 - 1.01 0.030 1.85 1.06 -3.24 0.999 0.00 0.00 - OCJ 
Weight (referent <400 kgs) 
400-600 kgs 0.078 1.87 0.93 - 3.77 0.046 2.09 1.01- 4.31 0.426 0.48 0.08 -2.92 
>600 kgs 0.005 3.93 1.51-10.22 0.093 2.43 0.86 - 6.87 0.999 0.00 0.00 - OCJ 
Duration of GA (referent < 60 mins) 
60-90 mins 0.001 4.52 1.89 -10.52 0.020 2.54 1.16 - 5.57 0.999 0.00 0.00 - OCJ 
90 -110 mins <0.001 5.78 2.28 -14.62 0.001 3.91 1.70- 9.04 1.000 1.00 0.00 - OCJ 
> 110 mins <0.001 5.57 2.25 -13.82 0.007 3.12 1.36 -7.13 0.999 0.00 0.00 - OCJ 
Duration of Surgery (referent < 30 mins) 
30 -50 mins 0.255 1.49 0.75 -2.98 0.108 1.77 0.88 - 3.56 0.856 0.77 0.05 -12.50 
50 -65 mins 0.119 1.91 0.85 -4.31 0.140 1.88 0.81-4.34 0.999 0.00 0.00 - OCJ 
> 65 mins 0.010 2.65 1.27 - 5.52 0.045 2.20 1.02 - 4.73 0.814 1.40 0.09022.71 
Length of incision (referent < Scm) 
5-10cm 0.003 0.16 0.05-0.53 0.009 0.25 0.09 - 0.70 0.999 0.00 0.00 - OCJ 
>10 cm 0.035 0.11 0.02 - 0.86 0.046 0.13 0.02 - 0.96 0.001 19.84 3.15 - 125.05 
>1 incision <0.001 3.59 2.01- 6.43 0.007 2.12 1.23 -3.66 0.127 0.18 0.02 -1.63 
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Appendix 12.7, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Volume of dead space left (referent small) 
Moderate <0.001 0.05 0.01- 0.22 <0.001 0.23 0.10- 0.51 0.781 0.73 0.08 - 6.63 
Large 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 X x X 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 0.353 1.93 0.48 -7.78 0.503 1.72 0.35 - 8.51 1.000 0.00 0.00 - 00 
>24hrs 0.030 1.90 1.06-3.39 <0.001 4.99 2.78- 8.95 0.983 0.98 0.10 - 9.51 
Surgical site shaved 0.955 1.02 0.51-2.04 <0.001 4.79 2.60- 8.82 0.723 1.49 0.16-13.60 
Type of dressing used (referent none used) 
Cast <0.001 23.21 4.64 -116.00 0.516 0.49 0.06-4.18 0.999 0.00 0.00 - 00 
Bandage <0.001 21.57 5.15 - 90.43 <0.001 5.99 2.62 -13.70 0.508 0.51 0.07 -3.70 
Adhesive /stent 0.001 13.15 2.79- 61.95 0.057 2.78 0.97 -7.96 0.974 0.96 0.09 - 10.85 
Type of surgical procedure performed (referent orthopaedic) 
Soft tissue <0.001 0.02 0.00 - 0.17 <0.001 0.17 0.07 - 0.40 0.545 1.75 0.29 -10.60 
Suture pattern used in closure of deep layer (referent no deep closure) 
Simple interrupted 0.060 0.24 0.05 - 1.06 0.150 0.22 0.03 - 1.72 0.999 0.00 0.00 - 00 
Simple continuous <0.001 0.18 0.10 - 0.34 0.645 l.l3 0.68 - 1.87 0.282 0.30 0.03 -2.70 
MattresslNear-far Far- 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 X x X 
near 
Suture pattern used in closure of subcutaneous layer (referent no closure) 
Simple interrupted 0.493 0.72 0.28 -1.84 0.176 0.42 0.12 -1.48 0.999 0.00 0.00 - 00 
Simple continuous <0.001 0.31 0.18 - 0.53 0.435 0.81 0.48-1.37 0.431 2.42 0.27 - 21.91 
MattresslNear-far Far- 1.000 0.00 0.00 - 00 0.999 0.00 0.00 - 00 1.000 0.00 0.00 - 00 
near 
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Appendix 12.7, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
P OR 95% CI p OR 95% CI P OR 95% CI 
Suture pattern used in closure of skin (referent none) 
Simple interrupted 0.094 1.92 0.89 - 4.11 0.001 0.34 0.18 - 0.62 0.921 0.89 0.10-8.14 
Simple continuous 0.058 0.13 0.02 - 1.08 0.001 0.11 0.03 - 0.41 0.999 0.00 0.00 - 00 
Cruciate 0.999 0.00 0.00 - 00 0.373 0.36 0.04 - 3.42 1.000 0.00 0.00 - 00 
MattresslNear-far Far- 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 X X X 
near 
Suture material used in closure of deep layer (referent none) 
Vicryl/ polysorb <0.001 0.18 0.10 - 0.33 0.963 1.01 0.61 - 1.67 0.726 0.72 0.12-4.39 
PDS/biosyn 0.226 0.27 0.03 -2.25 0.569 0.54 0.06 -4.51 1.000 0.00 0.00 - 00 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb <0.001 0.36 0.22-0.60 0.309 0.77 0.46 - 1.28 0.481 2.21 0.24-19.91 
PDS/biosyn 0.398 0.39 0.04 -3.45 0.688 0.64 0.07 - 5.68 1.000 0.00 0.00 - 00 
Suture material used in closure of skin (referent none) 
Staples 0.020 2.49 1.16 - 5.36 0.002 0.38 0.20-0.71 0.997 1.00 0.10 - 9.72 
Nylon/prolene 0.999 0.00 0.00 - 00 0.373 0.36 0.04 - 3.42 X x X 
Vicryl/polysorb 0.011 0.07 0.01- 0.53 <0.001 0.06 0.02-0.20 0.941 0.90 0.06 -14.65 
PDSlbiosyn 0.501 0.47 0.05-4.15 0.970 1.02 0.29 - 3.63 X X X 
Type of antimicrobials administered prior to induction of anaesthesia (referent none) 
Procaine 0.469 2.18 0.26 -18.09 0.834 0.84 0.17 -4.28 1.000 0.00 0.00 - 00 
penicillin/Sodium 
penicillin 
Procaine penicillin and 0.703 1.56 0.16-15.12 0.817 0.81 0.13-4.91 1.000 0.00 0.00 - 00 
gentamicin 
Sodium penicillin and 0.498 2.14 0.24 - 19.33 0.922 0.92 0.16 - 5.21 1.000 1.00 0.00 - 00 
gentamicin 
Other combination 0.478 0.35 0.02 - 6.38 0.998 0.00 0.00 - 00 1.000 1.00 0.00 - 00 
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Appendix 12.7, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Neurectomy 0.007 0.35 0.17-0.76 0.001 3.19 1.60 - 6.35 0.645 1.93 0.12 - 31.42 
Fracture repair 0.045 0.45 0.21- 0.98 0.309 0.62 0.25 -1.56 0.999 0.00 0.00 - CIJ 
Desmotomy 0.291 1.60 0.67 - 3.83 0.148 1.99 0.78 - 5.07 0.999 0.00 0.00 - CIJ 
Other orthopaedic 0.002 0.10 0.02- 0.43 0.434 0.66 0.23 - 1.89 0.382 3.48 0.21- 57.32 
procedure 
Castration 0.995 0.00 0.00 - CIJ 0.996 0.00 0.00 - CIJ 0.999 0.00 0.00 - CIJ 
Laparotomy 0.998 0.00 0.00 - CIJ 0.387 0.39 0.05 - 3.26 0.999 0.00 0.00 - CIJ 
Enucleation 0.999 0.00 0.00 - CIJ 0.362 2.36 0.37 - 14.95 1.000 0.00 0.00 - CIJ 
Other soft tissue 0.020 0.09 0.01- 0.68 0.609 0.71 0.19-2.65 0.038 13.50 1.16 - 157.58 
procedure 
Anatomical location of surgical incision (referent distal limb) 
Proximal limb 0.767 1.11 0.55 -2.25 0.786 0.90 0.43 -1.91 0.999 0.00 0.00 - CIJ 
Body 0.998 0.00 0.00 - CIJ 0.998 0.00 0.00 - CIJ 0.004 21.40 2.73 -167.91 
Head & neck 0.030 0.11 0.01- 0.80 0.319 0.56 0.18 -1.74 0.191 5.10 0.44 - 58.57 
Ventral abdomen, 0.995 0.00 0.00 - CIJ <0.001 0.06 0.02 - 0.27 0.998 0.00 0.00 - CIJ 
inguinal & penis 
Abnormal incisional 0.035 1.82 1.04-3.19 X x X 0.962 0.95 0.10 - 8.60 
drainage 
Partial or total 0.340 2.41 0.40 - 14.66 0.962 0.95 0.10-8.60 X x X 
incisional dehiscence 
Abnormal incisional X x X 0.035 1.82 1.04 - 3.19 0.340 2.41 0.40 - 14.66 
swelling 
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Appendix 12.8: Clean orthopaedic surgical procedures - incisional outcome by variable 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI p OR 95% CI 
Age (referent < 3 yrs) 
3 - 6 yrs 0.546 1.26 0.59 -2.69 0.025 2.69 1.13 - 6.41 0.999 0.00 0.00 - 00 
6 -10 yrs 0.576 1.22 0.60 -2.49 0.002 3.50 1.56 -7.84 1.000 1.00 0.00 - 00 
> 10 yrs 0.l49 1.71 0.83 - 3.56 0.001 4.00 1.73 - 9.24 0.999 0.00 0.00 - 00 
Gender (referent female) 
M 0.l45 0.58 0.28 - 1.21 0.079 0.42 0.16 -1.10 0.218 4.58 0.41- 51.77 
MN 0.026 0.51 0.29-0.92 0.065 1.73 0.97 - 3.11 0.998 0.00 0.00 - 00 
Weight (referent <400 kgs) 
400-600 kgs 0.237 1.59 0.74-3.51 0.063 2.27 0.96 - 5.38 0.999 0.00 0.00 - 00 
>600 kgs 0.080 2.47 0.90 - 6.78 0.209 2.08 0.66 - 6.50 1.000 1.00 0.00 - 00 
Duration of GA (referent < 75 mins) 
75 -100 mins 0.947 1.02 0.49 - 2.12 0.066 2.10 0.95 -4.63 0.999 0.00 0.00 - 00 
100 -115 mins 0.335 1.45 0.68 - 3.09 0.212 1.73 0.73 -4.07 0.999 0.00 0.00 - 00 
> 115 mins 0.701 1.16 0.55 -2.46 0.052 2.25 0.99 - 5.09 0.940 1.11 0.07 - 18.17 
Duration of Surgery (referent < 35 mins) 
35 - 55 mins 0.363 0.73 0.36 - 1.45 0.662 1.17 0.57-2.41 0.999 0.00 0.00 - 00 
55 -65 mins 0.809 0.90 0.37-2.l9 0.939 0.96 0.37 - 2.53 0.999 0.00 0.00 - 00 
> 65 mins 0.538 1.26 0.61-2.59 0.424 1.37 0.63 -2.98 0.966 1.06 0.07 -17.37 
Length of incision (referent < 5cm) 
5-10cm 0.700 0.73 0.14-3.68 0.842 0.85 0.17-4.30 1.000 0.00 0.00 - 00 
>10 cm 0.104 0.18 0.02 - 1.42 0.998 0.00 0.00 - 00 0.065 10.25 0.87 - 12l.l1 
>1 incision 0.080 1.75 0.94 -3.29 0.650 1.15 0.62-2.14 0.166 0.18 0.02 -2.03 
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Appendix 12.8, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Volume of dead space left (referent small) 
Moderate 0.064 0.15 0.02 -1.12 0.464 0.62 0.17 - 2.24 0.089 8.40 0.72 - 97.96 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 0.939 0.95 0.23 - 3.84 0.834 1.19 0.24 - 5.95 1.000 0.00 0.00 - 00 
>24hrs 0.798 0.92 0.50 - 1.69 <0.001 3.67 1.96- 6.88 0.999 0.00 0.00 - 00 
Surgical site shaved 0.166 0.61 0.30 - 1.23 <0.001 3.43 1.84 - 6.41 0.569 2.02 0.18-22.69 
Type of dressing used (referent none used) 
Cast 0.856 1.18 0.19-7.32 0.071 0.09 0.01- l.23 1.000 1.00 0.00 - 00 
Bandage 0.896 1.12 0.21- 5.93 0.874 1.15 0.22 - 6.07 1.000 0.00 0.00 - 00 
Adhesive /stent 0.761 0.76 0.13 -4.52 0.545 0.57 0.09 - 3.49 1.000 0.00 0.00 - 00 
Suture pattern used in closure of deep layer (referent no deep closure) 
Simple interrupted 0.424 0.41 0.04 -3.70 0.893 0.86 0.09 -7.91 1.000 0.00 0.00 - 00 
Simple continuous <0.001 0.31 0.16 - 0.59 0.019 1.96 1.12-3.44 0.999 0.00 0.00 - 00 
MattresslNear-far Far- 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 X x X 
near 
Suture pattern used in closure of subcutaneous layer (referent no closure) 
Simple interrupted 0.651 1.30 0.42 - 3.98 0.382 0.50 0.11-2.36 1.000 0.00 0.00 - 00 
Simple continuous 0.012 0.49 0.28 - 0.86 0.409 l.26 0.73 -2.20 0.636 1.79 0.16-19.99 
MattresslNear-far Far- 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 1.000 0.00 0.00 - 00 
near 
Suture pattern used in closure of skin (referent none) 
Simple interrupted 0.089 1.97 0.90 -4.32 0.001 0.31 0.16 - 0.60 0.999 0.00 0.00 - 00 
Simple continuous 1.000 1.00 0.10 - 10.07 0.999 0.00 0.00 - 00 1.000 1.00 0.00 - 00 
Cruciate 0.999 0.00 0.00 - 00 0.246 0.26 0.03 -2.52 1.000 1.00 0.00 - 00 
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Appendix 12.8, contd. 
Abnormal swelling 
p OR 95% CI 
Suture material used in closure of deep layer (referent none) 
Vicryl/ polysorb <0.001 0.28 0.15 - 0.53 
PDS/biosyn 0.734 1.62 0.10 - 26.36 
p 
0.032 
0.999 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.029 0.56 0.33 - 0.94 0.535 
PDS/biosyn 0.702 1.73 0.11-28.31 0.999 
Suture material used in closure of skin (referent none) 
Staples 0.080 2.01 0.92- 4.42 <0.001 
Nylon/prolene 0.999 0.00 0.00 - DO 0.975 
Vicryl/polysorb 1.000 1.00 0.10-10.07 0.999 
PDS/biosyn 0.538 0.50 0.06 -4.53 0.398 
Abnormal drainage 
OR 95% CI 
1.83 
0.00 
1.19 
0.00 
0.30 
1.05 
0.00 
0.51 
1.05-3.18 
0.00 - DO 
0.69 -2.05 
0.00 - DO 
0.15- 0.58 
0.06 -17.77 
0.00 - DO 
0.12-2.35 
Type of antimicrobials administered prior to induction of anaesthesia (referent none) 
Procaine 0.626 0.50 0.03 - 8.13 0.543 0.42 0.03 - 6.85 
penicillin/Sodium 
penicillin 
Procaine penicillin and 0.439 0.31 0.02 - 5.96 0.540 0.40 0.02 -7.48 
gentamicin 
Sodium penicillin and 0.477 0.35 0.02 - 6.17 0.375 0.27 0.02 -4.80 
gentamicin 
Other combination 0.122 0.07 0.00 -2.06 0.998 0.00 0.00 - DO 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Neurectomy 0.007 0.35 0.17-0.76 0.001 3.19 1.60 - 6.35 
Fracture repair 0.045 0.45 0.21- 0.98 0.309 0.62 0.25 - 1.56 
Desmotomy 0.291 1.60 0.67 - 3.83 0.148 1.99 0.78 - 5.07 
Other orthopaedic 0.002 0.10 0.02- 0.43 0.434 0.66 0.23 - 1.89 
procedure 
p 
0.939 
1.000 
0.691 
1.000 
0.999 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
0.645 
0.999 
0.999 
0.382 
Dehiscence 
OR 95% CI 
0.91 
0.00 
1.63 
0.00 
0.00 
1.00 
1.00 
1.00 
0.00 
0.00 
1.00 
1.00 
1.93 
0.00 
0.00 
3.48 
0.08 -10.16 
0.00 - DO 
0.15 -18.20 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.00 - DO 
0.12-31.42 
0.00 - DO 
0.00 - DO 
0.21 - 57.32 
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Appendix 12.8, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI p OR 95% CI P OR 95% CI 
Anatomical location of surgical incision (referent distal limb ) 
Proximal limb 0.767 1.l1 0.55 - 2.25 0.786 0.90 0.43 - 1.91 0.999 0.00 0.00 - 00 
Body 0.998 0.00 0.00 - 00 0.998 0.00 0.00 - 00 0.051 11.89 0.98 - 143.60 
Head & neck 0.999 0.00 0.00 - 00 0.999 0.00 0.00 - 00 1.000 0.00 0.00 - 00 
Abnormal incisional 0.471 1.24 0.69 - 2.21 X X x 0.794 1.38 0.12 - 15.46 
drainage 
Partial or total 0.205 4.76 0.43 - 53.23 0.794 1.38 0.12-15.46 X x X 
incisional dehiscence 
Abnormal incisional X x X 0.471 1.24 0.69-2.21 0.205 4.76 0.43 - 53.25 
swelling 
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Appendix 12.9: Clean soft-tissue surgical procedures - incisional outcome by variable 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Age (referent < 2 yrs) 
2 -3 yrs 1.000 1.00 0.00 - OCJ 0.998 0.00 0.00 - OCJ 0.998 0.00 0.00 - OCJ 
3 - 4 yrs 1.000 1.00 0.00 - OCJ 0.455 3.00 0.17-53.71 0.999 0.00 0.00 - OCJ 
>4yrs 0.999 0.00 0.00 - OCJ 0.124 6.00 0.61 - 58.71 0.999 0.00 0.00 - OCJ 
Gender (referent female) 
M 0.999 0.00 0.00 - OCJ 0.997 0.00 0.00 - OCJ 0.268 0.20 0.01-3.41 
MN 1.000 0.00 0.00 - OCJ 0.208 3.50 0.50 -24.56 1.000 0.00 0.00 - OCJ 
Weight (referent <400 kgs) 
400-600 kgs 0.999 0.00 0.00 - OCJ 0.444 0.52 0.10-2.74 0.999 0.00 0.00 - OCJ 
>600 kgs 1.000 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 
Duration of GA (referent < 50 mins) 
50 -60 mins 1.000 1.00 0.00 - OCJ 0.458 2.34 0.25 - 22.18 1.000 1.00 0.00 - OCJ 
60-70 mins 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 1.00 0.00 - OCJ 
> 70 mins 1.000 1.00 0.00 - OCJ 0.900 1.20 0.07 -20.43 0.999 0.00 0.00 - OCJ 
Duration of Surgery (referent < 29 mins) 
29 -39 mins 1.000 1.00 0.00 - OCJ 0.998 0.00 0.00 - OCJ 1.000 l.00 0.00 - OCJ 
39 -45 mins 0.999 0.00 0.00 - OCJ 0.162 5.05 0.52 -49.03 0.999 0.00 0.00 - OCJ 
> 45 mins 1.000 1.00 0.00 - OCJ 0.812 1.41 0.08 -24.18 l.000 l.00 0.00 - OCJ 
Length of incision (referent < Scm) 
5-10cm 0.999 0.00 0.00 - OCJ 0.982 0.98 0.13-7.25 1.000 l.00 0.00 - OCJ 
>10 cm l.000 1.00 0.00 - OCJ 0.598 1.95 0.16 - 23.58 0.998 0.00 0.00 - OCJ 
>1 incision 0.999 0.00 0.00 - OCJ 0.879 1.19 0.13 -1l.33 0.999 0.00 0.00 - OCJ 
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Appendix 12.9, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Volume of dead space left (referent small) 
Moderate 0.999 0.00 0.00 - OCJ 0.417 0.48 0.08 -2.83 0.998 0.00 0.00 - OCJ 
Large 1.000 1.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ X x X 
Type of dressing used (referent none used) 
Bandage 1.000 1.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 
Adhesive Istent 0.998 0.00 0.00 - OCJ 0.495 2.20 0.23 - 21.21 1.000 0.00 0.00 - OCJ 
Suture pattern used in closure of deep layer (referent no deep closure) 
Simple interrupted 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 
Simple continuous 1.000 1.00 0.00 - OCJ 0.843 1.25 0.14-11.42 0.316 0.24 0.01-3.97 
Suture pattern used in closure of subcutaneous layer (referent no closure) 
Simple interrupted 0.999 0.00 0.00 - OCJ 0.892 0.82 0.04 -15.00 1.000 1.00 0.00 - OCJ 
Simple continuous 1.000 1.00 0.00 - OCJ 0.509 0.46 0.05 -4.59 0.999 0.00 0.00 - OCJ 
Suture pattern used in closure of skin (referent none) 
Simple interrupted 1.000 0.00 0.00 - OCJ 0.462 0.39 0.03 -4.75 0.364 0.27 0.02 -4.58 
Simple continuous 1.000 1.00 0.00 - OCJ 0.937 0.91 0.08 - 9.74 0.999 0.00 0.00 - OCJ 
MattresslNear-far Far- 1.000 1.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ X x X 
near 
Suture material used in closure of deep layer (referent none) 
Vicryl/ polysorb 0.999 0.00 0.00 - OCJ 0.293 0.89 0.09 - 8.52 0.286 0.22 O.oI - 3.61 
PDS/biosyn 1.000 1.00 0.00 - OCJ 0.415 3.40 0.18 - 64.68 1.000 0.00 0.00 - OCJ 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 1.000 0.00 0.00 - OCJ 0.457 0.42 0.04 - 4.16 0.999 0.00 0.00 - OCJ 
PDS/biosyn 1.000 1.00 0.00 - OCJ 0.482 3.00 0.14 - 64.27 1.000 1.00 0.00 - OCJ 
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Abnormal swelling Abnormal drainage 
p OR 95% CI p OR 95% CI 
Suture material used in closure of skin (referent none) 
Staples 0.999 0.00 0.00 - <Xl 0.998 0.00 0.00 - <Xl 
Nylon/prolene 1.000 1.00 0.00 - <Xl 0.999 0.00 0.00 - <Xl 
Vicryl/polysorb 1.000 1.00 0.00 - <Xl 0.460 0.41 0.04 -4.34 
PDSlbiosyn 1.000 1.00 0.00 - <Xl 0.063 20.00 0.85 - 471.60 
Type of antimicrobials administered prior to induction of anaesthesia (referent none) 
Procaine 1.000 1.00 0.00 - <Xl 0.126 
penicillin/Sodium 
penicillin 
Procaine penicillin and 1.000 0.00 0.00 - <Xl 0.602 
gentamicin 
Sodium penicillin and 1.000 1.00 0.00 - <Xl 0.398 
gentamicin 
Other combination 1.000 1.00 0.00 - <Xl 0.999 
Surgical procedure performed (referent arthroscopy or tenoscopy) 
Castration 0.999 0.00 0.00 - <Xl 
Laparotomy 0.999 0.00 0.00 - <Xl 
Enucleation 1.000 0.00 0.00 - <Xl 
Other soft tissue X x x 
procedure 
Anatomical location of surgical incision (referent distal limb ) 
Proximal limb X x X 
Body 1.000 1.00 0.00 - <Xl 
Head & neck 0.999 0.00 0.00 - <Xl 
Ventral abdomen, X x X 
inguinal & penis 
0.997 
0.633 
0.278 
X 
X 
1.000 
0.011 
X 
0.14 
0.45 
3.33 
0.00 
0.00 
0.56 
3.33 
x 
x 
0.00 
10.00 
x 
0.01- 1.76 
0.02 - 8.83 
0.20 - 54.53 
0.00 - <Xl 
0.00 - <Xl 
0.05 - 6.18 
0.38 - 29.39 
x 
X 
0.00 - <Xl 
1.69 - 59.31 
x 
p 
0.999 
X 
0.284 
X 
1.000 
1.000 
1.000 
1.000 
0.998 
0.999 
0.999 
X 
X 
<0.001 
0.999 
X 
Dehiscence 
OR 95% CI 
0.00 
X 
0.21 
x 
0.00 
1.00 
1.00 
1.00 
0.00 
0.00 
0.00 
x 
x 
0.00 
0.00 
X 
0.00 - <Xl 
X 
0.01 - 3.59 
X 
0.00 - <Xl 
0.00 - <Xl 
0.00 - <Xl 
0.00 - <Xl 
0.00 - <Xl 
0.00 - <Xl 
0.00 - <Xl 
X 
X 
0.00 - <Xl 
0.00 - <Xl 
X 
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Appendix 12.9, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Abnormal incisional 1.000 0.00 0.00 - OJ X x X 1.000 0.00 0.00 - OJ 
drainage 
Partial or total 1.000 0.00 0.00 - OJ 1.000 0.00 0.00 - OJ X x x 
incisional dehiscence 
Abnormal incisional X x X 1.000 0.00 0.00 - OJ 1.000 0.00 0.00 - OJ 
swelling 
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Appendix 12.10: Clean contaminated surgical procedures - incisional outcome by variable 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Age (referent < 3 yrs) 
3 -7 yrs 0.517 0.52 0.07 - 3.70 0.546 1.67 0.32 - 8.74 1.000 1.00 0.00 - <Xl 
7 -11 yrs 0.809 1.22 0.24 - 6.23 0.100 3.67 0.78 - 17.25 0.999 0.00 0.00 - <Xl 
> 11 yrs 0.808 0.73 0.06 - 8.92 0.022 18.33 1.51 - 222.88 1.000 1.00 0.00 - <Xl 
Gender (referent female) 
M 0.812 1.43 0.08 -26.90 0.083 0.12 0.01 - 1.32 1.000 1.00 0.00 - <Xl 
MN 0.310 3.10 0.35 -27.66 0.467 0.61 0.16-2.34 0.999 0.00 0.00 - <Xl 
Weight (referent <400 kgs) 
400-600 kgs 0.931 0.90 0.08 - 9.75 0.730 0.70 0.09 - 5.46 1.000 0.00 0.00 - <Xl 
>600 kgs 0.373 0.25 0.01 - 5.26 0.683 0.63 0.07 - 5.97 1.000 0.00 0.00 - <Xl 
Duration of GA (referent < 67 mins) 
67 - 97 mins 0.150 0.17 0.02 - 1.88 0.629 1.43 0.34- 6.08 0.999 0.00 0.00 - <Xl 
97 -117 mins 0.718 1.47 0.18-11.72 0.515 1.88 0.28 - 12.46 1.000 1.00 0.00 - <Xl 
> 117 mins 0.407 2.04 0.38 - 10.94 0.133 3.33 0.69 - 16.02 0.999 0.00 0.00 - <Xl 
Duration of Surgery (referent < 40 mins) 
40 - 65 mins 0.288 0.28 0.03 -2.96 0.335 2.04 0.48 - 8.71 0.999 0.00 0.00 - <Xl 
65 - 80 mins 0.056 6.67 0.95 -46.56 0.105 4.67 0.72 - 30.11 0.999 0.00 0.00 - <Xl 
> 80 mins 0.657 1.50 0.25 - 8.98 0.032 5.60 1.16 -27.08 0.812 1.42 0.08 -24.95 
Length of incision (referent < 5cm) 
5-10cm 0.537 2.04 0.21- 19.49 0.263 2.62 0.49-14.11 0.999 0.00 0.00 - <Xl 
>10 cm 0.105 6.87 0.67 -70.82 0.006 16.67 2.27 -122.21 1.000 1.00 0.00 - <Xl 
>1 incision 0.999 0.00 0.00 - <Xl 0.778 0.150 0.09 -25.26 1.000 0.00 0.00 - <Xl 
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Appendix 12.10, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Volume of dead space left (referent small) 
Moderate 0.744 0.67 0.06 -7.57 0.919 0.91 0.15-5.66 0.999 0.00 0.00 - OCJ 
Large 0.319 3.23 0.32 - 32.48 0.109 4.64 0.71 - 30.42 0.999 0.00 0.00 - OCJ 
Surgical site clipped prior to induction (referent not clipped) 
<24hrs 0.755 1.32 0.23 -7.59 0.323 0.43 0.08 -2.30 0.999 0.00 0.00 - OCJ 
>24hrs 0.514 2.31 0.19-28.72 0.999 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 
Type of dressing used (referent none used) 
Cast 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 
Adhesive /stent 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 0.00 0.00 - CIJ 
Suture pattern used in closure of deep layer (referent no deep closure) 
Simple interrupted 0.998 0.00 0.00 - CIJ 0.130 0.26 0.05 - 1.48 0.999 0.00 0.00 - CIJ 
Simple continuous 0.049 0.19 0.03 - 0.99 0.956 0.97 0.29 - 3.18 0.998 0.00 0.00 - CIJ 
MattresslNear-far Far- 0.999 0.00 0.00 - OCJ 0.910 1.18 0.07-21.18 X x X 
near 
Suture pattern used in closure of subcutaneous layer (referent no closure) 
Simple interrupted 0.058 0.11 0.01-1.08 0.870 1.14 0.23- 5.67 0.999 0.00 0.00 - OCJ 
Simple continuous 0.020 0.17 0.04-0.76 0.893 1.09 0.29-4.10 0.999 0.00 0.00 - CIJ 
Suture pattern used in closure of skin (referent none) 
Simple interrupted 0.100 0.28 0.06 -1.27 0.525 1.62 0.37 -7.10 0.999 0.00 0.00 - OCJ 
Simple continuous 0.999 0.00 0.00 - OCJ 0.273 4.67 0.30 -73.39 1.000 1.00 0.00 - OCJ 
Suture material used in closure of deep layer (referent none) 
Vicryll polysorb 0.009 0.11 0.02 - 0.58 0.531 0.71 0.24-2.08 0.836 0.74 0.04 -12.50 
PDS/biosyn 0.999 0.00 0.00 - CIJ 0.999 0.00 0.00 - CIJ 1.000 0.00 0.00 - CIJ 
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Abnormal swelling 
p OR 95% CI p 
Suture material used in closure of subcutaneous layer (referent none) 
Vicryl/polysorb 0.012 0.16 0.04 - 0.66 0.897 
PDS/biosyn 0.999 0.00 0.00 - 00 0.758 
Suture material used in closure of skin (referent none) 
Staples 0.055 0.21 0.04 - 1.03 
Nylon/prolene 0.794 1.50 0.07 - 31.58 
Vicryl/polysorb 0.447 0.37 0.03 - 4.71 
0.659 
0.590 
0.089 
Abnormal drainage 
OR 95% CI 
1.09 
1.60 
1.40 
2.33 
9.33 
0.30 -3.90 
0.08 - 31.77 
0.31- 6.25 
0.11 - 50.99 
0.71 - 122.58 
Type of antimicrobials administered prior to induction of anaesthesia (referent none) 
Procaine 1.000 0.00 0.00 - 00 0.999 
penicillin/Sodium 
penicillin 
Procaine penicillin and 1.000 0.00 0.00 - 00 0.999 
gentamicin 
Sodium penicillin and 1.000 0.00 0.00 - 00 0.999 
gentamicin 
Other combination 0.999 0.00 0.00 - 00 0.999 
Surgical procedure performed (referent arthroscopy or ten os copy) 
Laryngoplasty 
Sinus & Dental 
Penile 
Other c1ean-
contaminated 
procedure 
1.000 
1.000 
1.000 
0.999 
0.00 0.00 - 00 0.999 
0.00 0.00 - 00 0.999 
1.00 0.00 - 00 0.999 
0.00 0.00 - 00 0.999 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.00 0.00 - 00 
0.00 0.00 - 00 
p 
0.999 
1.000 
0.999 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
1.000 
Dehiscence 
OR 95% CI 
0.00 
1.00 
0.00 
1.00 
1.00 
0.00 
0.00 
1.00 
1.00 
1.00 
0.00 
0.00 
1.00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
0.00 - 00 
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Appendix 12.10, contd. 
Abnormal swelling Abnormal drainage Dehiscence 
p OR 95% CI P OR 95% CI P OR 95% CI 
Anatomical location of surgical incision (referent distal limb) 
Proximal limb 1.000 1.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 1.00 0.00 - OCJ 
Body 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 1.00 0.00 - OCJ 
Head & neck 0.999 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 
Ventral abdomen, 1.000 0.00 0.00 - OCJ 0.999 0.00 0.00 - OCJ 1.000 0.00 0.00 - OCJ 
inguinal & penis 
Abnormal incisional 0.022 5.51 1.28- 23.80 X x X 0.999 0.00 0.00 - OCJ 
drainage 
Partial or total 0.302 4.50 0.26 -78.21 0.999 0.00 0.00 - OCJ X x x 
incisional dehiscence 
Abnormal incisional X x X 0.022 5.51 1.28-23.81 0.302 4.50 0.26 -78.21 
swelling 
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